rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAAGGGGGGGCCGTGGTGGGCAGTACTTCGGGCCA	CASSLRGGRGGQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	9	0	11	1	10	18	33	41	34	51														CASSLRGGRGGQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTCGTTCCCCGCAATCAGCCCCAGCATTTTGGTGAT	CASSFVPRNQPQHF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	8	6	2	0	6	18	-1	34	32	40						01,02								CASSFVPRNQPQHF+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01	TCRBD02-01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCGTGGCTGGGCCTAAATGAAAAACTGTTTTTTGGCAGT	CASSPWLGLNEKLFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	8	0	5	8	3	18	30	42	38	45														CASSPWLGLNEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCTCCGGGTCGGCAGCACAGATACGCAGTATTTTGGCCCA	CASSLRVGSTDTQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	8	4	0	3	5	18	30	37	33	42						01,02								CASSLRVGSTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCTAGCAGCTTAAACTCAGGGTCGTCATATGATGAGCAGTTCTTCGGGCCA	CASSLNSGSSYDEQFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	3	8	4	10	18	33	42	37	52														CASSLNSGSSYDEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCACGAGGCTAGCGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CATRLAGNTGELFF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	4	4	1	5	0	18	25	-1	30	38						01,02								CATRLAGNTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCATCAGTCGGACTAACATAGATACGCAGTATTTTGGCCCA	CASSISRTNIDTQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	9	5	7	4	18	30	43	37	47						01,02								CASSISRTNIDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCAAGATAGCGGGACCTACGAGCAGTACTTCGGGCCG	CASSQDSGTYEQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	5	3	2	5	0	18	30	-1	35	43														CASSQDSGTYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCAGGGTCTGGGTTGGGGTACGAGCAGTACTTCGGGCCG	CASSSGSGLGYEQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	4	0	12	18	-1	36	31	48														CASSSGSGLGYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGGCCACCGGGACAGGGATCGGCAGAGCAGTACTTCGGGCCG	CASRPPGQGSAEQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	7	6	7	18	29	44	35	51														CASRPPGQGSAEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCGCCCAAGGCCGGACAGGGAGGTTCGGCACTGAAGCTTTCTTTGGACAA	CASAQGRTGRFGTEAFF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	51	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	1	3	4	10	8	18	27	45	37	53														CASAQGRTGRFGTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGCGGTCGCGCAGATACGCAGTATTTTGGCCCA	CASSLGGRADTQYF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	7	5	4	0	5	18	-1	38	34	43						01,02								CASSLGGRADTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGGGGGGACACCGAGAGAGACCCAGTACTTCGGGCCA	CASSGGTPRETQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	42	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-05	01	5	0	6	4	3	5	18	30	39	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGGTPRETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCCCAGACTAGGATTTTCGGGGAGCTGTTTTTTGGAGAA	CASSPQTRIFGELFF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	2	8	7	5	6	18	30	41	35	47						01,02								CASSPQTRIFGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCGAAGCTGGGGGCCCTACGAGCAGTACTTCGGGCCG	CASSRSWGPYEQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	6	0	2	7	0	18	30	-1	37	43														CASSRSWGPYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTCGAACAGGACCGCTACGAGCAGTACTTCGGGCCG	CASSFEQDRYEQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	4	3	3	4	18	32	40	35	44														CASSFEQDRYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCTAGCAGCTTTAATGCGGGACGGAGTGGGGAGACCCAGTACTTCGGGCCA	CASSFNAGRSGETQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	7	3	5	4	9	18	32	42	36	51														CASSFNAGRSGETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCGGGCTAGCGGTGAATACGAGCAGTACTTCGGGCCG	CASSRASGEYEQYF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	5	4	4	4	18	30	41	34	45						01,02								CASSRASGEYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGTGTGGACAGGGAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	31	1.164936172771308E-4		49	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	1	3	2	3	1	18	34	45	37	46														X+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTTTTGGCGATAGCGGGAGAGAACGAGCAGTACTTCGGGCCG	CASSFLAIAGENEQYF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	2	5	8	3	18	32	49	40	52														CASSFLAIAGENEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTTAGCGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSFSGGSYEQYF	In	VDJ	1	58	2.179558000668899E-4	2.5806566436335646E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	5	2	0	0	0	18	-1	-1	32	41														CASSFSGGSYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGCTGGGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSLAGAQETQYF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	7	0	1	4	0	18	32	-1	36	41														CASSLAGAQETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGTGTCCGTCTACAATGAGCAGTTCTTCGGGCCA	CASSLVSVYNEQFF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	8	6	3	4	1	18	34	40	38	41						01,02								CASSLVSVYNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGTGGGGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSLVGGSYEQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	9	0	1	1	0	19	35	-1	36	43														CASSLVGGSYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTACGCAGGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSLRRGSYEQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	1	2	0	19	34	-1	36	43														CASSLRRGSYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAAGTCTAGCGGGGGGATGGTATACGCAGTATTTTGGCCCA	CASSLSLAGGWYTQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	4	1	7	3	5	19	34	48	37	53														CASSLSLAGGWYTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGGCTTAGCGGCGGTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	21	7.891503105870151E-5		44	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	5	5	6	4	4	19	33	43	37	47						01,02								X+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCCCGCACGTACGAGTCAAGAGACCCAGTACTTCGGGCCA	CASSPARTSQETQYF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	11	2	2	11	1	19	31	45	42	46														CASSPARTSQETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCTCCCTCCCGACGGGGGCCGGGAAGGAGACCCAGTACTTCGGGCCA	CASSLPTGAGKETQYF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	48	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-05	01	8	6	0	5	12	7	19	27	45	39	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLPTGAGKETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTAAAAGGGAGGGGGGCTAGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	26	9.770432416791615E-5		47	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	0	4	4	7	19	32	43	36	50														X+TCRBV07-05+TCRBJ01-02	TCRBV07-05*01	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCGATAGCGGGGCCTAACTACGAGCAGTACTTCGGGCCG	CASSSIAGPNYEQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	5	3	3	3	5	19	32	43	35	48														CASSSIAGPNYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTGGGACAGGGTCAATCCACCCCTCCACTTTGGGAAC	CASSWDRVNPPLHF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	3	11	0	6	19	-1	41	32	47														CASSWDRVNPPLHF+TCRBV07-05+TCRBJ01-06	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCCGGTAGCGGGAGGACGCACAGATACGCAGTATTTTGGCCCA	CASSPVAGGRTDTQYF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	5	1	1	4	2	19	31	45	35	47														CASSPVAGGRTDTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCCCGGACTAGCGGGAGGGACAATGAGCAGTTCTTCGGGCCA	CASSSRTSGRDNEQFF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	1	0	5	3	0	19	32	-1	35	50														CASSSRTSGRDNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCTACTAGTCACCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLLVTSSYEQYF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	3	8	0	2	7	19	31	38	33	45						01,02								CASSLLVTSSYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCGAAATTAATCGGGGTTCCGGGGAGCTGTTTTTTGGAGAA	CASSEINRGSGELFF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	8	3	6	9	2	19	31	45	40	47														CASSEINRGSGELFF+TCRBV07-05+TCRBJ02-02	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCCTGGGGGACAGGAGGCAGAGACCCAGTACTTCGGGCCA	CASSPGGQEAETQYF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	4	4	5	4	19	31	44	36	48														CASSPGGQEAETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAACCAGGGTAGCGGGAGTCAATGAGCAGTTCTTCGGGCCA	CASSLTRVAGVNEQFF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	5	2	6	7	1	19	34	50	41	51														CASSLTRVAGVNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTATCTAGCGGGAGGTTAGGAAACATTCAGTACTTCGGCGCC	CASSLSSGRLGNIQYF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	1	4	1	6	1	5	19	34	46	35	51														CASSLSSGRLGNIQYF+TCRBV07-05+TCRBJ02-04	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCAGAATGGGGCAAAGCCTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	74	2.7808153801637674E-4		46	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	7	0	4	6	7	19	31	42	37	49														X+TCRBV07-05+TCRBJ01-02	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTACGGACACATTACCGGGGAGCTGTTTTTTGGAGAA	CASSYGHITGELFF	In	VDJ	2	106	3.983330139153505E-4	4.7163724866406526E-4	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	1	6	5	2	4	19	32	39	34	43														CASSYGHITGELFF+TCRBV07-05+TCRBJ02-02	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCAAGGACGGGATTACTATGGCTACACCTTCGGTTCG	CASSQGRDYYGYTF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	8	3	3	6	2	23	35	46	41	48			01,02										Vb 1	CASSQGRDYYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCACCCGACAGGGGGTTGAAGCTTTCTTTGGACAA	CASSVTRQGVEAFF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	1	7	5	1	23	37	51	42	52			01,02										Vb 1	CASSVTRQGVEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAGGTTAGGGGAAATGAGCAGTTCTTCGGGCCA	CASSEVRGNEQFF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	2	7	7	1	23	34	46	41	47			01,02										Vb 1	CASSEVRGNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGGGGGGACAGGGTCCACCTACTACGAGCAGTACTTCGGGCCG	CASSGGTGSTYYEQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	3	4	8	23	34	47	38	55			01,02										Vb 1	CASSGGTGSTYYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGACAGGGTGGCAATGAGCAGTTCTTCGGGCCA	CASSGQGGNEQFF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	3	6	0	3	23	-1	43	36	46			01,02										Vb 1	CASSGQGGNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGTAGTGACCAGGGTCTGACTGAAGCTTTCTTTGGACAA	CASSDQGLTEAFF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	4	3	5	7	4	23	31	43	38	47			01,02										Vb 1	CASSDQGLTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCTTGACTAGTTCCGAGCAGTACTTCGGGCCG	CASSALTSSEQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	2	8	6	4	3	23	36	46	40	49			01,02			01,02							Vb 1	CASSALTSSEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTAACAACTACAATGAGCAGTTCTTCGGGCCA	CASSNNYNEQFF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	36	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	6	3	2	1	23	34	39	36	40			01,02										Vb 1	CASSNNYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCTTAGCACAGATACGCAGTATTTTGGCCCA	CASSLSTDTQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	10	0	0	1	23	-1	37	35	38			01,02			01,02							Vb 1	CASSLSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCAGGACAGGGGTGGGAAACACCATATATTTTGGAGAG	CASSVRTGVGNTIYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	1	2	4	2	2	23	37	48	39	50			01,02										Vb 1	CASSVRTGVGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACAACGGGTTGGACCGGGGAGCTGTTTTTTGGAGAA	CASTTGWTGELFF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	8	4	5	3	4	23	33	40	36	44			01,02			01,02							Vb 1	CASTTGWTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCACAGGGGGCAGGGAACACTGAAGCTTTCTTTGGACAA	CASSAQGAGNTEAFF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	0	1	1	3	23	36	46	37	49			01,02										Vb 1	CASSAQGAGNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAGGACAGGGGTTAAAGGTTCTATAATTCACCCCTCCACTTTGGGAAC	CASSEDRG*RFYNSPLHF	Stop	VDJ	1	33	1.2400933452081666E-4		54	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	2	3	3	9	23	34	46	37	55			01,02										Vb 1	CASSEDRG*RFYNSPLHF+TCRBV09-01+TCRBJ01-06	TCRBV09-01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAAAGGGCCATAGGGACAGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSERAIGTGSTDTQYF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	54	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	0	13	0	23	34	-1	47	56			01,02										Vb 1	CASSERAIGTGSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCGACGCTGAATACGAGCAGTACTTCGGGCCG	CASSVDAEYEQYF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	2	2	7	4	1	6	23	37	41	38	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVDAEYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTTAATAGCGGCCAAGAGACCCAGTACTTCGGGCCA	CASSVNSGQETQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	5	5	1	3	0	23	37	-1	40	46			01,02			01,02							Vb 1	CASSVNSGQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAAAGATACACAGATACGCAGTATTTTGGCCCA	CASSERYTDTQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	5	2	8	2	1	6	23	34	37	35	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSERYTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGAGACGTATCCTACGAGCAGTACTTCGGGCCG	CASRDVSYEQYF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	36	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	5	2	7	1	1	3	23	34	38	35	41			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASRDVSYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAAGCGGGAAGACCCAGTACTTCGGGCCA	CASSVSGKTQYF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	6	3	6	0	0	23	-1	-1	38	45			01,02										Vb 1	CASSVSGKTQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTCCACTCCGGGACAGGGGGGGAGGGCCCCAGCATTTTGGTGAT	CASSPLRDRGGGPQHF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	1	9	8	5	23	34	53	42	58			01,02										Vb 1	CASSPLRDRGGGPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCAAGTTTCAGGGAACACTGAAGCTTTCTTTGGACAA	CASSQVSGNTEAFF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	4	1	7	0	23	35	-1	42	46			01,02										Vb 1	CASSQVSGNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCTAGCGGAACCACAGATACGCAGTATTTTGGCCCA	CASSSSGTTDTQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	5	2	1	3	23	35	43	36	46			01,02			01,02							Vb 1	CASSSSGTTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCAGGGGAGTGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSQGSGGTDTQYF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	2	1	0	7	23	-1	41	35	48			01,02										Vb 1	CASSQGSGGTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCTATCGGGGGGCTGGAAACACCATATATTTTGGAGAG	CASSAYRGAGNTIYF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	3	8	1	2	5	0	23	36	-1	41	48			01,02										Vb 1	CASSAYRGAGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD02-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGTGACAGAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVGDRANTGELFF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	5	0	2	2	23	39	46	41	48			01,02										Vb 1	CASSVGDRANTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTACGGATCTACGAGCAGTACTTCGGGCCG	CASSVRIYEQYF	In	VDJ	1	58	2.179558000668899E-4	2.5806566436335646E-4	36	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	1	1	8	3	1	1	23	38	42	39	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVRIYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGACGTGGGGAGGGCAGTAAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	62	2.329872345542616E-4		46	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	9	0	7	5	5	23	34	46	39	51			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-06	TCRBV09-01	TCRBD02-01*02	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSVGSNQPQHF	In	VDJ	1	68	2.555343862853192E-4	3.025597444260041E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-05	01	0	0	10	1	0	0	23	-1	-1	39	41			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGSNQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTAACAGGGCTACTGAAGCTTTCTTTGGACAA	CASSPNRATEAFF	In	VDJ	1	74	2.7808153801637674E-4	3.2925619246359274E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	5	4	2	23	35	45	39	47			01,02										Vb 1	CASSPNRATEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCACCTGCAGAATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	92	3.4572299320954946E-4		44	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	5	0	5	2	23	35	43	40	45			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAAGGGTCGAACACTGAAGCTTTCTTTGGACAA	CASSVEGSNTEAFF	In	VDJ	2	100	3.757858621842929E-4	4.4494080062647663E-4	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	0	5	3	1	1	2	23	39	44	40	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVEGSNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGAAGGGGGGTCCCTACGAGCAGTACTTCGGGCCG	CASSVEKGGPYEQYF	In	VDJ	2	105	3.9457515529350753E-4	4.6718784065780046E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	0	5	1	2	3	3	23	39	48	42	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVEKGGPYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGTTCGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSVGSGANTEAFF	In	VDJ	2	105	3.9457515529350753E-4	4.6718784065780046E-4	45	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	0	6	0	1	4	0	23	39	-1	43	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGSGANTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCTCGCCACCTATAATTCACCCCTCCACTTTGGGAAC	CASSLATYNSPLHF	In	VDJ	2	110	4.133644484027222E-4	4.894348806891243E-4	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-06	01	4	4	6	2	5	0	23	35	-1	40	42			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSLATYNSPLHF+TCRBV09-01+TCRBJ01-06	TCRBV09-01		TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCCGGCACCCACCTGAACACTGAAGCTTTCTTTGGACAA	CASSVAGTHLNTEAFF	In	VDJ	3	174	6.538674002006696E-4	7.741969930900694E-4	48	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	0	9	0	0	2	7	23	39	44	41	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVAGTHLNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCACAAATAATGTGACAGAGCCACTCACCGGGGAGCTGTTTTTTGGAGAA	CASSTNNVTEPLTGELFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	54	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	5	4	11	7	19	31	47	42	54														CASSTNNVTEPLTGELFF+TCRBV11-01+TCRBJ02-02	TCRBV11-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTGGGAGGTCTGAACACAGATACGCAGTATTTTGGCCCA	CASSLGGLNTDTQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	45	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	1	2	0	6	19	-1	39	33	45														CASSLGGLNTDTQYF+TCRBV11-01+TCRBJ02-03	TCRBV11-01*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCCTGCGGAGCGGGCAAGAGACCCAGTACTTCGGGCCA	CASSLRSGQETQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	42	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	6	4	2	6	0	19	31	-1	37	43						01,02								CASSLRSGQETQYF+TCRBV11-01+TCRBJ02-05	TCRBV11-01*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTAATGGGTTATAGCACAGATACGCAGTATTTTGGCCCA	CASSLMGYSTDTQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	45	TCRBV11	TCRBV11-01	01				TCRBJ02	TCRBJ02-03	01	2	0	9	0	2	4	19	34	39	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLMGYSTDTQYF+TCRBV11-01+TCRBJ02-03	TCRBV11-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCCAAAACCCGGGACTAGCGGGGGGAGATACGCAGTATTTTGGCCCA	CASSQNPGLAGGDTQYF	In	VDJ	1	60	2.2547151731057573E-4	2.66964480375886E-4	51	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	0	1	5	8	0	19	31	-1	39	54														CASSQNPGLAGGDTQYF+TCRBV11-01+TCRBJ02-03	TCRBV11-01*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACAACCGGGCCATGAGCAGTTCTTCGGGCCA	CASSQQPGHEQFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	2	8	0	8	5	1	29	44	53	49	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQQPGHEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGACTAGCGGGACCTACGAACAGTACTTCGGGCCG	CASSQGTSGTYEQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	1	3	10	0	8	29	-1	57	45	65													Vb 16	CASSQGTSGTYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTAGAAGCAGTATCTGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	27	1.0146218278975909E-4		55	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	14	5	26	38	56	52	61													Vb 16	X+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGACAGGGGGTTCTTTGGACAA	CASSQGDRGFF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	33	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	1	14	0	0	29	-1	-1	45	56													Vb 16	CASSQGDRGFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCCACGAAGCCGCTAACTATGGCTACACCTTCGGTTCG	CASSPHEAANYGYTF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	6	7	0	7	2	29	42	52	49	54						01,02							Vb 16	CASSPHEAANYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGGCTACAGGGGGCGTCTACTGAAGCTTTCTTTGGACAA	CASRLQGASTEAFF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	0	5	3	4	29	40	52	43	56													Vb 16	CASRLQGASTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGATAACAGCCATACGAGCAGTACTTCGGGCCG	CASSQG*QPYEQYF	Stop	VDJ	1	36	1.3528291038634543E-4		42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	5	4	4	3	29	45	53	49	56													Vb 16	CASSQG*QPYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTCAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQVRNTGELFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	4	5	1	1	0	29	45	-1	46	49													Vb 16	CASSQVRNTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTGATCCGGCAGGTCGAACGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	42	1.5783006211740302E-4		53	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	4	1	8	6	28	44	56	52	62													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGGGACATAGTGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	42	1.5783006211740302E-4		44	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	6	7	0	6	29	-1	52	46	58													Vb 16	X+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTATATCGAGGGGAAGCTTTCTTTGGACAA	CASSQVYRGEAFF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	11	0	8	6	0	29	45	-1	51	56													Vb 16	CASSQVYRGEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAACTAGGACAGGGAACGAATCACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	45	1.691036379829318E-4		56	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	4	5	10	25	42	55	47	65													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATTCACTCTCCTACGAGCAGTACTTCGGGCCG	CASSQDSLSYEQYF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	10	0	3	0	29	46	-1	49	52						01,02							Vb 16	CASSQDSLSYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGAAGTGAATCCCCCATACAATGAGCAGTTCTTCGGGCCA	CASSQEVNPPYNEQFF	In	VDJ	1	59	2.217136586887328E-4	2.625150723696212E-4	48	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	3	1	8	4	0	13	29	-1	46	43	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQEVNPPYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTCCTTGAGGGGCTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSSLRGSSTDTQYF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	48	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	5	5	2	0	6	4	29	41	52	47	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSSLRGSSTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGAGCTAGCGGGAGAACCTACGAGCAGTACTTCGGGCCG	CASSRASGRTYEQYF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	4	2	2	3	2	29	42	55	45	57													Vb 16	CASSRASGRTYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTCGGGGGAAACACCATATATTTTGGAGAG	CASSQVGGNTIYF	In	VDJ	1	73	2.7432367939453383E-4	3.2480678445732795E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	8	4	4	1	0	29	45	-1	46	50						01,02							Vb 16	CASSQVGGNTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD02-01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTAAAGACCCAGTACTTCGGGCCA	CASSQVKTQYF	In	VDJ	1	74	2.7808153801637674E-4	3.2925619246359274E-4	33	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	5	9	6	0	1	29	-1	47	45	48						01,02							Vb 16	CASSQVKTQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGTAGCGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVAANTGELFF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	5	0	1	0	29	41	-1	42	48						01,02							Vb 16	CASSVAANTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GATTCTGGAGTTTATTTCTGTGCCAGAAAACCGGGATCCAACGAGCCCTGTTATACTGAAGAGACCCAGTACTTCGGGCCA	CARKPGSNEPCYTEETQYF	In	VDJ	2	93	3.494808518313924E-4	4.1379494458262326E-4	57	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	9	8	3	3	5	22	18	26	36	31	58													Vb 16	CARKPGSNEPCYTEETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACTTCCGGGACAGGGGGCCACGATCGGCCTGTTTTTTGGCAGT	CASSQLPGQGATIGLFF	In	VDJ	2	119	4.4718517599930856E-4	5.294795527455073E-4	51	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	0	14	5	10	29	44	61	49	71													Vb 16	CASSQLPGQGATIGLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGCCGGGGCTTGAACACTGAAGCTTTCTTTGGACAA	CASSRRGLNTEAFF	In	VDJ	2	128	4.810059035958949E-4	5.695242248018901E-4	42	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	4	7	0	0	3	1	29	42	50	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSRRGLNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGATAGGGAATACCTACGAGCAGTACTTCGGGCCG	CASSQIGNTYEQYF	In	VDJ	2	130	4.885216208395808E-4	5.784230408144197E-4	42	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	3	0	8	2	4	3	29	43	51	47	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQIGNTYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCATAATCTTAACAGGGTGCCTGAAGCTTTCTTTGGACAA	CASSHNLNRVPEAFF	In	VDJ	2	131	4.922794794614237E-4	5.828724488206844E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	3	6	8	3	29	43	57	51	60													Vb 16	CASSHNLNRVPEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTGTCCGGGGAGCTGTTTTTTGGAGAA	CASSQVSGELFF	In	VJ	3	154	5.78710227763811E-4	6.852088329647741E-4	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-02	01	1	0	0	6	0	3	29	-1	45	-1	48													Vb 16	CASSQVSGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGTGACTAGCGGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	156	5.86225945007497E-4		46	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	2	4	5	4	0	29	45	-1	49	59						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCCAGCCTGTTGTAGCGGGGGAGGCTGCGAGCAGTACTTCGGGCCG		Out	VDJ	3	190	7.139931381501565E-4		53	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	5	2	6	12	6	28	41	62	53	68													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGTCAGGGTAGGCAACTACGAGCAGTACTTCGGGCCG	CASSQDVRVGNYEQYF	In	VDJ	3	194	7.290245726375282E-4	8.631851532153647E-4	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	3	3	7	29	46	54	49	61													Vb 16	CASSQDVRVGNYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTCCACAACCGTCGGCAGCACACCAATACGAGCAGTACTTCGGGCCG	CASSPQPSAAHQYEQYF	In	VDJ	4	216	8.116974623180727E-4	9.610721293531896E-4	51	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	6	3	6	4	3	19	29	40	46	43	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSPQPSAAHQYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCAGGGTGGGAGACCCAGTACTTCGGGCCA	CASSPGWETQYF	In	VDJ	4	238	8.943703519986171E-4	0.0010589591054910145	36	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	5	0	3	29	-1	47	42	50													Vb 16	CASSPGWETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGGGACAGGACGAACACTGAAGCTTTCTTTGGACAA	CASSRDRTNTEAFF	In	VDJ	7	393	0.001476838438384271	0.0017486173464620533	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	4	1	0	2	29	-1	50	42	52													Vb 16	CASSRDRTNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGATGGTAGGGGGGAGTTCCCGAGCAGTACTTCGGGCCG		Out	VDJ	8	484	0.0018188035729719777		50	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	1	5	1	6	8	7	29	45	59	53	66				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAACCGGAACAGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	9	540	0.0020292436557951816		41	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	5	3	6	0	29	44	-1	50	54													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTTCCGACGGGTACAATGAGCAGTTCTTCGGGCCA	CASSSDGYNEQFF	In	VDJ	9	554	0.0020818536765009827	0.002464972035470681	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	8	4	4	6	0	29	40	-1	46	50						01,02							Vb 16	CASSSDGYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAGGGGACAATACTCTGGAAACACCATATATTTTGGAGAG	CASSRGQYSGNTIYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	6	0	1	3	24	37	44	38	47														CASSRGQYSGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCGAGACGGTGGTGAAGCTTTCTTTGGACAA	CASSRDGGEAFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	36	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	5	2	7	7	3	5	24	36	42	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDGGEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGACACAGATACGCAGTATTTTGGCCCA	CASSVDTDTQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	8	2	1	1	24	36	40	37	41						01,02								CASSVDTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTAATACTAGCGGGAGAGCAGTACTTCGGGCCG	CASSLILAGEQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	3	3	7	6	0	24	35	-1	41	51														CASSLILAGEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCACGCACAGGGCCCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	19	7.139931381501565E-5		47	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	3	3	2	3	2	24	37	46	40	48														X+TCRBV21-or09_02+TCRBJ02-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTTCGGGCGGACTCTCCTACGAGCAGTACTTCGGGCCG	CASSPSGGLSYEQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	10	0	9	0	24	36	-1	45	50						01,02								CASSPSGGLSYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCCGGGTGGGGGGCGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	7.139931381501565E-5		37	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	10	6	0	4	8	1	24	31	45	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACGTACTCGGGGGGGCAGGAGCAGTACTTCGGGCCG	CASTYSGGQEQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	10	8	0	7	9	3	24	31	48	40	51														CASTYSGGQEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGCCCCGATCCCAGAAAATCAGCCCCAGCATTTTGGTGAT	CASAPIPENQPQHF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-05	01	10	4	5	4	12	2	24	31	46	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASAPIPENQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAGGGGTTATTTCCGGGAAAAGTACTTCGGGCCG		Out	VDJ	1	21	7.891503105870151E-5		41	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	8	3	11	10	2	24	40	55	50	57														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAGACCTACTCGACGGAATATATTACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	7.891503105870151E-5		50	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	4	1	8	5	12	7	24	37	52	49	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGCAAGATGAGGGGGACGCTGAAGCTTTCTTTGGACAA	CASRQDEGDAEAFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	1	6	8	3	24	35	49	43	52														CASRQDEGDAEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTACTAGCGGGGGGGCCGGATACGCAGTATTTTGGCCCA	CASSVLAGGPDTQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	3	0	6	2	3	24	36	51	38	54														CASSVLAGGPDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTCACAGGGGGCAGATACGCAGTATTTTGGCCCA	CASSSQGADTQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	1	4	3	0	24	35	-1	38	46														CASSSQGADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAGATCGGTGAGCAGTTCTTCGGGCCA	CASSVEIGEQFF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	8	9	1	7	24	36	40	37	47						01,02								CASSVEIGEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGGTAACAGGGGACAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	24	9.01886069242303E-5		41	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	3	2	0	4	2	24	31	42	35	44														X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCACACTCTCAACCGGGGCGACCCTACGAGCAGTACTTCGGGCCG	CASSAHSQPGRPYEQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	51	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	5	7	0	2	14	3	24	36	55	50	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAHSQPGRPYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAACGGGCAGGGGCGAGCAGTTCTTCGGGCCA	CASSLTGRGEQFF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	10	8	1	24	36	50	44	51														CASSLTGRGEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCTCCCCCGGGACTAGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLPRD*GYNEQFF	Stop	VDJ	1	27	1.0146218278975909E-4		48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	8	3	7	2	24	36	51	43	53						01,02								CASSLPRD*GYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGGACTAATGGAGATACGCAGTATTTTGGCCCA	CASSGTNGDTQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	9	5	0	4	24	-1	43	36	47						01,02								CASSGTNGDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCTCAACCCAAGACGAGACCTACGAGCAGTACTTCGGGCCG	CASSTQDETYEQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	10	2	7	2	11	4	24	31	45	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTQDETYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAAGGCCGGGGCTAGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	1.1273575865528787E-4		41	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	10	7	0	4	8	3	24	31	44	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCAGTCTTGGCTACAGATAGTTCAAAAACATTCAGTACTTCGGCGCC	CASSPSLGYR*FKNIQYF	Stop	VDJ	1	30	1.1273575865528787E-4		54	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	3	5	3	13	6	24	36	53	49	59														CASSPSLGYR*FKNIQYF+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAATGGGGACTCACCAAGAGACCCAGTACTTCGGGCCA	CASSVMGTHQETQYF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	10	0	6	1	24	36	48	42	49						01,02								CASSVMGTHQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGTGACTAGCGGGGGCGCAGATACGCAGTATTTTGGCCCA	CASSVTSGGADTQYF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	2	2	4	3	2	24	35	50	38	52														CASSVTSGGADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTGCGGGGGGCGGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSLRGAVTGELFF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	7	1	4	2	4	24	36	46	38	50														CASSLRGAVTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCTCCGAGGGGGAGCGGGGTTCTTACAATGGGTACAATGAGCAGTTCTTCGGGCCA	CASSEGERGSYNGYNEQFF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	57	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	6	3	4	12	13	24	31	50	43	63														CASSEGERGSYNGYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCGACGGGAGGAACTGAAGCTTTCTTTGGACAA	CASSPTGGTEAFF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	1	5	4	1	24	36	47	40	48														CASSPTGGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGGTAACAGGGGAGGCCTATGGCTACACCTTCGGTTCG	CASRVTGEAYGYTF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	2	4	4	4	24	35	46	39	50														CASRVTGEAYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGATGCGCTCTAGGCTACATTGGCATCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	33	1.2400933452081666E-4		53	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	4	8	5	7	14	24	35	46	42	60						01,02								X+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGACAGGGGGATGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	34	1.277671931426596E-4		41	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	1	3	0	5	24	-1	43	35	48														X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAGGGACTAGCGGTCACCGACAATGAGCAGTTCTTCGGGCCA	CASSVEGLAVTDNEQFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	5	5	6	24	36	52	41	58						01,02								CASSVEGLAVTDNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAATGAGAGGGGCCCAGGGGTGGAGAGCAATCAGCCCCAGCATTTTGGTGAT	CASNERGPGVESNQPQHF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	54	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	4	2	1	15	5	24	31	52	46	57														CASNERGPGVESNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGAAAGGACTAGCGGGAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	37	1.3904076900818837E-4		49	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	2	3	1	0	0	24	-1	-1	40	51														X+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGCCCCGGGGACAGTCTGTATCACACCGGGGAGCTGTTTTTTGGAGAA	CASSGPGDSLYHTGELFF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	54	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	5	3	7	8	24	36	50	43	58														CASSGPGDSLYHTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTTGGGGGGATTACCTCCGGGGAGCTGTTTTTTGGAGAA	CASSVGGITSGELFF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	9	1	6	3	7	24	36	45	39	52														CASSVGGITSGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCGGTCCAGGGGCGGTTACGAGCAGTACTTCGGGCCG	CASSRSRGGYEQYF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	4	5	4	24	36	47	41	51														CASSRSRGGYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCCTGGACAGGGGTGACTTATGGCTACACCTTCGGTTCG	CASSSWTGVTYGYTF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	2	5	4	5	24	36	49	40	54														CASSSWTGVTYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGGCCTGGCAGGGGGATACGAGCAGTACTTCGGGCCG	CASGLAGGYEQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	4	1	4	9	1	24	31	47	40	48														CASGLAGGYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGGACTAGCGGGAGGAAAGGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	43	1.6158792073924595E-4		53	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	1	1	3	2	5	24	36	52	38	57														X+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGGCGCACGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	44	1.6534577936108889E-4		47	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	8	3	0	7	0	24	36	-1	43	48														X+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTCAACTCGGGGGGCATCTTCGAGACCCAGTACTTCGGGCCA	CASSVNSGGIFETQYF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	1	5	7	7	24	36	50	43	57														CASSVNSGGIFETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGAGGGAACGGCGGAGAGACCCAGTACTTCGGGCCA	CASSVGGNGGETQYF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	10	0	4	3	8	24	36	45	39	53														CASSVGGNGGETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGTGTAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVGVSSYNEQFF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	5	5	4	0	2	6	24	36	41	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGVSSYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTAGGTAGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSVVGRENTEAFF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	5	0	8	1	10	0	24	36	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVVGRENTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGCATGGACAGCCGTCTCTGGAAACACCATATATTTTGGAGAG	CASSAWTAVSGNTIYF	In	VDJ	1	48	1.803772138484606E-4	2.135715843007088E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	5	0	5	4	24	35	46	40	50														CASSAWTAVSGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGACCGGGACGGGAGGAAACACCATATATTTTGGAGAG	CASRTGTGGNTIYF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-03	01	6	0	7	4	4	4	24	35	44	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRTGTGGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTGGGAGGTACTGAAGCTTTCTTTGGACAA	CASSVVGGTEAFF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	1	5	5	1	24	36	47	41	48														CASSVVGGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTCACAGGGACTAACACTGAAGCTTTCTTTGGACAA	CASSVTGTNTEAFF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	5	3	3	2	3	3	24	36	45	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVTGTNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCAGGGGAGGGGATATTTGAATGAGCAGTTCTTCGGGCCA	CASSQGRGYLNEQFF	In	VDJ	1	53	1.9916650695767524E-4	2.3581862433203263E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	0	7	3	8	24	36	46	39	54														CASSQGRGYLNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAACAGGGGGCTCAGCAAGAAAAACTGTTTTTTGGCAGT	CASSEQGAQQEKLFF	In	VDJ	1	53	1.9916650695767524E-4	2.3581862433203263E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	0	8	3	7	24	35	47	38	54														CASSEQGAQQEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCTACGGGACTAGCGGGAGTGCGGGAGCTGTTTTTTGGAGAA	CASSSTGLAGVRELFF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	0	2	9	5	3	24	36	55	41	58														CASSSTGLAGVRELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGATGGACCGGTGTTCTCCCTTTCTTTGGACAA	CASRWTGVLPFF	In	VDJ	1	59	2.217136586887328E-4	2.625150723696212E-4	36	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	6	1	7	12	2	11	24	35	41	37	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRWTGVLPFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGTCAGCAGCTCATCCCGGGACGGCGGGCCGGAGACCCAGTACTTCGGGCCA	CVSSSSRDGGPETQYF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	48	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-05	01	5	0	7	5	7	9	24	36	48	43	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CVSSSSRDGGPETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCATGAAGGATCCCACAGGGGCTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	68	2.555343862853192E-4		44	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	3	2	3	11	3	24	31	49	42	52														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCGGGACGAAACACAACAGTTCTTCGGGCCA	CASSRDETQQFF	In	VDJ	1	69	2.592922449071621E-4	3.0700915243226886E-4	36	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	6	0	7	13	2	9	24	35	42	37	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDETQQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCATACTAGACTAGTCGGGCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	70	2.6305010352900505E-4		46	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	8	6	5	6	24	37	48	42	54						01,02								X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGGGACAGGGCAATGAAAAACTGTTTTTTGGCAGT	CASSAGQGNEKLFF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	5	2	1	24	36	47	38	48														CASSAGQGNEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCACCTCCGGGACTAGAAACACCGGGGAGCTGTTTTTTGGAGAA	CATSGTRNTGELFF	In	VDJ	1	78	2.931129725037485E-4	3.470538244886518E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	0	8	2	5	1	24	31	44	36	45						01,02								CATSGTRNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTTGCGGGGGGAGGGGCAGATACGCAGTATTTTGGCCCA	CASSVVAGGGADTQYF	In	VDJ	2	92	3.4572299320954946E-4	4.093455365763585E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	1	4	6	5	24	36	50	42	55														CASSVVAGGGADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACCCCTGGGGAATCCACCGACTCCGGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	2	105	3.9457515529350753E-4		53	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	10	8	3	4	25	0	24	31	-1	56	61														X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGACGTAAGAAGAGACCCAGTACTTCGGGCCA	CASSVGT*EETQYF	Stop	VDJ	2	138	5.185844898143242E-4		42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-05	01	5	0	7	3	3	5	24	36	44	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGT*EETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGATGCCGCCATTGGCTACGAGCAGTACTTCGGGCCG	CASSVDAAIGYEQYF	In	VDJ	3	161	6.050152381167115E-4	7.163546890086274E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	3	1	13	24	36	40	37	53						01,02								CASSVDAAIGYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAGCGGGACTTCCTCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	7	399	0.0014993855901153288		50	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	0	0	10	0	0	5	24	-1	47	41	52						01,02								X+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCCCCCCCAGGGACCCTGACTATGGCTACACCTTCGGTTCG	CASPPRDPDYGYTF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	42	TCRBV27	TCRBV27-01	01				TCRBJ01	TCRBJ01-02	01	8	0	7	3	7	4	23	32	44	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASPPRDPDYGYTF+TCRBV27-01+TCRBJ01-02	TCRBV27-01*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCTTACAGGGATTCTATGGCTACACCTTCGGTTCG	CASLQGFYGYTF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	36	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	3	3	4	2	3	23	32	40	34	43													Vb 14	CASLQGFYGYTF+TCRBV27-01+TCRBJ01-02	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTTCTCCTAGCGGTTGAGTACAATGAGCAGTTCTTCGGGCCA	CASSFLLAVEYNEQFF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	48	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	5	4	4	5	23	37	48	41	53						01,02							Vb 14	CASSFLLAVEYNEQFF+TCRBV27-01+TCRBJ02-01	TCRBV27-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGCCAAGGATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQGYSNQPQHF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	42	TCRBV27	TCRBV27-01	01				TCRBJ01	TCRBJ01-05	01	6	1	8	0	4	2	23	34	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASSQGYSNQPQHF+TCRBV27-01+TCRBJ01-05	TCRBV27-01*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTCCGCGCTGGGGGCGGGTCATGGATACGCAGTATTTTGGCCCA	CASSPRWGRVMDTQYF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	48	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	6	0	6	7	8	23	35	48	42	56													Vb 14	CASSPRWGRVMDTQYF+TCRBV27-01+TCRBJ02-03	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTAACTCAGGGCCCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	51	1.9165078971398938E-4		46	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	0	3	3	23	38	46	41	49													Vb 14	X+TCRBV27-01+TCRBJ01-01	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTGAGGGGGCGGGAGATACGCAGTATTTTGGCCCA	CSVVEGAGDTQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	5	0	5	3	3	25	35	45	38	48													Vb 4	CSVVEGAGDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCCTGGGGGCGGCTATGGCTACACCTTCGGTTCG	CSVPGGGYGYTF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	6	0	4	3	2	25	34	43	37	45													Vb 4	CSVPGGGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCCGCGCAGGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	6.764145519317272E-5		43	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	0	5	0	25	38	-1	43	48													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGCTGGCGGGGTGGGGCTACACCTTCGGTTCG	CSVEGLAGWGYTF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	7	3	8	5	3	25	38	49	43	52													Vb 4	CSVEGLAGWGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGGTGGGCCAGGGGGTTTAGGGACCCAGTACTTCGGGCCA	CSVGGGPGGLGTQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	1	7	9	6	25	35	51	44	57													Vb 4	CSVGGGPGGLGTQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCCACTAGCGGGGGACCCTATCGGTACAATGAGCAGTTCTTCGGGCCA	CSVSTSGGPYRYNEQFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	3	2	4	3	10	25	34	48	37	58													Vb 4	CSVSTSGGPYRYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGCTCGGACAGGGCCTAGCACAGATACGCAGTATTTTGGCCCA	CSVARTGPSTDTQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	3	0	5	3	25	33	46	38	49													Vb 4	CSVARTGPSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGCAAATGAAAGGGGGTTTAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	19	7.139931381501565E-5		49	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	5	1	4	9	3	25	38	53	47	56													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACAGGGTCCCTCGTCCAAGAGACCCAGTACTTCGGGCCA	CSVETGSLVQETQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	3	1	0	8	25	-1	43	37	51													Vb 4	CSVETGSLVQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCAGGACAGACTAGCGCGAGGGGGGAGACCCAGTACTTCGGGCCA	CSAGQTSARGETQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	2	6	5	7	8	25	32	47	39	55						01,02							Vb 4	CSAGQTSARGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGGGGACCGGGGAGCTGTTTTTTGGAGAA	CSVEGGTGELFF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	1	6	1	5	0	0	25	-1	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGGTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTCGGACTTCCGGGGGCGAGCAGTACTTCGGGCCG	CSARTSGGEQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	8	2	6	10	0	25	32	-1	42	48													Vb 4	CSARTSGGEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCAGAGAATTACGAGCAGTACTTCGGGCCG	CSVEAENYEQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	1	4	5	4	0	5	25	-1	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEAENYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGATGCCAGGGGACCTTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	27	1.0146218278975909E-4		44	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	2	0	5	4	25	32	43	37	47													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGACTAGCGGGGACCTACGAGCAGTACTTCGGGCCG	CSVGLAGTYEQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	2	3	2	0	1	25	-1	46	35	47													Vb 4	CSVGLAGTYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGTGACTAGCGGGGGAGAGACCCAGTACTTCGGGCCA	CSVGVTSGGETQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	2	2	4	4	0	25	35	-1	39	51													Vb 4	CSVGVTSGGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTGGACAGGGGACGAGACCCAGTACTTCGGGCCA	CSVWTGDETQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	2	5	1	2	25	34	44	35	46													Vb 4	CSVWTGDETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATAAAGGAGGGATAGTCGGAGCTTTCTTTGGACAA	CSVEDKGGIVGAFF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	0	10	4	8	25	39	49	43	57													Vb 4	CSVEDKGGIVGAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGACGGGCCCGGGGGGCTACACCTTCGGTTCG	CSVVTGPGGYTF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	8	3	8	9	0	25	35	-1	44	49													Vb 4	CSVVTGPGGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTTCCAAGGGGTGAACACTGAAGCTTTCTTTGGACAA	CSFQGVNTEAFF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	5	2	0	5	0	25	31	-1	36	41													Vb 4	CSFQGVNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAAGGACTAGCGGGAGTAAATGAGCAGTTCTTCGGGCCA	CSVQGLAGVNEQFF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	2	2	7	0	2	25	-1	50	38	52													Vb 4	CSVQGLAGVNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGCGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVSGGSYNEQFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	2	0	0	0	25	-1	-1	34	42													Vb 4	CSVSGGSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACCCCTGGGACAGGGGGTCGGCTACACCTTCGGTTCG	CSVEPLGQGVGYTF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	1	8	5	2	25	37	53	42	55													Vb 4	CSVEPLGQGVGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCGCAACTGGGGGGCTCACAGATACGCAGTATTTTGGCCCA	CATGGLTDTQYF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	11	6	0	2	7	1	25	28	41	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CATGGLTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCGTCGGAGTCACAGGGGGGATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	39	1.4655648625187424E-4		47	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	3	1	8	11	1	25	35	54	46	55													Vb 4	X+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTCCCTGCTGGAACCGGGGAGCTGTTTTTTGGAGAA	CSVLPAGTGELFF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	5	1	8	5	9	0	25	34	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVLPAGTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCTAGGAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVSRNSGANVLTF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	4	8	0	1	3	25	34	39	35	42						01,02							Vb 4	CSVSRNSGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD02-01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCTTACAGGGAGGGGGCCAGCCCCAGCATTTTGGTGAT	CSALQGGGQPQHF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	7	5	0	7	10	0	25	32	-1	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSALQGGGQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAGAGGGGGCAAGGCAGCCCCAGCATTTTGGTGAT	CSVGEGARQPQHF	In	VDJ	1	48	1.803772138484606E-4	2.135715843007088E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	6	0	7	0	4	25	-1	45	39	49													Vb 4	CSVGEGARQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTTTGGGACTTAGCACAGATACGCAGTATTTTGGCCCA	CSVVLGLSTDTQYF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	10	0	4	1	25	35	45	39	46						01,02							Vb 4	CSVVLGLSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTCAACGGTTGACTACACTGAAGCTTTCTTTGGACAA	CSSTVDYTEAFF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	8	2	10	3	9	0	25	31	-1	40	44						01,02							Vb 4	CSSTVDYTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGGACGCACAGGGTCCCGATTGAACACTGAAGCTTTCTTTGGACAA	CSVGRTGSRLNTEAFF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	0	7	7	25	33	46	40	53													Vb 4	CSVGRTGSRLNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACGTACGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVDVRSYNEQFF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	3	3	7	0	3	1	25	36	41	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVDVRSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAGAGGACAGCATAGCACAGATACGCAGTATTTTGGCCCA	CSVRGQHSTDTQYF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	5	0	4	3	25	33	43	37	46													Vb 4	CSVRGQHSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACCCGAAGCCCGAAGGGAGCAGTTCTTCGGGCCA	CSVEPEARREQFF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	2	5	4	10	12	0	25	37	-1	49	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEPEARREQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGGACAGGGAACTACGAGCAGTACTTCGGGCCG	CSVGTGNYEQYF	In	VDJ	1	65	2.442608104197904E-4	2.8921152040720983E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	3	1	2	25	33	43	34	45													Vb 4	CSVGTGNYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGGACAGGGAGAGGCACTGAAGCTTTCTTTGGACAA	CSVGTGRGTEAFF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	4	1	5	25	33	43	34	48													Vb 4	CSVGTGRGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGGTCACCGCACAGATACGCAGTATTTTGGCCCA	CSAGHRTDTQYF	In	VDJ	1	87	3.269337001003348E-4	3.870984965450347E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	8	5	1	1	5	25	32	36	33	41						01,02							Vb 4	CSAGHRTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAAGGGCAGGGTTTAACACTGAAGCTTTCTTTGGACAA	CSVRAGFNTEAFF	In	VDJ	1	88	3.3069155872217777E-4	3.9154790455129943E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	2	5	3	25	33	43	38	46													Vb 4	CSVRAGFNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGTGGGGACAGCAATCAGCCCCAGCATTTTGGTGAT	CSVGGDSNQPQHF	In	VDJ	2	93	3.494808518313924E-4	4.1379494458262326E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	4	0	7	1	3	0	25	35	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGGDSNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGACAGCAGCTACAATGAGCAGTTCTTCGGGCCA	CSGDSSYNEQFF	In	VDJ	2	96	3.607544276969212E-4	4.271431686014176E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	5	3	0	3	25	-1	39	32	42													Vb 4	CSGDSSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTAACGGGGGGTCAGCAAGAGACCCAGTACTTCGGGCCA	CSVEVTGGQQETQYF	In	VDJ	2	106	3.983330139153505E-4	4.7163724866406526E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	8	1	2	3	4	25	38	48	41	52													Vb 4	CSVEVTGGQQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAAAGAAAGGATCCTACCCCTTAGCACAGATACGCAGTATTTTGGCCCA	CSVKERILPLSTDTQYF	In	VDJ	2	110	4.133644484027222E-4	4.894348806891243E-4	51	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	0	1	8	0	2	11	25	39	44	41	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVKERILPLSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGTAACTAGATTCTACGAGCAGTACTTCGGGCCG	CSVVTRFYEQYF	In	VDJ	2	111	4.1712230702456514E-4	4.938842886953891E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	3	8	3	4	3	25	33	42	37	45						01,02							Vb 4	CSVVTRFYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGAGGGGCAGGGGGAACGCGAGCAGTACTTCGGGCCG	CSVEGQGEREQYF	In	VDJ	2	113	4.24638024268251E-4	5.027831047079186E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	1	6	7	4	25	33	47	40	51													Vb 4	CSVEGQGEREQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGCGACTAGCGGCTACAATGAGCAGTTCTTCGGGCCA	CSVGATSGYNEQFF	In	VDJ	2	116	4.359116001337798E-4	5.161313287267129E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	5	3	4	0	25	35	-1	39	48						01,02							Vb 4	CSVGATSGYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGGGACAGGGACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVGGTGTSGANVLTF	In	VDJ	2	119	4.4718517599930856E-4	5.294795527455073E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	0	3	0	2	2	25	35	46	37	48													Vb 4	CSVGGTGTSGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCGGACAGCCGAACACTGAAGCTTTCTTTGGACAA	CSVVGQPNTEAFF	In	VDJ	2	119	4.4718517599930856E-4	5.294795527455073E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	1	2	2	25	35	43	37	45													Vb 4	CSVVGQPNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACGTGCTGGGGAACTACGAGCAGTACTTCGGGCCA	CSVDVLGNYEQYF	In	VDJ	2	126	4.734901863522091E-4	5.606254087893606E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	3	0	8	11	7	8	25	36	47	43	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVDVLGNYEQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGGGCGAAGAGCGGGAGTAGTCTTCGGGCCA	CSVGGRRAGVVF	In	VDJ	2	137	5.148266311924812E-4	6.09568896858273E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	6	2	17	10	3	25	35	53	45	56													Vb 4	CSVGGRRAGVVF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCCCGGGAAACCGGACGGGCAATGAGCAGTTCTTCGGGCCA	CSVAPGNRTGNEQFF	In	VDJ	2	140	5.261002070580101E-4	6.229171208770673E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	3	6	3	11	25	35	43	38	54													Vb 4	CSVAPGNRTGNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGAATCCGGGACAGGGGACACTGAAGCTTTCTTTGGACAA	CSVESGTGDTEAFF	In	VDJ	3	157	5.899838036293398E-4	6.985570569835683E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	2	3	3	0	25	37	-1	40	50													Vb 4	CSVESGTGDTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGACCGGGACTAGCGGGAGGTGGGGGGCCTACGAGCAGTACTTCGGGCCG	CSVEGTGTSGRWGAYEQYF	In	VDJ	3	165	6.200466726040833E-4	7.341523210336865E-4	57	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	0	1	2	5	7	24	37	57	42	64													Vb 4	CSVEGTGTSGRWGAYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGTACAGAGCTCCCCCCCCCACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	178	6.688988346880414E-4		47	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	5	2	2	14	25	35	41	37	55													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGGGGGACTAGCGGGGCCTACGAGCAGTACTTCGGGCCG	CSVGGTSGAYEQYF	In	VDJ	3	183	6.876881277972561E-4	8.142416651464523E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	2	4	0	25	33	-1	37	50													Vb 4	CSVGGTSGAYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTACAGGAGAAGAACACTGAAGCTTTCTTTGGACAA	CSVQEKNTEAFF	In	VDJ	3	184	6.914459864190989E-4	8.18691073152717E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	4	1	0	4	25	-1	38	33	42													Vb 4	CSVQEKNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATTTCGGGGCCTACGAGCAGTACTTCGGGCCG	CSVDFGAYEQYF	In	VDJ	3	195	7.327824312593712E-4	8.676345612216294E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	3	2	3	0	25	36	-1	39	44													Vb 4	CSVDFGAYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATCCTTAGGGATTAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVESLGINSGANVLTF	In	VDJ	4	221	8.304867554272873E-4	9.833191693845134E-4	51	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-06	01	2	0	8	0	6	4	25	37	47	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVESLGINSGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01		TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACCACTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	228	8.567917657801878E-4		35	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	10	1	2	0	25	37	-1	39	42						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGTAGCCACAGATACGCAGTATTTTGGCCCA	CSVGVATDTQYF	In	VDJ	6	369	0.0013866498314600408	0.0016418315543116988	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	5	7	2	3	0	25	35	-1	38	42						01,02							Vb 4	CSVGVATDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATTTTAGCGGGAGAGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CSVEDFSGRGAYNEQFF	In	VDJ	7	428	0.0016083634901487736	0.00190434662668132	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	5	2	2	3	5	25	39	51	42	56													Vb 4	CSVEDFSGRGAYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGATGACAGAGACGAACACTGAAGCTTTCTTTGGACAA	CSVRMTETNTEAFF	In	VDJ	8	463	0.0017398885419132762	0.002060075906900587	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	1	5	4	25	34	44	39	48													Vb 4	CSVRMTETNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCGCAGGCTAGTGTTGAAGCTTTCTTTGGACAA	CSVEAQASVEAFF	In	VDJ	15	923	0.0034685035079610235	0.004106803589782379	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	1	4	4	7	2	7	25	38	44	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEAQASVEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGACAGGGGACGGTCGAGCAGTACTTCGGGCCG	CSVEGQGTVEQYF	In	VDJ	35	2068	0.0077712516299711775	0.009201375756955538	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	6	0	5	25	-1	46	36	51													Vb 4	CSVEGQGTVEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAAGCGAAAGGGAGGGTCAATCAGCCCCAGCATTTTGGTGAT	CASSEAKGRVNQPQHF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	9	0	3	4	1	24	41	52	45	53														CASSEAKGRVNQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01	TCRBD02-01*02	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGCTAGCGGGGGGCGTGGAAAGACCCAGTACTTCGGGCCA	CASSEGASGGRGKTQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	51	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	4	1	6	3	7	23	39	53	42	60														CASSEGASGGRGKTQYF+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTCAGGGGGTACACTGAAGCTTTCTTTGGACAA	CASSEVRGYTEAFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	1	3	1	1	23	39	47	40	48														CASSEVRGYTEAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGGTAAAGATTCACCCCTCCACTTTGGGAAC	CASSEGGKDSPLHF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	42	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-06	01	1	6	2	8	0	5	23	-1	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGGKDSPLHF+TCRBV06-01+TCRBJ01-06	TCRBV06-01*01		TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGCGGGGGGGCCTCCGGGGAGCTGTTTTTTGGAGAA	CASSEGGGASGELFF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	45	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	7	0	6	0	3	23	-1	48	39	51														CASSEGGGASGELFF+TCRBV06-01+TCRBJ02-02	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCCCAGATACTATGGCTACACCTTCGGTTCG	CASSEAPRYYGYTF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	5	3	3	2	23	40	46	43	48														CASSEAPRYYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGGAGGGCTGGGGAGCTTTCTTTGGACAA	CASSEAEGWGAFF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	39	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	0	10	0	6	23	-1	46	40	52														CASSEAEGWGAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGTGGGACCGTGTACGGTACTTCGGCGCC	CASSEAWDRVRYF	In	VDJ	2	96	3.607544276969212E-4	4.271431686014176E-4	39	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-04	01	0	0	7	15	2	8	23	40	47	42	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAWDRVRYF+TCRBV06-01+TCRBJ02-04	TCRBV06-01*01		TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCTGGGTTCGGGGAGCTGTTTTTTGGAGAA	CASSEAGFGELFF	In	VDJ	7	391	0.0014693227211405853	0.0017397185304495236	39	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-02	01	0	0	9	7	1	2	23	40	44	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAGFGELFF+TCRBV06-01+TCRBJ02-02	TCRBV06-01*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTCCATCGGGAGGACTGAAGCTTTCTTTGGACAA	CASSSIGRTEAFF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	39	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	1	5	4	0	22	35	-1	39	46														CASSSIGRTEAFF+TCRBV07-04+TCRBJ01-01	TCRBV07-04*01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTAACTGGGGGAAACTATGGCTACACCTTCGGTTCG	CASSLTGGNYGYTF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	42	TCRBV07	TCRBV07-04	01				TCRBJ01	TCRBJ01-02	01	2	6	1	2	3	1	22	37	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTGGNYGYTF+TCRBV07-04+TCRBJ01-02	TCRBV07-04*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTAGGTGGGAGGGCGAAAGAGACCCAGTACTTCGGGCCA	CASSLGGRAKETQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	45	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	9	0	3	2	3	22	38	47	40	50														CASSLGGRAKETQYF+TCRBV07-04+TCRBJ02-05	TCRBV07-04*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTAACGTGGAACACTGAAGCTTTCTTTGGACAA	CASSLTWNTEAFF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	39	TCRBV07	TCRBV07-04	01				TCRBJ01	TCRBJ01-01	01	2	3	7	1	0	3	22	-1	39	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTWNTEAFF+TCRBV07-04+TCRBJ01-01	TCRBV07-04*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGACAGACGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	18	6.764145519317272E-5		43	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	2	5	1	0	3	26	-1	44	39	47													Vb 20	X+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCCTACAGGAGGGGTGGAACAGATACGCAGTATTTTGGCCCA	CAWAYRRGGTDTQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	0	3	7	5	26	35	48	42	53													Vb 20	CAWAYRRGGTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCAGCTTTCTCCGAGCAGTACTTCGGGCCG	CAWAAFSEQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	33	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	5	4	5	6	1	7	26	35	39	36	46			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWAAFSEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAGCAGAGAGCCAAAAACATTCAGTACTTCGGCGCC	CAWSEQRAKNIQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-04	01	1	4	5	0	2	2	26	39	44	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSEQRAKNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01		TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGGTCTGGGGCGCCCCAGCATTTTGGTGAT	CAWSVGSGAPQHF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	7	0	9	7	0	26	40	-1	47	52													Vb 20	CAWSVGSGAPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTCGGTCAGCCCCAGCATTTTGGTGAT	CAWSVLGQPQHF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	3	10	6	0	3	26	-1	43	40	46			unresolved			01,02							Vb 20	CAWSVLGQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD02-01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCTGGACTAGCGGGAGTCGCGGCCTCACCGGGGAGCTGTTTTTTGGAGAA	CAWSPWTSGSRGLTGELFF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	57	TCRBV30	TCRBV30-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	1	2	4	4	9	24	36	53	40	62			01,02										Vb 20	CAWSPWTSGSRGLTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGCAGTCGATACGCAGTATTTTGGCCCA	CAWSAVDTQYF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	33	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	5	6	2	2	26	37	42	39	44			unresolved										Vb 20	CAWSAVDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTACATCCTCTGGGGAAGGTGAGCTCCTACGAGCAGTACTTCGGGCCG	CALHPLGKVSSYEQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	48	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	7	0	8	0	11	7	26	33	48	44	55			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CALHPLGKVSSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCCTGGACAGGGATGGGAAACACCATATATTTTGGAGAG	CASWTGMGNTIYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	1	3	4	3	3	26	33	44	36	47													Vb 20	CASWTGMGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGTGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAWSVVAGANVLTF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-06	01	0	0	10	2	3	0	26	40	-1	43	45			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVVAGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01		TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGACCGATTCTACGAGCAGTACTTCGGGCCG	CAWGDRFYEQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	5	0	7	3	1	5	26	35	41	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWGDRFYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCGATCCCCAGGGGATCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	32	1.2025147589897372E-4		38	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	2	4	7	2	26	33	46	40	48													Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTACTGTATGGTTATAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	33	1.2400933452081666E-4		52	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-06	01	5	3	6	5	15	5	26	35	53	50	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01		TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCCGGAACGGCGGTTTGGACCCAGTACTTCGGGCCA	CAWAGTAVWTQYF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	7	5	7	9	4	26	35	48	44	52						01,02							Vb 20	CAWAGTAVWTQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGCTAGCGGGGGGCCTAGAGACCCAGTACTTCGGGCCA	CAWTLAGGLETQYF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	4	1	4	2	3	26	36	49	38	52													Vb 20	CAWTLAGGLETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCCGCGGAGAAACGGAGCAGTACTTCGGGCCG		Out	VDJ	1	38	1.427986276300313E-4		37	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	7	5	7	3	7	26	37	44	40	51						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCAAGACAGAAGCTCCTACGAGCAGTACTTCGGGCCG	CAWRQDRSSYEQYF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	5	0	4	3	26	37	46	41	49			unresolved										Vb 20	CAWRQDRSSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTATTTGGTTACACTGAAGCTTTCTTTGGACAA	CAWSVFGYTEAFF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	0	0	10	3	4	2	26	40	46	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVFGYTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTACTCCGGGACAGTGGGTCCGGCTACACCTTCGGTTCG		Out	VDJ	1	45	1.691036379829318E-4		44	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	5	8	6	7	26	38	51	44	58			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGGGGGGGGCTAATGAAAAACTGTTTTTTGGCAGT	CAWTGGANEKLFF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	4	8	0	3	0	1	26	-1	44	36	45			unresolved										Vb 20	CAWTGGANEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGCCGGCGAGCTCCTACGAGCAGTACTTCGGGCCG	CAWKPASSYEQYF	In	VDJ	1	52	1.954086483358323E-4	2.3136921632576786E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-07	01	4	9	0	0	4	3	26	36	43	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKPASSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACCGGGGGGTCCCTACGAGCAGTACTTCGGGCCG	CAWSVPGGPYEQYF	In	VDJ	1	53	1.9916650695767524E-4	2.3581862433203263E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	1	2	2	2	26	40	49	42	51													Vb 20	CAWSVPGGPYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGTTTCCGAGACAGGGGGGCAATGAGCAGTTCTTCGGGCCA	CAWKFPRQGGNEQFF	In	VDJ	1	58	2.179558000668899E-4	2.5806566436335646E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	1	6	9	1	26	36	54	45	55													Vb 20	CAWKFPRQGGNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCTGCTCTTGGGGGAGATGAAAAACTGTTTTTTGGCAGT	CAWSAALGGDEKLFF	In	VDJ	1	60	2.2547151731057573E-4	2.66964480375886E-4	45	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-04	01	1	6	1	6	8	2	26	39	52	47	54			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSAALGGDEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGTCGTCAGCGCATAACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	60	2.2547151731057573E-4		46	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	6	6	2	6	6	26	39	49	45	55						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCCGTCTGGACTAGCGAGGGATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	63	2.3674509317610454E-4		40	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	1	6	4	5	5	26	32	46	37	51			unresolved			01,02							Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTGGGCGTGAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSLGVSNQPQHF	In	VDJ	1	65	2.442608104197904E-4	2.8921152040720983E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	8	0	1	2	3	26	38	44	40	47													Vb 20	CAWSLGVSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAAACAGGGATGGACTGAAGCTTTCTTTGGACAA	CAWSVKQGWTEAFF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	3	5	3	4	26	40	49	43	53			unresolved										Vb 20	CAWSVKQGWTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGAGCGCGGGACAGTTAACGTCTGGAAACACCATATATTTTGGAGAG	CAWRSAGQLTSGNTIYF	In	VDJ	1	68	2.555343862853192E-4	3.025597444260041E-4	51	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	5	1	6	6	26	37	50	43	56			unresolved										Vb 20	CAWRSAGQLTSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGACTCCTAGGAAGGACTAGCGAAAGGTACGAGCAGTACTTCGGGCCG	CA*LLGRTSERYEQYF	Stop	VDJ	1	69	2.592922449071621E-4		48	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	1	6	4	11	5	26	34	54	45	59						01,02							Vb 20	CA*LLGRTSERYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCGGCTAGCGGGAGAGTTCACCTACGAGCAGTACTTCGGGCCG	CAWSRLAGEFTYEQYF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	2	2	4	6	26	37	51	41	57													Vb 20	CAWSRLAGEFTYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTGCCGGGACAGGTATGAGCTCCTACGAGCAGTACTTCGGGCCG	CAWSVAGTGMSSYEQYF	In	VDJ	1	72	2.7056582077269087E-4	3.203573764510632E-4	51	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	4	0	4	6	26	40	52	44	58													Vb 20	CAWSVAGTGMSSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCTTTTTGGTCTGGAAACACCATATATTTTGGAGAG	CAWSAFWSGNTIYF	In	VDJ	1	79	2.968708311255914E-4	3.515032324949166E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	1	0	10	1	6	0	26	39	-1	45	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSAFWSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCCAGGAAGGGGGCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	83	3.119022656129631E-4		34	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	5	0	4	5	0	26	32	-1	37	44			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGAACCAGGGGAAGCAATTCACCCCTCCACTTTGGGAAC	CAWGTRGSNSPLHF	In	VDJ	1	83	3.119022656129631E-4	3.693008645199756E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	2	7	5	4	26	35	46	40	50			unresolved										Vb 20	CAWGTRGSNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCCCCTTGGGGACTGGAAACACCATATATTTTGGAGAG	CACPLGTGNTIYF	In	VDJ	1	89	3.344494173440207E-4	3.9599731255756423E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	6	0	8	2	7	0	26	34	-1	41	45			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CACPLGTGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATCGGGACTAACACAGATACGCAGTATTTTGGCCCA	CAWSIGTNTDTQYF	In	VDJ	2	90	3.382072759658636E-4	4.00446720563829E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	9	2	3	1	26	38	48	41	49						01,02							Vb 20	CAWSIGTNTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACCGGGACAGGGCCTACGAGCAGTACTTCGGGCCG	CAWNRDRAYEQYF	In	VDJ	2	92	3.4572299320954946E-4	4.093455365763585E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	2	3	0	26	36	-1	39	48			unresolved										Vb 20	CAWNRDRAYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGGGGGAACAGGGCCACTGAAGCTTTCTTTGGACAA	CAWSVGGNRATEAFF	In	VDJ	2	96	3.607544276969212E-4	4.271431686014176E-4	45	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	0	3	3	4	8	1	26	40	54	48	55			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGGNRATEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAGTTTGAATTCGGTGAGCAGTTCTTCGGGCCA	CAWSEFEFGEQFF	In	VDJ	2	98	3.6827014494060707E-4	4.360419846139471E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	8	5	9	10	0	26	39	-1	49	52			unresolved			01,02							Vb 20	CAWSEFEFGEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTATCAGAAAAACTGTTTTTTGGCAGT	CAWSVSEKLFF	In	VDJ	2	98	3.6827014494060707E-4	4.360419846139471E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	6	8	2	0	26	40	-1	42	44			unresolved										Vb 20	CAWSVSEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCCAGGGGGTTGGCTACACCTTCGGTTCG	CAWSVQGVGYTF	In	VDJ	2	99	3.7202800356245E-4	4.404913926202119E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	1	7	1	1	26	40	48	41	49													Vb 20	CAWSVQGVGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTACCCTGATGCATGAGCAGTTCTTCGGGCCA	CAWSVTLMHEQFF	In	VDJ	2	101	3.7954372080613584E-4	4.4939020863274143E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	0	2	8	8	6	3	26	40	48	46	51			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVTLMHEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCTTCGGACAGGGGGCCTCTGAAGCTTTCTTTGGACAA	CAWSVFGQGASEAFF	In	VDJ	2	105	3.9457515529350753E-4	4.6718784065780046E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	0	6	4	2	26	40	55	44	57			unresolved										Vb 20	CAWSVFGQGASEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCGGGGACCTACACTGAGCAGTTCTTCGGGCCA	CAWSAGTYTEQFF	In	VDJ	2	110	4.133644484027222E-4	4.894348806891243E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	1	0	7	9	2	6	26	39	46	41	52			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSAGTYTEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
YCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCAAGGATATCGGCTAGCGGGAGGGCCAAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	112	4.2088016564640804E-4		56	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	0	7	13	4	25	37	62	50	66			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGACCCAGCGGGCGGTACGAGCAGTACTTCGGGCCG	CAWRPSGRYEQYF	In	VDJ	2	117	4.396694587556227E-4	5.205807367329777E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	6	4	4	4	3	26	37	47	41	50			unresolved			01,02							Vb 20	CAWRPSGRYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTCTTGGACAGGAGGATATGGCTACACCTTCGGTTCG	CAWSWTGGYGYTF	In	VDJ	2	121	4.5470089324299443E-4	5.383783687580367E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	4	5	4	4	26	35	46	39	50													Vb 20	CAWSWTGGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGAACGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CAWRNGGNQPQHF	In	VDJ	2	125	4.697323277303661E-4	5.561760007830958E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	3	2	3	0	26	37	-1	40	45													Vb 20	CAWRNGGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAAGGTCGGAGGGGACAGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	136	5.110687725706384E-4		44	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	5	4	10	0	26	37	-1	47	54													Vb 20	X+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGTCCCGGGAGAGGGACCCAGTACTTCGGGCCA	CAWSGPGRGTQYF	In	VDJ	3	150	5.636787932764394E-4	6.67411200939715E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	8	2	7	4	3	26	39	49	43	52			unresolved										Vb 20	CAWSGPGRGTQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAATGGGGGGCGGCAATCAGCCCTAGCATTTTGGTGAT	CAWSVMGGGNQP*HF	Stop	VDJ	3	154	5.78710227763811E-4		45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	0	6	0	14	4	13	26	40	50	44	63			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVMGGGNQP*HF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAACAGGACTAGCGGGGTACAATGAGCAGTTCTTCGGGCCA	CAWSVTGLAGYNEQFF	In	VDJ	3	161	6.050152381167115E-4	7.163546890086274E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	1	3	4	4	0	26	40	-1	44	56			unresolved										Vb 20	CAWSVTGLAGYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGCGACAGGGACAGGTGAGCAGTACTTCGGGCCG	CAWRATGTGEQYF	In	VDJ	3	164	6.162888139822403E-4	7.297029130274217E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	4	7	7	1	26	37	52	44	53			unresolved										Vb 20	CAWRATGTGEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGCAGATACGCAGTATTTTGGCCCA	CAWSGADTQYF	In	VDJ	3	166	6.238045312259263E-4	7.386017290399512E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-03	01	1	0	9	4	0	0	26	-1	-1	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSGADTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCAAGGCATCCCCAACTTAGCTTTCTTTGGACAA	CAWTQGIPNLAFF	In	VDJ	3	167	6.275623898477691E-4	7.43051137046216E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	4	5	4	10	4	12	26	36	43	40	55			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWTQGIPNLAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTTGCCTAATAACCCCCGGACCCACCAGTAGCAGTACTTCGGGCCG		Out	VDJ	3	170	6.388359657132979E-4		55	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	0	1	7	8	18	8	26	40	62	58	70			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGGAGCGGGAGTCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	209	7.853924519651722E-4		44	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	6	2	1	3	2	26	38	49	41	51			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAAAATCGACAGGGGACTTTCTTTGGACAA	CAWSENRQGTFF	In	VDJ	4	210	7.891503105870151E-4	9.343756813156009E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	2	12	6	1	26	39	53	45	54			unresolved										Vb 20	CAWSENRQGTFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCCGGAGGTGGGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASGGGSSYNSPLHF	In	VDJ	4	213	8.004238864525438E-4	9.477239053343953E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	7	9	2	0	8	0	26	33	-1	41	46			unresolved										Vb 20	CASGGGSSYNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTCGAAAGGGGACAATCGAACACTGAAGCTTTCTTTGGACAA	CAFERGQSNTEAFF	In	VDJ	4	220	8.267288968054443E-4	9.788697613782487E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	6	1	7	3	26	33	46	40	49			unresolved										Vb 20	CAFERGQSNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAACCGCAGAAGACATTCAGTACTTCGGCGCC		Out	VDJ	4	236	8.868546347549312E-4		35	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	4	5	8	5	3	26	36	44	41	47			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACAGGGGGAGACGGACTGAAGCTTTCTTTGGACAA	CAWDRGRRTEAFF	In	VDJ	5	272	0.0010221375451412767	0.0012102389777040165	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	5	0	6	26	-1	44	35	50													Vb 20	CAWDRGRRTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTCCGGGGCAGCCATAACTATGGCTACACCTTCGGTTCG	CAWSFRGSHNYGYTF	In	VDJ	5	278	0.0010446846968723343	0.0012369354257416052	45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	2	7	0	1	4	5	26	38	47	42	52			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSFRGSHNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGGGACAGCCTAATGAAAAACTGTTTTTTGGCAGT	CAWKGQPNEKLFF	In	VDJ	5	298	0.0011198418693091929	0.0013259235858669005	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	5	3	1	1	26	36	44	37	45			unresolved										Vb 20	CAWKGQPNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCAGAGGGGAAGAAACTAATGAAAAACTGTTTTTTGGCAGT	CAWTRGEETNEKLFF	In	VDJ	7	406	0.001525690600468229	0.0018064596505434952	45	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-04	01	4	5	2	1	4	4	26	36	45	40	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWTRGEETNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACAGGGGGGGAAAAAGCAGTACTTCGGGCCG	CAWSVQGGKKQYF	In	VDJ	11	632	0.002374966649004731	0.0028120258599593326	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	1	8	0	6	26	-1	48	40	54													Vb 20	CAWSVQGGKKQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCAAACGGCCCTCCGAGACTATGGCTACACCTTCGGTTCG		Out	VDJ	13	759	0.0028522146939787833		37	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	9	9	0	3	4	8	26	31	38	35	46			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAGAGACAGGGGAATGAGCAGTTCTTCGGGCCA	CAWERQGNEQFF	In	VDJ	15	920	0.0034572299320954946	0.004093455365763585	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	2	7	4	0	26	35	-1	39	47			unresolved										Vb 20	CAWERQGNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCATCCTTGGCCGGCGGGGCGGTTGGCGAGCAGTACTTCGGGCCG	CASSPSLAGGAVGEQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	7	3	6	13	7	19	31	50	44	57													Vb 5.1	CASSPSLAGGAVGEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGGGACTAGCGGGGGGGTAAAAGAGACCCAGTACTTCGGGCCA	CASSGTSGGVKETQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	0	0	3	0	3	19	-1	47	31	50													Vb 5.1	CASSGTSGGVKETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGCGACGTGGCTGCAGGCTACGAGCAGTACTTCGGGCCG	CASSLGDVAAGYEQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	4	3	12	0	19	35	-1	47	51													Vb 5.1	CASSLGDVAAGYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGCGGGGGGACACAGATACGCAGTATTTTGGCCCA	CASSLGRGDTDTQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	1	2	1	1	19	35	44	36	45													Vb 5.1	CASSLGRGDTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTCGGACAGGGTTACGAGCAGTACTTCGGGCCG	CASSLVGQGYEQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	3	4	2	1	19	35	45	37	46													Vb 5.1	CASSLVGQGYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCATGGACGGGAGGGCCGTGATCAATGAGCAGTTCTTCGGGCCA	CASMDGRAVINEQFF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	0	6	4	7	19	29	41	33	48													Vb 5.1	CASMDGRAVINEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCACGGGACTAGCGGGGGGCAGTTGGAGTTCTTCGGGCCA	CASSHGTSGGQLEFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	0	1	14	3	7	19	31	49	34	56													Vb 5.1	CASSHGTSGGQLEFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGGACAGGGTAAACTCAGGCCACGGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	18	6.764145519317272E-5		61	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	3	0	0	16	19	-1	41	32	57													Vb 5.1	X+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGGGACATGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	7.139931381501565E-5		46	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	6	0	1	4	19	35	42	36	46													Vb 5.1	X+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTAGGTCCGGGGGGAACCAAGAGACCCAGTACTTCGGGCCA	CASSRSGGNQETQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	1	0	6	1	19	30	43	36	44													Vb 5.1	CASSRSGGNQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGCCGGGGAAACTATGGCTACACCTTCGGTTCG	CASSLGRGNYGYTF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	3	2	2	1	19	35	42	37	43													Vb 5.1	CASSLGRGNYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCCTTTATCTTTGCGCCAGCAGCCAAGATAGGTGGGCAGGGGGGATAATCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSQDRWAGGIISYNSPLHF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	63	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	4	1	0	13	6	18	30	50	43	56													Vb 5.1	CASSQDRWAGGIISYNSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGATTGGGGGCACGTCCACCTAGCGGACCATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	21	7.891503105870151E-5		61	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	5	4	17	4	19	34	58	51	62						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGATTGGGGTGGGACTGAAGCTTTCTTTGGACAA	CASSLDWGGTEAFF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	0	6	2	5	3	4	19	35	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLDWGGTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCGGCCACGATGAACACTGAAGCTTTCTTTGGACAA	CASSLAATMNTEAFF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	0	9	0	0	1	5	19	35	39	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLAATMNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCAGTGGCGGGAGGGACAGATACGCAGTATTTTGGCCCA	CASSSVAGGTDTQYF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	0	3	5	0	19	32	-1	37	46													Vb 5.1	CASSSVAGGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCTCAAGGGTCACGGTCTGGGGCTTTCTTTGGACAA	CASSPQGSRSGAFF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	4	5	3	11	5	12	19	31	40	36	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSPQGSRSGAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGACAGGGGTACAGATACGCAGTATTTTGGCCCA	CASSSDRGTDTQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	2	3	2	1	19	32	42	34	43													Vb 5.1	CASSSDRGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGGATGGGGCGAGGCAGACCCAGTACTTCGGGCCA	CASSSDGARQTQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	7	0	6	5	5	19	32	42	37	47													Vb 5.1	CASSSDGARQTQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTATCGGGAGGGCACTCCTACGAGCAGTACTTCGGGCCG	CASSLSGGHSYEQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	8	0	0	2	2	19	33	43	35	45													Vb 5.1	CASSLSGGHSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGACTAGCGGGAGAGGTGGTGAGCAGTTCTTCGGGCCA	CASSLGTSGRGGEQFF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	1	2	9	0	6	19	-1	48	35	54													Vb 5.1	CASSLGTSGRGGEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAACCGGGGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSLTGGGNQPQHF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	2	8	0	2	3	0	19	33	-1	36	44													Vb 5.1	CASSLTGGGNQPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTTAGCGGACTACAAGATGAGCAGTTCTTCGGGCCA	CASSLVSGLQDEQFF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	1	9	8	5	4	19	35	46	40	50						01,02							Vb 5.1	CASSLVSGLQDEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAAGGAATTCGGGACAGCTATGGCTACACCTTCGGTTCG	CASSQGIRDSYGYTF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	4	10	0	19	31	-1	41	48													Vb 5.1	CASSQGIRDSYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAATCACTGGGGGTGGCTCAAGAGACCCAGTACTTCGGGCCA	CASSQSLGVAQETQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-05	01	4	6	1	2	8	5	19	31	44	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSQSLGVAQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAAGGAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLEGAKNIQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-04	01	0	5	4	0	1	0	19	35	-1	36	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLEGAKNIQYF+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01		TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAGACAGGGGGAGGCCCCTACGAGCAGTACTTCGGGCCG	CASSQTGGGPYEQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	1	2	2	5	19	31	42	33	47													Vb 5.1	CASSQTGGGPYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCCCCCCTAGCGGGGGGCGGTACGAGCAGTACTTCGGGCCG	CASSLAPPSGGRYEQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	4	1	4	6	3	19	35	52	41	55													Vb 5.1	CASSLAPPSGGRYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGTACTATCCTCTCAAGAGACCCAGTACTTCGGGCCA	CASSVLSSQETQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	3	9	2	2	6	19	31	37	33	43						01,02							Vb 5.1	CASSVLSSQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCACTAGCGGGAGCAATGAGCAGTTCTTTGGGCCA	CASSSTSGSNEQFF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02			3	3	2	22	2	16	19	32	45	34	61								TCRBJ02-01,TCRBJ02-05					Vb 5.1	CASSSTSGSNEQFF+TCRBV05-01+TCRBJ02-X	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCAGCGGGGGGGAGTATGAGACCCAGTACTTCGGGCCA	CASSFSGGEYETQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	6	0	5	1	5	19	33	44	34	49													Vb 5.1	CASSFSGGEYETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAGAAGCTAGCGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLEASGAYNEQFF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	3	2	5	0	19	33	-1	38	47													Vb 5.1	CASSLEASGAYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCAGGGACAGGGGGCCGCCAAGAGACCCAGTACTTCGGGCCA	CASSPGTGGRQETQYF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	0	1	3	2	19	31	46	34	48													Vb 5.1	CASSPGTGGRQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGCAGGCGTAACCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	31	1.164936172771308E-4		47	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	4	1	2	6	19	35	41	37	47													Vb 5.1	X+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCCGGGACAGTTCCGCGAATGAAAAACTGTTTTTTGGCAGT	CASSFRDSSANEKLFF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	5	5	2	7	19	33	42	35	49													Vb 5.1	CASSFRDSSANEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGACTAGCGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLTSGATGELFF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	3	3	4	0	1	19	-1	44	34	45													Vb 5.1	CASSLTSGATGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAGCGGGGACTCCTACACAGATACGCAGTATTTTGGCCCA	CASSSGDSYTDTQYF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	3	2	0	7	19	-1	38	31	45													Vb 5.1	CASSSGDSYTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAGACTAGCGGAGCATACGAGCAGTACTTCGGGCCG	CASSQTSGAYEQYF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	2	5	4	2	4	19	31	42	33	46						01,02							Vb 5.1	CASSQTSGAYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAACCTTGGACAGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLNLGQGYNEQFF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	3	3	6	0	19	34	-1	40	48													Vb 5.1	CASSLNLGQGYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGGCAGGTCTGAACACTGAAGCTTTCTTTGGACAA	CASSLGAGLNTEAFF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	4	0	3	2	19	35	42	38	44													Vb 5.1	CASSLGAGLNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAATGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSLEWVNTEAFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	0	0	9	0	3	0	19	35	-1	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLEWVNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCACAAATGGGGGTTGGAGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSHKWGLESSYEQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	51	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	4	6	1	0	7	8	19	31	43	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSHKWGLESSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCGGCAGAGAACACTGAAGCTTTCTTTGGACAA	CASSLAAENTEAFF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	0	4	5	1	3	1	19	35	41	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLAAENTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCGCACCCCGGGGGGCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASAPRGAGSYNEQFF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	8	1	1	6	5	19	28	41	34	46													Vb 5.1	CASAPRGAGSYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCCTCCGGGAGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSFLRESSYEQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	8	2	0	4	2	19	33	43	37	45													Vb 5.1	CASSFLRESSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAGGGGGTTCGGTTCGCCCCAGCATTTTGGTGAT		Out	VDJ	1	49	1.8413507247030353E-4		41	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	5	1	9	0	8	19	-1	39	33	47													Vb 5.1	X+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGTAGACAGGGGCCGCGGGAACTGAAGCTTTCTTTGGACAA	CASSP*TGAAGTEAFF	Stop	VDJ	1	50	1.8789293109214644E-4		48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	2	5	5	8	19	31	44	36	52													Vb 5.1	CASSP*TGAAGTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAAGGACCGCAAGTGAGGACAGATACGCAGTATTTTGGCCCA	CASSLEGPQVRTDTQYF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	51	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	0	1	7	3	2	11	19	35	41	37	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLEGPQVRTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGCGTGCTGAGCAGGAGGGTAGGACAGATACGCAGTATTTTGGCCCA	CASSLRAEQEGRTDTQYF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	54	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	10	0	3	11	4	19	34	51	45	55													Vb 5.1	CASSLRAEQEGRTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTCTCTGGGGTCGAATGAGCAGTTCTTCGGGCCA	CASSLSLGSNEQFF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	1	6	2	7	5	3	19	34	43	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLSLGSNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGACAGGCGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLTGGSSYEQYF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	7	2	0	4	0	19	34	-1	38	45													Vb 5.1	CASSLTGGSSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTACGAATACTGACGGTCGAGGGACCATATATTTTGGAGAG		Out	VDJ	6	336	0.0012626404969392241		46	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	11	0	10	16	0	19	32	-1	48	53													Vb 5.1	X+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCCCATAGAATATTTCTGGGAAAGACCTATGGCTACACCATCGGTTCG		Out	VDJ	1	19	7.139931381501565E-5		49	TCRBV17	TCRBV17-01	01				TCRBJ01	TCRBJ01-02	01	5	0	8	18	15	19	22	31	50	46	69				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV17-01+TCRBJ01-02	TCRBV17-01*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTTTCCGGGACAGGGGGCTGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	6.38835965713298E-5		49	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	0	4	7	3	25	36	55	43	58													Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATATTATAGGGGAAATCAGCCCCAGCATTTTGGTGAT	CASSLYYRGNQPQHF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	5	2	4	5	1	25	41	51	46	52													Vb 3	CASSLYYRGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTAGGTCAGCCCCAGCATTTTGGTGAT	CASSLLGQPQHF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	1	5	4	6	1	0	25	41	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLLGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCTCGTGGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSPSWGSYEQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	5	6	1	1	7	0	25	37	-1	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPSWGSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTTGGACTAGCGGGAGAGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSSWTSGRGTGELFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	1	2	5	3	4	25	38	54	41	58													Vb 3	CASSSWTSGRGTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGGCAGAGGGGGGGAGGGCCCCGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	7.515717243685859E-5		46	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	9	0	6	7	7	25	37	51	44	58						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGTAGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSFVGAYNEQFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	5	2	2	3	0	25	39	-1	42	47													Vb 3	CASSFVGAYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCAGGGACTAGCGGGAGGGACTCCCTTTCCTACGAGCAGTACTTCGGGCCG	CASSPGTSGRDSLSYEQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	57	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	0	0	1	4	8	24	35	55	39	63													Vb 3	CASSPGTSGRDSLSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAAACGGGGGGGACGGGGAGGAATGAGCAGTTCTTCGGGCCA	CASKTGGTGRNEQFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	8	0	7	3	9	25	35	46	38	55													Vb 3	CASKTGGTGRNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCCCCCGTTTGGGGCTCGTTCTTCGAGCAGTACTTCGGGCCG	CASSAPVWGSFFEQYF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	7	0	6	10	8	25	37	52	47	60													Vb 3	CASSAPVWGSFFEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTATGACACAGGGGACTCGGCAGCCCCAGCATTTTGGTGAT	CASMTQGTRQPQHF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	3	2	7	6	6	25	33	46	39	52													Vb 3	CASMTQGTRQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCTAGCGGGGAAAAAATACAATGAGCAGTTCTTCGGGCCA	CASTLAGKKYNEQFF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	4	3	4	2	6	25	35	46	37	52													Vb 3	CASTLAGKKYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCAGATAGCGGGAGCGGGCACAGATACGCAGTATTTTGGCCCA	CASSQIAGAGTDTQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	2	1	4	3	25	37	50	41	53													Vb 3	CASSQIAGAGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGCGGGACCGACGAGCAGTACTTCGGGCCG	CASSLSGTDEQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	6	3	5	0	3	25	-1	47	40	50													Vb 3	CASSLSGTDEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGAAGGTGAACTATGGCTACACCTTCGGTTCG	CASKKVNYGYTF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	7	5	4	2	3	2	25	35	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASKKVNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGCAGGGACTAGCGGGAGGGGAGCAGTACTTCGGGCCG	CASSWQGLAGGEQYF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	0	0	7	4	0	25	38	-1	42	58													Vb 3	CASSWQGLAGGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTATTAGGGTGGAAAAGGAGACCCAGTACTTCGGGCCA	CASSFIRVEKETQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	3	5	3	5	4	8	25	39	47	43	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFIRVEKETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATATGGCAGGGGACCTACGAGCAGTACTTCGGGCCG	CASSIWQGTYEQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	2	1	1	25	42	49	43	50													Vb 3	CASSIWQGTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGTACAGGGGGCCTTCGAGCAGTACTTCGGGCCG	CASSLVQGAFEQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	0	6	2	3	25	40	51	42	54													Vb 3	CASSLVQGAFEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTCCCGGACTAGCGGGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	29	1.0897790003344495E-4		50	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	1	3	2	5	0	25	39	-1	44	56													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCACCGGGACCATGAGCTACACCTTCGGTTCG	CASSLTGTMSYTF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	5	0	7	9	6	5	25	37	48	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLTGTMSYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGAATCTTACGGCACAGATACGCAGTATTTTGGCCCA	CASSFESYGTDTQYF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	3	2	8	1	1	8	25	39	42	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFESYGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTGACAGGGATGGATTCACCCCTCCACTTTGGGAAC	CASSLLTGMDSPLHF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	2	3	8	1	4	25	41	49	42	53													Vb 3	CASSLLTGMDSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGTCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFVNTGELFF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	8	6	2	0	2	25	-1	41	39	43						01,02							Vb 3	CASSFVNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCGGGGGGTTCAAGTTCCACTGAAGCTTTCTTTGGACAA	CASSPGGSSSTEAFF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	1	4	2	9	25	36	45	38	54													Vb 3	CASSPGGSSSTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCTTAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSFLSGTDTQYF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	6	1	3	0	25	39	-1	42	47						01,02							Vb 3	CASSFLSGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGCGGCGGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	34	1.277671931426596E-4		46	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	7	5	0	2	0	25	42	-1	44	48						01,02							Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACAAAAGTACGGTCCCTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTKVRSLSYNEQFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	8	5	0	8	5	25	35	46	43	51						01,02							Vb 3	CASTKVRSLSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACACAGGCTTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASTQASTNEKLFF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	3	4	0	1	3	25	35	41	36	44													Vb 3	CASTQASTNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCTTAGCGGGGGGAACACAGATACGCAGTATTTTGGCCCA	CASSSLSGGNTDTQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	5	1	2	4	2	25	38	52	42	54													Vb 3	CASSSLSGGNTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTAGCGGGAGGGCCTCACGGAACAATGAGCAGTTCTTCGGGCCA	CASSPSGRASRNNEQFF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	0	5	1	9	25	37	50	38	59													Vb 3	CASSPSGRASRNNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCTTCGGGGGGGGTGGGGAGACCCAGTACTTCGGGCCA	CASSPFGGGGETQYF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	0	5	6	5	25	36	50	42	55													Vb 3	CASSPFGGGGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATCAGTACAAACATTCAGTACTTCGGCGCC	CASSLISTNIQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	4	5	6	2	3	25	40	45	42	48													Vb 3	CASSLISTNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATATGCCCCCCGCAGGCTAGCGGATTACGAGCAGTACTTCGGGCCG	CASSLYAPRRLADYEQYF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	4	5	4	14	2	25	41	62	55	64						01,02							Vb 3	CASSLYAPRRLADYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGTTTACAGGGGGGCCCCAGCATTTTGGTGAT	CASRFTGGPQHF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	1	9	4	0	25	36	-1	40	48													Vb 3	CASRFTGGPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGGCTCTACGGGCGGATCGGTAGATACGCAGTATTTTGGCCCA	CAGSTGGSVDTQYF	In	VDJ	1	48	1.803772138484606E-4	2.135715843007088E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	11	8	0	5	8	8	25	31	43	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CAGSTGGSVDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCTAGGGCCAACGTCCTGACTTTCGGGGCC	CASRPRANVLTF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	4	9	5	2	0	25	36	-1	38	41						01,02							Vb 3	CASRPRANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCTACTAGCGGCCACACTCACAGATACGCAGTATTTTGGCCCA	CASSSLLAATLTDTQYF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	3	5	2	4	7	25	38	50	42	57						01,02							Vb 3	CASSSLLAATLTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAAGACTAGCGGAGGCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	52	1.954086483358323E-4		43	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	5	4	2	4	25	36	47	38	51						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCCCGGTGATAGGGGGCATAAAAAACTGTTTTTTGGCAGT	CASRPGDRGHKKLFF	In	VDJ	1	52	1.954086483358323E-4	2.3136921632576786E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	5	0	9	10	3	25	36	53	46	56													Vb 3	CASRPGDRGHKKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGGGACAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGGQNTGELFF	In	VDJ	1	52	1.954086483358323E-4	2.3136921632576786E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	6	1	2	0	25	40	-1	42	48													Vb 3	CASSLGGQNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAATCCCGGGGGCTAGCGGTCTACGAGCAGTACTTCGGGCCG	CASKSRGLAVYEQYF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	4	5	3	11	1	25	35	53	46	54						01,02							Vb 3	CASKSRGLAVYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCAGACGGAATCCAAGAGACCCAGTACTTCGGGCCA	CASSPDGIQETQYF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	5	1	8	1	6	2	25	37	46	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPDGIQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCCCCGATACAGGGGGCTGTGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	54	2.0292436557951818E-4		50	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	0	7	8	4	25	39	56	47	60													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGAAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSLKGNQPQHF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	3	5	4	2	2	0	25	39	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLKGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTACAGGGGATCGATTGGCTATGGCTACACCTTCGGTTCG	CASYRGSIGYGYTF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	3	2	4	1	9	25	34	42	35	51													Vb 3	CASYRGSIGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCAGGGGGCCGGGGCTACACCTTCGGTTCG	CASSLSGGRGYTF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	0	8	0	3	25	-1	49	41	52													Vb 3	CASSLSGGRGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGGAAGGTAACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASGKVTGANVLTF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-06	01	8	0	8	2	0	6	25	-1	38	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASGKVTGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01		TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCCTAACGTTGACTATCAGTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	58	2.179558000668899E-4		47	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	2	9	1	10	4	25	32	47	42	51						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCATGGGGACTAGCGGGAGACGCCCCCACAATGAGCAGTTCTTCGGGCCA	CASSPMGTSGRRPHNEQFF	In	VDJ	1	60	2.2547151731057573E-4	2.66964480375886E-4	57	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	2	5	7	8	24	35	56	42	64													Vb 3	CASSPMGTSGRRPHNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCAGGGTGCCAAAAACATTCAGTACTTCGGCGCC	CASSQGAKNIQYF	In	VDJ	1	60	2.2547151731057573E-4	2.66964480375886E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	4	3	1	1	1	25	36	42	37	43													Vb 3	CASSQGAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGGGGACCTTTAATGAAAAACTGTTTTTTGGCAGT	CASSSGTFNEKLFF	In	VDJ	1	60	2.2547151731057573E-4	2.66964480375886E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	4	0	7	4	2	3	25	38	45	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSGTFNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCGCCCCCGTACAGGGTAATAAGCTCCGGGGAGCTGTTTTTTGGAGAA	CASSLSPPYRVISSGELFF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	57	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	3	3	6	9	9	24	40	55	49	64													Vb 3	CASSLSPPYRVISSGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGGGGGGGCTAGCGGCCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGGASGRSYNEQFF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	0	0	10	25	-1	44	36	54													Vb 3	CASSGGASGRSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCTAGGGACGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	61	2.2922937593241867E-4		38	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-02	01	4	0	8	7	5	0	25	38	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAGTCCGGGACTAGCGGGAGGTGAGCAGTTCTTCGGGCCA	CASSSPGLAGGEQFF	In	VDJ	1	63	2.3674509317610454E-4	2.803127043946803E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	1	9	5	0	25	37	-1	42	57													Vb 3	CASSSPGLAGGEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCGTTTTGGGCTAGCGGGTCCTACTACGAGCAGTACTTCGGGCCG	CASSLPFWASGSYYEQYF	In	VDJ	1	63	2.3674509317610454E-4	2.803127043946803E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	4	3	10	5	25	40	58	50	63						01,02							Vb 3	CASSLPFWASGSYYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTCACAGCCCACCGGGGAGCTGTTTTTTGGAGAA	CASTSQPTGELFF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	3	5	4	4	2	25	35	43	39	45													Vb 3	CASTSQPTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTCTCCCGGACAGGCCCTCCTACGAGCAGTACTTCGGGCCG	CASSPLPDRPSYEQYF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	4	0	9	2	25	36	52	45	54													Vb 3	CASSPLPDRPSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCAGGGGCGGAAGAGACCCAGTACTTCGGGCCA	CASSLSGAEETQYF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	2	3	0	3	25	-1	47	41	50													Vb 3	CASSLSGAEETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGTGGCACCGAAAACTATGGCTACACCTTCGGTTCG	CASSLGGTENYGYTF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	3	0	9	2	0	10	25	-1	42	39	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGGTENYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCACGGACTAGCGGGAGGGTACGAGCAGTACTTCGGGCCG	CASSHGLAGGYEQYF	In	VDJ	1	65	2.442608104197904E-4	2.8921152040720983E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	1	0	4	3	0	25	37	-1	40	55													Vb 3	CASSHGLAGGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTACAGGCCCAACACTGAAGCTTTCTTTGGACAA	CASSYRPNTEAFF	In	VDJ	1	65	2.442608104197904E-4	2.8921152040720983E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	4	2	0	3	25	-1	43	38	46													Vb 3	CASSYRPNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACTCGTGCTTTAGCGCGGGACAATGAGCAGTTCTTCGGGCCA	CASTRALARDNEQFF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	5	6	5	9	4	25	35	49	44	53						01,02							Vb 3	CASTRALARDNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCTTCGGACAGGGTCGTCAGCCCCAGCATTTTGGTGAT	CASSPFGQGRQPQHF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	3	6	7	3	25	36	51	43	54													Vb 3	CASSPFGQGRQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTTTCGCGGAACTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	73	2.7432367939453383E-4		47	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	7	5	2	4	4	25	41	49	45	53						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCTATCCGGCACAGATACGCAGTATTTTGGCCCA	CASSFLSGTDTQYF	In	VDJ	1	73	2.7432367939453383E-4	3.2480678445732795E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	9	1	1	4	25	39	43	40	47						01,02							Vb 3	CASSFLSGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGTCGGCATTTCTCCTACGAGCAGTACTTCGGGCCG	CASSLSRHFSYEQYF	In	VDJ	1	77	2.893551138819055E-4	3.4260441648238703E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	2	9	0	0	4	4	25	40	47	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLSRHFSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGACCGGACAGGGCGGCACAGATACGCAGTATTTTGGCCCA	CASSLTGQGGTDTQYF	In	VDJ	1	78	2.931129725037485E-4	3.470538244886518E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	3	1	4	2	25	39	51	43	53													Vb 3	CASSLTGQGGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTATAACGATTACTAGCGGGAGTGATACCGGGGAGCTGTTTTTTGGAGAA	CASSSITITSGSDTGELFF	In	VDJ	1	80	3.0062868974743435E-4	3.559526405011813E-4	57	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	3	2	5	11	4	24	37	59	48	63													Vb 3	CASSSITITSGSDTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGACCGGGACTTCCTATGGGCAATGAGCAGTTCTTCGGGCCA	CASSRPGLPMGNEQFF	In	VDJ	1	81	3.0438654836927726E-4	3.6040204850744606E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	10	6	6	9	25	36	48	42	57						01,02							Vb 3	CASSRPGLPMGNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGCCTTTAGGCGGGAGTTGGCGGGGAGCTGTTTTTTGGAGAA	CASSRL*AGVGGELFF	Stop	VDJ	1	81	3.0438654836927726E-4		48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	7	2	7	9	4	25	37	53	46	57													Vb 3	CASSRL*AGVGGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTCGGACTAGCGGCAGAAGCAATGAGCAGTTCTTCGGGCCA	CASSSRTSGRSNEQFF	In	VDJ	1	81	3.0438654836927726E-4	3.6040204850744606E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	5	6	3	6	25	38	51	41	57						01,02							Vb 3	CASSSRTSGRSNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTACGTAAGAGGGTGGAACTACGAGCAGTACTTCGGGCCG	CASSYVRGWNYEQYF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	11	0	3	6	5	25	38	49	44	54													Vb 3	CASSYVRGWNYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCGGGACAGCTAATCAGCCCCAGCATTTTGGTGAT	CASSSGTANQPQHF	In	VDJ	1	89	3.344494173440207E-4	3.9599731255756423E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	5	4	2	2	25	38	47	40	49													Vb 3	CASSSGTANQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTAGAAGGGATAATGAAAAACTGTTTTTTGGCAGT	CASSSRRDNEKLFF	In	VDJ	2	90	3.382072759658636E-4	4.00446720563829E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	4	0	8	4	6	0	25	38	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSRRDNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAGCGGGATTCTCAGTACTTCGGGCCA	CASSLQRDSQYF	In	VDJ	2	90	3.382072759658636E-4	4.00446720563829E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	6	3	11	1	4	25	40	48	41	52													Vb 3	CASSLQRDSQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCACAGGGACTAGCGGGACTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	92	3.4572299320954946E-4		47	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	3	6	4	2	25	37	54	41	56													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGGTCGCACAGATACGCAGTATTTTGGCCCA	CASSPGRTDTQYF	In	VDJ	2	94	3.532387104532353E-4	4.1824435258888806E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	8	5	1	2	2	25	37	42	39	44						01,02							Vb 3	CASSPGRTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTGGCAGGGCGAGCAGTACTTCGGGCCG	CASSFWQGEQYF	In	VDJ	2	94	3.532387104532353E-4	4.1824435258888806E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	6	4	0	25	39	-1	43	48													Vb 3	CASSFWQGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGACTAGCACCTACGAGCAGTACTTCGGGCCG	CASSLTSTYEQYF	In	VDJ	2	94	3.532387104532353E-4	4.1824435258888806E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	2	7	2	0	1	25	-1	46	39	47						01,02							Vb 3	CASSLTSTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCTTAGCGGGACAGATACGCAGTATTTTGGCCCA	CASSFLSGTDTQYF	In	VDJ	2	96	3.607544276969212E-4	4.271431686014176E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	4	3	3	0	25	39	-1	42	49						01,02							Vb 3	CASSFLSGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCACCACAGATACGCAGTATTTTGGCCCA	CASSFTTDTQYF	In	VDJ	2	97	3.645122863187641E-4	4.3159257660768235E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	3	3	7	2	1	0	25	39	-1	40	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFTTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCAACAGACAGGGGGCAGGAGAGCAGTACTTCGGGCCG	CATNRQGAGEQYF	In	VDJ	2	99	3.7202800356245E-4	4.404913926202119E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	2	0	7	6	4	25	32	48	38	52													Vb 3	CATNRQGAGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGGCCGCCCCGGTACCAAGAGACCCAGTACTTCGGGCCA	CASGPPRYQETQYF	In	VDJ	2	99	3.7202800356245E-4	4.404913926202119E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	8	0	0	0	9	25	-1	38	34	47													Vb 3	CASGPPRYQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCGGGAGGGAATGAGGATACGCAGTATTTTGGCCCA	CASSPGGNEDTQYF	In	VDJ	2	104	3.908172966716646E-4	4.627384326515357E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	8	0	6	2	6	25	36	46	38	52													Vb 3	CASSPGGNEDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGTCCGGGACGGCCGTGTGGGGCTACACCTTCGGTTCG	CASRSGTAVWGYTF	In	VDJ	2	104	3.908172966716646E-4	4.627384326515357E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	6	0	7	8	4	10	25	36	45	40	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRSGTAVWGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGGACAGCCTCCCCACGAGCAGTACTTCGGGCCG	CASSPGQPPHEQYF	In	VDJ	2	105	3.9457515529350753E-4	4.6718784065780046E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	5	5	3	7	25	37	46	40	53													Vb 3	CASSPGQPPHEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCTGGGGGGCTAGTAGAGGGCTACGAGCAGTACTTCGGGCCG	CASTPGGLVEGYEQYF	In	VDJ	2	107	4.020908725371934E-4	4.7608665667033E-4	48	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	7	6	0	3	6	10	25	35	47	41	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTPGGLVEGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGATTTAACCTATCGGGGCTACACCTTCGGTTCG	CASSLDLTYRGYTF	In	VDJ	2	110	4.133644484027222E-4	4.894348806891243E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	4	9	8	8	4	25	40	51	48	55						01,02							Vb 3	CASSLDLTYRGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACGACAGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSLTTGGSGNTIYF	In	VDJ	2	111	4.1712230702456514E-4	4.938842886953891E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	2	1	0	2	0	25	40	-1	42	51													Vb 3	CASSLTTGGSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTATAGTAAGGAGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSFIVRSSNQPQHF	In	VDJ	2	111	4.1712230702456514E-4	4.938842886953891E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	10	2	0	8	0	25	39	-1	47	51													Vb 3	CASSFIVRSSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACGTCAACTGGAGCAGTACTTCGGGCCG	CASSLRQLEQYF	In	VDJ	2	113	4.24638024268251E-4	5.027831047079186E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	10	7	5	1	25	40	48	45	49						01,02							Vb 3	CASSLRQLEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTTTAGCGGGAGTACTAATGAGCAGTTCTTCGGGCCA	CASSFFSGSTNEQFF	In	VDJ	2	113	4.24638024268251E-4	5.027831047079186E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	2	7	3	4	25	39	51	42	55													Vb 3	CASSFFSGSTNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTACTTTAGACAGGGGGTACGAGCAGTACTTCGGGCCG	CASSFTLDRGYEQYF	In	VDJ	2	115	4.321537415119368E-4	5.116819207204482E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	1	4	7	0	25	39	-1	46	55													Vb 3	CASSFTLDRGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGACTAATCGGAGCGACTAGCACAGATACGCAGTATTTTGGCCCA	CASSRLIGATSTDTQYF	In	VDJ	2	119	4.4718517599930856E-4	5.294795527455073E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	9	0	2	12	25	36	43	38	55						01,02							Vb 3	CASSRLIGATSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGCGGGGGGGCTAAAAACATTCAGTACTTCGGCGCC	CASSLGGGAKNIQYF	In	VDJ	2	119	4.4718517599930856E-4	5.294795527455073E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	7	0	4	1	2	25	40	50	41	52													Vb 3	CASSLGGGAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCGCGCGGGGTTAGAGACCCAGTACTTCGGGCCA	CASSFRAGLETQYF	In	VDJ	2	127	4.77248044974052E-4	5.650748167956253E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	3	4	4	2	25	39	49	43	51													Vb 3	CASSFRAGLETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCAACTTAGGGTCTGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CASSPNLGSGGNQPQHF	In	VDJ	2	129	4.8476376221773785E-4	5.739736328081549E-4	51	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	5	5	3	2	8	7	25	37	49	45	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPNLGSGGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCGGGAGGCTATGGCTACACCTTCGGTTCG	CASSLPGGYGYTF	In	VDJ	2	132	4.960373380832666E-4	5.873218568269492E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	8	1	4	1	0	25	40	-1	41	48													Vb 3	CASSLPGGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGAGGCTAGCGGGGTTGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	138	5.185844898143242E-4		49	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	0	4	3	25	39	52	43	55													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACACGGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASRHGASTDTQYF	In	VDJ	2	140	5.261002070580101E-4	6.229171208770673E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	6	7	0	0	4	1	25	36	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRHGASTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCCCTCTTCGGTAGTCCACGAGCAGTACTTCGGGCCG	CASSPPSSVVHEQYF	In	VDJ	2	141	5.29858065679853E-4	6.273665288833321E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	5	13	3	25	37	53	50	56						01,02							Vb 3	CASSPPSSVVHEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACTACGGTAGGGGGAGCTCTTTACGAGCAGTACTTCGGGCCG	CASTTVGGALYEQYF	In	VDJ	2	142	5.336159243016959E-4	6.318159368895968E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	5	1	4	7	7	25	35	48	42	55													Vb 3	CASTTVGGALYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGACAGCCCGGATCTACAATGAGCAGTTCTTCGGGCCA	CASSLTARIYNEQFF	In	VDJ	2	143	5.373737829235389E-4	6.362653448958616E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	5	3	0	7	25	-1	44	39	51													Vb 3	CASSLTARIYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCCGGACCTGGCGGGTCAGCTCTGGAAACACCATATATTTTGGAGAG	CARTWRVSSGNTIYF	In	VDJ	2	146	5.486473587890677E-4	6.496135689146559E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	11	7	4	0	8	4	25	31	44	39	48						01,02							Vb 3	CARTWRVSSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGTTGGGGGAGAAATGGGACAATGAGCAGTTCTTCGGGCCA	CASSLLGEKWDNEQFF	In	VDJ	3	151	5.674366518982823E-4	6.718606089459797E-4	48	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	3	6	1	5	3	9	25	39	47	42	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLLGEKWDNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGGCCTACGAGCAGTACTTCGGGCCG	CASSLWAYEQYF	In	VDJ	3	152	5.711945105201252E-4	6.763100169522445E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	0	0	10	2	0	0	25	-1	-1	42	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLWAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCGAGCGGGAGTCTTTTATGACACCGGGGAGCTGTTTTTTGGAGAA	CASRAGVFYDTGELFF	In	VDJ	3	160	6.012573794948687E-4	7.119052810023626E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	6	2	3	2	9	25	34	44	36	53													Vb 3	CASRAGVFYDTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAAGCGTCAATCTACGAGCAGTACTTCGGGCCG	CASSLQASIYEQYF	In	VDJ	3	161	6.050152381167115E-4	7.163546890086274E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	6	6	3	2	5	25	40	46	42	51						01,02							Vb 3	CASSLQASIYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCAAAAGGAAGCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	3	169	6.35078107091455E-4		47	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	3	1	8	0	5	3	25	39	47	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGCGGTGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	171	6.425938243351408E-4		40	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	3	8	0	1	0	4	25	-1	43	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTGTCGGGCGGGAGAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	180	6.764145519317272E-4		44	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	7	2	2	6	1	25	34	47	40	48													Vb 3	X+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTTTAAAATACGGTCGCTGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	182	6.839302691754131E-4		46	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	9	8	5	1	9	7	25	33	45	42	52						01,02							Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGACAGGCAATCAGCCCCAGCATTTTGGTGAT	CASSPTGNQPQHF	In	VDJ	3	185	6.952038450409419E-4	8.231404811589818E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	5	2	2	0	25	37	-1	39	44													Vb 3	CASSPTGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGACAGGGGGGGATACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	199	7.478138657467429E-4		43	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	1	2	0	5	25	-1	46	36	51													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAAAAAGGGGAGGGGAGACCCAGTACTTCGGGCCA	CASRKRGGETQYF	In	VDJ	4	214	8.041817450743868E-4	9.5217331334066E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	0	5	6	0	25	36	-1	42	49													Vb 3	CASRKRGGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTCCGGACTAGCGGGAGATACACCGGGGAGCTGTTTTTTGGAGAA	CASSLFRTSGRYTGELFF	In	VDJ	4	216	8.116974623180727E-4	9.610721293531896E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	1	2	3	3	2	25	41	57	44	59													Vb 3	CASSLFRTSGRYTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGACAGCGAGGACTAGCGGGAGTTCGTACTTCGGGCCG	CASSLTARTSGSSYF	In	VDJ	4	218	8.192131795617585E-4	9.699709453657191E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	1	2	12	8	3	25	39	60	47	63													Vb 3	CASSLTARTSGSSYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCCCCGGGGGGGATATATATGGGACACTGAAGCTTTCTTTGGACAA	CASSFPRGGYIWDTEAFF	In	VDJ	4	223	8.380024726709731E-4	9.92217985397043E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	0	3	4	11	25	39	51	43	62													Vb 3	CASSFPRGGYIWDTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGGACAGGCTGCAGCCCCAGCATTTTGGTGAT	CASSSDRLQPQHF	In	VDJ	4	227	8.530339071583449E-4	0.001010015617422102	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	4	7	1	3	25	38	46	39	49													Vb 3	CASSSDRLQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGGGGACACAGACGAAGCTTTCTTTGGACAA	CASSPGDTDEAFF	In	VDJ	4	239	8.981282106204601E-4	0.0010634085134972793	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	8	4	5	25	37	47	41	52													Vb 3	CASSPGDTDEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGCGACTAGCGGGAGTCGCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	262	9.845589589228473E-4		47	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	2	2	8	2	5	25	39	53	41	58													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCAGGGTCCCCGAGCAGTACTTCGGGCCG	CASSFRVPEQYF	In	VDJ	4	263	9.883168175446903E-4	0.0011701943056476336	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	6	0	4	25	-1	44	39	48													Vb 3	CASSFRVPEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCAGCCCCGGGACAGGGTCTTTCTACGAGCAGTACTTCGGGCCG	CASSSPGTGSFYEQYF	In	VDJ	5	282	0.001059716131359706	0.0012547330577666641	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	3	7	5	25	36	52	43	57													Vb 3	CASSSPGTGSFYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGATTCTGGGACAGGGTGGACCGCATAACTATGGCTACACCTTCGGTTCG	CASSLILGQGGPHNYGYTF	In	VDJ	5	296	0.001112326152065507	0.001317024769854371	57	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	1	6	9	24	38	53	44	62													Vb 3	CASSLILGQGGPHNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGCAGAAGAGTTAGATACGAGCAGTACTTCGGGCCG	CASSLGRRVRYEQYF	In	VDJ	5	306	0.0011499047382839364	0.0013615188499170186	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	8	0	4	0	12	25	-1	43	39	55													Vb 3	CASSLGRRVRYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGTTTTTTCGGGTGAAGCTTTCTTTGGACAA	CASRVFSGEAFF	In	VDJ	5	324	0.001217546193477109	0.0014416081940297842	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	4	7	8	0	25	36	-1	44	48						01,02							Vb 3	CASRVFSGEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAGTGTGGGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSVGAGANVLTF	In	VDJ	6	356	0.0013377976693760827	0.001583989250230257	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-06	01	5	6	1	2	5	0	25	37	-1	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSVGAGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01		TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAACCCGACAGACGAGCAGTACTTCGGGCCG	CASSNPTDEQYF	In	VDJ	7	403	0.0015144170246027004	0.001793111426524701	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	5	5	0	25	37	-1	42	47													Vb 3	CASSNPTDEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAGAACAGGGCCTCTCTGGAAACACCATATATTTTGGAGAG	CASREQGLSGNTIYF	In	VDJ	12	715	0.0026868689146176943	0.003181326724479308	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	3	0	3	3	25	36	45	39	48													Vb 3	CASREQGLSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCTCCGGGACAGGGGTCCACGAGCAGTACTTCGGGCCG	CASSSSGTGVHEQYF	In	VDJ	12	735	0.0027620260870545527	0.0032703148846046034	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	5	5	3	25	38	53	43	56													Vb 3	CASSSSGTGVHEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGGGGACTAGCGGGACACAGATACGCAGTATTTTGGCCCA	CAGD*RDTDTQYF	Stop	VDJ	14	852	0.0032016955458101753		39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	0	3	2	1	0	25	31	-1	32	45													Vb 3	CAGD*RDTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAAGACTCRGCCCTGTATCTCTGCGCCAGCAGCCAAGACCCGACAGGGGGATACACTGAAGCTTTCTTTGGACAA	CASSQDPTGGYTEAFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	48	TCRBV04	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	1	3	3	2	23	40	52	43	54		TCRBV04-01,TCRBV04-03												CASSQDPTGGYTEAFF+TCRBV04-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGCCTCACCGGGGAGCAGTTCTTCGGGCCA	CASSLTGEQFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	33	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	8	4	10	6	0	28	39	-1	45	49		TCRBV06-04,TCRBV06-07				01,02								CASSLTGEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTCCACTAGCGGCCTACGAGCAGTACTTCGGGCCG	CASSPLAAYEQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	5	2	2	0	23	35	-1	37	45		TCRBV06-04,TCRBV06-08				01,02								CASSPLAAYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTACCTAACAGGTGGAAATCAGCCCCAGCATTTTGGTGAT	CASSYLTGGNQPQHF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	4	4	5	4	18	31	41	36	45		TCRBV07-05,TCRBV07-06												CASSYLTGGNQPQHF+TCRBV07-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGGGGCCAGGGAGGTCCACTGAAGCTTTCTTTGGACAA	CASSLGPGRSTEAFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	1	4	7	2	18	32	45	39	47		TCRBV11-01,TCRBV11-03												CASSLGPGRSTEAFF+TCRBV11-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCTGTTACCCAGGGGGCGGAGTCCTCGGCTACACCTTCGGTTCG	CASCYPGGGVLGYTF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	TCRBV12	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	0	8	3	9	22	35	46	38	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASCYPGGGVLGYTF+TCRBV12-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGGACTCSGCCGTGTATCTCTGTGCTAGCAGCTTTGCAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSFAGTGELFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	4	4	2	0	18	32	-1	34	38		TCRBV07-02,TCRBV07-08												CASSFAGTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCTKTGTACTTSTGTGCCAGCAGTTACTCGATTAGGACAGGGGGCGTGATTCGGGGCACAGATACGCAGTATTTTGGCCCA	CASSYSIRTGGVIRGTDTQYF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	63	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	1	0	1	5	10	10	27	43	32	53		TCRBV06-02,TCRBV06-03,TCRBV06-08												CASSYSIRTGGVIRGTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCCCCTGGGGGGGGCTGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPWGGLDTGELFF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	9	0	3	4	5	19	31	42	35	47		TCRBV07-05,TCRBV07-06												CASSPWGGLDTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTCCAATGACAGGGGTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSFQ*QGFTGELFF	Stop	VDJ	1	23	8.643074830238736E-5		48	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	2	4	5	2	19	33	46	38	48		TCRBV11-01,TCRBV11-03												CASSFQ*QGFTGELFF+TCRBV11-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGRGGACTYSGCYGTGTATCTCTGTGCCAGCAGCCCAACGGTCAATTCACCCCTCCACTTTGGGAAC	CASSPTVNSPLHF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	8	5	7	4	2	22	34	41	38	43		TCRBV07-01,TCRBV07-08				01,02								CASSPTVNSPLHF+TCRBV07-X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACCCACCGGGACTGTTGACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	24	9.01886069242303E-5		47	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	7	0	10	2	6	4	26	36	48	42	52		TCRBV06-07,TCRBV06-08				01,02								X+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTATGGCGGCAAGAGACCCAGTACTTCGGGCCA	CASSLWRQETQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	7	5	2	4	0	22	35	-1	39	43		TCRBV07-01,TCRBV07-04				01,02								CASSLWRQETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCACCAGGACTAGCGGGAGTTACGAGCAGTACTTCGGGCCG	CASTRTSGSYEQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	1	2	4	3	1	23	33	49	36	50		TCRBV06-04,TCRBV06-08												CASTRTSGSYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTCGAGAAGGGCTAGCTTGGTATTTTGGCCCA	CASSREGLAWYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	36	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	7	14	9	3	26	38	52	47	55		TCRBV10-01,TCRBV10-02				01,02								CASSREGLAWYF+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACTCGGTCAGGGCCCCCGGTGGCTACACCTTCGGTTCG	CASSYSVRAPGGYTF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	7	3	7	28	45	53	48	60		TCRBV06-04,TCRBV06-07												CASSYSVRAPGGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGACCCAGCGGGGGGGGTACAGATACGCAGTATTTTGGCCCA	CASRPSGGGTDTQYF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	0	3	4	2	23	34	48	38	50		TCRBV06-04,TCRBV06-08												CASRPSGGGTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTATAGCGGGAGGACCATACAATGAGCAGTTCTTCGGGCCA	CASSIAGGPYNEQFF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	1	4	1	4	26	38	49	39	53		TCRBV06-07,TCRBV06-08												CASSIAGGPYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTGACTCGGCCGAGGCAGTACTTCGGGCCG		Out	VDJ	1	33	1.2400933452081666E-4		34	TCRBV06	unresolved					TCRBJ02	TCRBJ02-07	01	0	9	0	9	0	4	26	-1	46	43	50		TCRBV06-04,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCGGACTAGCGGGAGGGCCTATGAGCAGTTCTTCGGGCCA	CASSRTSGRAYEQFF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	1	0	8	1	3	19	31	47	32	50		TCRBV11-01,TCRBV11-03												CASSRTSGRAYEQFF+TCRBV11-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCARACWTCTGTKTACTTCTGTGCCTATACAGGGGTCCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	39	1.4655648625187424E-4		34	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	3	2	5	3	4	26	32	42	35	46		TCRBV06-02,TCRBV06-03,TCRBV06-07												X+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTAGCGGCACTAGCACAGATACGCAGTATTTTGGCCCA	CASSSGTSTDTQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	5	0	0	4	26	-1	43	38	47		TCRBV06-07,TCRBV06-08				01,02								CASSSGTSTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGATATATCTACCGGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	42	1.5783006211740302E-4		43	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	9	4	9	0	6	4	23	31	40	37	44		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAGGGCAGGGACGGTCTGGAAACACCATATATTTTGGAGAG	CASSLGQGRSGNTIYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	48	TCRBV07	unresolved					TCRBJ01	TCRBJ01-03	01	1	0	7	1	4	2	19	35	44	39	46		TCRBV07-05,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGQGRSGNTIYF+TCRBV07-X+TCRBJ01-03	unresolved		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTTACATGGTGAGGGCCCCCCCTGAGTTTGAGCAGTTCTTCGGGCCA	CASSYMVRAPPEFEQFF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	51	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	11	0	9	5	13	23	38	48	43	61		TCRBV06-08,TCRBV06-09												CASSYMVRAPPEFEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAACGGGGATACGAGCAGTACTTCGGGCCG	CASSERGYEQYF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	36	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	8	3	4	0	1	23	-1	43	38	44		TCRBV06-01,TCRBV06-07,TCRBV06-08												CASSERGYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACCCCCCAGCAGGGGGCCTGCGGAATAAGCAGTTCTTCGGGCCA	CASSYPPAGGLRNKQFF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	51	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	0	11	7	10	26	41	56	48	66		TCRBV06-07,TCRBV06-08												CASSYPPAGGLRNKQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACGCTGAATAGGGGTCTTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	46	1.7286149660477473E-4		53	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	5	2	0	10	4	23	35	50	45	54		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGAGAGACCGGGACAGGGGGCGATCACTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	46	1.7286149660477473E-4		53	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	0	3	3	7	23	38	53	41	60		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTGGGGCCCGGACAGGGGGGACTATGGCTACACCTTCGGTTCG	CASSWGPDRGDYGYTF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	1	3	7	1	23	36	53	43	54		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSWGPDRGDYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGCCAGGGGGCCTCTTCGCACGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	47	1.7661935522661766E-4		52	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	0	1	1	10	26	39	48	40	58		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTAAGCCCGAAAGAGACCCAGTACTTCGGGCCA	CASSLSPKETQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	6	7	3	2	4	22	35	40	37	44		TCRBV07-01,TCRBV07-02				01,02								CASSLSPKETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAAAACTCCATAGGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	48	1.803772138484606E-4		37	TCRBV10	unresolved					TCRBJ02	TCRBJ02-05	01	10	5	3	3	9	0	23	30	-1	39	43		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTCTACCCCGAACACACAGGGGGGCTACACCTTCGGTTCG	CASSSTPNTQGGYTF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	2	8	13	0	26	39	-1	52	59		TCRBV06-07,TCRBV06-08												CASSSTPNTQGGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCGGGGGCCTAGCACCCAATTAAGAAAAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	49	1.8413507247030353E-4		52	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	6	0	1	0	19	23	-1	35	29	54		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGGTTTAGCGTCTCAGATACGCAGTATTTTGGCCCA	CASRFSVSDTQYF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	6	4	3	3	18	29	37	32	40		TCRBV07-02,TCRBV07-08				01,02								CASRFSVSDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGTCCCCGACTCCGACCACCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	53	1.9916650695767524E-4		49	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	4	2	10	2	5	7	23	36	45	41	52		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAATACTCTGGAAACACCATATATTTTGGAGAG	CASSEYSGNTIYF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	39	TCRBV06	unresolved		unresolved			TCRBJ01	TCRBJ01-03	01	5	2	8	0	0	3	26	-1	40	38	43		TCRBV06-01,TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02										CASSEYSGNTIYF+TCRBV06-X+TCRBJ01-03	unresolved	unresolved	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTTGGGGCAGGAGAATGGCTACACCTTCGGTTCG	CASSLGQENGYTF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	7	0	6	1	6	26	39	45	40	51		TCRBV06-07,TCRBV06-08												CASSLGQENGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTCRGCYRTGTATCKCTGTGCCAGCAGCTCACCTTCGCCGGGCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	56	2.1044008282320402E-4		44	TCRBV07	unresolved					TCRBJ02	TCRBJ02-01	01	4	8	0	5	10	0	18	31	-1	41	45		TCRBV07-04,TCRBV07-06		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTCAGCYRTGTATCKCTGTGCCAGCAGCTTAACGTAGGGATTGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	58	2.179558000668899E-4		43	TCRBV07	unresolved					TCRBJ02	TCRBJ02-07	01	2	0	8	4	5	4	22	37	46	42	50		TCRBV07-04,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCCTAGGGGCCCTTCTCATACAATAAGCAGTTCTTCGGGCCA		Out	VDJ	1	60	2.2547151731057573E-4		47	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	5	2	11	4	16	23	34	43	38	59		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGGTGTCCGATGGCTACACCTTCGGTTCG	CASSESVSDGYTF	In	VDJ	1	60	2.2547151731057573E-4	2.66964480375886E-4	39	TCRBV10	unresolved					TCRBJ01	TCRBJ01-02	01	0	0	10	6	0	6	26	-1	45	43	51		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESVSDGYTF+TCRBV10-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGCTCCGGGACCGCAACCCCGCAGTATTTTGGCCCA	CASSSGTATPQYF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	39	TCRBV10	unresolved					TCRBJ02	TCRBJ02-03	01	6	0	7	10	4	8	26	37	46	41	54		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGTATPQYF+TCRBV10-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTCCCCGGAGAACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPRRTTNEKLFF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	10	2	0	4	2	23	35	43	39	45		TCRBV06-04,TCRBV06-08												CASSPRRTTNEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCCTGGAGGGACGATAACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	64	2.4050295179794745E-4		38	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	11	10	0	5	2	6	22	28	36	30	42		TCRBV07-01,TCRBV07-04												X+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGGACTAGCGGCACCACAGAGGGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	66	2.480186690416333E-4		55	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	5	5	3	13	26	38	51	41	64		TCRBV06-01,TCRBV06-07				01,02								X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCATCCCAGGGGGACAGATTGAAGCTTTCTTTGGACAA	CASIPGGQIEAFF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	5	7	7	2	23	33	47	40	49		TCRBV06-04,TCRBV06-08												CASIPGGQIEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGCCCCCGGGTACTGAGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	69	2.592922449071621E-4		43	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	8	4	7	5	8	23	34	43	39	51		TCRBV06-07,TCRBV06-08				01,02								X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCCCGCTAGCGGGGGGGACGTTCTTCTACGAGCAGTACTTCGGGCCG	CASSPLAGGTFFYEQYF	In	VDJ	1	69	2.592922449071621E-4	3.0700915243226886E-4	51	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	4	0	3	3	8	19	31	46	34	54		TCRBV07-06,TCRBV07-07												CASSPLAGGTFFYEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACCCTACTGGGATTAATTCACCCCTCCACTTTGGGAAC	CASSYPTGINSPLHF	In	VDJ	1	71	2.6680796215084796E-4	3.159079684447984E-4	45	TCRBV06	unresolved					TCRBJ01	TCRBJ01-06	01	2	0	8	6	6	1	26	41	51	47	52		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPTGINSPLHF+TCRBV06-X+TCRBJ01-06	unresolved		TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGSGACTYGGCTGTGTATCTCTGTGCCAGCAGGCCACTCCTACTAGCGGGAGTTCGCGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	72	2.7056582077269087E-4		52	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	3	2	5	12	6	19	27	50	39	56		TCRBV07-01,TCRBV07-05												X+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGAAGGGATAAGCCGACTATGGCTACACCTTCGGTTCG	CASSEKG*ADYGYTF	Stop	VDJ	1	75	2.818393966382197E-4		45	TCRBV10	unresolved					TCRBJ01	TCRBJ01-02	01	2	0	8	3	2	7	23	38	44	40	51		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEKG*ADYGYTF+TCRBV10-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCACTCGAACAGGGGTGGTCTATGGCTACACCTTCGGTTCG	CASSTRTGVVYGYTF	In	VDJ	1	76	2.855972552600626E-4	3.3815500847612223E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	2	4	7	4	23	34	48	41	52		TCRBV06-07,TCRBV06-08												CASSTRTGVVYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCRTGTATSTCTGTGCTAGCAGCCCTGGGGCGGGGACAGGGCAGTACGAGCAGTACTTCGGGCCG	CASSPGAGTGQYEQYF	In	VDJ	1	78	2.931129725037485E-4	3.470538244886518E-4	48	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	4	9	3	19	31	49	40	52		TCRBV11-01,TCRBV11-03												CASSPGAGTGQYEQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCCTCCCGATAATTAGCGGGAGCAAAAACATTCAGTACTTCGGCGCC	CASLPIISGSKNIQYF	In	VDJ	1	79	2.968708311255914E-4	3.515032324949166E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	8	5	2	3	11	0	23	32	-1	43	52		TCRBV06-07,TCRBV06-08												CASLPIISGSKNIQYF+TCRBV06-X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAGAAGCCCGGCAGGGTTTACGAGCAGTACTTCGGGCCG	CASSEKPGRVYEQYF	In	VDJ	1	89	3.344494173440207E-4	3.9599731255756423E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	4	11	2	26	38	54	49	56		TCRBV06-07,TCRBV06-08												CASSEKPGRVYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCACACTTCGGACTGACTTAGACTAGCGGGCTAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	90	3.382072759658636E-4		58	TCRBV11	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	2	4	4	18	2	19	31	59	49	61		TCRBV11-01,TCRBV11-03				01,02								X+TCRBV11-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTATAGGGTAGCGGGGGCTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	93	3.494808518313924E-4		49	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	5	2	3	5	2	23	37	51	42	53		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAAGAGGATCTTCTCTTCTCCGGGCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	117	4.396694587556227E-4		52	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	8	4	2	18	0	26	36	-1	54	58		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGGGACAGGGGAGGTATGGCTACACCTTCGGTTCG	CASSESGQGRYGYTF	In	VDJ	2	135	5.073109139487954E-4	6.006700808457435E-4	45	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	2	5	0	3	26	-1	53	43	56		TCRBV10-01,TCRBV10-02												CASSESGQGRYGYTF+TCRBV10-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTATCGGGACAGGCCCTTACGAGCAGTACTTCGGGCCG	CASSIGTGPYEQYF	In	VDJ	2	136	5.110687725706384E-4	6.051194888520082E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	4	3	4	23	35	46	38	50		TCRBV06-07,TCRBV06-08												CASSIGTGPYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGACTAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASRTSGGTDTQYF	In	VDJ	2	141	5.29858065679853E-4	6.273665288833321E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	1	0	0	26	-1	-1	37	48		TCRBV06-07,TCRBV06-08												CASRTSGGTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAATGTGGACAGCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASNVDSGNTGELFF	In	VDJ	2	145	5.448895001672247E-4	6.451641609083911E-4	45	TCRBV12	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	12	1	5	1	9	3	26	31	46	40	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASNVDSGNTGELFF+TCRBV12-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGGACAGGGCCAACAATGAGCAGTTCTTCGGGCCA	CASRDRANNEQFF	In	VDJ	3	179	6.726566933098843E-4	7.964440331213932E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	3	5	0	3	23	-1	42	34	45		TCRBV06-07,TCRBV06-08												CASRDRANNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGGCCAGAGAGGGGGGCCACAGATACGCAGTATTTTGGCCCA	CASRPERGATDTQYF	In	VDJ	4	221	8.304867554272873E-4	9.833191693845134E-4	45	TCRBV10	unresolved					TCRBJ02	TCRBJ02-03	01	6	5	1	2	7	2	26	37	50	44	52		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPERGATDTQYF+TCRBV10-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAAGGGGTAGGGGTCTACGAGCAGTACTTCGGGCCG	CASSEGVGVYEQYF	In	VDJ	4	245	9.206753623515176E-4	0.0010901049615348677	42	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	5	2	3	0	7	23	-1	42	37	49		TCRBV10-01,TCRBV10-02												CASSEGVGVYEQYF+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACCACGTTGATGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASTTLMSSYNSPLHF	In	VDJ	4	260	9.770432416791616E-4	0.0011568460816288393	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	7	11	2	0	10	0	23	33	-1	43	46		TCRBV06-07,TCRBV06-08												CASTTLMSSYNSPLHF+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCCCCCGAGGTCCTAGAAGAGCAGTACTTCGGGCCG		Out	VDJ	8	470	0.0017661935522661767		37	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	4	8	7	10	2	23	32	46	42	48		TCRBV06-07,TCRBV06-08				01,02								X+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCACCCCCGGCGGTACGCAGTATTTTGGCCCA	YASTPGGTQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	33	TCRBV26	TCRBV26-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	7	5	8	6	0	27	37	-1	43	47						01,02								YASTPGGTQYF+TCRBV26-01+TCRBJ02-03	TCRBV26-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCGGGACAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	7.515717243685859E-5		32	TCRBV26	TCRBV26-01	01				TCRBJ01	TCRBJ01-02	01	8	0	7	2	0	0	27	-1	-1	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV26-01+TCRBJ01-02	TCRBV26-01*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCAGCTGGACGAAGGGCTACACCTTCGGTTCG	YASSWTKGYTF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	33	TCRBV26	TCRBV26-01	01				TCRBJ01	TCRBJ01-02	01	6	1	7	8	2	4	27	38	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									YASSWTKGYTF+TCRBV26-01+TCRBJ01-02	TCRBV26-01*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCAGTAGACAGGAGACCCAGTACTTCGGGCCA	YASSRQETQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	33	TCRBV26	TCRBV26-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	5	5	1	0	27	39	-1	40	45														YASSRQETQYF+TCRBV26-01+TCRBJ02-05	TCRBV26-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCCCATCGTCGGGCAGGGGGTATTGGAACACTGAAGCTTTCTTTGGACAA	CASRPSSGRGYWNTEAFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	54	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	1	11	5	18	30	48	41	53														CASRPSSGRGYWNTEAFF+TCRBV12-02+TCRBJ01-01	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGGCGGGGGCCTACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	8.267288968054444E-5		44	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	7	2	2	0	4	18	-1	41	34	45														X+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAACCTCCCGCCGGGACTCCTGAATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	8.643074830238736E-5		55	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	10	1	10	6	18	33	49	43	55						01,02								X+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCGGGGACAGGGCCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	1.0522004141160201E-4		41	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	5	1	2	18	30	40	31	42														X+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGTAGTCAAGGCGGGACAGCGTCATCCTACGAGCAGTACTTCGGGCCG	CASSQGGTASSYEQYF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	48	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	5	1	9	5	18	27	43	36	48														CASSQGGTASSYEQYF+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCCCCTGACAGGGGGAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	32	1.2025147589897372E-4		44	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	2	1	2	4	2	18	28	41	32	43														X+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGGCTCCTGGGTAGCGGCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	35	1.3152505176450253E-4		49	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	5	5	9	1	18	34	49	43	50						01,02								X+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCTTGAAGAGCGGCCCACTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	57	2.1419794144504696E-4		43	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	12	6	5	0	7	4	18	23	35	30	39						01,02								X+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGCCTCCGTTTCTCTTCAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	59	2.217136586887328E-4		55	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	5	0	13	0	18	35	-1	48	51														X+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCAAGTTCTCACAGGGGCGAAGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	60	2.2547151731057573E-4		43	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	3	2	3	4	5	18	27	38	31	43														X+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCGGATCGTGGGGACAGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CAGSWGQTNTGELFF	In	VDJ	1	78	2.931129725037485E-4	3.470538244886518E-4	45	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	12	0	5	0	9	1	18	23	39	32	40														CAGSWGQTNTGELFF+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAAGGCCGGGACAGGGTTGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	90	3.382072759658636E-4		43	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	12	0	3	2	7	2	18	23	39	30	41														X+TCRBV12-02+TCRBJ01-05	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCACCGACCCAGACTAGCCAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	128	4.810059035958949E-4		44	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	12	2	7	0	10	1	18	23	40	33	41						01,02								X+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCGTCAGGAGGGGTGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAVRRGAGANVLTF	In	VDJ	2	134	5.035530553269524E-4	5.962206728394787E-4	42	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	12	10	0	2	5	3	18	23	34	28	37														CAVRRGAGANVLTF+TCRBV12-02+TCRBJ02-06	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAATTTCACACAGGCTACGAGCAGTACTTCGGGCCG	CASSQFHTGYEQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	4	3	6	0	23	38	-1	44	49														CASSQFHTGYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTCAGAGCGTTTAGGGACAGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	18	6.764145519317272E-5		49	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	5	3	12	0	23	36	-1	48	55														X+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATTTCGGGACGTCGAATGAGCAGTTCTTCGGGCCA	CASSQDFGTSNEQFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	45	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	0	0	7	7	4	4	23	40	49	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDFGTSNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGTCTCCGGGACCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	7.515717243685859E-5		38	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-02	01	6	0	7	4	5	1	23	34	44	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGTCGACAGGGGGCCGGTGGCTACACCTTCGGTTCG	CASSRQGAGGYTF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	39	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	0	7	2	3	23	34	46	36	49														CASSRQGAGGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGTCCACTAGCGGGGCCCACAATGAGCAGTTCTTCGGGCCA	CASSQSTSGAHNEQFF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	3	3	5	4	3	23	37	51	41	54														CASSQSTSGAHNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCGGACAGGGATTCTATGGCTACACCTTCGGTTCG	CASSGQGFYGYTF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	39	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	4	0	3	23	-1	43	35	46														CASSGQGFYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAAGACTCAGCTGCGTATCTCTGCGCCAGCCCCCAGACTATCGGGGGGCGGTGGGAGGTTGTCTACAATGAGCAGTTCTTCGGGCCA	CASPQTIGGRWEVVYNEQFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	60	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	8	1	3	11	14	21	30	48	41	62														CASPQTIGGRWEVVYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCGGACACTGTAGGGCCCTACGAGCAGTACTTCGGGCCG	CASSPDTVGPYEQYF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	6	2	1	9	23	36	42	37	51														CASSPDTVGPYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCGGAACCCATCCTGAGCGGGAGGTTTCCTACGAGCAGTACTTCGGGCCG	CTGTHPEREVSYEQYF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	11	6	1	1	13	2	23	29	51	42	53														CTGTHPEREVSYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTGGGGACAGGGCCGAGCACAGATACGCAGTATTTTGGCCCA	CASSQVGTGPSTDTQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	3	0	2	3	23	39	50	41	53														CASSQVGTGPSTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGATCCCACCCGTGACCCAGTACTTCGGGCCA	CASSQEIPPVTQYF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	42	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-05	01	0	2	8	7	0	10	23	-1	42	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEIPPVTQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCATAGGACTCCTCGACGCGCAGTATTTTGGCCCA		Out	VDJ	1	48	1.803772138484606E-4		40	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	1	10	10	2	8	23	37	44	39	52						01,02								X+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCTGAGAATCCGGTCGCGGGGGGCCCGGGAGACCCAGTACTTCGGGCCA	CTSSLRIRSRGARETQYF	In	VDJ	1	48	1.803772138484606E-4	2.135715843007088E-4	54	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	7	1	5	13	5	23	36	57	49	62														CTSSLRIRSRGARETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAATGGTGTTGGCGGAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	51	1.9165078971398938E-4		53	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	5	0	10	1	23	40	54	50	55						01,02								X+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGCCCTGCGGCCACGGAAGCTTTCTTTGGACAA	CASSQGPAATEAFF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	7	5	8	5	5	23	39	48	44	53						01,02								CASSQGPAATEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGATTGAGTCGGGAGACAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSRLSRETATNEKLFF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	54	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	8	2	0	8	4	23	36	50	44	54														CASSRLSRETATNEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGACTAGCGGCTACTACGAGCAGTACTTCGGGCCG	CASSQGTSGYYEQYF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	1	5	3	0	3	23	-1	49	39	52						01,02								CASSQGTSGYYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAAAGGGCGATGAGCAGTTCTTCGGGCCA	CASSQKGDEQFF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	36	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	2	5	3	8	1	2	23	38	43	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQKGDEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGACAAGGGTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQTRVSNQPQHF	In	VDJ	2	103	3.870594380498217E-4	4.582890246452709E-4	45	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-05	01	3	2	6	0	0	5	23	-1	41	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTRVSNQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCGTAACCAAGGGGACGGGCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVTKGTGGANVLTF	In	VDJ	2	115	4.321537415119368E-4	5.116819207204482E-4	51	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-06	01	5	0	7	4	9	4	23	35	49	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVTKGTGGANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01		TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGACCTTCTCGTGACACGGGATATACGAGCAGTACTTCGGGCCG		Out	VDJ	2	116	4.359116001337798E-4		52	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	3	4	13	2	23	40	58	53	60														X+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGACCCCCCGGGAGCGACACCTCAGTACGAGCAGTACTTCGGGCCG	CASSQDPPGATPQYEQYF	In	VDJ	2	137	5.148266311924812E-4	6.09568896858273E-4	54	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	2	4	5	11	23	40	51	45	62														CASSQDPPGATPQYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAACCGCGGGGGTTACTCCTACGAGCAGTACTTCGGGCCG	CTSNRGGYSYEQYF	In	VDJ	3	156	5.86225945007497E-4	6.941076489773036E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	7	2	0	3	3	23	33	43	36	46														CTSNRGGYSYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACAGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQQVNTGELFF	In	VDJ	3	161	6.050152381167115E-4	7.163546890086274E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	4	1	0	1	23	-1	42	38	43														CASSQQVNTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCACCGTGCCGGAGGCGAGCAGTACTTCGGGCCG	CASSHRAGGEQYF	In	VDJ	3	180	6.764145519317272E-4	8.00893441127658E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	1	6	7	0	23	37	-1	44	49														CASSHRAGGEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCACCACTAAGGGAGTCTAGCGGGACTAAGAGACCCAGTACTTCGGGCCA	CTTTKGV*RD*ETQYF	Stop	VDJ	3	193	7.252667140156854E-4		48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	10	4	3	3	13	2	23	30	52	43	54														CTTTKGV*RD*ETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAACAGGCGGGGACAGGAACAATGAGCAGTTCTTCGGGCCA	CASSQTGGDRNNEQFF	In	VDJ	4	241	9.056439278641459E-4	0.0010723073295098088	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	4	5	7	1	23	38	53	45	54														CASSQTGGDRNNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCCACTCCCGGGACTGGGCGGAGACCCAGTACTTCGGGCCA	CASSPHSRDWAETQYF	In	VDJ	4	244	9.169175037296747E-4	0.001085655553528603	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	10	5	9	5	23	36	51	45	56						01,02								CASSPHSRDWAETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAATCAACGGGACTAGCGGGTTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	4	268	0.001007106110653905		56	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	4	0	6	2	23	38	56	44	58						01,02								X+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCGTAACAGCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDRNSANTGELFF	In	VDJ	6	359	0.0013490712452416116	0.0015973374742490512	51	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-02	01	0	3	5	0	5	2	23	40	49	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRNSANTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATGACGGGACAGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSQDDGTGGNEQFF	In	VDJ	11	645	0.002423818811088689	0.0028698681640407743	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	1	6	4	0	23	40	-1	44	55														CASSQDDGTGGNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAACGGGACAGGGGTTGGGAGAGACCCAGTACTTCGGGCCA	CASSLTGQGLGETQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	48	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	2	4	4	5	22	35	49	39	54														CASSLTGQGLGETQYF+TCRBV07-01+TCRBJ02-05	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCTAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLSSYNEQFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	39	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	9	0	0	2	22	-1	37	34	39						01,02								CASSLSSYNEQFF+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTGGGGACAGTGAACACTGAAGCTTTCTTTGGACAA	CASSLGTVNTEAFF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	42	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	0	2	0	22	35	-1	37	44														CASSLGTVNTEAFF+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGATCTTAATTCACCCCTCCACTTTGGGAAC	CASSLDLNSPLHF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	39	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	4	5	8	6	0	4	22	-1	38	35	42						01,02								CASSLDLNSPLHF+TCRBV07-01+TCRBJ01-06	TCRBV07-01*01	TCRBD02-01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCTAAGGGACAGGGGTTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	28	1.0522004141160201E-4		49	TCRBV07	TCRBV07-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	2	0	0	1	22	-1	48	38	49														X+TCRBV07-03+TCRBJ01-05	TCRBV07-03*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCTCGACTAGTATAAATGAGCAGTTCTTCGGGCCA	CASSSTSINEQFF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	39	TCRBV07	TCRBV07-08		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	8	7	1	4	20	33	40	34	44			01,02			01,02								CASSSTSINEQFF+TCRBV07-08+TCRBJ02-01	TCRBV07-08	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCGCAGACAGGGTATACTACGAGCAGTACTTCGGGCCG	CASSADRVYYEQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	42	TCRBV07	TCRBV07-08		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	3	3	4	20	32	42	35	46			01,02											CASSADRVYYEQYF+TCRBV07-08+TCRBJ02-07	TCRBV07-08	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCTCGACGGGAAGAGCTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	19	7.139931381501565E-5		43	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	8	8	3	3	4	6	23	32	41	36	47													Vb 12	X+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCTGTCGTGGGCCGACCTCTGAAGCTTTCTTTGGACAA	CASCRGPTSEAFF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	8	0	6	6	6	23	32	42	38	48													Vb 12	CASCRGPTSEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTGGGGAAACCCCGGGGAGCTGTTTTTTGGAGAA	CASSWGNPGELFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	39	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-02	01	5	0	8	6	2	4	23	35	41	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSWGNPGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCGGGGGGGTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSGGVAKNIQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	6	8	0	0	0	1	23	-1	42	34	43													Vb 12	CASSGGVAKNIQYF+TCRBV10-02+TCRBJ02-04	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCAGTAGGGGACACTGAAGCTTTCTTTGGACAA	CASSESVGDTEAFF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	2	3	3	0	23	40	-1	43	48													Vb 12	CASSESVGDTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTCCCTAACCTACAATGAGCAGTTCTTCGGGCCA	CASSSLTYNEQFF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	9	2	3	1	23	35	41	38	42						01,02							Vb 12	CASSSLTYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACCGAGTAGGGTCAGGTACCGAGCAGTACTTCGGGCCG		Out	VDJ	1	29	1.0897790003344495E-4		41	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-07	01	7	4	4	6	11	3	23	33	48	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGTCTTGGACGAGCAGTACTTCGGGCCG	CASSEVLDEQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	36	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-07	01	2	0	10	5	5	0	23	38	-1	43	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEVLDEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAAGGGGGGTAAACACTGAAGCTTTCTTTGGACAA	CASSERGVNTEAFF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	3	5	1	2	1	3	23	37	44	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSERGVNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCAAGGGGTTATCCTTCACCCCTCCACTTTGGGAAC	CASSESRGYPSPLHF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	5	2	9	1	6	23	40	46	41	52													Vb 12	CASSESRGYPSPLHF+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACAGGGGCGGGAGGGTATTCGGCCGGGGAGCTGTTTTTTGGAGAA	CASTGAGGYSAGELFF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	7	0	6	5	7	23	33	47	38	54													Vb 12	CASTGAGGYSAGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACCGACGGAGTCGGGGAGCTGTTTTTTGGAGAA	CASTDGVGELFF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	36	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	10	2	7	5	1	23	33	42	38	43													Vb 12	CASTDGVGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCCCTGGTAGGGAATAGCCAAAAACATTCAGTACTTCGGCGCC	CASPW*GIAKNIQYF	Stop	VDJ	1	43	1.6158792073924595E-4		45	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-04	01	8	0	8	0	8	2	23	32	44	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASPW*GIAKNIQYF+TCRBV10-02+TCRBJ02-04	TCRBV10-02*01		TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCGCAGCCCGGGACACCAATCAGCCCCAGCATTTTGGTGAT	CAAARDTNQPQHF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	0	6	3	7	1	23	29	42	36	43													Vb 12	CAAARDTNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGACTCTAGCGGGAGAAGTGCAGTTCTTCGGGCCA	CASSESTLAGEVQFF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	2	12	4	4	23	40	54	44	58													Vb 12	CASSESTLAGEVQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCGGAGCGAAGGGCTGGAACACTGAAGCTTTCTTTGGACAA	CAGAKGWNTEAFF	In	VDJ	1	52	1.954086483358323E-4	2.3136921632576786E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	11	5	3	1	7	3	23	29	40	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAGAKGWNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAAAGAAAGGGGGTTAAGCTACGAGCAGTACTTCGGGCCG	CASKERGLSYEQYF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	5	1	3	5	5	23	33	44	38	49													Vb 12	CASKERGLSYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGAGACAGGATTACGAGCAGTACTTCGGGCCG	CASRRQDYEQYF	In	VDJ	1	59	2.217136586887328E-4	2.625150723696212E-4	36	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	4	4	2	2	23	34	42	36	44													Vb 12	CASRRQDYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGTTGGGGCTAGCGAGATACCTTGGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	67	2.517765276634762E-4		58	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	6	3	7	12	23	38	51	45	63						01,02							Vb 12	X+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGTGTATTTCTGCGCCAGCAATGAGTCCGGACTAGCGGGAGAAGTATGGAGGCCCCCCCATCGAGCAGTACTTCGGGCCG		Out	VDJ	2	116	4.359116001337798E-4		64	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	1	2	6	1	20	10	27	41	28	61													Vb 12	X+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCTAGCGGGAGGTTTGGAGACCCAGTACTTCGGGCCA	CASSELAGGLETQYF	In	VDJ	2	142	5.336159243016959E-4	6.318159368895968E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	4	1	5	0	4	23	-1	49	38	53													Vb 12	CASSELAGGLETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCGGAAAGGACGATCTGAGGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	4	216	8.116974623180727E-4		53	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-06	01	8	5	2	1	15	0	23	32	-1	47	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ02-06	TCRBV10-02*01		TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCGACAGGGGGCCATGAACACTGAAGCTTTCTTTGGACAA	CASRQGAMNTEAFF	In	VDJ	35	2072	0.007786283064458549	0.009219173388980597	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	2	0	0	1	2	23	32	43	33	45													Vb 12	CASRQGAMNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGACCGCTCTAGAAACACCATATATTTTGGAGAG	CAISDRSRNTIYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	39	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	3	4	9	5	5	0	24	38	-1	43	46						01,02							Vb 12	CAISDRSRNTIYF+TCRBV10-03+TCRBJ01-03	TCRBV10-03*01	TCRBD02-01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGATTTCGGGGGGCACTGAAGCTTTCTTTGGACAA	CAISESISGGTEAFF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	45	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	1	4	5	0	23	40	-1	45	52													Vb 12	CAISESISGGTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTACCATCAGTGAGTCGTGGGCGGGAGGGTCAGATACGCAGTATTTTGGCCCA	CTISESWAGGSDTQYF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	0	4	4	1	23	40	53	44	54													Vb 12	CTISESWAGGSDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAAAGGGTTTTTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	34	1.277671931426596E-4		35	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-07	01	7	5	3	4	1	5	24	34	39	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGACCACATACAATGAGCAGTTCTTCGGGCCA	CAISETTYNEQFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	39	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	6	4	3	0	23	38	-1	41	44													Vb 12	CAISETTYNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCTCCCCTGGGACGGGGGTAAGGGTCACTGAAGCTTTCTTTGGACAA	CASPGTGVRVTEAFF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	45	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	11	8	2	4	10	7	24	30	46	40	53													Vb 12	CASPGTGVRVTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGCGATACAATGAGCAGTTCTTCGGGCCA	CAISERYNEQFF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	36	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-01	01	2	2	8	4	1	0	23	38	-1	39	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISERYNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTGGGGGCCAACTAATGAAAAACTGTTTTTTGGCAGT	CAISEWGPTNEKLFF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	6	0	0	0	0	23	-1	-1	39	45													Vb 12	CAISEWGPTNEKLFF+TCRBV10-03+TCRBJ01-04	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGCATTGGGGAACACTGAAGCTTTCTTTGGACAA	CAISESALGNTEAFF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	45	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-01	01	0	0	9	1	6	0	23	40	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESALGNTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGGGGGGTACGAGCAGTACTTCGGGCCG	CAISEGGYEQYF	In	VDJ	1	53	1.9916650695767524E-4	2.3581862433203263E-4	36	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	9	1	4	0	0	23	-1	-1	38	44													Vb 12	CAISEGGYEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGAGCTTCGATATCGGGAAGACCGGGGAGCTGTTTTTTGGAGAA	CAISESSFDIGKTGELFF	In	VDJ	1	65	2.442608104197904E-4	2.8921152040720983E-4	54	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	8	3	5	12	2	23	40	57	52	59													Vb 12	CAISESSFDIGKTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTTTTCCCGCGGCGGGGAGCTGTTTTTTGGAGAA	CAISEFSRGGELFF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	7	5	7	6	0	23	39	-1	45	49						01,02							Vb 12	CAISEFSRGGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGACAGGGGTTTATGGCGAGCAGTACTTCGGGCCG	CAISETGVYGEQYF	In	VDJ	1	73	2.7432367939453383E-4	3.2480678445732795E-4	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	2	6	0	7	23	-1	45	38	52													Vb 12	CAISETGVYGEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGTGTACTTCTGTGCCATCAGACTCACGCGGGACTAGCGGGAGGGCCGTGTGGGCACCGGGGAGCTGTTTTTTGGAGAA	CAIRLTRD*REGRVGTGELFF	Stop	VDJ	2	109	4.0960658978087927E-4		63	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	0	0	4	8	9	10	21	45	29	54													Vb 12	CAIRLTRD*REGRVGTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGACCGGGACACTTGGTACCCAGTACTTCGGGCCA	CAISETGTLGTQYF	In	VDJ	4	254	9.54496089948104E-4	0.0011301496335912506	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	6	8	3	6	23	38	47	41	53													Vb 12	CAISETGTLGTQYF+TCRBV10-03+TCRBJ02-05	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGACAGGGTATTTAGGAGGCTACACCTTCGGTTCG	CAISETGYLGGYTF	In	VDJ	6	363	0.0013641026797289832	0.0016151351062741101	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	3	8	0	9	23	-1	44	38	53													Vb 12	CAISETGYLGGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGATAAAAACTATGGCTACACCTTCGGTTCG	CASSIDKNYGYTF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	2	8	2	1	4	27	41	44	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDKNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGGGAGATAACTATGGCTACACCTTCGGTTCG	CASSGGDNYGYTF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	6	1	1	0	3	27	-1	44	39	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSGGDNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTCAAACCTGGGCGCGGGTACCCCGGGGAGCTGTTTTTTGGAGAA	CASSLKPGRGYPGELFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	7	4	6	14	4	27	38	57	52	61			01,02			01,02							Vb 17	CASSLKPGRGYPGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTGGGGGGACAGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSLGGQGNQPQHF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	2	4	6	0	27	38	-1	44	54			01,02										Vb 17	CASSLGGQGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCTCGACAGGGCCCCGGCTACACCTTCGGTTCG	CASSSRQGPGYTF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	8	4	4	27	39	50	43	54			01,02										Vb 17	CASSSRQGPGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCCACTAGCGGGGGACCTAAAATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	7.515717243685859E-5		55	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	3	2	1	4	8	26	40	55	44	63			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATGTACAGGGGGCGGTTTTTGGCTACACCTTCGGTTCG	CASNVQGAVFGYTF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	0	7	4	6	27	37	50	41	56			01,02										Vb 17	CASNVQGAVFGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCTGAGGAGGCTACCTATGGCTACACCTTCGGTTCG	CASTPEEATYGYTF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	10	1	4	7	4	27	37	49	44	53			01,02										Vb 17	CASTPEEATYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCATAGAGAACACTGAAGCTTTCTTTGGACAA	CASSIIENTEAFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	5	8	1	2	1	27	41	46	43	47			01,02			01,02							Vb 17	CASSIIENTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCGTCCTGGGGGCCTCTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSSVLGASSNQPQHF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	6	0	0	8	3	27	39	53	47	56			01,02										Vb 17	CASSSVLGASSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCGATATGGGGGGTCCATGAACACTGAAGCTTTCTTTGGACAA	CATRYGGSMNTEAFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	10	9	1	0	8	4	27	34	48	42	52			01,02										Vb 17	CATRYGGSMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTCACCGGGACTCCGAGCAGTACTTCGGGCCA	CASSFHRDSEQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	10	11	7	5	27	39	52	46	57			01,02			01,02							Vb 17	CASSFHRDSEQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGCCCACATAGGGTCCCTGGGGATACGCAGTATTTTGGCCCA	CASGPHRVPGDTQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	8	5	3	6	9	8	27	36	49	45	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASGPHRVPGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCAGACGGGGTGGGGGGTCGATGAGCAGTTCTTCGGGCCA	CASSQTGWGVDEQFF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	9	1	8	11	3	27	38	55	49	58			01,02										Vb 17	CASSQTGWGVDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACACCGGGGGCGGGAGGCAATGAGCAGTTCTTCGGGCCA	CASSTPGAGGNEQFF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	1	6	8	0	27	40	-1	48	56			01,02										Vb 17	CASSTPGAGGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTCCCGGGACAAGGACGGACGAGCAGTACTTCGGGCCG	CASSIGPGTRTDEQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	6	5	5	7	27	43	54	48	61			01,02										Vb 17	CASSIGPGTRTDEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGCAGACCCAGTACTTCGGGCCA	CASSMGQTQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	7	0	6	0	0	27	-1	-1	41	46			01,02										Vb 17	CASSMGQTQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTCTCTGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSVSGTGELFF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	5	0	9	5	6	0	27	39	-1	45	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVSGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAAAGCGGGATTCGAGGGTGGCTACACCTTCGGTTCG	CASSIKAGFEGGYTF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	6	3	7	2	8	27	42	51	44	59			01,02										Vb 17	CASSIKAGFEGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGACAGGGGGCAAGTGAGCAGTACTTCGGGCCG	CASSGQGASEQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	0	7	1	4	27	38	50	39	54			01,02										Vb 17	CASSGQGASEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGGCGGCAGGGGGTGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	28	1.0522004141160201E-4		52	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	1	1	8	2	27	43	58	51	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAATCGGGACTAGCGGGAGGTAGCGAGCAGTACTTCGGGCCG	CASKSGLAGGSEQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	0	1	6	4	3	27	37	56	41	59			01,02										Vb 17	CASKSGLAGGSEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCCGATGGGGGGGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	29	1.0897790003344495E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	9	0	5	8	0	27	38	-1	46	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGACAGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSIRQGSYEQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	2	1	2	0	27	41	-1	43	51			01,02										Vb 17	CASSIRQGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTTGCCGGTTACTCTGGAAACACCATATATTTTGGAGAG	CASSLAGYSGNTIYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	8	5	0	5	3	27	39	47	44	50			01,02			01,02							Vb 17	CASSLAGYSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAGAGAAACAGGGCGAACGAGCAGTACTTCGGGCCG	CASSERNRANEQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	5	7	3	27	39	52	46	55			01,02										Vb 17	CASSERNRANEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTCCTCAGCGGGAGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSVLSGRGYNEQFF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	0	4	6	2	27	39	55	45	57			01,02										Vb 17	CASSVLSGRGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACCCGACAGGGGGCGGTTTAAGACCCCTCCACTTTGGGAAC	CASNPTGGGLRPLHF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	2	0	12	4	8	27	37	51	41	59			01,02										Vb 17	CASNPTGGGLRPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGAGGACAGACCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASRRTDLAKNIQYF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	1	5	0	2	4	27	38	46	40	50			01,02										Vb 17	CASRRTDLAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCCCCCCGCAAAGAACCTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	31	1.164936172771308E-4		44	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	9	2	8	4	12	4	27	35	49	47	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGACAGGGGGCAACGAGCAGTACTTCGGGCCG	CASSIGTGGNEQYF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	0	5	0	1	27	-1	54	43	55			01,02										Vb 17	CASSIGTGGNEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGGGGGCTCGGGCAGTACTTCGGGCCG	CASSPRGLGQYF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	5	6	0	9	4	4	27	39	49	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPRGLGQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTGGCTAGCGGGGGGAAGATCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIWLAGGRSNTGELFF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	57	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	4	1	0	4	5	24	38	53	42	58			01,02										Vb 17	CASSIWLAGGRSNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTCAGATTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSISDSGANVLTF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	4	5	1	2	2	27	41	46	43	48			01,02										Vb 17	CASSISDSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCTCGGGGGGGGTGAAACTGTTTTTTGGCAGT	CASSPSGGVKLFF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	8	0	11	5	3	27	38	51	43	54			01,02										Vb 17	CASSPSGGVKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAAACAGGACCCCACCTACGAGCAGTACTTCGGGCCG	CASSIKQDPTYEQYF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	4	2	3	6	27	41	49	44	55			01,02										Vb 17	CASSIKQDPTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTGGGGAGGCGGGAGCGGCGAGACCCAGTACTTCGGGCCA	CASSIWGGGSGETQYF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	7	2	5	8	4	27	41	56	49	60			01,02										Vb 17	CASSIWGGGSGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGTCACCGTAACCTCGAACACTGAAGCTTTCTTTGGACAA	CVTVTSNTEAFF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	13	3	7	1	2	9	27	31	35	33	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CVTVTSNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCAAGCCTCTAGCGGAGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSTKPLAEAYNEQFF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	5	2	8	3	27	40	55	48	58			01,02			01,02							Vb 17	CASSTKPLAEAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCCGATGGGGGGGGAATGAAAAACTGTTTTTTGGCAGT	CASSPRWGGNEKLFF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	9	0	5	8	1	27	38	53	46	54			01,02										Vb 17	CASSPRWGGNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCGGGGACCCGCTATGGCTACACCTTCGGTTCG	CASSIAGTRYGYTF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	1	0	7	4	2	3	27	43	50	45	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAGTRYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCGTGGTAGGCAGCCGGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSMRGRQPGGNEQFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	1	6	14	0	27	41	-1	55	62			01,02										Vb 17	CASSMRGRQPGGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAATAGCGACAGGGGACGGCAGCCCCAGCATTTTGGTGAT	CANSDRGRQPQHF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	2	7	1	4	27	38	47	39	51			01,02										Vb 17	CANSDRGRQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACCTACTAGCGGGGGGTCCTACCGGGGAGCTGTTTTTTGGAGAA	CASNLLAGGPTGELFF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	3	1	5	4	4	27	37	53	41	57			01,02										Vb 17	CASNLLAGGPTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGGGGGGAAACACTGAAGCTTTCTTTGGACAA	CASSMGGGNTEAFF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	0	2	0	3	27	-1	48	41	51			01,02										Vb 17	CASSMGGGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCTAGTAGATTACAGGGGGAGAGCACAGATACGCAGTATTTTGGCCCA	CASRLQGESTDTQYF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	1	0	3	2	27	38	49	41	51			01,02										Vb 17	CASRLQGESTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCTAGTAGTATAAGGGACAGGGGTTATGTTTTGAACACTGAAGCTTTCTTTGGACAA	CASSIRDRGYVLNTEAFF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	2	0	1	8	27	42	53	43	61			01,02										Vb 17	CASSIRDRGYVLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCACAAGGGAGGTTTTGACGAGCAGTACTTCGGGCCG	CASSHKGGFDEQYF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	1	5	6	5	27	38	50	44	55			01,02										Vb 17	CASSHKGGFDEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGCGGGACAGGGTTGGCAATCAGCCCCAGCATTTTGGTGAT	CASSPRDRVGNQPQHF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	3	2	4	3	27	39	52	43	55			01,02										Vb 17	CASSPRDRVGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGACAGTAATCAGCCCCAGCATTTTGGTGAT	CASSKDSNQPQHF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	5	4	1	1	27	40	47	41	48			01,02										Vb 17	CASSKDSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCTAGGGGGCGCATCTTTATCGCAGTATTTTGGCCCA	CASSMLGGASLSQYF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	5	0	10	3	10	27	41	51	44	61			01,02										Vb 17	CASSMLGGASLSQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGAAGTGAAATCCCCTACGAGCAGTACTTCGGGCCG	CASSGSEIPYEQYF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	5	1	8	2	0	10	27	-1	42	39	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSGSEIPYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACGAGCCTATGGCTACACCTTCGGTTCG	CASSIRAYGYTF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	6	7	4	2	0	27	42	-1	44	47			01,02			01,02							Vb 17	CASSIRAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGCAGCGGGAGGGATTCACAGATACGCAGTATTTTGGCCCA	CASTQREGFTDTQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	6	0	2	3	3	27	37	50	40	53			01,02										Vb 17	CASTQREGFTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTGTATCAGGGAGGCAGCCCCAGCATTTTGGTGAT	CASTVSGRQPQHF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	9	1	7	8	0	27	37	-1	45	51			01,02										Vb 17	CASTVSGRQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGGACAGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRGQANTGELFF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	4	0	1	0	27	40	-1	41	49			01,02										Vb 17	CASSRGQANTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGTCGAGAGTCAGCGGGAGGGCCGGAAATGAGCAGTTCTTCGGGCCA	CASTSRVSGRAGNEQFF	In	VDJ	1	48	1.803772138484606E-4	2.135715843007088E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	6	0	7	11	5	27	37	58	48	63			01,02										Vb 17	CASTSRVSGRAGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTGGGCAGGGGATGGCTACACCTTCGGTTCG	CASSMWAGDGYTF	In	VDJ	1	48	1.803772138484606E-4	2.135715843007088E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	2	6	5	0	27	41	-1	46	52			01,02										Vb 17	CASSMWAGDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGACGGGGACATGTCTTATGGCTACACCTTCGGTTCG	CASSTDGDMSYGYTF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	6	5	6	5	27	40	52	46	57			01,02										Vb 17	CASSTDGDMSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACGGTAGGGCTGAAGCTTTCTTTGGACAA	CASSIDGRAEAFF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	0	5	3	6	4	0	27	44	-1	48	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDGRAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACACAGGGGTCGACTGGAAACACCATATATTTTGGAGAG	CASTQGSTGNTIYF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	3	2	2	1	4	27	37	45	38	49			01,02										Vb 17	CASTQGSTGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTGGAGGGAGCACTGAAGCTTTCTTTGGACAA	CASSIGGGSTEAFF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	10	0	4	2	2	27	43	51	45	53			01,02										Vb 17	CASSIGGGSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGGATCAGCCCCAGCATTTTGGTGAT	CASSIGDQPQHF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	3	5	0	0	27	-1	-1	41	46			01,02										Vb 17	CASSIGDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCAGGGGTGGAACATTCAGTACTTCGGCGCC	CASSMQGWNIQYF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	4	2	7	1	3	27	41	48	42	51			01,02										Vb 17	CASSMQGWNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGACACCAGGCTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASGHQAYSNQPQHF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	1	6	0	0	9	27	-1	41	36	50			01,02										Vb 17	CASGHQAYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGACTAGCGGGGCCCCCCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	52	1.954086483358323E-4		49	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	2	3	6	2	6	27	41	54	43	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCGACAGGGTTTTTTTCGGCTACACCTTCGGTTCG		Out	VDJ	1	53	1.9916650695767524E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	3	8	2	8	27	41	50	43	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCGACAGTTGGTATAGGCTATGGCTACACCTTCGGTTCG	CASTPTVGIGYGYTF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	5	4	4	10	27	37	46	41	56			01,02										Vb 17	CASTPTVGIGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAAAGTCAACCAGCGGGATCCAATGAGCAGTTCTTCGGGCCA	CASKSQPAGSNEQFF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	6	3	6	10	2	27	37	54	47	56			01,02										Vb 17	CASKSQPAGSNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTGGTCCAGCGGGGGTGAAAAACTGTTTTTTGGCAGT	CASRWSSGGEKLFF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	6	2	7	7	0	27	38	-1	45	53			01,02										Vb 17	CASRWSSGGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCACCGGGCTCCAAGAGGAAACACCATATATTTTGGAGAG	CASSHRAPRGNTIYF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	5	8	0	4	4	7	27	39	47	43	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSHRAPRGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACAGGGGGACAGGGGGCTGTACGAGCAGTACTTCGGGCCG	CASRQGDRGLYEQYF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	0	4	5	2	27	38	55	43	57			01,02										Vb 17	CASRQGDRGLYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSPGVNTEAFF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	3	0	2	0	27	39	-1	41	46			01,02										Vb 17	CASSPGVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAGGGGGGTTTGTGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSEGGLWGQETQYF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	5	5	1	1	1	10	27	39	46	40	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSEGGLWGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	57	2.1419794144504696E-4		32	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	5	3	1	0	27	38	-1	39	42			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGAGGGACTGAAACTTTCTTTGGACAA	CASSIGGTETFF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	0	10	12	4	4	27	41	51	45	55			01,02			01,02							Vb 17	CASSIGGTETFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACGGCGGGGCTACGAGCAGTACTTCGGGCCG	CASSIRRGYEQYF	In	VDJ	1	58	2.179558000668899E-4	2.5806566436335646E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	7	3	3	2	0	27	42	-1	44	50			01,02										Vb 17	CASSIRRGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCCAGGGTCTTGCCAAAAACATTCAGTACTTCGGCGCC	CASSSQGLAKNIQYF	In	VDJ	1	60	2.2547151731057573E-4	2.66964480375886E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	3	1	3	4	27	39	47	42	51			01,02										Vb 17	CASSSQGLAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTAGAAGGGACAAGGGCACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	60	2.2547151731057573E-4		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	6	3	6	6	27	37	49	43	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGACTAGCTGGGGGCACACAGATACGCAGTATTTTGGCCCA	CASSIGTSWGHTDTQYF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	7	2	1	8	27	41	51	42	59			01,02			01,02							Vb 17	CASSIGTSWGHTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAGTGTAGGGGGAGCCAAAAACATTCAGTACTTCGGCGCC	CASSSVGGAKNIQYF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	5	1	0	6	0	27	38	-1	44	50			01,02										Vb 17	CASSSVGGAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAACAGCCGCCACTGAAGCTTTCTTTGGACAA	CASSTTAATEAFF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	5	4	2	4	27	40	46	42	50			01,02										Vb 17	CASSTTAATEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTATCGGGTGGGTCGGTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	62	2.329872345542616E-4		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	8	4	3	4	8	27	39	47	43	55			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACCGCTCAGGGGGTATTCTATGGCTACACCTTCGGTTCG	CASSTAQGVFYGYTF	In	VDJ	1	63	2.3674509317610454E-4	2.803127043946803E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	1	4	7	4	27	38	52	45	56			01,02										Vb 17	CASSTAQGVFYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACGGAAAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	65	2.442608104197904E-4		38	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	1	8	1	3	2	27	38	44	41	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAAGGGACAGGAAGCCTCTGGAAACACCATATATTTTGGAGAG	CASSKGQEASGNTIYF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	4	0	3	4	27	38	49	41	53			01,02										Vb 17	CASSKGQEASGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGACTAGCGGCTACAATGAGCAGTTCTTCGGGCCA	CASSIGTSGYNEQFF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	5	3	0	0	27	-1	-1	43	53			01,02			01,02							Vb 17	CASSIGTSGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGGGACAGGGACGTACGAGCAGTACTTCGGGCCG	CASSPGTGTYEQYF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	4	3	3	27	39	51	42	54			01,02										Vb 17	CASSPGTGTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACACGGGCAGGGAACGGGAACACTGAAGCTTTCTTTGGACAA	CATRAGNGNTEAFF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	4	3	1	6	5	27	34	45	40	50			01,02										Vb 17	CATRAGNGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAGGGACAGGGGCTAAAAAACATTCAGTACTTCGGCGCC	CASSEGQGLKNIQYF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	2	4	2	3	27	39	51	41	54			01,02										Vb 17	CASSEGQGLKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGGGGACAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRGQGNTGELFF	In	VDJ	1	68	2.555343862853192E-4	3.025597444260041E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	0	3	1	3	0	27	35	-1	38	47			01,02										Vb 17	CASRGQGNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCCCTCCCCGGCCGGGGAGCTGTTTTTTGGAGAA	CASPSPAGELFF	In	VDJ	1	68	2.555343862853192E-4	3.025597444260041E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	8	5	6	7	0	27	36	-1	43	46			01,02			01,02							Vb 17	CASPSPAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGCGGGACAGGGTCCTACGAGCAGTACTTCGGGCCG	CASSGGTGSYEQYF	In	VDJ	1	69	2.592922449071621E-4	3.0700915243226886E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	1	4	0	27	38	-1	42	51			01,02										Vb 17	CASSGGTGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCAGCGGGAGGACCTCTGATGAGCAGTTCTTCGGGCCA	CASSLSGRTSDEQFF	In	VDJ	1	71	2.6680796215084796E-4	3.159079684447984E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	1	8	3	7	27	39	51	42	58			01,02										Vb 17	CASSLSGRTSDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTTCCGGGCTAGCGGGAGCTCAGACCTACAATGAGCAGTTCTTCGGGCCA	CASSPSGLAGAQTYNEQFF	In	VDJ	1	74	2.7808153801637674E-4	3.2925619246359274E-4	57	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	2	9	6	24	36	55	45	61			01,02										Vb 17	CASSPSGLAGAQTYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCGCAGGGGGCGCCTCCTACGAGCAGTACTTCGGGCCG	CATAGGASYEQYF	In	VDJ	1	74	2.7808153801637674E-4	3.2925619246359274E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	4	0	0	3	2	27	34	45	37	47			01,02										Vb 17	CATAGGASYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGCTCGGCACCTACAATGAGCAGTTCTTCGGGCCA	CASKLGTYNEQFF	In	VDJ	1	74	2.7808153801637674E-4	3.2925619246359274E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	7	9	0	2	5	1	27	37	45	42	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASKLGTYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCTCCCCGGGAACTGAAGCTTTCTTTGGACAA	CASSTSPGTEAFF	In	VDJ	1	74	2.7808153801637674E-4	3.2925619246359274E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	3	5	6	0	27	40	-1	46	51			01,02										Vb 17	CASSTSPGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCGAGTGACAGGGACTGGAAACACCATATATTTTGGAGAG	CASTRVTGTGNTIYF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	2	3	2	7	1	27	37	51	44	52			01,02										Vb 17	CASTRVTGTGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGGTGACAGGGAGATTTTATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	75	2.818393966382197E-4		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	3	8	4	7	27	38	49	42	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGTTCGGGACAGGGAATGAAAAACTGTTTTTTGGCAGT	CASSRFGTGNEKLFF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	3	5	5	0	27	40	-1	45	54			01,02										Vb 17	CASSRFGTGNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCGACAGGGAATGAAAAACTGTTTTTTGGCAGT	CASSIATGNEKLFF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	2	3	5	1	0	27	43	-1	44	51			01,02										Vb 17	CASSIATGNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCCGGGACGCTGTTAACTATGGCTACACCTTCGGTTCG	CASSIVRDAVNYGYTF	In	VDJ	1	77	2.893551138819055E-4	3.4260441648238703E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	1	0	7	1	3	5	27	43	51	46	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIVRDAVNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCTCAGGGCCTCTAATGAAAAACTGTTTTTTGGCAGT	CASSALRASNEKLFF	In	VDJ	1	77	2.893551138819055E-4	3.4260441648238703E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	3	3	5	3	27	39	49	44	52			01,02										Vb 17	CASSALRASNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCGACACCCGCTCCTACGAGCAGTACTTCGGGCCG	CASSSDTRSYEQYF	In	VDJ	1	78	2.931129725037485E-4	3.470538244886518E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	6	0	3	4	27	39	46	42	50			01,02										Vb 17	CASSSDTRSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACAACCACCACAACCGGGGAGCTGTTTTTTGGAGAA	CASSTTTTTGELFF	In	VDJ	1	79	2.968708311255914E-4	3.515032324949166E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	6	5	1	9	27	38	42	39	51			01,02										Vb 17	CASSTTTTTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGACAGGGGGTCATGAAAAACTGTTTTTTGGCAGT	CASSRTGGHEKLFF	In	VDJ	1	79	2.968708311255914E-4	3.515032324949166E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	1	6	1	2	27	39	50	40	52			01,02										Vb 17	CASSRTGGHEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTACCCATGGACAGGGCGCCTATGGCTACACCTTCGGTTCG	CATTHGQGAYGYTF	In	VDJ	1	82	3.0814440699112016E-4	3.6485145651371086E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	1	3	4	8	3	27	34	50	42	53			01,02										Vb 17	CATTHGQGAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCCAGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLQGAGELFF	In	VDJ	1	82	3.0814440699112016E-4	3.6485145651371086E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	1	6	3	0	27	39	-1	42	49			01,02										Vb 17	CASSLQGAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGGCTCAGGGATAGGGCAGTATAATTCACCCCTCCACTTTGGGAAC	CASGSGIGQYNSPLHF	In	VDJ	1	83	3.119022656129631E-4	3.693008645199756E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	9	4	3	4	5	9	27	35	45	40	54			01,02										Vb 17	CASGSGIGQYNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCACAGGGGGCGTCGGAGCAGTACTTCGGGCCG	CASSPQGASEQYF	In	VDJ	1	83	3.119022656129631E-4	3.693008645199756E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	0	7	2	4	27	39	50	41	54			01,02										Vb 17	CASSPQGASEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATACAGGGGGCGACTGAAGCTTTCTTTGGACAA	CASIQGATEAFF	In	VDJ	1	83	3.119022656129631E-4	3.693008645199756E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	0	5	1	1	27	37	47	38	48			01,02										Vb 17	CASIQGATEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACAGCAGGCGGACACTGAAGCTTTCTTTGGACAA	CASRQQADTEAFF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	3	5	3	0	7	27	-1	42	38	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRQQADTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCATTAAGGACAGGGGGAATAGATACGCAGTATTTTGGCCCA	CASSPLRTGGIDTQYF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	1	5	7	3	27	39	56	46	59			01,02										Vb 17	CASSPLRTGGIDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAAACAGGGGGAGGGATGATGGCTACACCTTCGGTTCG	CASRNRGRDDGYTF	In	VDJ	1	86	3.231758414784919E-4	3.826490885387699E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	1	6	2	7	27	38	48	40	55			01,02										Vb 17	CASRNRGRDDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATAGGAGCGTTACCTACGAGCAGTACTTCGGGCCG	CASSIDRSVTYEQYF	In	VDJ	1	87	3.269337001003348E-4	3.870984965450347E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	6	6	2	4	3	27	44	52	48	55			01,02			01,02							Vb 17	CASSIDRSVTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCGAGGGGGGGCTACGAGCAGTACTTCGGGCCG	CASSPRGGYEQYF	In	VDJ	2	91	3.4196513458770655E-4	4.048961285700938E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	9	0	3	5	0	27	38	-1	43	50			01,02										Vb 17	CASSPRGGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTAGTTGGACATCGGTTCCCTATGGCTACACCTTCGGTTCG	CASSPSWTSVPYGYTF	In	VDJ	2	91	3.4196513458770655E-4	4.048961285700938E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	6	4	7	8	27	39	51	46	59			01,02										Vb 17	CASSPSWTSVPYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGAACGGCGCGGGAGGGGTAGGAGACCCAGTACTTCGGGCCA	CASSRTAREG*ETQYF	Stop	VDJ	2	91	3.4196513458770655E-4		48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	7	0	5	8	4	27	39	56	47	60			01,02										Vb 17	CASSRTAREG*ETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCGACGGAAAATCAGCCCCAGCATTTTGGTGAT	CASSATENQPQHF	In	VDJ	2	91	3.4196513458770655E-4	4.048961285700938E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	1	8	4	5	1	27	39	47	44	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSATENQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCCGGGACCACGGGACCCAGTACTTCGGGCCA	CASSSRDHGTQYF	In	VDJ	2	97	3.645122863187641E-4	4.3159257660768235E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	5	0	7	7	4	5	27	39	48	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSRDHGTQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCGACAGCGTACCACGAGCAGTACTTCGGGCCG	CASSPTAYHEQYF	In	VDJ	2	99	3.7202800356245E-4	4.404913926202119E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	5	5	3	6	27	38	46	41	52			01,02										Vb 17	CASSPTAYHEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGACAGGGCCGAGGGAAAACTGTTTTTTGGCAGT	CASSDRAEGKLFF	In	VDJ	2	105	3.9457515529350753E-4	4.6718784065780046E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	3	10	1	7	27	38	46	39	53			01,02										Vb 17	CASSDRAEGKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCTTAGCGGGAGTGCAGATACGCAGTATTTTGGCCCA	CASSILSGSADTQYF	In	VDJ	2	105	3.9457515529350753E-4	4.6718784065780046E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	2	4	3	2	27	41	53	44	55			01,02										Vb 17	CASSILSGSADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGGTCAGACTGAGGTCACCCCTCCACTTTGGGAAC	CASSIGVRLRSPLHF	In	VDJ	2	105	3.9457515529350753E-4	4.6718784065780046E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	3	6	2	10	1	11	27	41	46	42	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGVRLRSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCGACAGGGTTGGAGGGTCAGCCCCAGCATTTTGGTGAT	CASSTGLEGQPQHF	In	VDJ	2	107	4.020908725371934E-4	4.7608665667033E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	2	3	6	2	8	27	36	45	38	53			01,02										Vb 17	CASSTGLEGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCCCCCACACCGCGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSSPHTAGQETQYF	In	VDJ	2	109	4.0960658978087927E-4	4.8498547268285955E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	7	3	2	11	0	27	40	-1	51	57			01,02										Vb 17	CASSSPHTAGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGGGACAGGGCCGCCCGAGCAGTACTTCGGGCCG	CASSPGTGPPEQYF	In	VDJ	2	109	4.0960658978087927E-4	4.8498547268285955E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	6	3	5	27	39	51	42	56			01,02										Vb 17	CASSPGTGPPEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGCAGGAAGAAACACCATATATTTTGGAGAG	CASSMAGRNTIYF	In	VDJ	2	111	4.1712230702456514E-4	4.938842886953891E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	4	4	5	2	2	27	41	47	43	49			01,02										Vb 17	CASSMAGRNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGCTACAGGGGCCTCCTACGAGCAGTACTTCGGGCCG	CASSMATGASYEQYF	In	VDJ	2	113	4.24638024268251E-4	5.027831047079186E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	2	0	4	1	27	41	52	45	53			01,02										Vb 17	CASSMATGASYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTGAGCGGCTACGAGCAGTACTTCGGGCCG	CASSIVSGYEQYF	In	VDJ	2	114	4.283958828900939E-4	5.072325127141834E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	6	5	3	2	0	27	43	-1	45	50			01,02			01,02							Vb 17	CASSIVSGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGCTCACTGAAGCTTTCTTTGGACAA	CASSIGLTEAFF	In	VDJ	2	116	4.359116001337798E-4	5.161313287267129E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	9	0	4	0	1	27	-1	46	43	47			01,02										Vb 17	CASSIGLTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTTGGACTCGACAGCGCGGTACACTGAAGCTTTCTTTGGACAA	CASRLDSTARYTEAFF	In	VDJ	2	117	4.396694587556227E-4	5.205807367329777E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	2	5	3	9	6	27	38	52	47	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRLDSTARYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTAGCGGGAGAAATGAGCAGTTCTTCGGGCCA	CASSTSGRNEQFF	In	VDJ	2	117	4.396694587556227E-4	5.205807367329777E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	4	2	7	0	1	27	-1	50	40	51			01,02										Vb 17	CASSTSGRNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGGCCAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIRPNTGELFF	In	VDJ	2	117	4.396694587556227E-4	5.205807367329777E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	3	5	4	2	1	3	27	41	45	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRPNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCACTTGGGGGGGTGGCTACACCTTCGGTTCG	CASTTWGGGYTF	In	VDJ	2	120	4.5094303462115147E-4	5.33928960751772E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	7	9	0	7	6	0	27	37	-1	43	50			01,02										Vb 17	CASTTWGGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACCCCAGGGAGCTCTTGAAGCTTTCTTTGGACAA	CASRPQGALEAFF	In	VDJ	2	121	4.5470089324299443E-4	5.383783687580367E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	4	3	7	4	6	27	38	47	42	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRPQGALEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTACAGGGTACCCGCAATCAGCCCCAGCATTTTGGTGAT	CASSVQGTRNQPQHF	In	VDJ	2	123	4.6221661048668025E-4	5.472771847705662E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	2	2	5	27	39	47	41	52			01,02										Vb 17	CASSVQGTRNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCATAGTAGCGGACAGCAACACTGAAGCTTTCTTTGGACAA	CAIVADSNTEAFF	In	VDJ	2	123	4.6221661048668025E-4	5.472771847705662E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	10	1	5	2	7	1	27	34	47	41	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CAIVADSNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGCCTGAGGGCCCTCTCAACCTTTAGCACAGATACGCAGTATTTTGGCCCA	CASGLRALSTFSTDTQYF	In	VDJ	2	127	4.77248044974052E-4	5.650748167956253E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	11	0	0	5	14	27	36	46	41	60			01,02										Vb 17	CASGLRALSTFSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGAGGAGGGGAGGCGAGACCCAGTACTTCGGGCCA	CASRRRGGETQYF	In	VDJ	2	133	4.997951967051096E-4	5.917712648332139E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	1	5	6	1	27	38	50	44	51			01,02										Vb 17	CASRRRGGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTATGAGGAGCCTCAACACTGAAGCTTTCTTTGGACAA	CASSPMRSLNTEAFF	In	VDJ	2	135	5.073109139487954E-4	6.006700808457435E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	2	2	7	4	27	39	50	46	54			01,02										Vb 17	CASSPMRSLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCCAGGAATTCTTGGACAGATACGCAGTATTTTGGCCCA	CASSIARNSWTDTQYF	In	VDJ	2	136	5.110687725706384E-4	6.051194888520082E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	4	3	1	9	27	43	48	44	57			01,02										Vb 17	CASSIARNSWTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAACAAAAGACAGGGACCCTGGAAACACCATATATTTTGGAGAG	CASRTKDRDPGNTIYF	In	VDJ	2	142	5.336159243016959E-4	6.318159368895968E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	3	2	7	3	27	38	52	45	55			01,02										Vb 17	CASRTKDRDPGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAGGACGGACTTACCAAGAGACCCAGTACTTCGGGCCA	CASSRGRTYQETQYF	In	VDJ	2	142	5.336159243016959E-4	6.318159368895968E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	1	10	0	6	1	27	40	51	46	52			01,02			01,02							Vb 17	CASSRGRTYQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAAACGTCGACAGGGCCTCAGACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	142	5.336159243016959E-4		52	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	3	3	8	6	27	41	56	49	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTTGGTCGGCGGACGAGTTCATTCACCCCTCCACTTTGGGAAC	CASSILVGGRVHSPLHF	In	VDJ	2	144	5.411316415453817E-4	6.407147529021264E-4	51	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	3	1	7	8	10	6	27	41	55	51	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSILVGGRVHSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGGAGGGGGTTGGGCAGATACGCAGTATTTTGGCCCA	CASRGGGWADTQYF	In	VDJ	2	147	5.524052174109105E-4	6.540629769209206E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	9	0	4	0	7	27	-1	45	38	52			01,02										Vb 17	CASRGGGWADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGGACTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSGTSNQPQHF	In	VDJ	2	149	5.599209346545964E-4	6.629617929334502E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	6	0	7	0	1	0	27	38	-1	39	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSGTSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCCGGGACAGGTGCTGACTATGGCTACACCTTCGGTTCG		Out	VDJ	3	155	5.82468086385654E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	0	4	3	3	5	27	35	46	38	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCCCCGACGGACTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	157	5.899838036293398E-4		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	1	10	3	9	0	27	41	-1	50	55			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACAGCTCCCTATAATTCACCCCTCCACTTTGGGAAC	CASSITAPYNSPLHF	In	VDJ	3	159	5.974995208730257E-4	7.074558729960979E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	3	5	2	0	3	27	-1	46	42	49			01,02										Vb 17	CASSITAPYNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGGGACAGGGGTCGCACAGATACGCAGTATTTTGGCCCA	CASRDRGRTDTQYF	In	VDJ	3	164	6.162888139822403E-4	7.297029130274217E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	9	0	2	1	2	2	27	35	47	37	49			01,02										Vb 17	CASRDRGRTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTCGGGGGAGGCACACTGAAGCTTTCTTTGGACAA	CASSFRGRHTEAFF	In	VDJ	3	165	6.200466726040833E-4	7.341523210336865E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	2	3	3	4	27	39	48	42	52			01,02			01,02							Vb 17	CASSFRGRHTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTCTCCTTACCGGGGACAGGGGGCGAATCAGCCCCAGCATTTTGGTGAT	CASSPYRGQGANQPQHF	In	VDJ	3	167	6.275623898477691E-4	7.43051137046216E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	0	0	4	12	1	27	35	59	47	60			01,02										Vb 17	CASSPYRGQGANQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGGGGGGGGCACACTGAAGCTTTCTTTGGACAA	CASSRGGHTEAFF	In	VDJ	3	167	6.275623898477691E-4	7.43051137046216E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	0	3	1	2	27	38	47	39	49			01,02										Vb 17	CASSRGGHTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCGGGGTAAATCAGCCCCAGCATTTTGGTGAT	CASIGVNQPQHF	In	VDJ	3	168	6.313202484696121E-4	7.475005450524808E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	7	8	3	4	1	2	27	37	43	38	45			01,02										Vb 17	CASIGVNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGCCGGGGGCTACACTGAAGCTTTCTTTGGACAA	CASSTAGGYTEAFF	In	VDJ	3	172	6.463516829569838E-4	7.652981770775398E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	4	6	0	3	5	1	27	40	51	45	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTAGGYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACACCGGGACAGGGAATGCCAATGAGCAGTTCTTCGGGCCA	CASSIDTGTGNANEQFF	In	VDJ	3	172	6.463516829569838E-4	7.652981770775398E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	6	4	5	27	44	57	48	62			01,02										Vb 17	CASSIDTGTGNANEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTAAACCGGGACAACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	175	6.576252588225126E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	0	6	0	7	0	27	37	-1	44	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGAGGGCGTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSTRASSTDTQYF	In	VDJ	3	175	6.576252588225126E-4	7.786464010963341E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	11	0	0	1	5	27	40	46	41	51			01,02										Vb 17	CASSTRASSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGCCCTACAGGGGCTCTACGAGCAGTACTTCGGGCCG	CASSIALQGLYEQYF	In	VDJ	3	176	6.613831174443555E-4	7.830958091025989E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	2	3	6	2	27	41	54	47	56			01,02										Vb 17	CASSIALQGLYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAGGGGAAAGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	177	6.651409760661984E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	2	4	0	5	27	-1	47	41	52			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCACTAGCACAATCTACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	178	6.688988346880414E-4		50	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	3	7	3	1	8	27	43	50	44	58			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGGGGTCTGACCGAGAAAAACATTCAGTACTTCGGCGCC	CASSWGLTEKNIQYF	In	VDJ	3	178	6.688988346880414E-4	7.919946251151285E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-04	01	5	6	2	4	1	10	27	39	44	40	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSWGLTEKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01		TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGCCACAGGGGGGACAGGGTTGACCCACGAGCAGTACTTCGGGCCG	CAATGGTGLTHEQYF	In	VDJ	3	181	6.801724105535701E-4	8.053428491339227E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	0	3	5	9	7	27	33	51	42	58			01,02										Vb 17	CAATGGTGLTHEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCTGCGGGTGAGCAGTTCTTCGGGCCA	CASSSAGEQFF	In	VDJ	3	188	7.064774209064707E-4	8.364887051777761E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	4	9	3	0	27	39	-1	42	47			01,02			01,02							Vb 17	CASSSAGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTCTCGAGGGCCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSRGPTNEKLFF	In	VDJ	3	189	7.102352795283136E-4	8.409381131840409E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	9	11	0	0	5	1	27	35	45	40	46			01,02										Vb 17	CASSRGPTNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*02	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTGGACAGGGGTGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	192	7.215088553938424E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	2	4	2	2	27	39	50	41	52			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCGAAGGGACTAGTCAGAGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASTEGTSQRAYNEQFF	In	VDJ	3	203	7.628453002341145E-4	9.032298252717476E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	8	2	5	8	27	37	50	42	58			01,02			01,02							Vb 17	CASTEGTSQRAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGACAGGGCGGAGACCCAGTACTTCGGGCCA	CASSKDRAETQYF	In	VDJ	3	204	7.666031588559575E-4	9.076792332780124E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	3	5	1	2	27	40	49	41	51			01,02										Vb 17	CASSKDRAETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCCGCCCGATCGGTCCCGTCGGGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	204	7.666031588559575E-4		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	11	8	4	3	17	0	27	33	-1	50	54			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCACGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSHGSYNEQFF	In	VDJ	3	205	7.703610174778005E-4	9.121286412842771E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	5	1	2	1	27	39	44	41	45			01,02			01,02							Vb 17	CASSHGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCACAGGGGGCCCCAGCGCGAGCAGTACTTCGGGCCG	CASSTHRGPQREQYF	In	VDJ	4	210	7.891503105870151E-4	9.343756813156009E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	0	6	3	7	27	40	52	43	59			01,02										Vb 17	CASSTHRGPQREQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCAAGGGACAGAGCACAGATACGCAGTATTTTGGCCCA	CATKGQSTDTQYF	In	VDJ	4	213	8.004238864525438E-4	9.477239053343953E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	0	5	0	4	0	27	34	-1	38	45			01,02										Vb 17	CATKGQSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGATCCGGGACAGGGGTACAATGAGCAGTTCTTCGGGCCA	CASRDPGQGYNEQFF	In	VDJ	4	215	8.079396036962298E-4	9.566227213469248E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	2	4	6	0	27	38	-1	44	54			01,02										Vb 17	CASRDPGQGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCGGACTAGCGGATTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSGLADSYNEQFF	In	VDJ	4	218	8.192131795617585E-4	9.699709453657191E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	5	1	3	2	27	39	52	42	54			01,02			01,02							Vb 17	CASSSGLADSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGGACGGATCTACGAGCAGTACTTCGGGCCG	CASGRIYEQYF	In	VDJ	4	222	8.342446140491303E-4	9.877685773907782E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	9	1	7	3	1	4	27	35	40	36	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASGRIYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGTGGGACAGGACACTACGAGCAGTACTTCGGGCCG	CASSSGTGHYEQYF	In	VDJ	4	231	8.680653416457166E-4	0.001027813249447161	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	4	3	2	3	27	40	50	42	53			01,02										Vb 17	CASSSGTGHYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGAACCGGGACAGTGAGTAGTGAGCAGTACTTCGGGCCG		Out	VDJ	4	232	8.718232002675596E-4		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	7	8	8	27	39	54	47	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGTTAGGGATGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	4	235	8.830967761330883E-4		47	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	3	0	8	3	6	3	27	41	51	47	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCAACCCGGGACAGAGTAATGAAAAACTGTTTTTTGGCAGT	CASSSNPGQSNEKLFF	In	VDJ	4	243	9.131596451078317E-4	0.0010812061455223382	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	5	4	7	2	27	40	54	47	56			01,02										Vb 17	CASSSNPGQSNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAGACAGGGATGGGATGAGCAGTACTTCGGGCCG	CASSRQGWDEQYF	In	VDJ	4	246	9.244332209733605E-4	0.0010945543695411325	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	7	2	7	27	38	47	40	54			01,02										Vb 17	CASSRQGWDEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTCACCGGGACTCCGAGCAGTACTTCGGGCCG	CASSFHRDSEQYF	In	VDJ	4	256	9.620118071917898E-4	0.0011390484496037801	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	10	6	7	1	27	39	52	46	53			01,02			01,02							Vb 17	CASSFHRDSEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCCTACAGCCTTGGCGGAGACCCAGTACTTCGGGCCA	CASSMPTALAETQYF	In	VDJ	4	258	9.695275244354757E-4	0.0011479472656163098	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	5	5	4	8	27	41	49	45	57			01,02										Vb 17	CASSMPTALAETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGGGGGGCCGAGGGACTGAAGCTTTCTTTGGACAA	CASGGGRGTEAFF	In	VDJ	4	259	9.732853830573187E-4	0.0011523966736225746	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	8	9	0	5	0	8	27	-1	43	36	51			01,02										Vb 17	CASGGGRGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACTACAGGAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSITTGSSYNSPLHF	In	VDJ	4	264	9.920746761665333E-4	0.0011746437136538983	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	3	4	0	3	3	27	42	50	45	53			01,02										Vb 17	CASSITTGSSYNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCGGGAGAGCGCTGAACACTGAAGCTTTCTTTGGACAA	CASSAGRALNTEAFF	In	VDJ	5	271	0.0010183796865194338	0.0012057895696977517	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	2	0	2	5	27	39	47	41	52			01,02										Vb 17	CASSAGRALNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASIGVNTEAFF	In	VDJ	5	290	0.0010897790003344494	0.0012903283218167823	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	6	2	0	2	0	27	37	-1	39	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASIGVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTTAGCGGGAGATACGCAGTATTTTGGCCCA	CASRLAGDTQYF	In	VDJ	5	303	0.0011386311624184075	0.0013481706258982242	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	4	5	2	0	27	38	-1	40	47			01,02			01,02							Vb 17	CASRLAGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAGACAGCGGATGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	5	313	0.0011762097486368369		44	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	5	2	5	5	3	6	27	39	47	42	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCACTAGCGCAGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	5	324	0.001217546193477109		49	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	3	6	0	2	5	27	43	52	45	57			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACTTTATGGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSNFMGPYNEQFF	In	VDJ	6	333	0.0012513669210736955	0.0014816528660861672	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	7	0	2	7	0	27	40	-1	47	52			01,02										Vb 17	CASSNFMGPYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGACCAGGCAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSIDQASSYEQYF	In	VDJ	6	353	0.001326524093510554	0.0015706410262114625	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	4	0	4	4	27	41	49	45	53			01,02										Vb 17	CASSIDQASSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGCACGGGGATGAAAAACTGTTTTTTGGCAGT	CASSTHGDEKLFF	In	VDJ	7	413	0.0015519956108211296	0.0018376055065873486	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	4	8	3	6	4	0	27	40	-1	44	49			01,02										Vb 17	CASSTHGDEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATTTAGCGGGGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSIFSGGSTDTQYF	In	VDJ	8	488	0.0018338350074593493	0.002171311107057206	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	5	2	0	2	1	27	42	53	44	54			01,02										Vb 17	CASSIFSGGSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAACCGACCGGCCTGGGGTTGAAAAACTGTTTTTTGGCAGT	CASRTDRPGVEKLFF	In	VDJ	8	502	0.0018864450281651504	0.002233602819144913	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	6	6	2	7	13	1	27	38	55	51	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRTDRPGVEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCAACACCCATACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQHPYSYNEQFF	In	VDJ	12	692	0.002600438166315307	0.0030789903403352185	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	6	0	3	6	27	38	44	41	50			01,02										Vb 17	CASSQHPYSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGCCTGACAGGGGCGGGCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	12	694	0.0026079538835589926		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	2	7	5	4	27	38	51	43	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCACACAGGGGGCCGAAAAACTGTTTTTTGGCAGT	CASTQGAEKLFF	In	VDJ	33	1953	0.00733909788845924	0.008689693836235088	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	3	0	8	3	1	27	35	47	38	48			01,02										Vb 17	CASTQGAEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGGATAGGACTAGCGGGACACAATGAGCAGTTCTTCGGGCCA	CASSGIGLAGHNEQFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	1	3	5	5	1	23	36	53	41	54													Vb 11	CASSGIGLAGHNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGGGGATAATTCACCCCTCCACTTTGGGAAC	CASSEGDNSPLHF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	39	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-06	01	2	6	2	5	0	0	23	-1	-1	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSEGDNSPLHF+TCRBV25-01+TCRBJ01-06	TCRBV25-01*01		TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCTAGCAGTATTCGACAGGGGATTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIRQGINTGELFF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	48	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	2	2	4	3	23	35	47	39	50													Vb 11	CASSIRQGINTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCAACGAGTACTTTGGTTGCCGGAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	28	1.0522004141160201E-4		55	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-02	01	6	1	8	2	20	0	23	34	-1	54	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGGACCGGGACAGGGGGCTCGGGCACTGAAGCTTTCTTTGGACAA	CASSGTGTGGSGTEAFF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	51	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	0	4	5	5	23	36	53	41	58													Vb 11	CASSGTGTGGSGTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGCGGGAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSEAGDTGELFF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	7	2	3	0	0	23	-1	-1	38	45													Vb 11	CASSEAGDTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACCGCCCGCGGAGAAGAGACCCAGTACTTCGGGCCA	CASTARGEETQYF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	7	5	3	6	2	23	33	43	39	45						01,02							Vb 11	CASTARGEETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGATGATTTCGGGGCGGGAGGGTACTACAATGAGCAGTTCTTCGGGCCA	CASSDDFGAGGYYNEQFF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	54	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	0	3	10	2	23	37	56	47	58													Vb 11	CASSDDFGAGGYYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACCAAGACAGGGAGCCACAGATACGCAGTATTTTGGCCCA	CASSEPRQGATDTQYF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	48	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	3	2	4	3	23	38	49	42	52													Vb 11	CASSEPRQGATDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACCAAAGCCGGGGGTACGGGGAGCTGTTTTTTGGAGAA	CASSDQSRGYGELFF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	8	2	7	7	2	23	37	50	44	52													Vb 11	CASSDQSRGYGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATCCCGGACGGAGAACACTGAAGCTTTCTTTGGACAA	CASSESRTENTEAFF	In	VDJ	1	85	3.1941798285664894E-4	3.7819968053250515E-4	45	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	1	1	7	1	3	3	23	39	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSESRTENTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATCTTTGGGGGGCCTTGACACTGAAGCTTTCTTTGGACAA	CASSESLGGLDTEAFF	In	VDJ	2	92	3.4572299320954946E-4	4.093455365763585E-4	48	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	1	6	0	3	5	4	23	39	50	44	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSESLGGLDTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGTAACAGTAAAACTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	92	3.4572299320954946E-4		56	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	6	5	13	5	23	36	54	49	59													Vb 11	X+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCAGGTTTGAGACTGGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	2	100	3.757858621842929E-4		50	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	5	0	8	4	13	5	23	35	52	48	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACGACAGGTTGGGAGCAGTACTTCGGGCCG		Out	VDJ	2	106	3.983330139153505E-4		37	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	4	7	1	4	23	37	44	38	48													Vb 11	X+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAACCTCGAAATCGACAGGGAGCGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	117	4.396694587556227E-4		46	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	2	3	4	11	3	23	30	48	41	51													Vb 11	X+TCRBV25-01+TCRBJ01-03	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAACCCCCAGACAGTCTTGTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	126	4.734901863522091E-4		46	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	2	5	4	7	5	23	33	45	40	50													Vb 11	X+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAACCACTCAGCGTCTGGTACTAGTTAGTCCCCAGATACGCAGTATTTTGGCCCA	CANHSASGTS*SPDTQYF	Stop	VDJ	3	174	6.538674002006696E-4		54	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	3	8	4	17	8	23	30	52	47	60						01,02							Vb 11	CANHSASGTS*SPDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGATCCCTTCAGGCGGGGTGAAGCTTTCTTTGGACAA	CASSDPFRRGEAFF	In	VDJ	3	178	6.688988346880414E-4	7.919946251151285E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	7	3	7	9	0	23	37	-1	46	52													Vb 11	CASSDPFRRGEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCGGATGAGGGGCGGTTGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	4	211	7.92908169208858E-4		44	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-05	01	8	5	2	2	5	5	23	32	42	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ01-05	TCRBV25-01*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAACGGTCTCAAATGAAAAACTGTTTTTTGGCAGT	CASSETVSNEKLFF	In	VDJ	4	219	8.229710381836015E-4	9.744203533719838E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	8	5	5	1	5	23	38	42	39	47						01,02							Vb 11	CASSETVSNEKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD02-01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCTGAGTTGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	4	240	9.018860692423029E-4		43	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	11	2	0	2	3	23	35	40	37	43													Vb 11	X+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGGGACAGGACTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSEGTGLNTGELFF	In	VDJ	4	248	9.319489382170464E-4	0.0011034531855536622	48	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	4	1	0	3	23	-1	46	38	49													Vb 11	CASSEGTGLNTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATATAGTGGCTCTGGAAACACCATATATTTTGGAGAG	CASSEYSGSGNTIYF	In	VDJ	6	371	0.0013941655487037267	0.0016507303703242283	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	0	5	8	0	0	3	23	-1	43	40	46						01,02							Vb 11	CASSEYSGSGNTIYF+TCRBV25-01+TCRBJ01-03	TCRBV25-01*01	TCRBD02-01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACCCTGGACAGGGTAGATTTCGGGATGAAAAACTGTTTTTTGGCAGT	CASSDPGQGRFRDEKLFF	In	VDJ	9	529	0.0019879072109549095	0.0023537368353140613	54	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	3	6	4	11	23	37	49	41	60													Vb 11	CASSDPGQGRFRDEKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATATCCCAACTCCTACGAGCAGTACTTCGGGCCG	CASSEYPNSYEQYF	In	VDJ	9	547	0.0020555486661480824	0.002433826179426827	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	6	0	3	1	23	40	45	43	46													Vb 11	CASSEYPNSYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACCCACGCCGGGGGGCGGTCAGACAATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	7.139931381501565E-5		50	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	8	1	4	7	11	23	33	47	40	58													Vb 22	X+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGCCCCGGGGGGGGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	19	7.139931381501565E-5		47	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	8	0	1	2	1	23	40	50	42	51													Vb 22	X+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCGGTGAGGGTTTTAGTCAGCCCCAGCATTTTGGTGAT	CASGEGFSQPQHF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	39	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-05	01	3	0	9	6	0	6	23	-1	40	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASGEGFSQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTCCACTAGCGGAGGGAGTCGGGAGCAGTACTTCGGGCCG	CASSSTSGGSREQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	5	7	3	10	23	35	46	38	56						01,02							Vb 22	CASSSTSGGSREQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGCGCTTGGGGGCACGGCGGTGGGCGAGCAGTACTTCGGGCCG	CASSEALGGTAVGEQYF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	51	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	6	0	6	4	11	23	40	50	44	61													Vb 22	CASSEALGGTAVGEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGAACGGACAGGGGGAAACTGAAGCTTTCTTTGGACAA	CASRNGQGETEAFF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	1	5	4	2	23	34	48	38	50													Vb 22	CASRNGQGETEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGTAGCTAGCGGGGGCGCCTACAATGAGCAGTTCTTCGGGCCA	CASSVASGGAYNEQFF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	2	2	5	2	23	34	49	39	51													Vb 22	CASSVASGGAYNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCGAGCAGAAGATACGCAGTATTTTGGCCCA	CASSRAEDTQYF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-03	01	5	4	5	5	4	1	23	35	42	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSRAEDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGAGGCAGGGGGGTTCGAGACCCAGTACTTCGGGCCA	CASSEEAGGFETQYF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	1	5	3	4	23	39	49	42	53													Vb 22	CASSEEAGGFETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGAACTAGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASRTSGTGELFF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	3	5	4	1	0	23	34	-1	35	43						01,02							Vb 22	CASRTSGTGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAATCCGGCGGGAGAAGGGGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	46	1.7286149660477473E-4		55	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	7	2	1	5	8	23	38	50	43	58													Vb 22	X+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTTTAGCGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSFSGGTDTQYF	In	VDJ	1	52	1.954086483358323E-4	2.3136921632576786E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	1	3	2	0	23	35	-1	37	47													Vb 22	CASSFSGGTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCGGGAGCCCGGCAGGGCCGAACACTGAAGCTTTCTTTGGACAA	CAGSPAGPNTEAFF	In	VDJ	1	52	1.954086483358323E-4	2.3136921632576786E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-01	01	11	4	3	1	10	2	23	29	44	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CAGSPAGPNTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACGAAGGGCAGCAGCTCCTACGAGCAGTACTTCGGGCCG	CASTKGSSSYEQYF	In	VDJ	1	60	2.2547151731057573E-4	2.66964480375886E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	7	5	3	0	3	6	23	33	40	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASTKGSSSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGAAAGATGACTAGCGGGGGGGTTGAGACCCAGTACTTCGGGCCA	CASRKMTSGGVETQYF	In	VDJ	1	79	2.968708311255914E-4	3.515032324949166E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	2	0	5	6	2	23	34	54	40	56													Vb 22	CASRKMTSGGVETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAGGCGGACAGGACCCTCTCTGGAAACACCATATATTTTGGAGAG	CASKADRTLSGNTIYF	In	VDJ	1	85	3.1941798285664894E-4	3.7819968053250515E-4	48	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	1	4	0	4	5	23	33	44	37	49													Vb 22	CASKADRTLSGNTIYF+TCRBV02-01+TCRBJ01-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGATCCGGCGGGGGTGCAAGAGACCCAGTACTTCGGGCCA	CASSDPAGVQETQYF	In	VDJ	2	94	3.532387104532353E-4	4.1824435258888806E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	2	2	4	2	23	37	48	41	50													Vb 22	CASSDPAGVQETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCCTACTTTGACAGGGCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPTLTGPSYNEQFF	In	VDJ	2	99	3.7202800356245E-4	4.404913926202119E-4	51	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	0	9	2	23	34	50	43	52													Vb 22	CASSPTLTGPSYNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGTCAGCAGAAAGACAGAGGTTCGGGGCACAGATACGCAGTATTTTGGCCCA	CVSRKTEVRGTDTQYF	In	VDJ	2	105	3.9457515529350753E-4	4.6718784065780046E-4	48	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	5	1	3	9	23	34	42	37	51													Vb 22	CVSRKTEVRGTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTGGCTAGCGGGGGCATAAACAATGAGCAGTTCTTCGGGCCA	CASSVASGGINNEQFF	In	VDJ	2	106	3.983330139153505E-4	4.7163724866406526E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	4	2	5	3	5	23	36	49	39	54													Vb 22	CASSVASGGINNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAATCGGGGCCGAAAAACATTCAGTACTTCGGCGCC	CASSESGPKNIQYF	In	VDJ	2	110	4.133644484027222E-4	4.894348806891243E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-04	01	2	7	0	4	2	2	23	38	45	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSESGPKNIQYF+TCRBV02-01+TCRBJ02-04	TCRBV02-01*01		TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGCTGGGGGGACTAGAGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSEAGGTRATGELFF	In	VDJ	2	128	4.810059035958949E-4	5.695242248018901E-4	51	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	0	8	4	4	3	23	40	52	44	55						01,02							Vb 22	CASSEAGGTRATGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCTCCAACACCGATTCACCCCTCCACTTTGGGAAC	CASSNTDSPLHF	In	VDJ	2	138	5.185844898143242E-4	6.140183048645377E-4	36	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	3	6	8	4	3	23	32	39	36	42													Vb 22	CASSNTDSPLHF+TCRBV02-01+TCRBJ01-06	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGGGGGACTAGAGGTCTACGAGCAGTACTTCGGGCCG	CASSEGGLEVYEQYF	In	VDJ	3	177	6.651409760661984E-4	7.875452171088637E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	8	3	1	4	23	39	48	40	52						01,02							Vb 22	CASSEGGLEVYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGGGGTGGTTCAAAAACATTCAGTACTTCGGCGCC	CASRGWFKNIQYF	In	VDJ	3	193	7.252667140156854E-4	8.587357452091E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-04	01	6	6	2	3	0	5	23	-1	38	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASRGWFKNIQYF+TCRBV02-01+TCRBJ02-04	TCRBV02-01*01		TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGAAGGGGCAGTTAATGAAAAACTGTTTTTTGGCAGT	CASSEGAVNEKLFF	In	VDJ	3	194	7.290245726375282E-4	8.631851532153647E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	8	0	4	0	3	23	-1	43	39	46													Vb 22	CASSEGAVNEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCTTCGGACAGTGGGCCGGCAAGAGTGAAAAACTGTTTTTTGGCAGT	CASFGQWAGKSEKLFF	In	VDJ	3	205	7.703610174778005E-4	9.121286412842771E-4	48	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	1	5	7	3	14	23	32	41	35	55													Vb 22	CASFGQWAGKSEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGGAACCGGGACAGACCATACGAGCAGTACTTCGGGCCG		Out	VDJ	6	341	0.0012814297900484387		43	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	5	4	2	4	23	38	47	40	51													Vb 22	X+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACCGGTACTGATTCCCTCACAGATACGCAGTATTTTGGCCCA	CASTGTDSLTDTQYF	In	VDJ	19	1127	0.004235106666816981	0.005014482823060392	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	3	10	2	5	8	23	33	41	38	49						01,02							Vb 22	CASTGTDSLTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAATTCGGGGGGTATGGCGAGCAGTACTTCGGGCCG	CASSEFGGYGEQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	42	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	1	6	3	5	28	42	52	45	57			01,02											CASSEFGGYGEQYF+TCRBV06-04+TCRBJ02-07	TCRBV06-04	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCATCAGCGACAGCTACGAGCAGTACTTCGGGCCG	CAISDSYEQYF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	33	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-07	01	2	5	5	3	0	0	28	-1	-1	43	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISDSYEQYF+TCRBV06-04+TCRBJ02-07	TCRBV06-04		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTAGGGGCTGGTCAGGCCGACTTCGGGCCA		Out	VDJ	1	17	6.38835965713298E-5		35	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	7	0	15	0	11	26	-1	45	40	56														X+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGGCAAACTATCACTCCGGCCCTTAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	6.764145519317272E-5		53	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	9	3	5	16	26	38	47	43	63						01,02								X+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCATACAGGGTCTCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	21	7.891503105870151E-5		43	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	0	3	3	26	37	46	40	49														X+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTAATAATAGCGGCGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	8.643074830238736E-5		41	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	5	5	4	4	2	26	40	50	44	52						01,02								X+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTAGCGATAGCGGTGTACCGGGGAGCTGTTTTTTGGAGAA	CASS*R*RCTGELFF	Stop	VDJ	1	23	8.643074830238736E-5		45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	5	5	5	4	3	26	40	50	44	53						01,02								CASS*R*RCTGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTAAGGAGTGGAGACAGGGTAAATGAATGAGCAGTTCTTCGGGCCA	CASS*GVETG*MNEQFF	Stop	VDJ	1	24	9.01886069242303E-5		51	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	3	7	9	6	26	40	56	49	62														CASS*GVETG*MNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCCAAAGCGTAAATGAGCAGTTCTTCGGGCCA	CASQSVNEQFF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	6	6	7	3	2	26	35	42	38	44						01,02								CASQSVNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACGGGACGGAACTGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	29	1.0897790003344495E-4		40	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-01	01	2	0	7	9	0	7	26	-1	46	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACGGGGTTTTAGGGAACTATGGCTACACCTTCGGTTCG	CASSYGVLGNYGYTF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	45	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-02	01	2	5	3	2	8	0	26	41	-1	49	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGVLGNYGYTF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	36	1.3528291038634543E-4		34	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	7	4	2	0	26	38	-1	40	43						01,02								X+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACGGACAGACCTCTGGAAACACCATATATTTTGGAGAG	CASSYGQTSGNTIYF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	1	5	0	0	2	26	-1	47	41	49														CASSYGQTSGNTIYF+TCRBV06-07+TCRBJ01-03	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAATTGGTAGGGGCGAGCAGTACTTCGGGCCG	CASSEIGRGEQYF	In	VDJ	1	52	1.954086483358323E-4	2.3136921632576786E-4	39	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	2	6	9	0	26	38	-1	47	52														CASSEIGRGEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGATATTTTGGGACCGACGTTTGGAGAG	CASSDILGPTF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	33	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-03	01	5	0	7	19	8	5	26	38	51	46	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDILGPTF+TCRBV06-07+TCRBJ01-03	TCRBV06-07*01		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGCGGGAACAGGGATCGGGCCCCAGCATTTTGGTGAT	CASSEAGTGIGPQHF	In	VDJ	1	63	2.3674509317610454E-4	2.803127043946803E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	6	3	9	2	11	26	38	47	40	58														CASSEAGTGIGPQHF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD02-01*02	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCACAGGGGCAGATACGCAGTATTTTGGCCCA	CASTGADTQYF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	33	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	4	2	4	0	0	26	-1	-1	36	42														CASTGADTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCGTCAGCGGGACACCGCCCAAGCACAGATACGCAGTATTTTGGCCCA	CASSYSSAGHRPSTDTQYF	In	VDJ	2	109	4.0960658978087927E-4	4.8498547268285955E-4	57	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	6	3	0	3	9	24	41	51	44	60														CASSYSSAGHRPSTDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGGCTATACTACAATGAGCAGTTCTTCGGGCCA	CASRLYYNEQFF	In	VDJ	2	116	4.359116001337798E-4	5.161313287267129E-4	36	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	9	3	1	2	26	37	41	38	43						01,02								CASRLYYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCCCGCTCAGCTAGCGCGGACTTGGGAGCAGTACTTCGGGCCG		Out	VDJ	3	156	5.86225945007497E-4		44	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	4	6	7	8	9	26	35	49	43	58						01,02								X+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCCGGGAGGACCCGCGGGGTGAGACCCAGTACTTCGGGCCA		Out	VDJ	4	251	9.432225140825752E-4		46	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	8	1	5	1	11	26	38	46	39	57														X+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAAAAAGGGTACTGAAGCTTTCTTTGGACAA	CASKKGTEAFF	In	VDJ	5	275	0.0010334111210068054	0.0012235872017228107	33	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-01	01	7	5	3	5	3	1	26	36	43	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKKGTEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAGATCTGGGGACAGGGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSLDLGTGVYNEQFF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	51	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	2	3	5	1	19	35	50	40	51														CASSLDLGTGVYNEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCAGCCATGTATCGCTGTGCCAGCATCAGAGACAGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASIRDRGQETQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	2	2	1	5	0	19	29	-1	34	42														CASIRDRGQETQYF+TCRBV07-07+TCRBJ02-05	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGGATCGGGCCCGGCAGGGGTCCAAAGGCCGGGGAGCTGTTTTTTGGAGAA	CASRIGPGRGPKAGELFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	54	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	2	6	12	8	19	30	48	42	56														CASRIGPGRGPKAGELFF+TCRBV07-07+TCRBJ02-02	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTCCGGGTCGGAGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSSGSEASTDTQYF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	48	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	10	1	0	7	2	19	32	44	39	46														CASSSGSEASTDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATCGGGTTACGAGCAGTACTTCGGGCCG	CASSQSGYEQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	36	TCRBV16	TCRBV16-01					TCRBJ02	TCRBJ02-07	01	0	0	9	4	0	1	29	-1	49	46	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSGYEQYF+TCRBV16-01+TCRBJ02-07	TCRBV16-01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTTTTGTGCCAGCAGCCTCTAAGGCTAGCGGGAGAAGTGGCGTATGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSL*G*REKWRMGSYNEQFF	Stop	VDJ	1	26	9.770432416791615E-5		66	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	4	2	1	7	15	4	17	34	24	49			01,02											CASSL*G*REKWRMGSYNEQFF+TCRBV16-01+TCRBJ02-01	TCRBV16-01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCTTGGACAGAATGAGCAGTTCTTCGGGCCA	CASSLGQNEQFF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	36	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	5	7	2	0	29	42	-1	44	50			01,02											CASSLGQNEQFF+TCRBV16-01+TCRBJ02-01	TCRBV16-01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAGGCCGGGGCCTACGAGCAGTACTTCGGGCCG	CASSQAGAYEQYF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	39	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	3	2	3	0	29	43	-1	46	51			01,02											CASSQAGAYEQYF+TCRBV16-01+TCRBJ02-07	TCRBV16-01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCACCCCCGGCTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSHPRLSYNEQFF	In	VDJ	1	73	2.7432367939453383E-4	3.2480678445732795E-4	45	TCRBV16	TCRBV16-01					TCRBJ02	TCRBJ02-01	01	3	9	0	0	5	1	29	43	51	48	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHPRLSYNEQFF+TCRBV16-01+TCRBJ02-01	TCRBV16-01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCCCGACTCCATCGGGTACGAGCAGTACTTCGGGCCG	CASSPDSIGYEQYF	In	VDJ	4	268	0.001007106110653905	0.0011924413456789575	42	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	2	10	4	2	8	29	42	48	44	56			01,02			01,02								CASSPDSIGYEQYF+TCRBV16-01+TCRBJ02-07	TCRBV16-01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCAGCAGTTTAGGTCAGGGACAGAACTTATACAATGAGCAGTTCTTCGGGCCA	CASSLGQGQNLYNEQFF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	51	TCRBV22	TCRBV22-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	13	0	5	4	17	6	25	28	52	45	58														CASSLGQGQNLYNEQFF+TCRBV22-01+TCRBJ02-01	TCRBV22-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGACGACAGGGTGGGCGGCTACACCTTCGGTTCG	CASSQDDRVGGYTF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	8	1	5	23	40	48	41	53													Vb 7.1	CASSQDDRVGGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGGGTGGGGGTCCCGTTCTGAAAAACTGTTTTTTGGCAGT	XASSQGWGSRSEKLFF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	48	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-04	01	1	6	1	7	3	8	22	38	46	41	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	XASSQGWGSRSEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGCGGGCAGCGGATTTGGAAACACCATATATTTTGGAGAG	CASSQAGSGFGNTIYF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	6	5	3	5	3	23	39	49	44	52						01,02							Vb 7.1	CASSQAGSGFGNTIYF+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01	TCRBD02-01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGAGGGGTGGGATGAGCAGTTCTTCGGGCCA	XASSQEGWDEQFF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	39	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-01	01	0	6	2	8	0	4	22	-1	43	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	XASSQEGWDEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCGGACTAGCGGGGGGAATGAGCAGTTCTTCGGGCCA	CASSQDRTSGGNEQFF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	1	1	7	2	0	23	40	-1	42	56													Vb 7.1	CASSQDRTSGGNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGATCGGGACTAGTGAGCAGTACTTCGGGCCG		Out	VDJ	1	38	1.427986276300313E-4		40	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	8	7	2	1	22	39	49	41	50						01,02							Vb 7.1	X+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATTCCACGGGGACCCAGTACTTCGGGCCA	CASSQDSTGTQYF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	39	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	8	4	7	5	0	23	40	-1	45	49						01,02							Vb 7.1	CASSQDSTGTQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGATCCGGGATCGAGCACAGATACGCAGTATTTTGGCCCA	YASSQDPGSSTDTQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	8	3	0	2	3	22	39	46	41	49													Vb 7.1	YASSQDPGSSTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGATAGGGCAGGGACAGATACGCAGTATTTTGGCCCA	XASSQDRAGTDTQYF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	3	3	5	0	22	39	-1	44	49													Vb 7.1	XASSQDRAGTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCGGGGGGTCCTATCCTACAATGAGCAGTTCTTCGGGCCA	CASSRGVLSYNEQFF	In	VDJ	1	68	2.555343862853192E-4	3.025597444260041E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	9	1	1	0	5	23	-1	42	36	47													Vb 7.1	CASSRGVLSYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGATCCAACAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	YASSQDPTGNTGELFF	In	VDJ	1	87	3.269337001003348E-4	3.870984965450347E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	3	4	1	4	0	22	39	-1	43	48													Vb 7.1	YASSQDPTGNTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCCGGACCTCAATCAGCCCCAGCATTTTGGTGAT	CASSQDPDLNQPQHF	In	VDJ	2	97	3.645122863187641E-4	4.3159257660768235E-4	45	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-05	01	0	1	7	3	3	2	23	40	47	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQDPDLNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAACGGACTACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQRTTNTGELFF	In	VDJ	2	103	3.870594380498217E-4	4.582890246452709E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	1	9	0	1	0	23	38	-1	39	45						01,02							Vb 7.1	CASSQRTTNTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTAAGCGGGGGAACCTACGAGCAGTACTTCGGGCCG	CASSQVSGGTYEQYF	In	VDJ	2	104	3.908172966716646E-4	4.627384326515357E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	6	2	2	2	2	23	39	49	41	51													Vb 7.1	CASSQVSGGTYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAACACAGACAGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	YASSQHRQGSYNEQFF	In	VDJ	2	115	4.321537415119368E-4	5.116819207204482E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	3	0	4	0	22	37	-1	41	48													Vb 7.1	YASSQHRQGSYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCARCAGCCGAAGGACAGGCGTCGGGGAGACCCAGTACTTCGGGCCA	CAXSRRTGVGETQYF	In	VDJ	2	132	4.960373380832666E-4	5.873218568269492E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	4	5	3	7	23	36	46	39	53													Vb 7.1	CAXSRRTGVGETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCTAAGACAGGGGGGCCCTCGAGCAGTACTTCGGGCCG	CASS*DRGALEQYF	Stop	VDJ	3	153	5.749523691419682E-4		42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	1	6	0	5	23	-1	47	40	52													Vb 7.1	CASS*DRGALEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCACGACTAGCGGGAGAAACAATGAGCAGTTCTTCGGGCCA	CASSTTSGRNNEQFF	In	VDJ	3	178	6.688988346880414E-4	7.919946251151285E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	2	2	5	2	2	23	35	49	37	51													Vb 7.1	CASSTTSGRNNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGTTACGGACAGGCTAACTATGGCTACACCTTCGGTTCG	CASSYGQANYGYTF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	42	TCRBV06	TCRBV06-09	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	4	0	1	0	26	40	-1	41	48													Vb 13.1	CASSYGQANYGYTF+TCRBV06-09+TCRBJ01-02	TCRBV06-09*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCTGGAGGCCAAGAGACCCAGTACTTCGGGCCA	CASSESGGQETQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	10	1	1	1	0	26	43	-1	44	49			01,02										Vb 12	CASSESGGQETQYF+TCRBV10-01+TCRBJ02-05	TCRBV10-01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCGAGAACCCTGTGGAACACTGAAGCTTTCTTTGGACAA	CASSESRTLWNTEAFF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	48	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	2	1	0	9	26	-1	46	43	55			01,02										Vb 12	CASSESRTLWNTEAFF+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAAACAAATTGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	32	1.2025147589897372E-4		40	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	3	6	0	1	5	26	36	40	37	45			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGATTAGTTGGGAAGTCTAGAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	54	2.0292436557951818E-4		47	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-04	01	3	0	8	6	6	7	26	40	50	46	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ02-04	TCRBV10-01		TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCCCGGGGAGGCTCCGTAGCACAGATACGCAGTATTTTGGCCCA	CAPGRLRSTDTQYF	In	VDJ	1	71	2.6680796215084796E-4	3.159079684447984E-4	42	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	9	1	0	3	6	26	32	41	35	47			01,02										Vb 12	CAPGRLRSTDTQYF+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCCGGAGGCGGGGGGGCGATCGTGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	88	3.3069155872217777E-4		49	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	8	7	0	7	5	8	26	35	49	40	57			01,02										Vb 12	X+TCRBV10-01+TCRBJ01-06	TCRBV10-01	TCRBD02-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAAAGAAGGCCGGGGGTGACGAGCAGTACTTCGGGCCG		Out	VDJ	2	100	3.757858621842929E-4		44	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	2	5	8	2	26	40	54	48	56			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-07	TCRBV10-01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGAAGGGGACAGGGGGTTGGGGCTACACCTTCGGTTCG	CATSRKGTGGWGYTF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	1	8	4	4	18	32	47	36	51														CATSRKGTGGWGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCTTAGTAGGGGTAGTGAGTACGGGTAAATACAATGAGCAGTTCTTCGGGCCA	CASSLVGVVSTGKYNEQFF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	57	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	2	4	5	17	18	30	40	35	57														CASSLVGVVSTGKYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGTTTGTTTAACGGGGGGGGCCCTCGGGAGACCCAGTACTTCGGGCCA	CASSLFNGGGPRETQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	0	5	9	8	18	29	46	38	54														CASSLFNGGGPRETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACGGAGCGGGGGGACAGGAAATGGGATGAGCAGTTCTTCGGGCCA	CATERGDRKWDEQFF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	9	6	1	8	2	12	18	26	37	28	49														CATERGDRKWDEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCCCTTCCAGGAGAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSPSRRTSTDTQYF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	48	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	5	4	4	0	5	6	18	30	39	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSRRTSTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGGTTCCGACAGGACAGGACTGAAGCTTTCTTTGGACAA	CATRFRQDRTEAFF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	4	5	9	0	18	29	-1	38	45														CATRFRQDRTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCCGACAGTTCCAGTACCAAGAGACCCAGTACTTCGGGCCA	CATSSRQFQYQETQYF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	5	0	2	7	18	32	39	34	46														CATSSRQFQYQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTCAGGTCTGGCGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	77	2.893551138819055E-4		43	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	7	4	7	9	0	18	32	-1	41	46						01,02								X+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTCTGGCGGGAGGTTAGGCGGGGAGCTGTTTTTTGGAGAA	CATSRDSGGRLGGELFF	In	VDJ	2	92	3.4572299320954946E-4	4.093455365763585E-4	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	7	1	7	5	5	18	35	48	40	53														CATSRDSGGRLGGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTCTTTCCGGACAGGGTGTATTAGAGACCCAGTACTTCGGGCCA	CATSSLSGQGVLETQYF	In	VDJ	2	96	3.607544276969212E-4	4.271431686014176E-4	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	3	4	7	6	18	32	47	39	53														CATSSLSGQGVLETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCTGGACGGAGGCAATGAAAAACTGTTTTTTGGCAGT	CATSRDLDGGNEKLFF	In	VDJ	2	111	4.1712230702456514E-4	4.938842886953891E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	10	1	5	7	1	18	35	47	42	48														CATSRDLDGGNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGGACGGGAGTCACCGGGGAGCTGTTTTTTGGAGAA	CATSRGTGVTGELFF	In	VDJ	2	115	4.321537415119368E-4	5.116819207204482E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	8	2	4	3	1	18	34	43	37	44														CATSRGTGVTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGGTCGTTACAGGACGTAGCTGATACGCAGTATTTTGGCCCA	CATRSLQDVADTQYF	In	VDJ	2	122	4.5845875186483734E-4	5.428277767643015E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	4	6	6	8	18	29	40	35	48														CATRSLQDVADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAGGGGTAACTATGGCTACACCTTCGGTTCG	CATSRDRGNYGYTF	In	VDJ	2	132	4.960373380832666E-4	5.873218568269492E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	1	1	0	18	35	-1	36	41														CATSRDRGNYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACGAGACACTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATRHFSGANVLTF	In	VDJ	3	180	6.764145519317272E-4	8.00893441127658E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	9	2	6	0	2	3	18	26	32	28	35														CATRHFSGANVLTF+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGGGGGGGTCAGCCCCAGCATTTTGGTGAT	CATSRDGGGQPQHF	In	VDJ	3	199	7.478138657467429E-4	8.854321932466885E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	9	0	6	1	1	18	35	43	36	44														CATSRDGGGQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGTTTGCGCGGGTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	221	8.304867554272873E-4		41	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	7	4	0	5	1	18	29	39	34	40						01,02								X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCGGGACTAGCGGCCGAGCGGCGCAGTATTTTGGCCCA	CATSSGTSGRAAQYF	In	VDJ	4	231	8.680653416457166E-4	0.001027813249447161	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	5	10	1	8	18	32	44	33	52						01,02								CATSSGTSGRAAQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGATCTGAGACTAGCGGGAGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	241	9.056439278641459E-4		49	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	2	2	3	5	1	18	33	50	38	51														X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGGCTCCAGGGGGAGACCCAGTACTTCGGGCCA	CATSRGLQGETQYF	In	VDJ	4	241	9.056439278641459E-4	0.0010723073295098088	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	2	5	7	0	18	32	-1	39	45														CATSRGLQGETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGATGGTCTGACAGGGGGCCACACCGGGGAGCTGTTTTTTGGAGAA	CATSDGLTGGHTGELFF	In	VDJ	4	246	9.244332209733605E-4	0.0010945543695411325	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	0	3	8	1	18	30	48	38	49														CATSDGLTGGHTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAAAACCCAGGGGCGGGTACAATGAGCAGTTCTTCGGGCCA	CATSRKPRGGYNEQFF	In	VDJ	4	251	9.432225140825752E-4	0.0011168014095724564	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	2	4	5	4	18	33	44	38	48														CATSRKPRGGYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAACCCGGGCCCGGATTTAGGCACTGAAGCTTTCTTTGGACAA	CATNPGPDLGTEAFF	In	VDJ	5	278	0.0010446846968723343	0.0012369354257416052	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	7	8	0	4	4	11	18	28	36	32	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATNPGPDLGTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGTGGAGGAATCAATCTCAATGAGCAGTTCTTCGGGCCA	CATSGGINLNEQFF	In	VDJ	5	280	0.0010522004141160202	0.0012458342417541346	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	10	1	6	1	9	18	29	35	30	44														CATSGGINLNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGTGGACAGAGCTCCTACGAGCAGTACTTCGGGCCG	CATSRGGQSSYEQYF	In	VDJ	5	283	0.0010634739899815489	0.0012591824657729289	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	5	0	4	2	18	32	42	36	44														CATSRGGQSSYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCTCCCCGGGACACTGAAGCTTTCTTTGGACAA	CATSRAPRDTEAFF	In	VDJ	6	342	0.0012851876486702817	0.00152169753814255	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	4	3	5	0	18	34	-1	39	43						01,02								CATSRAPRDTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSSGGNTGELFF	In	VDJ	6	343	0.0012889455072921246	0.0015261469461488148	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	8	2	1	0	0	18	-1	-1	32	38														CATSSGGNTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCCTACGGGACGGCAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CALRDGRNTGELFF	In	VDJ	6	358	0.0013453133866197686	0.0015928880662427864	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-02	01	11	0	7	1	4	5	18	24	33	28	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CALRDGRNTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGAGGGACAGGGGGGTACACTGAAGCTTTCTTTGGACAA	CATSRGGTGGYTEAFF	In	VDJ	7	397	0.0014918698728716429	0.0017664149784871123	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	1	3	2	2	18	34	47	36	49														CATSRGGTGGYTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTAGGAGGGGCAGATACGCAGTATTTTGGCCCA	CATSRVGGADTQYF	In	VDJ	7	399	0.0014993855901153288	0.0017753137944996418	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	10	0	4	2	1	18	34	42	36	43														CATSRVGGADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAAAGGGGTATCGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CATSKGVSGTNEKLFF	In	VDJ	8	484	0.0018188035729719777	0.002153513475032147	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	2	1	1	7	18	31	37	32	44														CATSKGVSGTNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAAGTACAGGGAAAGCGTCAATGAGCAGTTCTTCGGGCCA	CATSKYRESVNEQFF	In	VDJ	9	540	0.0020292436557951816	0.002402680323382974	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	6	3	7	18	31	40	34	47														CATSKYRESVNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGAGGGGTAACTAATGAAAAACTGTTTTTTGGCAGT	CATSRGGVTNEKLFF	In	VDJ	11	642	0.0024125452352231603	0.00285651994002198	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	1	5	2	1	1	1	18	34	40	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRGGVTNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTCAGGGGAACGATACAATGAGCAGTTCTTCGGGCCA	CATSRDSGERYNEQFF	In	VDJ	11	644	0.002420060952466846	0.0028654187560345095	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	4	2	5	18	35	43	37	48														CATSRDSGERYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCAAGGGACAAAACTAAACATTCAGTACTTCGGCGCC	CATSRDQGTKLNIQYF	In	VDJ	20	1182	0.004441788891018342	0.0052592002634049536	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	0	6	6	4	5	18	35	45	39	50														CATSRDQGTKLNIQYF+TCRBV15-01+TCRBJ02-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATSTCTGTGCCATAAGCTTGTAGCTATCGGAACTACGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	6.764145519317272E-5		50	TCRBV05	TCRBV05-03		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	3	9	1	11	1	18	33	48	44	49			01,02			01,02								X+TCRBV05-03+TCRBJ01-01	TCRBV05-03	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTGGACTAGCGGGGGGGCGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	67	2.517765276634762E-4		52	TCRBV05	TCRBV05-03		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	3	0	1	0	3	18	-1	47	34	50			01,02											X+TCRBV05-03+TCRBJ02-03	TCRBV05-03	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ACGACTCGGCCCTGTATCTCTGTGCCAGCAGTTTGACCCGGGACTACGAGCAGTACTTCGGGCCG	CASSLTRDYEQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	39	TCRBV05	TCRBV05-04	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	8	3	3	3	0	20	35	-1	38	43														CASSLTRDYEQYF+TCRBV05-04+TCRBJ02-07	TCRBV05-04*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCAGGTCAGGGGTGGCATTCAGTACTTCGGCGCC	CASSQVRGGIQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	2	9	5	3	18	30	41	35	44														CASSQVRGGIQYF+TCRBV07-02+TCRBJ02-04	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCACTGGGACCGGGGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	21	7.891503105870151E-5		44	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-01	01	5	0	7	3	3	5	18	30	38	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTCGTAGGAGCGGGGGGGCCCAATGAGCAGTTCTTCGGGCCA	CASSFVGAGGPNEQFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	48	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	6	0	6	6	2	18	32	48	38	50														CASSFVGAGGPNEQFF+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCTACAGGGATCCACTGAAGCTTTCTTTGGACAA	CASSLQGSTEAFF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	4	2	3	18	30	38	32	41														CASSLQGSTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAATTACTGGGAGGGGAGGAGCAGTACTTCGGGCCG	CASSQLLGGEEQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	0	7	8	3	18	30	45	38	48														CASSQLLGGEEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACAGGCCACGGGGACAGATACGCAGTATTTTGGCCCA	CASSPQATGTDTQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	3	4	3	2	8	18	30	37	32	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQATGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGTAGGGGAGGGGTATGGCTACACCTTCGGTTCG	CASSPVGEGYGYTF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	9	0	5	7	1	18	30	44	37	45														CASSPVGEGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATACAGAGCTCCAAGAGACCCAGTACTTCGGGCCA	CASSYTELQETQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	5	1	2	4	18	31	37	33	41														CASSYTELQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGGGGGTTAGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLRGLGANVLTF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	2	8	2	4	0	3	18	-1	39	33	42														CASSLRGLGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTACCAGCAGCGTAGGCCGATCTAGCACCGGGGAGCTGTTTTTTGGAGAA	CTSSVGRSSTGELFF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	4	8	4	6	0	18	34	-1	40	44						01,02								CTSSVGRSSTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCTTGCCGGACTAGCGGGAGTCGAGCAGTACTTCGGGCCG	CASSPLAGLAGVEQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	1	2	6	9	1	18	30	52	39	53														CASSPLAGLAGVEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACCGGGACATGAACACTGAAGCTTTCTTTGGACAA	CASSDRDMNTEAFF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	0	4	0	18	30	-1	34	40														CASSDRDMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTAACGACAGGGGTCTACGAGCAGTACTTCGGGCCG	CASSVTTGVYEQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	2	3	5	1	18	30	43	35	44														CASSVTTGVYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACTGTCGGGGATAGAGACCCAGTACTTCGGGCCA	CASSLLSGIETQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	3	4	4	2	18	33	42	37	44														CASSLLSGIETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACTAGCGAAGGGAACTGAGCAGTTCTTCGGGCCA	CASSLGLAKGTEQFF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	6	9	0	8	18	-1	42	34	50						01,02								CASSLGLAKGTEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACAGGGTCGAATCACTATGGCTACACCTTCGGTTCG	CASSLGTGSNHYGYTF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	3	3	0	7	18	-1	42	34	49														CASSLGTGSNHYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCAGGGGCATCTTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	7.139931381501565E-5		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	1	3	6	18	32	41	35	47														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCCAGACTAACTATGGCTACACCTTCGGTTCG	CASSLVQTNYGYTF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	5	0	2	1	18	34	39	36	40														CASSLVQTNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGACAGACTAGCGGGAGGTAGTAAAGAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	20	7.515717243685859E-5		61	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	2	1	2	4	9	18	32	49	36	58														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGACGCCGGGGACAAAGTCGGCTTTCTTTGGACAA	CASSLTPGTKSAFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	11	7	6	18	32	45	39	51														CASSLTPGTKSAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTTCAGTGGTCCGGGACAGGGAACGAGCAGTACTTCGGGCCG	CASSLVQWSGTGNEQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	5	13	1	18	32	54	45	55														CASSLVQWSGTGNEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGTCGGCCCTAGCGGGGCGCGAGCAGTACTTCGGGCCG	CASSLSALAGREQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	6	7	2	18	32	48	39	50														CASSLSALAGREQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAGGGGACCACGCCTACAATGAGCAGTTCTTCGGGCCA	CASRGDHAYNEQFF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	6	0	7	2	2	4	18	29	36	31	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGDHAYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACACAAGCAGGGCCGGGGGAGACCCAGTACTTCGGGCCA	CASSTQAGPGETQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	4	3	5	7	6	18	30	42	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTQAGPGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGACGGGGGGGACCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPTGGTSYNEQFF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	0	4	2	18	30	42	34	44														CASSPTGGTSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGGGATGTAGGGGGTGGACAGGTAACTACGTGCAGTACTTCGGGCCG		Out	VDJ	1	21	7.891503105870151E-5		58	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	4	9	15	9	18	35	57	50	66														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGGACAGGGGGGCTCAGATACGCAGTATTTTGGCCCA	CASSLVGQGGSDTQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	1	4	1	3	18	34	46	35	49														CASSLVGQGGSDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGTCCGGCCCGGGAGAGACCGGGGAGCTGTTTTTTGGAGAA	CASRSGPGETGELFF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	8	2	5	8	2	18	29	43	37	45														CASRSGPGETGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCGGGACTAGCGGGATCAAGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSTGTSGIKGYNEQFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	3	3	3	7	18	30	46	33	53														CASSTGTSGIKGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAGGTTGGGTCACACTGAAGCTTTCTTTGGACAA	CASSPRLGHTEAFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	4	3	2	7	18	30	36	32	43														CASSPRLGHTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTCCCCATCCGGTGACAGACCATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	22	8.267288968054444E-5		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	5	8	11	3	18	31	47	42	50														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATTTTTTTGGGGGAAGATACGCAGTATTTTGGCCCA	CASSLIFLGEDTQYF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	2	6	1	5	8	1	18	33	46	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIFLGEDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACGGGACTAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLDGTSSYEQYF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	8	0	1	0	18	35	-1	36	44						01,02								CASSLDGTSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGCCCAGATGGGAATCAGCCCCAGCATTTTGGTGAT	CASSFGPDGNQPQHF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	3	0	9	4	10	0	18	32	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGPDGNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGACCTTACGAGAGGCGGGCGTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSDLTRGGRSSYNEQFF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	7	4	0	15	5	18	31	51	46	56						01,02								CASSSDLTRGGRSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCCCCGGGAGAAAATTCCTCGAGCAGTACTTCGGGCCG	CASSLVPGRKFLEQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	8	2	6	4	9	18	34	44	38	53														CASSLVPGRKFLEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGCTACTGGCTACGAGCAGTACTTCGGGCCG	CASSLVATGYEQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	1	9	0	3	1	6	18	34	38	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVATGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTGGACAGCCCAAGAAAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	8.643074830238736E-5		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	5	5	2	10	18	32	40	34	50														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACTAGCGGGAGCCTACAATGAACAGTTCTTCGGGCCA	CASSLLAGAYNEQFF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	2	13	0	11	18	-1	43	33	54														CASSLLAGAYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGGGTACACAGATACGCAGTATTTTGGCCCA	CASSLGGYTDTQYF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	11	0	2	0	2	18	-1	39	34	41														CASSLGGYTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTTGGCGTGATAGGGGAGATGAGCAGTTCTTCGGGCCA	CASSLGWRDRGDEQFF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	1	5	2	8	11	2	18	34	50	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGWRDRGDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCATTTTAGGGGACAGATTACGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASTILGDRLRSGANVLTF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	57	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	0	5	0	9	6	18	28	44	37	50														CASTILGDRLRSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGACGGTTAACTATGGCTACACCTTCGGTTCG	CASSLGTVNYGYTF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	3	0	7	1	1	3	18	32	38	33	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTVNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACAGGGGGGGTTCCTGACAGATACGCAGTATTTTGGCCCA	CASRQGGFLTDTQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	1	3	0	8	18	-1	37	29	45														CASRQGGFLTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGGACTAGCGGGTCGCACAGATACGCAGTATTTTGGCCCA	CASSSGLAGRTDTQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	4	1	2	2	18	31	44	33	46						01,02								CASSSGLAGRTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATCGGGGGTACGAAGTCCGCAGATACGCAGTATTTTGGCCCA	CASSLIGGTKSADTQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	8	2	4	2	11	18	33	41	35	52														CASSLIGGTKSADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAACAGGTTACACTGAAGCTTTCTTTGGACAA	CASSLGTGYTEAFF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	4	3	2	2	18	34	41	36	43														CASSLGTGYTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCCCTCCCGGGACTAGCGGGGACGATGAGCAGTTCTTCGGGCCA	CASSTPPGTSGDDEQFF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	8	9	3	18	30	52	39	55														CASSTPPGTSGDDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAAAGGGGACGGTAGAGACCCAGTACTTCGGGCCA	CASSQKGTVETQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	0	7	4	6	3	18	30	41	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQKGTVETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGCAAGCGGGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSQQAGGQETQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	6	0	2	5	0	18	30	-1	35	45														CASSQQAGGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCCGGGACACTTACTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	27	1.0146218278975909E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	6	0	5	4	18	30	41	35	45														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCCGGACAGCTCAAGAGACCCAGTACTTCGGGCCA	CASSARTAQETQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	5	2	4	2	18	30	40	34	42														CASSARTAQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGACATCGCACAGATACGCAGTATTTTGGCCCA	CASSSRHRTDTQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	6	1	3	2	18	31	38	34	40														CASSSRHRTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCTAGGGGGGGGAAACATTCAGTACTTCGGCGCC	CASSSLGGGNIQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	4	9	0	6	5	1	18	31	43	36	44														CASSSLGGGNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCCATCAAGCGGGAGGCTTTTACGAGCAGTACTTCGGGCCG	CASSLVHQAGGFYEQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	6	1	4	7	4	18	34	50	41	54														CASSLVHQAGGFYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGCCCGACAGGGTTACGAGCAGTACTTCGGGCCG	CASSSARQGYEQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	3	4	6	1	18	31	44	37	45														CASSSARQGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTCAAAGGCGCTAGCTCCATACCTTACGAGCAGTACTTCGGGCCG	CASSFKGASSIPYEQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	7	4	8	9	18	32	45	40	54						01,02								CASSFKGASSIPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGCCCCCGGGGGGGCGGGAGACCCAGTACTTCGGGCCA	CASSLGPPGGRETQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	0	5	8	3	18	32	48	40	51														CASSLGPPGGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGACAGGGGATTCACCCCTCCACTTTGGGAAC	CASSPGTGDSPLHF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	2	8	3	0	18	30	-1	33	43														CASSPGTGDSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATGGCGGGGGGGGTCACAGATACGCAGTATTTTGGCCCA	CASSLMAGGVTDTQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	0	2	3	2	18	33	45	36	47														CASSLMAGGVTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACATACAGGAGCGGGAGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLHTGAGGYNEQFF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	1	3	8	0	18	33	-1	41	50														CASSLHTGAGGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTTTCGGCAGGGTGACTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	29	1.0897790003344495E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	3	6	7	4	18	33	45	40	49														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTAGGGACTAGTTACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	29	1.0897790003344495E-4		52	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	8	0	4	5	18	32	44	36	49						01,02								X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCCGGGACAGACAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	29	1.0897790003344495E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	5	0	1	1	18	30	38	31	39														X+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAATAGCTGGAAGGCTACCGTTGAGCCTACGAGCAGTACTTCGGGCCG	CASSQ*LEGYR*AYEQYF	Stop	VDJ	1	30	1.1273575865528787E-4		54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	7	2	3	18	18	30	37	33	55						01,02								CASSQ*LEGYR*AYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGGACAGGGCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	30	1.1273575865528787E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	3	3	3	1	18	32	44	35	45														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTATGGGGGCTTGCAGATACGCAGTATTTTGGCCCA	CASSLVWGLADTQYF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	6	0	4	5	3	18	32	43	37	46														CASSLVWGLADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCCTCCGGCGGATCGACCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	1.1273575865528787E-4		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	7	5	2	5	8	18	30	39	35	47						01,02								X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAGTATGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSKYATNEKLFF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	5	5	5	0	1	4	18	30	33	31	37				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKYATNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGACAGGGGGTTGGCAATCAGCCCCAGCATTTTGGTGAT	CASSQGQGVGNQPQHF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	1	2	3	3	18	30	43	33	46														CASSQGQGVGNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGACAGGGGGGCTAACTATGGCTACACCTTCGGTTCG	CASSPDRGANYGYTF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	1	0	2	1	18	30	42	32	43														CASSPDRGANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAATTTCGGGTTCACAGATACGCAGTATTTTGGCCCA	CASSLNFGFTDTQYF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	4	2	5	2	18	33	42	38	44						01,02								CASSLNFGFTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCAAAGCCGGGACAGCCAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	32	1.2025147589897372E-4		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	0	5	7	8	2	18	33	48	41	50														X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAACTAGCGGGAGTATCACCGGGGAGCTGTTTTTTGGAGAA	CASRTSGSITGELFF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	3	2	4	1	3	18	29	41	30	44														CASRTSGSITGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATCAGACAGGGACTTAATGAAAAACTGTTTTTTGGCAGT	CASSIRQGLNEKLFF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	4	4	3	18	30	41	34	44														CASSIRQGLNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTTAGGGCGATTGAAGGGGTACGCAGTATTTTGGCCCA		Out	VDJ	1	33	1.2400933452081666E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	5	2	8	12	0	18	32	-1	44	49														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCCCGACGGGCCCCGGGGAGACCCAGTACTTCGGGCCA	CASSPTGPGETQYF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	8	0	5	5	6	18	30	39	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTGPGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACAAGCGGGGCCTCAAGAGACCCAGTACTTCGGGCCA	CASSPQAGPQETQYF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	6	3	2	5	3	18	30	42	35	45														CASSPQAGPQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGGAATCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSGISGANVLTF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	4	4	0	0	3	18	-1	35	31	38														CASSSGISGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGGGGGTTCAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLRGVQNTGELFF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	2	5	1	1	0	5	18	-1	39	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRGVQNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCCCGCGGGGAATCCTACAATGAGCAGTTCTTCGGGCCA	CASSSPRGESYNEQFF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	3	1	6	2	18	31	43	37	45														CASSSPRGESYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCAGACAGGGGGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSRRQGGSTDTQYF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	1	0	4	2	18	30	43	34	45														CASSRRQGGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTGGCGGGACTAGCGGGAGGTCTTACGAGCAGTACTTCGGGCCG	CASSLSGGTSGRSYEQYF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	0	1	4	6	3	18	33	54	39	57														CASSLSGGTSGRSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAACCTCCGACAGGACAATCAGCCCCAGCATTTTGGTGAT	CASSNLRQDNQPQHF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	4	3	7	1	18	30	43	37	44														CASSNLRQDNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGCAACGGCGGGGAAAAACTGTTTTTTGGCAGT	CASSQGNGGEKLFF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	7	4	8	10	0	18	30	-1	40	45						01,02								CASSQGNGGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCAACCGGGACAGGCCAAAAACATTCAGTACTTCGGCGCC	CASSPQPGQAKNIQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	5	1	8	0	18	30	-1	38	45														CASSPQPGQAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAGCGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	37	1.3904076900818837E-4		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	6	4	0	0	2	18	-1	41	35	43						01,02								X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAGTGGGGATCTCCCTATCCTACGAGCAGTACTTCGGGCCG	CASSLEVGISLSYEQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	0	0	8	1	4	8	18	35	43	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEVGISLSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACCTGGACAGGGCTTCATAGATACGCAGTATTTTGGCCCA	CASRPGQGFIDTQYF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	3	5	4	6	18	29	41	33	47														CASRPGQGFIDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATACAAGGGGGAAGAACGAGCAGTACTTCGGGCCG	CASSHTRGKNEQYF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	1	5	6	4	18	30	42	36	46														CASSHTRGKNEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGACAGTTAATGAAAAACTGTTTTTTGGCAGT	CASSPGTVNEKLFF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	5	4	3	1	18	30	40	33	41														CASSPGTVNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCAGGGCAGGGTATAGCACAGATACGCAGTATTTTGGCCCA	CASSSRAGYSTDTQYF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	3	0	1	8	18	31	37	32	45														CASSSRAGYSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGATGGGTGCAGAGAACGGAAACACCATATATTTTGGAGAG	CASSSMGAENGNTIYF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	4	0	9	4	4	10	18	31	38	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSMGAENGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGATTCCGGGGGGAGCAGGGCCCTCCACTTTGGGAAC	CASSLDSGGSRALHF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	3	8	1	14	6	7	18	32	45	38	52														CASSLDSGGSRALHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGCCCCGGCAGGAGTTCCCCGTTCTCCGCCACCCATGGGCTTTGGAGAG	CASSPAPAGVPRSPPPMGF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	57	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	5	4	4	19	10	28	18	30	44	40	72				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPAPAGVPRSPPPMGF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGGGATTGGAAAAAATGAGCAGTTCTTCGGGCCA	CASSSGIGKNEQFF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	7	0	9	18	-1	36	31	45														CASSSGIGKNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGGGTTCGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLDGFGGYNEQFF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	2	3	6	0	18	35	-1	41	47														CASSLDGFGGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGGGACCGGGTCGAGAATACAATGAGCAGTTCTTCGGGCCA	CASSFGGPGREYNEQFF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	3	0	7	4	3	11	18	32	40	35	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGGPGREYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCATACAGGGGCCGCCTTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	40	1.5031434487371717E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	3	2	4	5	6	18	28	40	33	46														X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCGACAGGGGATTGCACAATGAGCAGTTCTTCGGGCCA	CASSRDRGLHNEQFF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	2	5	3	5	18	30	41	33	46														CASSRDRGLHNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACAGGGAGGTGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSQGGAGANVLTF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	4	3	3	2	1	5	18	31	38	32	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSQGGAGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSLEGGSGNTIYF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	5	1	0	0	0	18	-1	-1	35	41														CASSLEGGSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGGCAAGTCTCGGGGCAGCCCCAGCATTTTGGTGAT	CASSLRQVSGQPQHF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	3	7	11	0	18	32	-1	43	48														CASSLRQVSGQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAAACTCAGGGGTGGGTGTTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	41	1.5407220349556008E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	4	7	8	18	30	43	37	51														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCACGGGGCTAGCAGCCTACGAGCAGTACTTCGGGCCG	CASSSTGLAAYEQYF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	4	7	0	2	4	6	18	31	40	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTGLAAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATTCCCCCGGGACAGGGGCTTCGCAGTATTTTGGCCCA	CASSLDSPGTGASQYF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	2	10	7	3	18	35	52	42	55														CASSLDSPGTGASQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACAGGGATGGACTGAAGCTTTCTTTGGACAA	CASSLGQGWTEAFF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	3	5	0	4	18	-1	41	34	45														CASSLGQGWTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACTAGCGGGAGGATTGGGCGACAATGAGCAGTTCTTCGGGCCA	CASSLGLAGGLGDNEQFF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	2	1	5	0	8	18	-1	47	34	55														CASSLGLAGGLGDNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGGAGGGGCGGTCCTGGGACCCAGTACTTCGGGCCA	CASSGRGGPGTQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	9	0	7	0	10	18	-1	37	30	47														CASSGRGGPGTQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGCCCGGTCACAGATACGCAGTATTTTGGCCCA	CASSFGPVTDTQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	3	9	0	2	1	5	18	32	36	33	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGPVTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGTCGCCCGGTCACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	43	1.6158792073924595E-4		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	8	5	0	1	11	18	30	34	31	45						01,02								X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGTCGACAGGGGGCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSRSTGGSSYEQYF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	0	0	5	2	18	30	45	35	47														CASSRSTGGSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCCGGGACAGGGTCCGAAAAACTGTTTTTTGGCAGT	CASSSPGTGSEKLFF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	3	8	5	3	18	31	45	36	48														CASSSPGTGSEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTGACAGGGGATACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	44	1.6534577936108889E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	2	2	0	1	4	18	29	38	30	42														X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTACTCCGGGGGCCTCCAAGATACGCAGTATTTTGGCCCA	CASSPYSGGLQDTQYF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	6	0	5	9	5	18	30	45	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPYSGGLQDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCAGGTTCGGATCGGCGGGGCCTAACACAGATACGCAGTATTTTGGCCCA	CASSFRFGSAGPNTDTQYF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	57	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	3	2	13	5	18	32	51	45	56														CASSFRFGSAGPNTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGAGGGGGGAATAACGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSFEGGITSTGELFF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	3	5	1	4	2	10	18	32	40	34	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFEGGITSTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCCTCCTTCGGCCCTGCCCCCTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	45	1.691036379829318E-4		49	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	8	9	0	0	8	10	18	27	38	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCCAGGGGGGTTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSLQGGFTGELFF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	1	4	3	4	18	30	40	33	44														CASSLQGGFTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCCCGGGGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSAPGASYNEQFF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	6	0	0	5	0	18	30	-1	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAPGASYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTGGACGCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVDASSYNEQFF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	1	7	0	2	5	18	30	36	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVDASSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGCAACAGGGGATGGATACGCAGTATTTTGGCCCA	CASSWQQGMDTQYF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	2	6	4	3	18	31	42	35	45														CASSWQQGMDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAATGGGGCAGCCAGGGCCTAAAAGATGAGCAGTTCTTCGGGCCA	CASSLQWGSQGLKDEQFF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	3	8	12	8	18	33	50	45	58														CASSLQWGSQGLKDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGACTAGCGTATCATTCTACGAGCAGTACTTCGGGCCG	CASSPGTSVSFYEQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	6	3	3	7	18	30	43	33	50						01,02								CASSPGTSVSFYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGCCGGGAGGCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	47	1.7661935522661766E-4		41	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	1	3	3	2	18	31	41	34	43														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACAGGGGGGCTGATCGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGQGG*SYTGELFF	Stop	VDJ	1	47	1.7661935522661766E-4		54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	2	1	3	0	9	18	-1	43	34	52														CASSLGQGG*SYTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGGSNQPQHF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	1	0	10	0	2	0	18	34	-1	36	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTCGGGAGATCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	47	1.7661935522661766E-4		43	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	8	2	6	2	3	18	34	42	36	45														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTGGGGGCCAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	47	1.7661935522661766E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	6	0	4	2	2	18	34	42	36	44														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAAAAATCCGCGGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	49	1.8413507247030353E-4		43	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	7	5	2	8	1	18	29	41	37	42						01,02								X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCAACCTAGCGGGGGGACAGCAGGTGAGCAGTTCTTCGGGCCA	CASSQPSGGTAGEQFF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	1	9	4	8	18	30	45	34	53														CASSQPSGGTAGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTTATCGTCGGGGGCTGGGCAGCCCCAGCATTTTGGTGAT	CASSPLSSGAGQPQHF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	6	0	7	11	4	18	30	47	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLSSGAGQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCAAGAGGTCTGTGAACACTGAAGCTTTCTTTGGACAA	CASTKRSVNTEAFF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	11	1	0	4	4	18	28	36	32	40														CASTKRSVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCGATGGGGTACTCGGTTACAATGAGCAGTTCTTCGGGCCA	CASSTDGVLGYNEQFF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	6	2	4	6	8	18	30	40	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTDGVLGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAGACGGGCGGGAACTACAATGAGCAGTTCTTCGGGCCA	CASSETGGNYNEQFF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	3	3	7	1	18	30	43	37	44														CASSETGGNYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAGGGGGCCTCTGGAAACACCATATATTTTGGAGAG	CASSLKGASGNTIYF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	5	0	0	1	0	18	33	-1	34	41														CASSLKGASGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAACTAGCGGGGGGTCAGATACGCAGTATTTTGGCCCA	CASSSTSGGSDTQYF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	3	1	4	2	1	18	31	45	33	46														CASSSTSGGSDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGAATACCCGGGACAGGGAACTATGGCTACACCTTCGGTTCG	CASSLRIPGTGNYGYTF	In	VDJ	1	52	1.954086483358323E-4	2.3136921632576786E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	3	2	9	0	18	33	-1	42	51														CASSLRIPGTGNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGGACAGACTCCTACGAGCAGTACTTCGGGCCG	CASSQGTDSYEQYF	In	VDJ	1	53	1.9916650695767524E-4	2.3581862433203263E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	0	3	1	18	30	40	33	41														CASSQGTDSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGAGGGGACGGAGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	53	1.9916650695767524E-4		47	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	0	7	0	5	5	18	30	40	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGTCGGGACTAGCCACCACCGGGGAGCTGTTTTTTGGAGAA	CASSRSGLATTGELFF	In	VDJ	1	53	1.9916650695767524E-4	2.3581862433203263E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	7	4	5	3	18	30	44	35	47						01,02								CASSRSGLATTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTCTCTAGCGGGAGCCTCCAAGAGCAGTTCTTCGGGCCA	CASSVSSGSLQEQFF	In	VDJ	1	53	1.9916650695767524E-4	2.3581862433203263E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	10	4	7	18	30	44	34	51														CASSVSSGSLQEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACGGCCCGAGGCAATCAGCTCCAGCATTTTGGTGAT	CASSLTARGNQLQHF	In	VDJ	1	53	1.9916650695767524E-4	2.3581862433203263E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	11	1	12	7	9	18	33	44	40	53														CASSLTARGNQLQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCGGGACAGGGGGAACGAACACTGAAGCTTTCTTTGGACAA	CASSTGTGGTNTEAFF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	1	1	3	3	18	30	44	33	47														CASSTGTGGTNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGGTACTCAAATCACTACGAGCAGTACTTCGGGCCG	CASSPGYSNHYEQYF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	3	1	11	18	30	36	31	47														CASSPGYSNHYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATATAGGGGAGCCGGGGAGCTGTTTTTTGGAGAA	CASSLYRGAGELFF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	2	5	2	6	3	2	18	33	41	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLYRGAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGCCGGATTCTTACACAGATACGCAGTATTTTGGCCCA	CASRPDSYTDTQYF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	6	1	8	2	3	6	18	29	35	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPDSYTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGGGGGAACAGCCCCTATGGCTACACCTTCGGTTCG	CASSPRGNSPYGYTF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	2	4	3	8	18	30	39	33	47														CASSPRGNSPYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAGACCAAGTGGGGACAGGGAGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	57	2.1419794144504696E-4		55	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	3	4	11	2	18	33	53	44	55														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGAGGACAGGGTGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	57	2.1419794144504696E-4		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	3	4	3	2	18	33	44	36	46														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATGGAGGGCACCCACGAGCAGTACTTCGGGCCG	CASSLMEGTHEQYF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	0	5	2	5	18	33	41	35	46														CASSLMEGTHEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGCTGGCAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLATNTGELFF	In	VDJ	1	58	2.179558000668899E-4	2.5806566436335646E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	9	0	0	5	2	18	30	38	35	40														CASSPLATNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCCGGCCCGCCCTCGAGAGCAGTACTTCGGGCCG	CASSSPARPREQYF	In	VDJ	1	58	2.179558000668899E-4	2.5806566436335646E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	4	9	0	7	4	10	18	31	38	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPARPREQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCAGGGGTATACAATGAGCAGTTCTTCGGGCCA	CASSLAGVYNEQFF	In	VDJ	1	59	2.217136586887328E-4	2.625150723696212E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	2	4	2	2	18	32	40	34	42														CASSLAGVYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCTAGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSPLASTDTQYF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	7	0	3	1	18	30	38	33	39						01,02								CASSPLASTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGCGGGGGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLERGVNTGELFF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	6	1	1	2	1	18	32	43	34	44														CASSLERGVNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGATTGGTGTGGGGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	62	2.329872345542616E-4		43	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	6	6	2	3	8	0	18	29	-1	37	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCGGACAGTCTCGGATACAATGAGCAGTTCTTCGGGCCA	CASSADSLGYNEQFF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	5	4	2	7	18	30	38	32	45														CASSADSLGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGAGGGCTCGGATGGAGCAGTTCTTCGGGCCA	CASSFGRARMEQFF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	0	10	1	8	18	32	40	33	48														CASSFGRARMEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAAGGCCCGCCACCCACAGATACGCAGTATTTTGGCCCA	CASSKGPPPTDTQYF	In	VDJ	1	63	2.3674509317610454E-4	2.803127043946803E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	5	4	2	2	9	18	30	35	32	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKGPPPTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGACATGGGAAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPDMGSTGELFF	In	VDJ	1	63	2.3674509317610454E-4	2.803127043946803E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	5	0	8	4	8	2	18	30	42	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPDMGSTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGAGAGTCGGATGAACACTGAAGCTTTCTTTGGACAA	CASSRESRMNTEAFF	In	VDJ	1	63	2.3674509317610454E-4	2.803127043946803E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	2	0	0	7	18	-1	36	30	43														CASSRESRMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGAGTAGCGGGAAGGAGACCCAGTACTTCGGGCCA	CASSWSSGKETQYF	In	VDJ	1	63	2.3674509317610454E-4	2.803127043946803E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	5	3	5	4	2	18	31	43	35	45														CASSWSSGKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGTATGGTGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFGYGANTGELFF	In	VDJ	1	63	2.3674509317610454E-4	2.803127043946803E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	3	0	9	0	1	7	18	32	36	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGYGANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAAGGGTGGGAGTCACAGATACGCAGTATTTTGGCCCA	CASRRVGVTDTQYF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	9	2	2	6	1	18	29	40	35	41														CASRRVGVTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATGGGGGACTAGCGCACTTCAAGAGACCCAGTACTTCGGGCCA	CASSLWGTSALQETQYF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	0	6	2	3	5	18	33	46	36	51						01,02								CASSLWGTSALQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGCGGCGACGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFGGDVSYNEQFF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	7	5	0	2	6	18	32	38	34	44						01,02								CASSFGGDVSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCGGGGCGGACCATTATGGCTACACCTTCGGTTCG	CASSLVGADHYGYTF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	1	7	0	5	2	7	18	34	41	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGADHYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATCCTGGAAACAGAGACCCAGTACTTCGGGCCA	CASSLILETETQYF	In	VDJ	1	69	2.592922449071621E-4	3.0700915243226886E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	2	1	8	4	5	3	18	33	41	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLILETETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAGGCTACGGTCACCTCGGGTACGAGCAGTACTTCGGGCCG	CASSLGYGHLGYEQYF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	8	4	4	13	0	18	34	-1	47	51						01,02								CASSLGYGHLGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTGCTAGCGGGACTTACGAGCAGTACTTCGGGCCG	CASSLVASGTYEQYF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	4	3	4	3	2	18	34	46	37	48														CASSLVASGTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACGGGACTAGCGGGGGGCGGGAGGACAGTTCTTCGGGCCA		Out	VDJ	1	71	2.6680796215084796E-4		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	1	13	3	8	18	30	48	33	56														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGACTAGCGGGGGGCCGGGAGACCCAGTACTTCGGGCCA	CASSSGLAGGRETQYF	In	VDJ	1	71	2.6680796215084796E-4	3.159079684447984E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	1	1	5	2	4	18	31	47	33	51														CASSSGLAGGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCTTTTTGGCGGGAGGAATGAGCAATTCTTCGGGCCA	CASSLLFGGRNEQFF	In	VDJ	1	72	2.7056582077269087E-4	3.203573764510632E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	1	16	8	9	18	32	48	40	57														CASSLLFGGRNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTAAAGCCGACCTAAGGGGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	74	2.7808153801637674E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	1	8	12	0	18	31	-1	43	49														X+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAAATCGGGGACACTGAAGCTTTCTTTGGACAA	CASSLEIGDTEAFF	In	VDJ	1	74	2.7808153801637674E-4	3.2925619246359274E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	3	3	6	0	18	32	-1	38	43														CASSLEIGDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGACCTGGGGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSLRPGGAKNIQYF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	9	1	1	6	0	18	33	-1	39	45														CASSLRPGGAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTACCTCGACGACCACGCACGAGCAGTACTTCGGGCCG	CASSTSTTTHEQYF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	6	2	7	5	6	8	18	29	38	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTSTTTHEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGACTAGCGGGAGTCCGGTCCTACGAGCAGTACTTCGGGCCG	CASSSGLAGVRSYEQYF	In	VDJ	1	76	2.855972552600626E-4	3.3815500847612223E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	0	2	1	1	5	18	31	46	32	51														CASSSGLAGVRSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCAACGGAGGGCAGCTAGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASQRRAASGTGELFF	In	VDJ	1	76	2.855972552600626E-4	3.3815500847612223E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	4	5	4	13	0	18	27	-1	40	47						01,02								CASQRRAASGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGCCAGGGGAGGATGGAGACCCAGTACTTCGGGCCA	CASSSQGRMETQYF	In	VDJ	1	77	2.893551138819055E-4	3.4260441648238703E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	4	2	5	3	6	18	30	39	33	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSQGRMETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTCGGTGGGACACGCCAAGAGACCCAGTACTTCGGGCCA	CASSFGGTRQETQYF	In	VDJ	1	80	3.0062868974743435E-4	3.559526405011813E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	6	1	7	2	18	29	42	36	44														CASSFGGTRQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCCGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSLVRGSYEQYF	In	VDJ	1	81	3.0438654836927726E-4	3.6040204850744606E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	8	3	0	2	0	18	34	-1	36	41														CASSLVRGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGACTAGCGAGGAATGAGCAGTTCTTCGGGCCA	CASSSGLARNEQFF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	6	7	1	3	18	31	42	32	45						01,02								CASSSGLARNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCGGCGGGAGGGGGGGAGACCCAGTACTTCGGGCCA	CASSLAAGGGETQYF	In	VDJ	1	85	3.1941798285664894E-4	3.7819968053250515E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	7	0	5	4	3	18	32	45	36	48														CASSLAAGGGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCGCCGGGGGTGAGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLVAGGESSYEQYF	In	VDJ	1	87	3.269337001003348E-4	3.870984965450347E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	8	2	0	4	6	18	34	44	38	50														CASSLVAGGESSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGACAGGCTCCTACGAGCAGTACTTCGGGCCG	CASSLVTGSYEQYF	In	VDJ	1	87	3.269337001003348E-4	3.870984965450347E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	4	0	1	0	18	34	-1	35	41														CASSLVTGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGGACAGGGGGCGACGAAGCTTTCTTTGGACAA	CASSSGTGGDEAFF	In	VDJ	1	88	3.3069155872217777E-4	3.9154790455129943E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	0	8	2	3	18	31	45	33	48														CASSSGTGGDEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGCGGGATCCTACGAGCAGTACTTCGGGCCG	CASSLGAGSYEQYF	In	VDJ	1	88	3.3069155872217777E-4	3.9154790455129943E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	7	3	1	2	0	18	34	-1	36	42														CASSLGAGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACGGGACGGCCCTAGATCAGCCCCAGCATTTTGGTGAT	CASSDGTALDQPQHF	In	VDJ	2	90	3.382072759658636E-4	4.00446720563829E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	0	7	5	3	8	18	30	38	33	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDGTALDQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACCGCTAGCGGGAGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	93	3.494808518313924E-4		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	4	2	1	4	0	18	33	-1	37	47														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAACCACAGGGTGTGAACACTGAAGCTTTCTTTGGACAA	CASSLQPQGVNTEAFF	In	VDJ	2	93	3.494808518313924E-4	4.1379494458262326E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	0	5	2	18	33	44	38	46														CASSLQPQGVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGGACCACGGGATGAGCAGTTCTTCGGGCCA	CASSLVGPRDEQFF	In	VDJ	2	93	3.494808518313924E-4	4.1379494458262326E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	1	0	7	8	1	6	18	34	40	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGPRDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCAGGGGTGCTAATGAAAAACTGTTTTTTGGCAGT	CASSFRGANEKLFF	In	VDJ	2	94	3.532387104532353E-4	4.1824435258888806E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	2	3	0	2	18	-1	38	32	40														CASSFRGANEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACAGTATTACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGQYYTGELFF	In	VDJ	2	102	3.8330157942797875E-4	4.538396166390062E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	5	3	2	4	18	30	39	32	43														CASSPGQYYTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCGGTTCGTGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGGSWNTGELFF	In	VDJ	2	102	3.8330157942797875E-4	4.538396166390062E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	3	8	0	1	0	8	18	-1	36	32	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGSWNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTATAGTGACTGGATGGGCGAGCAGTACTTCGGGCCG	CASSLGYSDWMGEQYF	In	VDJ	2	104	3.908172966716646E-4	4.627384326515357E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	2	10	6	8	7	18	34	46	42	53						01,02								CASSLGYSDWMGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTGCACGACTATCTCGCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	108	4.0584873115903636E-4		53	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	8	2	9	5	5	14	18	27	37	32	51						01,02								X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCGACCGGGACAGTAGAGACCCAGTACTTCGGGCCA	CASSATGTVETQYF	In	VDJ	2	112	4.2088016564640804E-4	4.983336967016538E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	5	4	6	1	18	30	43	36	44														CASSATGTVETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAAACAGGGTCACGACAGATACGCAGTATTTTGGCCCA	CASSPNRVTTDTQYF	In	VDJ	2	113	4.24638024268251E-4	5.027831047079186E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	3	3	4	5	18	30	40	34	45														CASSPNRVTTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCAACCGGGGAGAAGAGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	118	4.434273173774656E-4		52	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	3	0	5	8	18	32	42	37	50						01,02								X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGATGAATTTCAACACTGAAGCTTTCTTTGGACAA	CASSSMNFNTEAFF	In	VDJ	2	120	4.5094303462115147E-4	5.33928960751772E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	4	2	8	2	1	8	18	31	34	32	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSMNFNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGGAGGGAGGCGAGGGGGGAATGAGCAGTTCTTCGGGCCA	CASSWGGRRGGNEQFF	In	VDJ	2	123	4.6221661048668025E-4	5.472771847705662E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	9	0	7	1	12	18	31	39	32	51														CASSWGGRRGGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACTAGGGGAGGTCAGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSTRGGQGSYEQYF	In	VDJ	2	124	4.659744691085232E-4	5.517265927768311E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	4	2	1	12	0	18	30	-1	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTRGGQGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCCTAGCGGGGGGGCGGAGACCCAGTACTTCGGGCCA	CASSFPSGGAETQYF	In	VDJ	2	132	4.960373380832666E-4	5.873218568269492E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	4	0	5	2	2	18	32	46	34	48														CASSFPSGGAETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAGGGGCCGGGTCCTACGAGCAGTACTTCGGGCCG	CASSRGAGSYEQYF	In	VDJ	2	134	5.035530553269524E-4	5.962206728394787E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	5	2	1	2	5	18	30	37	32	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGAGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCTACTCAGGGAAAGCTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASTLLRESFSGANVLTF	In	VDJ	2	142	5.336159243016959E-4	6.318159368895968E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	4	3	0	7	7	18	28	40	35	47														CASTLLRESFSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGGCCCGACCACTGAAGCTTTCTTTGGACAA	CASSLGGPTTEAFF	In	VDJ	2	142	5.336159243016959E-4	6.318159368895968E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	6	0	4	1	5	18	32	39	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGPTTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAAACCGGGACTATCCAAGAGACCCAGTACTTCGGGCCA	CASSKTGTIQETQYF	In	VDJ	2	144	5.411316415453817E-4	6.407147529021264E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	9	1	6	1	18	30	43	36	44						01,02								CASSKTGTIQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTCGACGAGGACGGAGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	148	5.561630760327535E-4		49	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	3	1	7	1	8	4	18	32	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGACCTTGGAATCCTCACAGATACGCAGTATTTTGGCCCA	CASSDLGILTDTQYF	In	VDJ	3	151	5.674366518982823E-4	6.718606089459797E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	1	8	2	6	5	18	30	39	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDLGILTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACAACTAGAAGAGACCCAGTACTTCGGGCCA	CASSLGQLEETQYF	In	VDJ	3	155	5.82468086385654E-4	6.896582409710388E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	6	3	0	5	18	-1	38	32	43														CASSLGQLEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGGAGGGGGGGACTATGGCTACACCTTCGGTTCG	CASSLDGGGDYGYTF	In	VDJ	3	156	5.86225945007497E-4	6.941076489773036E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	9	0	3	4	0	18	35	-1	39	46														CASSLDGGGDYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAATGGACAGGGACGGCCTACGAGCAGTACTTCGGGCCG	CASSQWTGTAYEQYF	In	VDJ	3	162	6.087730967385545E-4	7.208040970148921E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	2	4	4	18	30	42	34	46														CASSQWTGTAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGACGTTTGAGTACCAAGAGACCCAGTACTTCGGGCCA	CASSRTFEYQETQYF	In	VDJ	3	162	6.087730967385545E-4	7.208040970148921E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	1	7	0	1	8	18	30	35	31	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTFEYQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACCCAACAGGGTGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	175	6.576252588225126E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	3	3	5	2	18	33	44	38	46														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCATACCTTGGAGGGACGGTGAACACTGAAGCTTTCTTTGGACAA	CASSAYLGGTVNTEAFF	In	VDJ	3	177	6.651409760661984E-4	7.875452171088637E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	0	0	9	4	18	30	45	39	49														CASSAYLGGTVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGGTCCGGGACAGGGGTTGAAAAACTGTTTTTTGGCAGT	CASSLRSGTGVEKLFF	In	VDJ	3	182	6.839302691754131E-4	8.097922571401875E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	2	7	7	1	18	32	49	39	50														CASSLRSGTGVEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAGCCGCCAGCCCATCTGAAGCTTTCTTTGGACAA	CASSRAASPSEAFF	In	VDJ	3	193	7.252667140156854E-4	8.587357452091E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	4	5	6	8	5	18	30	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRAASPSEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAAGTCCCAGCTCCACTGAAGCTTTCTTTGGACAA	CASSPSPSSTEAFF	In	VDJ	4	218	8.192131795617585E-4	9.699709453657191E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	4	5	4	8	3	18	30	41	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSPSSTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACGCCTGGGGCAGAGGGCACTGAAGCTTTCTTTGGACAA	CASSTPGAEGTEAFF	In	VDJ	4	219	8.229710381836015E-4	9.744203533719838E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	7	0	4	6	6	18	30	41	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTPGAEGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGGGACGGAACACTGAAGCTTTCTTTGGACAA	CASSLEGRNTEAFF	In	VDJ	4	242	9.094017864859889E-4	0.0010767567375160735	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	0	1	0	3	18	-1	38	32	41														CASSLEGRNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCATCACAGGGGTGGGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	4	249	9.357067968388894E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	3	2	7	4	4	18	31	42	35	46														X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCAGGGCGACTTCACCCCTCCACTTTGGGAAC	CASSLVRATSPLHF	In	VDJ	5	302	0.0011348733037965645	0.0013437212178919594	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	4	3	9	1	4	18	34	40	35	44														CASSLVRATSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGCGTTAGCACGACAGATACGCAGTATTTTGGCCCA	CASSFGVSTTDTQYF	In	VDJ	5	313	0.0011762097486368369	0.0013926647059608718	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	7	3	6	3	18	32	42	38	45						01,02								CASSFGVSTTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTAAGGGGTGATCGGCCCTACGAGCAGTACTTCGGGCCG	CASSLVRGDRPYEQYF	In	VDJ	5	318	0.0011949990417460515	0.0014149117459921958	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	5	2	2	4	8	18	32	41	36	49														CASSLVRGDRPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCTTATCAAGCGGGGGGGCTATTGAGCAGTTCTTCGGGCCA	CASSLSSGGAIEQFF	In	VDJ	6	332	0.0012476090624518525	0.0014772034580799024	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	6	0	9	3	4	18	33	46	36	50														CASSLSSGGAIEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGGGGGAGGCCCACAGGATTACACAGATACGCAGTATTTTGGCCCA	CASGGGPQDYTDTQYF	In	VDJ	7	423	0.001589574197039559	0.0018820995866499963	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	9	1	2	2	12	18	27	35	29	47														CASGGGPQDYTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGAGCGGGGGGGCGGAGACCCAGTACTTCGGGCCA	CASSSSGGAETQYF	In	VDJ	17	1041	0.0039119308253384895	0.004631833734521622	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	6	0	5	2	2	18	31	43	33	45														CASSSSGGAETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGATACGGTCGGACTGAAGCTTTCTTTGGACAA	CASSSGYGRTEAFF	In	VDJ	40	2365	0.008887335640658528	0.010522849934816173	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	3	5	0	9	18	-1	36	31	45														CASSSGYGRTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAAACGGACAGGGGCCCCCGGGGGCGAGCAGTACTTCGGGCCG	CASKRTGAPGGEQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	12	1	2	6	8	10	26	31	48	39	58														CASKRTGAPGGEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCCAGACTAGCGGGGGGGCTGATACGCAGTATTTTGGCCCA	CASTQTSGGADTQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	2	0	6	9	2	26	31	54	40	56														CASTQTSGGADTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGAGGACTAGCGGTTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	25	9.394646554607322E-5		50	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	2	1	5	0	1	2	26	41	52	42	54						01,02								X+TCRBV12-05+TCRBJ02-04	TCRBV12-05*01	TCRBD02-01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAACGACGGGAACCAAGAGACCCAGTACTTCGGGCCA	CASNDGNQETQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	12	8	3	0	9	0	26	31	-1	40	45														CASNDGNQETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCATTAAAACCGGGACGGGAGAAAAACTGTTTTTTGGCAGT	CASIKTGTGEKLFF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	42	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-04	01	12	0	7	8	13	4	26	31	49	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIKTGTGEKLFF+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCCGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRNTGELFF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	33	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-02	01	12	4	5	1	0	3	26	-1	34	31	37				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRNTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTGGGGAAGCCTTCTAACTATGGCTACACCTTCGGTTCG	CASGLVGKPSNYGYTF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	48	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	0	0	8	0	1	6	26	43	48	44	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLVGKPSNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGTTGTGGAGTTGAGTTAGGGGACTCCTACGAGCAGTACTTCGGGCCG	CASCGVELGDSYEQYF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	48	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	5	2	0	14	1	26	35	54	49	55														CASCGVELGDSYEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGACACCGGGGAGCTGTTTTTTGGAGAA	CASGLDTGELFF	In	VJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	36	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-02	01	1	0	0	3	0	0	26	-1	-1	-1	42														CASGLDTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTCGGGCGGGGATGGAAACACCATATATTTTGGAGAG	CASGLSGGDGNTIYF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	2	7	3	3	4	1	26	41	51	45	52														CASGLSGGDGNTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGACAATATAATTCACCCCTCCACTTTGGGAAC	CASGLGQYNSPLHF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	2	6	4	0	1	26	-1	46	42	47														CASGLGQYNSPLHF+TCRBV12-05+TCRBJ01-06	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGACAGGGTGCCGGGGAGCTGTTTTTTGGAGAA	CASGLGQGAGELFF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	2	3	6	0	2	26	-1	49	42	51														CASGLGQGAGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGTACGGGGAGAGGGGCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	39	1.4655648625187424E-4		41	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	7	5	2	4	9	1	26	36	50	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCAAGGGGAGGTACAATGAGCAGTTCTTCGGGCCA	CASTKGRYNEQFF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	12	9	1	4	10	0	26	31	-1	41	47														CASTKGRYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACTAGCGTCGTACAATGAGCAGTTCTTCGGGCCA	CASGLVLASYNEQFF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	6	4	0	3	26	-1	50	43	53						01,02								CASGLVLASYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCGAGCGGGAGGGTCGCCCACGAGCAGTACTTCGGGCCG	CASGRVAHEQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	12	6	0	5	1	6	26	31	42	32	48														CASGRVAHEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTTCCCCGAGGGGGGTTCACCCCTCCACTTTGGGAAC	CASGLFPEGGSPLHF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	45	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-06	01	2	5	1	9	7	1	26	41	54	48	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLFPEGGSPLHF+TCRBV12-05+TCRBJ01-06	TCRBV12-05*01		TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCTCCCCGAGGGGGTAAAGAGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	44	1.6534577936108889E-4		59	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	5	1	0	8	9	22	33	47	41	56														X+TCRBV12-05+TCRBJ02-06	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCTTAATTGGGAGCTAGCGGGGGCCAACTACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	46	1.7286149660477473E-4		59	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	4	2	2	18	7	22	27	55	45	62														X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCATCCTGACAGGATCAGATACGCAGTATTTTGGCCCA	CASILTGSDTQYF	In	VDJ	1	48	1.803772138484606E-4	2.135715843007088E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	12	2	4	4	9	2	26	31	46	40	48														CASILTGSDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCGTGGAGGCGACAGGGCATGGGAGACCCAGTACTTCGGGCCA	CASGRGGDRAWETQYF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	48	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	5	10	5	26	37	54	47	59														CASGRGGDRAWETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCCCAGTCTACCGGTGGGGCGGATACGCAGTATTTTGGCCCA	CASGLAQSTGGADTQYF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	51	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	7	0	6	14	1	26	42	61	56	62														CASGLAQSTGGADTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGAAGCGGATACAATGAGCAGTTCTTCGGGCCA	CASGLGSGYNEQFF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	6	5	4	2	1	26	42	49	44	50						01,02								CASGLGSGYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCCTCCGGAGGGCCGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	50	1.8789293109214644E-4		46	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	10	0	0	6	5	26	36	48	42	53														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCTCAGGGGTAAGCTCCTACGAGCAGTACTTCGGGCCG	CASASGVSSYEQYF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	4	2	0	3	4	26	36	45	39	49														CASASGVSSYEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTAAGCGGGACAGGAAGAGAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	52	1.954086483358323E-4		56	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	4	0	4	7	25	37	49	41	56														X+TCRBV12-05+TCRBJ02-06	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACGGCAAGCAATCAGCCCCAGCATTTTGGTGAT	CASTASNQPQHF	In	VDJ	1	53	1.9916650695767524E-4	2.3581862433203263E-4	36	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-05	01	12	4	5	1	0	7	26	-1	34	31	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTASNQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCTTGTCCCGGGGCTCACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	58	2.179558000668899E-4		46	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-03	01	2	7	0	2	4	3	26	41	50	45	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTGGAGTTTGAACACTGAAGCTTTCTTTGGACAA	CASGWSLNTEAFF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	2	0	0	2	26	-1	43	39	45														CASGWSLNTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCGGGACCTTTGGCAATCAGCCCCAGCATTTTGGTGAT	CASGTFGNQPQHF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	12	6	3	2	1	6	26	31	39	32	45														CASGTFGNQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD02-01*02	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTAAGGGGGGGCTGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	69	2.592922449071621E-4		46	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	9	0	3	2	3	26	43	52	45	55														X+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGTATCAGGAGGGCCCACCCGATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	75	2.818393966382197E-4		46	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	10	0	1	4	9	26	35	45	39	54														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTTAGAGTCCGGCACAGATACGCAGTATTTTGGCCCA	CASGLLESGTDTQYF	In	VDJ	1	88	3.3069155872217777E-4	3.9154790455129943E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	5	8	1	1	6	26	41	45	42	51						01,02								CASGLLESGTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCCGGACTAGCGGGGGACCTGCGGCCCAGTACTTCGGGCCA	CASTRTSGGPAAQYF	In	VDJ	2	100	3.757858621842929E-4	4.4494080062647663E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	12	1	2	9	8	8	26	31	52	39	60														CASTRTSGGPAAQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGCCGCAGGACAGGGTAGGAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	109	4.0960658978087927E-4		50	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	1	3	3	5	5	26	41	54	46	59														X+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTACCTCCCCCGGGACTAGAGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	130	4.885216208395808E-4		47	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	8	3	9	2	26	38	55	47	57						01,02								X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCTAGCGGYCAAGAGACCCAGTACTTCGGGCCA	CASGLASGQETQYF	In	VDJ	2	140	5.261002070580101E-4	6.229171208770673E-4	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	4	5	1	0	0	26	-1	-1	42	49						01,02								CASGLASGQETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCATTAGCGGGGGTTACCGGGGAGCTGTTTTTTGGAGAA	CASGSLAGVTGELFF	In	VDJ	2	149	5.599209346545964E-4	6.629617929334502E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	5	2	5	3	2	26	39	51	42	53														CASGSLAGVTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCATAGTGGGCTCTGGGGATACGCAGTATTTTGGCCCA	CASTIVGSGDTQYF	In	VDJ	3	150	5.636787932764394E-4	6.67411200939715E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	12	8	0	6	12	6	26	31	47	43	53														CASTIVGSGDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGACTCAGCCCTGTACTTCTGTGCCAGCAGCCAGGGTAATGGAAACACCATATATTTTGGAGAG	CASSQGNGNTIYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	39	TCRBV13	TCRBV13-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	3	3	0	3	20	-1	37	32	40													Vb 23	CASSQGNGNTIYF+TCRBV13-01+TCRBJ01-03	TCRBV13-01*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCTTAGAGGGGAGGCTCCTGTTTTTTGGCAGT	CASSLEGRLLFF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	36	TCRBV13	TCRBV13-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	1	9	1	14	2	3	23	39	47	41	50													Vb 23	CASSLEGRLLFF+TCRBV13-01+TCRBJ01-04	TCRBV13-01*01	TCRBD02-01*02	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCTTAGATGCCAGAACGGGCGAGCAGTACTTCGGGCCG	CASSLDARTGEQYF	In	VDJ	3	157	5.899838036293398E-4	6.985570569835683E-4	42	TCRBV13	TCRBV13-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	8	4	6	9	0	23	39	-1	48	52						01,02							Vb 23	CASSLDARTGEQYF+TCRBV13-01+TCRBJ02-07	TCRBV13-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGGGGGGGAGCGGGATCCGGGGAGCTGTTTTTTGGAGAA	CASRGGAGSGELFF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	6	3	6	6	1	20	31	44	37	45														CASRGGAGSGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGAGGGACTCCCTACCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	6.38835965713298E-5		50	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	10	1	2	6	20	37	45	39	51						01,02								X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGGGGGGGACTGGGGAGCTGTTTTTTGGAGAA	CASSQGGTGELFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	39	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-02	01	6	4	1	8	1	5	20	31	39	32	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGGTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTAGATCTGGCCGCGGGGCAGTACTTCGGGCCG	CASSLDLAAGQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	7	4	9	13	0	20	31	-1	44	49						01,02								CASSLDLAAGQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGGGCCCCGCCTACGAGCAGTACTTCGGGCCG	CASSLGPAYEQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	8	0	2	3	4	20	31	38	34	42														CASSLGPAYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCCTTCTTTCAGGTCGAGCAGTACTTCGGGCCG	CASSPFFQVEQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	4	6	10	1	20	31	45	41	46														CASSPFFQVEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCGAGGGCCCCGCGGCAGCAGGTGGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	7.891503105870151E-5		53	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	11	0	6	0	19	20	-1	38	33	57														X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTAAACGGTGATCAGCCCCAGCATTTTGGTGAT	CASSLNGDQPQHF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	8	5	5	6	2	20	31	40	37	42						01,02								CASSLNGDQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD02-01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCTCGGGGGAGCCCACAGATACGCAGTATTTTGGCCCA	CASSGEPTDTQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	8	2	2	1	4	20	29	36	30	40														CASSGEPTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGTGAGGGACTAGCGGGACTTTGGCCACTACGAGCAGTACTTCGGGCCG	CASSQVRD*RDFGHYEQYF	Stop	VDJ	1	26	9.770432416791615E-5		57	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	0	3	3	4	9	20	35	52	39	61														CASSQVRD*RDFGHYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGACAGGGCTCTGCTACGAGCAGTACTTCGGGCCG	CASSQTGLCYEQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	3	3	5	20	31	41	34	46														CASSQTGLCYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTCATTCACGAGCGGGAGGGGAAGGAATGAGCAGTTCTTCGGGCCA	CASSSFTSGRGRNEQFF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	6	0	7	10	5	20	31	51	41	56														CASSSFTSGRGRNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAATTTTCGGCCAGGGGCAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	1.0522004141160201E-4		49	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	2	2	9	1	20	35	50	44	51														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCGCTTGTCCGGGACTAGCGGGGAGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	1.1273575865528787E-4		53	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	3	11	2	20	31	55	42	57														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCATCGTGGGACAGATACGCAGTATTTTGGCCCA	CASSHRGTDTQYF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	39	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-03	01	6	0	9	3	7	0	20	31	-1	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHRGTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGGAGAGGACAGCTAACTATGGCTACACCTTCGGTTCG	CASSLERTANYGYTF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	5	0	8	0	20	31	-1	39	45														CASSLERTANYGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTCTTAGCGGGAGTAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFLAGVNTGELFF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	5	2	2	5	2	20	31	45	36	47														CASSFLAGVNTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTATCGATTTTCCCCCGAACAATGAGCAGTTCTTCGGGCCA	CASSIDFPPNNEQFF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	45	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-01	01	5	2	8	5	3	11	20	32	37	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSIDFPPNNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCGGGGGGCAGGTCAGGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	35	1.3152505176450253E-4		43	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-01	01	11	6	0	0	1	8	20	26	33	27	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGACACGGCACTGTATCTCTGCGCCAGCAGTCACTTCCGGGCCCCTAACGAAGCCGCCCAAAATTACAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	36	1.3528291038634543E-4		62	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-05	01	3	8	0	7	5	24	19	33	42	38	66				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCCCTCATGGGACAGGGGTATCGGGAGCAGTACTTCGGGCCG	CASSQSLMGQGYREQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	51	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	2	7	6	6	20	37	53	43	59														CASSQSLMGQGYREQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAACCTGGGAATTCACCCCTCCACTTTGGGAAC	CASSQPGNSPLHF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	39	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-06	01	2	0	9	7	3	0	20	35	-1	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQPGNSPLHF+TCRBV23-01+TCRBJ01-06	TCRBV23-01*01		TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCCGAAAGTAGGAATTGTCCGAGCAGTACTTCGGGCCG		Out	VDJ	1	41	1.5407220349556008E-4		44	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-07	01	4	1	8	6	9	6	20	33	45	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCTCAAGACAGGAAACGAGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	47	1.7661935522661766E-4		49	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	2	5	7	20	33	44	38	51														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGGGACAGGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	48	1.803772138484606E-4		46	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	3	1	0	1	20	-1	46	37	47														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAGCTAGGTCTTCAGGGTCTTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	51	1.9165078971398938E-4		52	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	1	10	4	20	35	50	45	54														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAAGCGAACTAGCGGTTCGATACAAGCAGTACTTCGGGCCG	CASSQSELAVRYKQYF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	5	8	5	9	20	35	48	40	57						01,02								CASSQSELAVRYKQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAACCGGACTTAGGCACAGATACGCAGTATTTTGGCCCA	CASSQPDLGTDTQYF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	1	10	1	2	3	20	35	42	37	45						01,02								CASSQPDLGTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGTCCGGCGGGGGGCAATCAGATACGCAGTATTTTGGCCCA	CASSQSGGGQSDTQYF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	7	1	4	8	4	20	31	47	39	51														CASSQSGGGQSDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAGATGCGAGGGGGTCTGTCGAGCAGTACTTCGGGCCG	CASSQDARGSVEQYF	In	VDJ	1	65	2.442608104197904E-4	2.8921152040720983E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	5	1	6	6	5	20	35	47	41	52														CASSQDARGSVEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCTCAAGACAGGGAAYGAGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	66	2.480186690416333E-4		49	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	2	5	6	20	33	45	38	51														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGTAGTTCAGGGGCCGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	92	3.4572299320954946E-4		49	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	2	5	6	3	20	37	49	43	52														X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGGGCAGACAGGGCATTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	97	3.645122863187641E-4		53	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	2	3	4	5	3	20	37	49	42	52														X+TCRBV23-01+TCRBJ01-06	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGGACAACAGGGGGAGGGACACTGAAGCTTTCTTTGGACAA	CASSQDNRGRDTEAFF	In	VDJ	2	113	4.24638024268251E-4	5.027831047079186E-4	48	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	1	3	8	4	20	31	47	39	51														CASSQDNRGRDTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAGGTTGGGCGAGGTTGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQVGRGWSYNEQFF	In	VDJ	2	125	4.697323277303661E-4	5.561760007830958E-4	51	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-01	01	3	8	0	1	4	8	20	34	42	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVGRGWSYNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCTCCTATCAGCCGGCATTTCGGGTTACCAAGAGACCCAGTACTTCGGGCCA	CASSLLSAGISGYQETQYF	In	VDJ	2	125	4.697323277303661E-4	5.561760007830958E-4	57	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	8	4	0	18	2	20	33	55	51	57						01,02								CASSLLSAGISGYQETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACATGAGCACGGGACTAGCCCTATCAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	127	4.77248044974052E-4		56	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	0	7	0	9	7	20	30	48	39	55						01,02								X+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCGGGGGGTCCCCGTAGCCGGCGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	142	5.336159243016959E-4		44	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	9	1	5	0	14	20	-1	35	29	49														X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCAGCGGACAGGTTATTCCCAACACCATATATTTTGGAGAG	CASSSGQVIPNTIYF	In	VDJ	3	155	5.82468086385654E-4	6.896582409710388E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	4	7	4	8	20	31	42	35	50														CASSSGQVIPNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGATGCAGGGGGCGAGGGCTACACCTTCGGTTCG		Out	VDJ	4	228	8.567917657801878E-4		44	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	0	8	4	3	20	37	49	41	52														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGCTAGCGGGGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSASGGATDTQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	4	0	2	2	1	23	34	48	36	49														CASSASGGATDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGGGACAGTAACTATGGCTACACCTTCGGTTCG	CASSRDSNYGYTF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	1	1	0	23	35	-1	36	43														CASSRDSNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTGCTTGGGGGGCAGGGTTCACCCCTCCACTTTGGGAAC	CASSYLLGGQGSPLHF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	2	6	0	9	7	4	23	38	51	45	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLLGGQGSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGCCGAGATGAACACTGAAGCTTTCTTTGGACAA	CASSYAEMNTEAFF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	11	2	0	4	1	23	37	44	41	45														CASSYAEMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGAAAACCGGCGGGGAGAGACCCAGTACTTCGGGCCA	CAISENRRGETQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	7	3	4	9	0	23	34	-1	43	49														CAISENRRGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCGATCAAGGTCGTTTCGGGACAAAACACAGATACGCAGTATTTTGGCCCA	CAIKVVSGQNTDTQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	12	0	6	2	15	3	23	28	49	43	52														CAIKVVSGQNTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACAGGAACCCTGGCTACACCTTCGGTTCG	CASSYDRNPGYTF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	4	7	0	5	23	-1	44	38	49														CASSYDRNPGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGACAGGGGGGCTACACCTTCGGTTCG	CASSSGQGGYTF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	2	8	2	0	23	36	-1	38	47														CASSSGQGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCCATAATAGCGGGAGCGGTCGAGCAGTACTTCGGGCCG	CASAIIAGAVEQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	5	2	6	7	4	23	32	48	39	52														CASAIIAGAVEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCCTCAACGTAGGCCGCTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	18	6.764145519317272E-5		37	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	11	5	4	7	8	4	23	29	40	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACAAATTGGGACAGGTCGGGGGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	7.139931381501565E-5		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	7	8	6	23	35	51	43	57														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTGCTGGGACAGTTGCCAAAAGCTCAAGAGACCCAGTACTTCGGGCCA	CASSYLLGQLPKAQETQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	5	2	5	12	23	38	50	43	62														CASSYLLGQLPKAQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTGTTAGTTGGCTACGAGCAGTACTTCGGGCCG	CASSYLLVGYEQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	5	8	3	4	4	23	38	45	42	49						01,02								CASSYLLVGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGACAGGGCCGGGAAGAGACCCAGTACTTCGGGCCA	CASSYGQGREETQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	1	3	3	0	5	23	-1	46	38	51														CASSYGQGREETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTACGGGGGTATAGGGCAAGAGACCCAGTACTTCGGGCCA	CASSYYGGIGQETQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	8	2	2	1	7	23	39	46	40	53														CASSYYGGIGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCTGTGTACTTGTGTGCCAGCAGTTCAGGGACTAGGAGGGGCGGACTCCCCCAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGTRRGGLPQNTGELFF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	63	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	8	1	2	18	12	25	35	27	53						01,02								CASSSGTRRGGLPQNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACAGGGTGGGGGAGACCCAGTACTTCGGGCCA	CASSDRVGETQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	5	0	5	23	-1	42	35	47														CASSDRVGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTTGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSDLGTGELFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	1	0	9	4	1	0	23	39	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDLGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGGGACAGGGGCCCCGAACACTGAAGCTTTCTTTGGACAA	CAISGTGAPNTEAFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	1	1	4	23	34	45	35	49														CAISGTGAPNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCCGGGACTAGCGGGGGGGGCGGAGAGACCCAGTACTTCGGGCCA	CAISAGTSGGGGETQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	0	0	4	3	4	23	35	54	38	58														CAISAGTSGGGGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGCCGCAGGGGCCGGCAATCAGCCCCAGCATTTTGGTGAT	CATAAGAGNQPQHF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	4	2	2	6	3	23	30	42	36	45														CATAAGAGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTGGGACGCAATGCTTATGGCTACACCTTCGGTTCG	CASSYLGRNAYGYTF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	0	7	5	2	8	23	38	45	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLGRNAYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGCCATTGGCAATCAGCCCCAGCATTTTGGTGAT	CASSYSAIGNQPQHF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	0	4	6	2	3	3	23	40	45	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSAIGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGACTAGCGGGGGGGCTATCCACAGATACGCAGTATTTTGGCCCA	CASSGLAGGLSTDTQYF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	0	2	0	5	23	-1	50	35	55														CASSGLAGGLSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGTCGAGGGGTTGGGCACAGATACGCAGTATTTTGGCCCA	CASSYGVEGLGTDTQYF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	2	5	2	1	7	4	23	38	50	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGVEGLGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTTGGACAGGGGGCGCGGGGCTACGAGCAGTACTTCGGGCCG	CASSYFGQGARGYEQYF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	0	3	2	6	23	39	52	41	58														CASSYFGQGARGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTATTAGCGGGACGTTACAATGAGCAGTTCTTCGGGCCA	CASSLLAGRYNEQFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	3	4	3	3	23	36	47	39	50														CASSLLAGRYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGACAGGGGTAACCTACGAGCAGTACTTCGGGCCG	CASSRTGVTYEQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	2	1	3	23	35	45	36	48														CASSRTGVTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGCTGATATATCAGCCCCAGCATTTTGGTGAT	CASSGLIYQPQHF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	8	0	5	0	6	23	-1	39	35	45														CASSGLIYQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTCCGCCGGGGCAGCGGGAGAAACAATGAGCAGTTCTTCGGGCCA	CASSYLRRGSGRNNEQFF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	2	5	12	2	23	38	58	50	60														CASSYLRRGSGRNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCCCGGGACAGGGACCCACGAGCAGTACTTCGGGCCG	CASSYSPGTGTHEQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	3	5	4	4	23	40	53	44	57														CASSYSPGTGTHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCGGGACTAGCGGTCGATACGCAGTATTTTGGCCCA	CASRPGLAVDTQYF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	5	6	3	2	23	34	48	37	50						01,02								CASRPGLAVDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGCGAACTGGGAGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	24	9.01886069242303E-5		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	9	2	4	8	0	23	35	-1	43	48														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTGGGGGCCAATCAGCCCCAGCATTTTGGTGAT	CASSYLGANQPQHF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	6	0	3	1	0	23	39	-1	40	46														CASSYLGANQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCCCCGGGACAGGGTTTATCACCCCTCCACTTTGGGAAC	CASRPPGQGLSPLHF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	3	10	6	4	23	34	49	40	53														CASRPPGQGLSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGTCGGGGGGATGGAAGGCTACACCTTCGGTTCG	CASSYSVGGMEGYTF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	1	8	3	6	23	40	50	43	56														CASSYSVGGMEGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTGGGGGATGGGCAGGGGGCAGTACTTCGGGCCG	CASWGMGRGQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	4	2	9	11	0	23	32	-1	43	49														CASWGMGRGQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGCGGACGAAAACACAGATACGCAGTATTTTGGCCCA	CASKADENTDTQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	7	1	7	2	4	5	23	33	41	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKADENTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCGAGGTGCGAATTCACCCCTCCACTTTGGGAAC	CASSPRGANSPLHF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	11	1	7	4	4	23	35	43	39	47														CASSPRGANSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCGGGACAGGGAGATTACACTGAAGCTTTCTTTGGACAA	CASSSPGQGDYTEAFF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	3	4	5	23	36	49	40	54														CASSSPGQGDYTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTTTTCAACAGGACTAGCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	26	9.770432416791615E-5		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	1	7	4	7	0	23	36	-1	43	51						01,02								X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAAGCGGTTTAGCGGGGGGGTTTCCTACAATGAGCAGTTCTTCGGGCCA	CASRKRFSGGVSYNEQFF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	5	0	1	9	2	23	34	54	43	56														CASRKRFSGGVSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATACAGCGGGGGGGGAGGAGACCCAGTACTTCGGGCCA	CASSYTAGGEETQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	6	0	5	3	3	23	37	50	40	53														CASSYTAGGEETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGCGACTAGCTCGGGTACGCAGTATTTTGGCCCA	CASSATSSGTQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	7	8	3	5	23	34	44	37	49						01,02								CASSATSSGTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGCCGGACAGGGAAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSSRTGKGNQPQHF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	3	2	4	4	23	35	47	39	51														CASSSRTGKGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAAACGTCAAAGGAGCCCCAGCATTTTGGTGAT	CASSQTSKEPQHF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	5	5	4	8	10	0	23	35	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTSKEPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCTAGGGGAGATAGCTCCTACGAGCAGTACTTCGGGCCG	CASARGDSSYEQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	8	5	2	0	3	6	23	32	40	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASARGDSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAACGGGGCCGCAAACGACTATGGCTACACCTTCGGTTCG	CASSNGAANDYGYTF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	7	0	3	3	8	23	35	43	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNGAANDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGTAGGGTTTCGGGCACTGAAGCTTTCTTTGGACAA	CASSYSRVSGTEAFF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	5	3	4	3	7	23	38	45	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSRVSGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACCCAGTTATACGAGCAGTACTTCGGGCCG	CASSYSTQLYEQYF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	2	7	4	0	7	23	-1	43	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSTQLYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGATAGCGGGAGGGCGCACCGGGGAGCTGTTTTTTGGAGAA	CASSYSIAGGRTGELFF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	5	0	4	2	2	23	40	53	42	55														CASSYSIAGGRTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGACAGGGAAGAACACTGAAGCTTTCTTTGGACAA	CASSSTGKNTEAFF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	1	1	2	23	36	44	37	46														CASSSTGKNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGAACGCGGGCGGGGCCAACGTCCTGACTTTCGGGGCC	CASKNAGGANVLTF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	7	7	4	4	5	1	23	33	43	38	44						01,02								CASKNAGGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCGGACGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	31	1.164936172771308E-4		44	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	1	7	0	3	3	23	38	45	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSYASSYNSPLHF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	2	7	6	0	0	2	23	-1	41	38	43						01,02								CASSYASSYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGCCCTATGGTGAAGGGAAGTCAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	31	1.164936172771308E-4		55	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	3	0	8	2	14	5	23	37	55	51	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAGGTAGGATTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	32	1.2025147589897372E-4		44	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	3	1	8	0	5	2	23	37	45	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCTCACTGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASLGSTDTQYF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	11	6	2	0	5	0	23	29	-1	34	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASLGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGTTCCAGATGACTCGACCTACGAGCAGTACTTCGGGCCG	CATVPDDSTYEQYF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	2	10	2	11	3	23	30	45	41	48						01,02								CATVPDDSTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTGGCGGTTGGCTACACCTTCGGTTCG		Out	VDJ	1	33	1.2400933452081666E-4		38	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	7	5	7	3	1	23	40	47	43	48						01,02								X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGAAGGAGGGGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	34	1.277671931426596E-4		40	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	0	5	4	1	23	38	48	42	49														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCACTGGGGGTGATCAGCCCCAGCATTTTGGTGAT	CASSYPTGGDQPQHF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	2	6	1	5	6	2	23	38	49	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPTGGDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGGTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYSGVSSYNEQFF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	6	1	0	0	4	23	-1	45	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGVSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGAGACAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSDSETGDTGELFF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	2	3	3	0	23	40	-1	43	51														CASSDSETGDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCGGCAGGGAGGAGGAGTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYPAGRRSGANVLTF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	2	9	1	3	6	5	23	38	50	44	55														CASSYPAGRRSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGATTGACACTTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	35	1.3152505176450253E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	6	4	4	3	23	40	48	44	51														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATGGTCGCCGGCAACTATGGCTACACCTTCGGTTCG	CASMVAGNYGYTF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	7	9	0	2	8	0	23	33	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASMVAGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAAGCGGGACGGGCCCCGTACGCAGTATTTTGGCCCA	CASSKRDGPRTQYF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	3	8	2	9	23	34	43	36	52														CASSKRDGPRTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCGCAGAGAGCGGCTACACCTTCGGTTCG	CASSYPAESGYTF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	4	5	8	4	5	23	38	45	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPAESGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTGGCGGGAGTCGTAGATACGCAGTATTTTGGCCCA	CASSYLAGVVDTQYF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	7	2	5	3	4	23	38	48	41	52														CASSYLAGVVDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACCGGGCAGGCATTAGCACAGATACGCAGTATTTTGGCCCA	CASSYDRAGISTDTQYF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	2	4	4	0	7	4	23	38	49	45	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYDRAGISTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTCGGGGACACTGAAGCTTTCTTTGGACAA	CASSLGDTEAFF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	3	3	3	0	23	34	-1	37	42														CASSLGDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCCCCCTCGGGACCTACGAGCAGTACTTCGGGCCG	CASSTPLGTYEQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	3	2	8	0	23	35	-1	43	48														CASSTPLGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGACAGGACCCCTATCAGCCCCAGCATTTTGGTGAT	CASSYSGQDPYQPQHF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	4	5	1	6	23	40	48	41	54														CASSYSGQDPYQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCGCGGGGACAGGGTTAACACCGGGGAGCTGTTTTTTGGAGAA	CAISRGDRVNTGELFF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	2	5	2	23	34	48	39	50														CAISRGDRVNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCAACCAGGGGGCTAGGTAATTCACCCCTCCACTTTGGGAAC	CASSATRGLGNSPLHF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	0	6	5	4	23	35	48	40	52														CASSATRGLGNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCCGGTTAGCGGGGGAAGGGATGAGCAGTTCTTCGGGCCA	CASSYPVSGGRDEQFF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	5	2	8	6	5	23	37	52	43	57														CASSYPVSGGRDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATTTGGGCGGCGCCCCCAGGGAGCAGTACTTCGGGCCG	CASSYLGGAPREQYF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	3	4	4	7	15	0	23	37	-1	52	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLGGAPREQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAACCGACAATAGCGTCGTACACTGAAGCTTTCTTTGGACAA	CASSQPTIASYTEAFF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	5	6	3	10	4	23	35	50	45	54						01,02								CASSQPTIASYTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGCATCCCCTAGCGGGGTTTGAGCAGTACTTCGGGCCG	CASSYQHPLAGFEQYF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	7	9	3	23	38	56	47	59														CASSYQHPLAGFEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTTGTCCTCCGGGACAGGGAACTATGGCTACACCTTCGGTTCG	CASTLSSGTGNYGYTF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	3	2	11	0	23	33	-1	44	53														CASTLSSGTGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGAGGTTGGGCCTACGAGCAGTACTTCGGGCCG	CASSRGWAYEQYF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	11	1	2	1	5	23	35	40	36	45														CASSRGWAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTACATGACATACCCGAGCAGTACTTCGGGCCG	CASSYLHDIPEQYF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	6	6	5	4	23	39	48	44	52														CASSYLHDIPEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGAAGTATGCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	40	1.5031434487371717E-4		43	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	3	2	8	2	0	7	23	-1	39	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCTTTGCTAACCAGCACAGATACGCAGTATTTTGGCCCA	CASSPLLTSTDTQYF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	9	0	7	3	23	34	44	41	47						01,02								CASSPLLTSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGCCGGACAGGCCCTCGCAGCGCACTTCGGGCCG	CASSAGQALAAHF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	4	14	4	12	23	34	45	38	57														CASSAGQALAAHF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGACACGAGCTCCAGCAGTACTTCGGGCCG	CASRGHELQQYF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	8	0	8	23	-1	40	34	48														CASRGHELQQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACCTTCGAGAGGAACTACAATGAGCAGTTCTTCGGGCCA	CASSYTFERNYNEQFF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	11	1	3	8	2	23	38	50	46	52														CASSYTFERNYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGTCTAACAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYGLTNTGELFF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	2	3	6	2	6	0	23	38	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGLTNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCTTAGGGAGGATCCCCCCAGATACGCAGTATTTTGGCCCA	CASSSLGRIPPDTQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	9	1	4	5	7	23	36	47	41	54														CASSSLGRIPPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGGGAAGACAGGGGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	42	1.5783006211740302E-4		37	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	2	2	5	4	0	23	31	-1	35	43														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACACCGGGCCCCGCGCAGATACGCAGTATTTTGGCCCA	CASSDTGPRADTQYF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	2	6	4	0	12	23	-1	39	35	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDTGPRADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCGGGACGTTGAACACTGAAGCTTTCTTTGGACAA	CASIGTLNTEAFF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	7	0	7	0	2	2	23	33	40	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIGTLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCCGGACAGGGTGGAGAATAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	44	1.6534577936108889E-4		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	2	4	8	23	34	46	38	54														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGACAGGGGTTAGTTCACCCCTCCACTTTGGGAAC	CASSRTGVSSPLHF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	2	9	1	4	23	35	45	36	49														CASSRTGVSSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGTATCGAGCAGTACTTCGGGCCG	CASSYSSIEQYF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	2	6	0	3	23	-1	43	40	46														CASSYSSIEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTCTGTCTCGGGACACTGAAGCTTTCTTTGGACAA	CASLSRDTEAFF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	9	8	4	3	7	0	23	31	-1	38	42						01,02								CASLSRDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCACCAGGGACTAGATGGCTACACCTTCGGTTCG	CASSHQGLDGYTF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	0	8	6	6	0	23	34	-1	40	48						01,02								CASSHQGLDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATGGCCCAACTAGCGGGGGACTTGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	45	1.691036379829318E-4		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	3	2	6	9	5	23	35	55	44	60														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTACCAGGGACAGGGGGCTGTTTTTTGGCAGT	CASSYSTRDRGLFF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	1	14	5	0	23	40	-1	45	56														CASSYSTRDRGLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGTCGGACAGGGCCGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	45	1.691036379829318E-4		38	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	1	3	1	3	3	23	29	40	32	43														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGATAGCGGGAGATCTGGTAATGAGCAGTTCTTCGGGCCA	CASSDDSGRSGNEQFF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	2	7	5	7	23	35	49	40	56														CASSDDSGRSGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGTCGACAGGGGGGCAGATACGCAGTATTTTGGCCCA	CAISVDRGADTQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	1	4	3	1	23	35	47	38	48														CAISVDRGADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGATGGGGACGCCAGAAGAGACCCAGTACTTCGGGCCA	CASRMGTPEETQYF	In	VDJ	1	48	1.803772138484606E-4	2.135715843007088E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	6	0	7	3	4	5	23	34	43	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRMGTPEETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCCTAAGGGGGGCCCGGAACTATGGCTACACCTTCGGTTCG	CATLRGARNYGYTF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	10	5	1	2	5	6	23	30	41	35	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATLRGARNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCAGACAGGGTACAATGAGCAGTTCTTCGGGCCA	CASSYQTGYNEQFF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	3	4	3	0	23	37	-1	40	47														CASSYQTGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTACCTTCTGAACACTGAAGCTTTCTTTGGACAA	CASRYLLNTEAFF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	4	10	0	0	2	23	-1	40	38	42						01,02								CASRYLLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTGGCAGGGGAAGCAGATGGCTACACCTTCGGTTCG	CASSYVAGEADGYTF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	2	6	4	6	23	38	48	42	54														CASSYVAGEADGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCCGCAGGGCGCCTACGAGCAGTACTTCGGGCCG	CAISPQGAYEQYF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	2	3	2	23	35	43	38	45														CAISPQGAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGAGCGGGGGGGCGTGTTGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	51	1.9165078971398938E-4		53	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	6	0	5	4	7	23	40	54	44	61														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAAGGGGGACACATTGAACACTGAAGCTTTCTTTGGACAA	CAIKGDTLNTEAFF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	0	6	0	6	3	23	30	42	36	45														CAIKGDTLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCCCCTAAAGCAGTACCAAGAGACCCAGTACTTCGGGCCA	CAISPLKQYQETQYF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	6	4	5	0	10	1	23	34	47	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISPLKQYQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGACATACCCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	53	1.9916650695767524E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	6	0	0	4	23	-1	40	35	44														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAAGGGACTCAGAACAGATACGCAGTATTTTGGCCCA	CASSYSKGLRTDTQYF	In	VDJ	1	53	1.9916650695767524E-4	2.3581862433203263E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	10	3	3	4	23	40	49	43	53						01,02								CASSYSKGLRTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTGTTGCGAGTGTGAACACTGAAGCTTTCTTTGGACAA	CASSSVASVNTEAFF	In	VDJ	1	53	1.9916650695767524E-4	2.3581862433203263E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	7	6	0	5	4	23	36	44	41	48						01,02								CASSSVASVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATAAGAGGGTCGACGGCTACACCTTCGGTTCG	CASSYKRVDGYTF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	11	0	8	3	5	23	37	45	40	50														CASSYKRVDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCCCGGGGACAGGGAGTATTCCGTGGCTACACCTTCGGTTCG	CASSRGQGVFRGYTF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	3	7	5	9	23	32	46	37	55														CASSRGQGVFRGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGGTGAACACTGAAGCTTTCTTTGGACAA	CASSYQVNTEAFF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	4	0	0	0	23	-1	-1	38	42														CASSYQVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCGGGAGGAACGAGCAGTACTTCGGGCCG	CASSYSGGRNEQYF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	1	5	2	1	23	40	50	42	51														CASSYSGGRNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTTGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASLGSGANVLTF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	8	0	9	0	2	0	23	32	-1	34	37				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASLGSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGTACCGGGACAGGGACGGTCGGAGCAGTACTTCGGGCCG	CASRVPGQGRSEQYF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	7	6	7	23	34	49	40	56														CASRVPGQGRSEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGACTAGCGGGAGGGCCGATAAGGGAGACCCAGTACTTCGGGCCA	CASSPGLAGGPIRETQYF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	1	0	5	3	9	23	35	53	38	62														CASSPGLAGGPIRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTGCGATATCCAGCGAAAACCTATACGCAGTATTTTGGCCCA	CASSYLRYPAKTYTQYF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	6	6	7	11	7	23	38	53	49	60						01,02								CASSYLRYPAKTYTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATGGGCAGCTTAAATCAGCCCCAGCATTTTGGTGAT	CASMGSLNQPQHF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	8	0	4	1	6	23	33	38	34	44														CASMGSLNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCCTTTGGGACTAGCGGGAGTCCACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	57	2.1419794144504696E-4		56	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	0	2	2	8	4	23	33	55	41	59														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTACCGACAGGGAGGGAATGAGCAGTTCTTCGGGCCA	CASSYYRQGGNEQFF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	1	2	3	7	3	4	23	39	49	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYYRQGGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGTGATACCGACAGAAAACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	57	2.1419794144504696E-4		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	5	2	8	4	23	39	52	47	56														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACGGACAGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRTDRGSYNEQFF	In	VDJ	1	58	2.179558000668899E-4	2.5806566436335646E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	2	0	3	0	23	34	-1	37	46														CASRTDRGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTGGCAGTGCAAGAGACCCAGTACTTCGGGCCA	CASSYLAVQETQYF	In	VDJ	1	58	2.179558000668899E-4	2.5806566436335646E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	5	2	3	2	23	39	45	42	47														CASSYLAVQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCACGGGGAGAGGGGATGGCTACACCTTCGGTTCG	CATTGRGDGYTF	In	VDJ	1	59	2.217136586887328E-4	2.625150723696212E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	10	5	2	6	10	0	23	30	-1	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATTGRGDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAAACAGGAAAAAGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	59	2.217136586887328E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	4	4	3	8	23	34	42	37	50														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGGAGTGGACACGGAACCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSDSGVDTEPSYNEQFF	In	VDJ	1	59	2.217136586887328E-4	2.625150723696212E-4	57	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	1	6	0	6	7	23	40	51	46	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSGVDTEPSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACTACAGGGAACTCAACTCCTACGAGCAGTACTTCGGGCCG	CASSYDYRELNSYEQYF	In	VDJ	1	59	2.217136586887328E-4	2.625150723696212E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	3	0	4	7	23	38	48	42	55														CASSYDYRELNSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAACTACAGGGGTAGTGAGCAGTTCTTCGGGCCA	CASRNYRGSEQFF	In	VDJ	1	60	2.2547151731057573E-4	2.66964480375886E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	2	9	5	3	23	34	46	39	49														CASRNYRGSEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGCGAGCGGACAGTCGCTCTGGAAACACCATATATTTTGGAGAG	CASSERADSRSGNTIYF	In	VDJ	1	60	2.2547151731057573E-4	2.66964480375886E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	5	0	8	3	23	35	49	43	52														CASSERADSRSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACCCACGACCTGATCAATCAGCCCCAGCATTTTGGTGAT	CASSTHDLINQPQHF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	2	7	3	7	5	23	34	44	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTHDLINQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTGACAGGGAACTACGAGCAGTACTTCGGGCCG	CASSLTGNYEQYF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	3	3	2	23	34	44	37	46														CASSLTGNYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGGCCGGGACAGGCGATAACCGGGGAGCTGTTTTTTGGAGAA	CASRPGQAITGELFF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	4	5	5	5	23	32	45	37	50														CASRPGQAITGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCACGGAGATAACTATGGCTACACCTTCGGTTCG	CASSHGDNYGYTF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	10	2	1	4	1	23	34	42	38	43														CASSHGDNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCTACAGAACGAAGGGGAGACCCAGTACTTCGGGCCA	CASLQNEGETQYF	In	VDJ	1	63	2.3674509317610454E-4	2.803127043946803E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	8	3	5	5	2	9	23	32	38	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASLQNEGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATACGGGAACACTGAAGCTTTCTTTGGACAA	CASRYGNTEAFF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	0	10	1	0	0	23	-1	-1	38	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRYGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCATCAACAGGGAAGGTACCAAGAGACCCAGTACTTCGGGCCA	CASHQQGRYQETQYF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	3	3	0	5	5	23	32	43	37	48														CASHQQGRYQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCGACAGGGAGGGACAGATACGCAGTATTTTGGCCCA	CASTRQGGTDTQYF	In	VDJ	1	65	2.442608104197904E-4	2.8921152040720983E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	7	2	3	3	3	4	23	33	43	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTRQGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCAAGTTCTCAGGGGCAAGAGGTACACTGAAGCTTTCTTTGGACAA	CASRQVLRGKRYTEAFF	In	VDJ	1	65	2.442608104197904E-4	2.8921152040720983E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	3	9	8	23	34	49	43	57														CASRQVLRGKRYTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAGGCTGGTTGGGAGACCCAGTACTTCGGGCCA	CASSQAGWETQYF	In	VDJ	1	65	2.442608104197904E-4	2.8921152040720983E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	4	5	0	8	23	-1	39	35	47														CASSQAGWETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGCGGAGGGGGAGAGACCCAGTACTTCGGGCCA	CASSYRGGGETQYF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	2	5	1	4	5	0	23	38	-1	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRGGGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCAAGGGACAGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASQGTVNTGELFF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	5	1	3	1	23	32	42	35	43														CASQGTVNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATAAAAGTAACGAGTGGACTAGCGGGGGGGACCACAGATACGCAGTATTTTGGCCCA	CAIKVTSGLAGGTTDTQYF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	1	0	2	14	2	23	30	59	44	61														CAIKVTSGLAGGTTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGCCCACGGTAGGGGTGGAACAGATACGCAGTATTTTGGCCCA	CAIAHGRGGTDTQYF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	5	2	3	11	4	23	30	46	41	50														CAIAHGRGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGGGGGACAGGGGAGATATGGCTACACCTTCGGTTCG	CASTGGQGRYGYTF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	2	5	4	3	23	33	47	37	50														CASTGGQGRYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATGAAGGGGCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASMKGLAKNIQYF	In	VDJ	1	68	2.555343862853192E-4	3.025597444260041E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	5	2	0	3	2	23	33	41	36	43														CASMKGLAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACCACTGGAACCTACGAGCAGTACTTCGGGCCG	CASSYTTGTYEQYF	In	VDJ	1	69	2.592922449071621E-4	3.0700915243226886E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	1	8	2	6	1	23	38	47	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTTGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGTAGGCAGGGTAAGAATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	69	2.592922449071621E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	4	3	3	6	7	23	32	43	38	50														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCGCCGGGACTAGCAAGCGCAGATACGCAGTATTTTGGCCCA	CASSPGLASADTQYF	In	VDJ	1	69	2.592922449071621E-4	3.0700915243226886E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	0	7	4	5	5	23	32	46	37	51						01,02								CASSPGLASADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGAGACAACTCACCTGGGAACATTCAGTACTTCGGCGCC	CASSRDNSPGNIQYF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	6	7	3	11	23	35	42	38	53														CASSRDNSPGNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCACCGTCAGGGTTCAATACAGATACGCAGTATTTTGGCCCA	CASAPSGFNTDTQYF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	4	3	3	7	6	23	32	44	39	50														CASAPSGFNTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCCTACAGTGGTGGGGCGGCTAGCGTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	70	2.6305010352900505E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	11	4	6	3	17	1	23	29	52	46	53						01,02								X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGGGGGGACACAAAATGAAAAACTGTTTTTTGGCAGT	CASSGGTQNEKLFF	In	VDJ	1	71	2.6680796215084796E-4	3.159079684447984E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	8	1	5	0	6	23	-1	41	34	47														CASSGGTQNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTCCCCCGGGGACCCTACGAGCAGTACTTCGGGCCG	CASSYFPRGPYEQYF	In	VDJ	1	72	2.7056582077269087E-4	3.203573764510632E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	1	0	7	2	7	0	23	39	-1	46	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYFPRGPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTAGCAGTTACCGGGACTTTGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	73	2.7432367939453383E-4		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	0	10	3	1	4	23	38	45	39	49						01,02								X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCAATCATATCAGCCCCAGCATTTTGGTGAT	CASSQSYQPQHF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	6	5	1	5	23	34	37	35	42														CASSQSYQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGGGGGGGCACAATGAGCAGTTCTTCGGGCCA	CASSRGGHNEQFF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	5	0	2	23	-1	43	35	45														CASSRGGHNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGTCAGGGAAACAATCAGCCCCAGCATTTTGGTGAT	CAISGQGNNQPQHF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	3	3	3	23	35	43	38	46														CAISGQGNNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGACCGTTAGGGGACAGGGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	76	2.855972552600626E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	0	3	2	8	1	23	31	48	39	49														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACCGGGACAGGGGAGGCCAACGTCCTGACTTTCGGGGCC	CASRTGTGEANVLTF	In	VDJ	1	76	2.855972552600626E-4	3.3815500847612223E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	0	2	6	4	1	23	34	48	38	49														CASRTGTGEANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGAAGGGGATCAGATACGCAGTATTTTGGCCCA	CASSRRGSDTQYF	In	VDJ	1	79	2.968708311255914E-4	3.515032324949166E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	2	4	3	2	23	35	43	38	45														CASSRRGSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTGCCATTGAGAAAGCACCCTACGAGCAGTACTTCGGGCCG	CASSFAIEKAPYEQYF	In	VDJ	1	79	2.968708311255914E-4	3.515032324949166E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	6	7	2	13	2	23	36	52	49	54						01,02								CASSFAIEKAPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCTCGGGTCGGTTAGGGACTGAAGCTTTCTTTGGACAA	CAISGRLGTEAFF	In	VDJ	1	79	2.968708311255914E-4	3.515032324949166E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	10	5	3	5	13	0	23	30	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISGRLGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAACACCGGTGGAGACCCAGTACTTCGGGCCA	CASSLTPVETQYF	In	VDJ	1	80	3.0062868974743435E-4	3.559526405011813E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	4	3	6	5	2	6	23	36	41	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTPVETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGGACAGGAGCAAGAGACCCAGTACTTCGGGCCA	CAIGQEQETQYF	In	VDJ	1	81	3.0438654836927726E-4	3.6040204850744606E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	1	4	2	2	2	23	30	39	32	41														CAIGQEQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGGAGGGCAGGGGTAACAGCCCCAGCATTTTGGTGAT	CASSEGGQG*QPQHF	Stop	VDJ	1	83	3.119022656129631E-4		45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	9	0	7	2	9	23	35	44	37	53														CASSEGGQG*QPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACGCATAGCGTCCGAGCAGTACTTCGGGCCG	CASRRIASEQYF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	5	6	6	5	2	23	34	44	39	46						01,02								CASRRIASEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACTAGCGGGGCCACCTGGGAGCAGTTCTTCGGGCCA	CASRTSGATWEQFF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	10	0	8	23	-1	45	34	53														CASRTSGATWEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGCTAGCGGGGGGTACCCACACTGGTACGCAGTATTTTGGCCCA		Out	VDJ	1	84	3.1566012423480603E-4		53	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	4	1	8	2	12	23	38	51	40	63														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGTAGCGGGGGGCCCTACGAGCAGTACTTCGGGCCG	CASSSGSGGPYEQYF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	5	1	2	4	1	23	36	50	40	51														CASSSGSGGPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCCCGGGACTAGCGGGAGCAGATACGCAGTATTTTGGCCCA	CASSAPGLAGADTQYF	In	VDJ	1	85	3.1941798285664894E-4	3.7819968053250515E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	0	2	4	5	0	23	35	-1	40	54														CASSAPGLAGADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTGGCGGGGGTTACAATGAGCAGTTCTTCGGGCCA	CASSSGGGYNEQFF	In	VDJ	1	85	3.1941798285664894E-4	3.7819968053250515E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	2	4	3	1	23	36	46	39	47														CASSSGGGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGACAGGGAGATACAATGAGCAGTTCTTCGGGCCA	CASGTGRYNEQFF	In	VDJ	1	85	3.1941798285664894E-4	3.7819968053250515E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	3	4	0	3	23	-1	41	32	44														CASGTGRYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCAGACAGGGTATAACAATGAGCAGTTCTTCGGGCCA	CASSDQTGYNNEQFF	In	VDJ	1	86	3.231758414784919E-4	3.826490885387699E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	3	5	5	4	23	35	47	40	51														CASSDQTGYNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGGAGATCTAGCGGGACCCTACGAGCAGTACTTCGGGCCG	CASSEGDLAGPYEQYF	In	VDJ	1	86	3.231758414784919E-4	3.826490885387699E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	4	3	2	9	1	23	35	53	44	54														CASSEGDLAGPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACAGGGGGCGCGTATGGCTACACCTTCGGTTCG	CASSTGGAYGYTF	In	VDJ	1	87	3.269337001003348E-4	3.870984965450347E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	0	5	1	3	23	34	44	35	47														CASSTGGAYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCAAAAGGGGCGGGGACTGAGTTGGAAACACCATATATTTTGGAGAG	CASSSKRGGD*VGNTIYF	Stop	VDJ	1	89	3.344494173440207E-4		54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	0	10	3	12	4	23	36	54	48	58						01,02								CASSSKRGGD*VGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGGGTCAGCCAATGAGCAGTTCTTCGGGCCA	CASSPGSANEQFF	In	VDJ	2	90	3.382072759658636E-4	4.00446720563829E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	8	4	6	3	5	23	34	41	37	46						01,02								CASSPGSANEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTGGGCACAAGAATCCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	90	3.382072759658636E-4		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	8	0	0	2	10	23	34	40	36	50														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGCTGGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSYRLGQGNTEAFF	In	VDJ	2	90	3.382072759658636E-4	4.00446720563829E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	1	5	0	23	38	-1	43	52														CASSYRLGQGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGACCCGGGGGTCTACGAGCAGTACTTCGGGCCG	CASRDPGVYEQYF	In	VDJ	2	91	3.4196513458770655E-4	4.048961285700938E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	2	3	5	1	23	34	45	39	46														CASRDPGVYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCAACTCGGGACAGGGGAGACAATGAGCAGTTCTTCGGGCCA	CASSATRDRGDNEQFF	In	VDJ	2	91	3.4196513458770655E-4	4.048961285700938E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	5	7	2	23	35	52	42	54														CASSATRDRGDNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCCCCAGGGGCATCCCACCGGGGAGCTGTTTTTTGGAGAA	CASSYPQGHPTGELFF	In	VDJ	2	92	3.4572299320954946E-4	4.093455365763585E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	2	4	4	5	23	37	47	41	52														CASSYPQGHPTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGGGTCGGCTGGCAGGGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	93	3.494808518313924E-4		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	2	3	12	0	23	34	-1	46	52														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTACAGGGAATTCGTGAAAAACTGTTTTTTGGCAGT	CASSLQGIREKLFF	In	VDJ	2	93	3.494808518313924E-4	4.1379494458262326E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	3	7	2	6	23	35	43	37	49														CASSLQGIREKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGAGACTAGCGGGAGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASETSGRGNTGELFF	In	VDJ	2	94	3.532387104532353E-4	4.1824435258888806E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	2	0	1	2	1	23	32	48	34	49														CASETSGRGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCTCTTGCAGGGTAGGCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	95	3.5699656907507823E-4		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	3	2	9	4	23	35	49	44	53														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCACACCAGCAYTGAAGCTTTCTTTGGACAA	CASSHTSXEAFF	In	VDJ	2	96	3.607544276969212E-4	4.271431686014176E-4	36	TCRBV06	TCRBV06-08	01	unresolved			TCRBJ01	TCRBJ01-01	01	6	3	6	4	2	4	23	34	39	36	43				TCRBD01,TCRBD02										CASSHTSXEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	unresolved	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGGCACCCCCCCTAGCGGAAGGAAAGAGACCCAGTACTTCGGGCCA	CASSGTPPSGRKETQYF	In	VDJ	2	97	3.645122863187641E-4	4.3159257660768235E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	4	5	3	11	5	23	34	52	45	57						01,02								CASSGTPPSGRKETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTCGGGGGTCAGATACGCAGTATTTTGGCCCA	CASSPRGSDTQYF	In	VDJ	2	97	3.645122863187641E-4	4.3159257660768235E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	2	4	3	1	23	35	44	38	45														CASSPRGSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGTGGGGCACAGATACGCAGTATTTTGGCCCA	CASSYEWGTDTQYF	In	VDJ	2	97	3.645122863187641E-4	4.3159257660768235E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	2	0	9	1	4	0	23	38	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYEWGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGACGACAGGGGAATTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	97	3.645122863187641E-4		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	2	2	3	3	4	23	39	50	42	54														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATCTAGCGGGGGACCCTACAATGAGCAGTTCTTCGGGCCA	CASRSSGGPYNEQFF	In	VDJ	2	98	3.6827014494060707E-4	4.360419846139471E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	2	2	2	2	23	34	46	36	48														CASRSSGGPYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAGCTTGGGGCAGGGACGGAATCAGCCCCAGCATTTTGGTGAT	CASRSLGQGRNQPQHF	In	VDJ	2	98	3.6827014494060707E-4	4.360419846139471E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	0	7	4	12	2	23	34	51	46	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSLGQGRNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGAACAGGGCTTGAACACTGAAGCTTTCTTTGGACAA	CASREQGLNTEAFF	In	VDJ	2	99	3.7202800356245E-4	4.404913926202119E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	0	3	2	23	34	43	37	45														CASREQGLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCGGGGGGCCCAGAGACCCAGTACTTCGGGCCA	CASSYPGGPETQYF	In	VDJ	2	99	3.7202800356245E-4	4.404913926202119E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	1	4	1	3	23	38	46	39	49														CASSYPGGPETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTGGAGGGACGCGGGGGATACGCAGTATTTTGGCCCA	CASSYSWRDAGDTQYF	In	VDJ	2	101	3.7954372080613584E-4	4.4939020863274143E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	3	6	10	0	23	40	-1	50	56						01,02								CASSYSWRDAGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGCCTACACTTCATGGTCGGGGAGACCCAGTACTTCGGGCCA	CASSRLHFMVGETQYF	In	VDJ	2	102	3.8330157942797875E-4	4.538396166390062E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	8	4	5	17	0	23	35	-1	52	56						01,02								CASSRLHFMVGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCGATGACATCGAACACTGAAGCTTTCTTTGGACAA	CASSYAMTSNTEAFF	In	VDJ	2	102	3.8330157942797875E-4	4.538396166390062E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	6	1	5	2	23	38	47	43	49														CASSYAMTSNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCGACTAGCGGGGGTCCCAGATACGCAGTATTTTGGCCCA	CASRRLAGVPDTQYF	In	VDJ	2	103	3.870594380498217E-4	4.582890246452709E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	2	2	4	2	3	23	34	48	36	51														CASRRLAGVPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGGATCCGGGACACGGGGGCTGAAGCTTTCTTTGGACAA	CAIRIRDTGAEAFF	In	VDJ	2	103	3.870594380498217E-4	4.582890246452709E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	0	6	6	5	6	23	34	45	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIRIRDTGAEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAACGACAGGGCTTACCAGCACAGATACGCAGTATTTTGGCCCA	CASSLTTGLTSTDTQYF	In	VDJ	2	104	3.908172966716646E-4	4.627384326515357E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	3	0	4	6	23	36	47	40	53														CASSLTTGLTSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGGACTGGCGCAGCTATGAGCAGTTCTTCGGGCCA	CASSSDWRSYEQFF	In	VDJ	2	105	3.9457515529350753E-4	4.6718784065780046E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	10	8	1	9	23	36	42	37	51						01,02								CASSSDWRSYEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGTGTCGGGGGCGATCAACGAGCAGTACTTCGGGCCG	CASTVSGAINEQYF	In	VDJ	2	108	4.0584873115903636E-4	4.805360646765948E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	7	6	0	5	7	5	23	33	46	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTVSGAINEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAACGACGGGACAGACTACGAGCAGTACTTCGGGCCG	CASSNDGTDYEQYF	In	VDJ	2	109	4.0960658978087927E-4	4.8498547268285955E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	3	6	1	23	35	48	41	49														CASSNDGTDYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCTTCTAACTATGGCTACACCTTCGGTTCG	CASSYPSNYGYTF	In	VDJ	2	112	4.2088016564640804E-4	4.983336967016538E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	4	10	0	1	1	23	38	41	39	42						01,02								CASSYPSNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGGGGGGCTGAGACAGATACGCAGTATTTTGGCCCA	CASSYSRGAETDTQYF	In	VDJ	2	113	4.24638024268251E-4	5.027831047079186E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	5	1	3	1	6	23	40	47	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSRGAETDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAACCGGGACTAGGGTACCGGACCCAGTACTTCGGGCCA	CASKPGLGYRTQYF	In	VDJ	2	114	4.283958828900939E-4	5.072325127141834E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	0	8	7	4	7	23	33	45	37	52						01,02								CASKPGLGYRTQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCCCCTAGCGGGAGTATCACTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	114	4.283958828900939E-4		53	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	4	2	3	2	8	23	40	52	42	60														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCCGGGACGGTAGCTCCTACGAGCAGTACTTCGGGCCG	CASSTRDGSSYEQYF	In	VDJ	2	116	4.359116001337798E-4	5.161313287267129E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	0	7	0	4	5	23	35	44	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTRDGSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGTACAGATATAATTCACCCCTCCACTTTGGGAAC	CASSEYRYNSPLHF	In	VDJ	2	121	4.5470089324299443E-4	5.383783687580367E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	5	4	4	1	23	35	43	39	44														CASSEYRYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAGCGGGAGGGCTGATAGGACAGATACGCAGTATTTTGGCCCA	CASRSGRADRTDTQYF	In	VDJ	2	122	4.5845875186483734E-4	5.428277767643015E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	0	3	1	8	23	34	45	35	53														CASRSGRADRTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTCTCTGAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	123	4.6221661048668025E-4		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	3	10	0	0	7	23	-1	37	34	44						01,02								X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAACCAGGGAAATACGCAGTATTTTGGCCCA	CASSNQGNTQYF	In	VDJ	2	124	4.659744691085232E-4	5.517265927768311E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	7	3	2	23	35	43	38	45														CASSNQGNTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGTGGGGAAAGGACAATCAGCCCCAGCATTTTGGTGAT	CASSEWGKDNQPQHF	In	VDJ	2	124	4.659744691085232E-4	5.517265927768311E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	5	0	8	3	5	5	23	35	44	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEWGKDNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGGGGGGACTAGCGGGACTCCCACAGATACGCAGTATTTTGGCCCA	CAGGTSGTPTDTQYF	In	VDJ	2	125	4.697323277303661E-4	5.561760007830958E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	0	3	2	3	4	23	29	45	32	49														CAGGTSGTPTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAACGACTGTTTTGGGAGCAGTACTTCGGGCCG	CASSQRLFWEQYF	In	VDJ	2	127	4.77248044974052E-4	5.650748167956253E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	10	7	4	7	23	35	43	39	50						01,02								CASSQRLFWEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCATCTGCGGGAGGGCCGGGCCCAGTACTTCGGGCCA	CASSHLREGRAQYF	In	VDJ	2	130	4.885216208395808E-4	5.784230408144197E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	7	0	9	6	5	23	34	49	40	54														CASSHLREGRAQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSYRGNQPQHF	In	VDJ	2	130	4.885216208395808E-4	5.784230408144197E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	2	5	3	2	0	0	23	-1	-1	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGGACAGCCAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSSGTASTGELFF	In	VDJ	2	130	4.885216208395808E-4	5.784230408144197E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	5	4	2	4	23	36	45	38	49														CASSSGTASTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGACGCGGGCAGGGGGCTAACTTTCTTTGGACAA	CASSDAGRGLTFF	In	VDJ	2	132	4.960373380832666E-4	5.873218568269492E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	0	12	9	3	23	34	51	43	54														CASSDAGRGLTFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAACACAGGGGGGTCCCCTGAAGCTTTCTTTGGACAA		Out	VDJ	2	135	5.073109139487954E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	1	6	2	5	23	37	47	39	52														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAACCCCGGGACTAGCGTGTATGAGCAGTTCTTCGGGCCA	CASRNPGTSVYEQFF	In	VDJ	2	139	5.223423484361671E-4	6.184677128708026E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	6	8	7	3	23	34	51	41	54						01,02								CASRNPGTSVYEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGAGGGACTAGCGGGGGGGCCCTCCGAGGCCCAGTACTTCGGGCCA	CASKEGLAGGPSEAQYF	In	VDJ	2	147	5.524052174109105E-4	6.540629769209206E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	0	0	9	4	10	23	33	53	37	63														CASKEGLAGGPSEAQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASTWGNTGELFF	In	VDJ	3	155	5.82468086385654E-4	6.896582409710388E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	7	6	2	1	3	0	23	33	-1	36	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTWGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACGGGACCGGGAGAGACCCAGTACTTCGGGCCA	CASSTGPGETQYF	In	VDJ	3	155	5.82468086385654E-4	6.896582409710388E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	0	7	4	2	4	23	35	42	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTGPGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGCAAGGGCCCAGACCTCGTGTCTACGAGCAGTACTTCGGGCCG	CASSYSGQGPRPRVYEQYF	In	VDJ	3	159	5.974995208730257E-4	7.074558729960979E-4	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	7	0	3	0	19	23	-1	45	40	64														CASSYSGQGPRPRVYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGGGCTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	161	6.050152381167115E-4		40	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	7	0	6	1	1	23	40	46	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACAGGGTCGTGGACTGAAGCTTTCTTTGGACAA	CASRTGSWTEAFF	In	VDJ	3	163	6.125309553603975E-4	7.25253505021157E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	5	1	6	23	34	41	35	47														CASRTGSWTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACAGAACTGGAAACACCATATATTTTGGAGAG	CASSYDRTGNTIYF	In	VDJ	3	163	6.125309553603975E-4	7.25253505021157E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	2	5	2	0	2	23	-1	43	38	45														CASSYDRTGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACTTCCAGGGGAAGGTCCTACGAGCAGTACTTCGGGCCG	CASSYTSRGRSYEQYF	In	VDJ	3	164	6.162888139822403E-4	7.297029130274217E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	1	5	4	23	38	49	43	53														CASSYTSRGRSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCAACTATGGGGAGAGACCCAGTACTTCGGGCCA	CASQLWGETQYF	In	VDJ	3	165	6.200466726040833E-4	7.341523210336865E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	8	6	2	4	7	0	23	32	-1	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASQLWGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTTCTAGCGGGAGGCGAGCAGTACTTCGGGCCG	CASSYLLAGGEQYF	In	VDJ	3	170	6.388359657132979E-4	7.563993610650103E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	4	1	6	3	0	23	38	-1	41	52														CASSYLLAGGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAAGGCGGGAGCAGCGTACGAGCAGTATTTCGGGCCG		Out	VDJ	3	178	6.688988346880414E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	2	16	3	17	23	37	47	40	64														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATTGGGGACAGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASRLGTGNTGELFF	In	VDJ	3	179	6.726566933098843E-4	7.964440331213932E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	4	2	4	1	23	34	46	38	47														CASRLGTGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCGCCGGCGGGTAGTTGGACTGAAGCTTTCTTTGGACAA	CASAPAGSWTEAFF	In	VDJ	3	180	6.764145519317272E-4	8.00893441127658E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	8	7	4	5	6	7	23	32	43	38	50						01,02								CASAPAGSWTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGTACGGCTATGGCTACACCTTCGGTTCG	CASSYGYGYGYTF	In	VDJ	3	181	6.801724105535701E-4	8.053428491339227E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	0	9	4	0	5	23	-1	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGYGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAATGACAGGGAAGAGCAATCAGCCCCAGCATTTTGGTGAT	CASRMTGKSNQPQHF	In	VDJ	3	194	7.290245726375282E-4	8.631851532153647E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	3	1	3	3	23	34	44	37	47														CASRMTGKSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGGACAGGGGGTTTGGACAGATACGCAGTATTTTGGCCCA	CAIGQGVWTDTQYF	In	VDJ	3	194	7.290245726375282E-4	8.631851532153647E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	1	1	3	2	5	23	30	42	32	47														CAIGQGVWTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCCGGACAGGGGTGGCCTATGGCTACACCTTCGGTTCG	CASSTRTGVAYGYTF	In	VDJ	3	198	7.440560071249E-4	8.809827852404238E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	2	4	4	4	23	35	48	39	52														CASSTRTGVAYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATCGGGACCCTCCAGATACGCAGTATTTTGGCCCA	CASNRDPPDTQYF	In	VDJ	4	211	7.92908169208858E-4	9.388250893218658E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	7	0	7	4	3	4	23	33	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNRDPPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTACGGGAACGACTACGAGCAGTACTTCGGGCCG	CASRYGNDYEQYF	In	VDJ	4	214	8.041817450743868E-4	9.5217331334066E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	0	8	3	0	4	23	-1	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRYGNDYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTTGGACAGGGGGCGAAGAGACCCAGTACTTCGGGCCA	CASSYSWTGGEETQYF	In	VDJ	4	223	8.380024726709731E-4	9.92217985397043E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	1	0	3	2	1	23	40	53	42	54														CASSYSWTGGEETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTTCGCAGCTCGGACTAAGGATACGAGCAGTACTTCGGGCCG		Out	VDJ	4	235	8.830967761330883E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	1	9	4	10	4	23	32	48	42	52						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACAGGGGGCTTGAGAAACACCATATATTTTGGAGAG	CASSYSTGGLRNTIYF	In	VDJ	4	248	9.319489382170464E-4	0.0011034531855536622	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	0	5	0	4	23	-1	50	40	54														CASSYSTGGLRNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGCCCGGGACATGACCTTTCCTACGAGCAGTACTTCGGGCCG	CASGPGHDLSYEQYF	In	VDJ	4	251	9.432225140825752E-4	0.0011168014095724564	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	6	1	5	7	23	32	43	37	50														CASGPGHDLSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACTAGCGGGGGGACACAAGAGACCCAGTACTTCGGGCCA	CASSTSGGTQETQYF	In	VDJ	4	266	9.995903934102192E-4	0.0011835425296664278	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	3	1	2	0	3	23	-1	47	35	50														CASSTSGGTQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTACTAGCGGGAGGGCTCGATGAGCAGTTCTTCGGGCCA	CASSLLAGGLDEQFF	In	VDJ	5	275	0.0010334111210068054	0.0012235872017228107	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	3	0	8	2	4	23	35	50	37	54														CASSLLAGGLDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGTACAGCGGGGCGTGACAGGGGGAGATGGGGCCAACGTCCTGACTTTCGGGGCC	CAVQRGVTGGDGANVLTF	In	VDJ	5	318	0.0011949990417460515	0.0014149117459921958	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	11	2	1	3	14	3	23	29	52	43	55														CAVQRGVTGGDGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGAGAAGACAGGGAGCTACTATAATTACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	6	331	0.0012438512038300095		55	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	9	2	3	0	4	14	23	31	42	35	56														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTCCGTTTCATGCAGACTGGAAACACCATATATTTTGGAGAG	CASSYLRFMQTGNTIYF	In	VDJ	6	383	0.0014392598521658418	0.0017041232663994055	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	5	2	12	1	23	38	53	50	54														CASSYLRFMQTGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAAATTGTGGGGGGCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQIVGGYSNQPQHF	In	VDJ	7	421	0.001582058479795873	0.0018732007706374666	51	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	5	6	0	0	9	2	23	35	50	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQIVGGYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGTTGATCCAAGAGACCCAGTACTTCGGGCCA	CASSRLIQETQYF	In	VDJ	8	494	0.001856382159190407	0.0021980075550947944	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	8	5	1	0	5	23	-1	38	35	43						01,02								CASSRLIQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGAGCCGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSEEPSSGNTIYF	In	VDJ	8	501	0.0018826871695433074	0.002229153411138648	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	10	2	0	2	5	23	35	41	37	46														CASSEEPSSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGGACTAACCTGATGGATGAGCAGTTCTTCGGGCCA	CASSYSGTNLMDEQFF	In	VDJ	11	666	0.002502733842147391	0.0029633057321723343	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	9	8	1	9	23	40	48	41	57						01,02								CASSYSGTNLMDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGGGGTAGCTTTGAGCACAGATACGCAGTATTTTGGCCCA	CASSDSGVALSTDTQYF	In	VDJ	12	720	0.0027056582077269087	0.003203573764510632	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	6	1	0	0	8	23	-1	45	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSGVALSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTAATACCACAGGACCCTGAGCAGTTCTTCGGGCCA	CASSLIPQDPEQFF	In	VDJ	32	1912	0.007185025684963681	0.008507268107978234	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	4	9	9	4	23	34	48	43	52														CASSLIPQDPEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACTAGCGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSYSTSGDTGELFF	In	VDJ	60	3582	0.013460649583441371	0.015937779478440394	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	2	3	3	0	0	23	-1	-1	40	51														CASSYSTSGDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCCGGGACAACACAGATACGCAGTATTTTGGCCCA	CASSLRDNTDTQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	6	2	3	1	24	37	46	40	47													Vb 18	CASSLRDNTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCCCTAGTGGGCGGAAATTACAATGAGCAGTTCTTCGGGCCA	CASSPLVGGNYNEQFF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	6	8	0	4	9	6	24	35	48	44	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLVGGNYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTACAGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSLQGANTEAFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	0	1	1	0	24	37	-1	38	47													Vb 18	CASSLQGANTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCAGGGGGTAGGATGGCTGAAGCTTTCTTTGGACAA	CASSPGGRMAEAFF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	6	1	6	0	8	24	-1	44	39	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGGRMAEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGAACAGGGGGTCGACTATGGCTACACCTTCGGTTCG	CASSPEQGVDYGYTF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	1	3	2	3	24	39	49	41	52													Vb 18	CASSPEQGVDYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGAGAGGGGGCTCAGGGGGCTACACCTTCGGTTCG	CASSPRGGSGGYTF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	5	0	8	3	6	24	38	48	41	54													Vb 18	CASSPRGGSGGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGCTTCGGACCTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPASDLNTGELFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	3	1	7	1	6	2	24	38	48	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPASDLNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAAGGGGTGACCGGGGAGCTGTTTTTTGGAGAA	CASSPQGVTGELFF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	5	2	5	1	2	24	40	46	41	48													Vb 18	CASSPQGVTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTACTACAGGGTACAGCTATGGCTACACCTTCGGTTCG	CASSPTTGYSYGYTF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	3	4	4	5	24	38	48	42	53													Vb 18	CASSPTTGYSYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCAACAGGGGGCGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPTGGAYNEQFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	0	2	0	1	24	-1	48	39	49													Vb 18	CASSPTGGAYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCACGGGACAGACTAACACCGGGGAGCTGTTTTTTGGAGAA	CASTGQTNTGELFF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	5	2	2	3	24	33	42	35	45													Vb 18	CASTGQTNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCCAAGAGGGTTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	25	9.394646554607322E-5		35	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	8	11	0	5	4	2	24	33	42	37	44													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGGGGTCCTATGGCTACACCTTCGGTTCG	CASSQGSYGYTF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	5	2	4	0	2	24	-1	42	37	44													Vb 18	CASSQGSYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGACGGGACCCACAGATACGCAGTATTTTGGCCCA	CASSLTGPTDTQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	4	0	7	2	4	1	24	37	46	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLTGPTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGGATCGGGGGGGCCGGTGAGCAGTTCTTCGGGCCA	CASSPPGIGGAGEQFF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	0	9	6	4	24	41	55	47	59													Vb 18	CASSPPGIGGAGEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGAGAACAGGGTTTCTACGAGCAGTACTTCGGGCCG	CASSPGEQGFYEQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	3	3	6	3	24	38	50	44	53													Vb 18	CASSPGEQGFYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATACCCCACAGGGGGAAAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSPYPTGGKGNQPQHF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	1	2	6	5	24	39	53	45	58													Vb 18	CASSPYPTGGKGNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTTGAGGGGAGGAGAAACATTCAGTACTTCGGCGCC	CASSPLEGRRNIQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	1	9	1	6	5	2	24	40	51	45	53													Vb 18	CASSPLEGRRNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGAGCTGGGACAGGGTTTCTATGGCTACACCTTCGGTTCG	CASSPELGQGFYGYTF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	3	4	5	3	24	39	53	44	56													Vb 18	CASSPELGQGFYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCGGAGGCGAGGGGACTAACTATGGCTACACCTTCGGTTCG	CAGGEGTNYGYTF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	11	5	2	0	7	1	24	30	42	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CAGGEGTNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTGGGGGAGGACTATGGCTACACCTTCGGTTCG	CASSPVGEDYGYTF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	9	1	3	4	0	24	39	-1	43	49													Vb 18	CASSPVGEDYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGGACATAGCCTACGAGCAGTACTTCGGGCCG	CASSPRDIAYEQYF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	6	2	0	3	24	-1	46	40	49													Vb 18	CASSPRDIAYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGAGGCGGGCTGTGGACTGAAGCTTTCTTTGGACAA	CASSPGGGLWTEAFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	7	4	5	4	6	24	39	48	43	54						01,02							Vb 18	CASSPGGGLWTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTGGAGGACTGGGGCGAGCAGTACTTCGGGCCG	CASSLEDWGEQYF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	10	6	5	4	24	36	46	41	50						01,02							Vb 18	CASSLEDWGEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTTTCAACCATTGGCAGCGAGCAGTACTTCGGGCCG	CASSPFSTIGSEQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	5	6	14	0	24	39	-1	53	56													Vb 18	CASSPFSTIGSEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCAAACTAGCGGGACGGGGGAGACCCAGTACTTCGGGCCA	CASSPQTSGTGETQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	3	3	5	4	5	24	38	52	42	57													Vb 18	CASSPQTSGTGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCTTAACGCGAACACTGAAGCTTTCTTTGGACAA	CASSLNANTEAFF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	6	3	7	1	5	2	24	35	42	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLNANTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTGACAGGCCGATTACCCCGCAGTACTTCGGGCCG		Out	VDJ	1	38	1.427986276300313E-4		44	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	4	9	1	11	24	40	47	41	58													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTCTGGGAGTAGCGGGATCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	38	1.427986276300313E-4		52	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	5	3	1	9	2	24	38	55	47	57													Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCTAAGGATGGGACAGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLRMGQGYNEQFF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	3	9	0	24	35	-1	44	53													Vb 18	CASSLRMGQGYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAAACGGACAGGGGCTACGAGCAGTACTTCGGGCCG	CASSQTDRGYEQYF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	2	3	4	0	24	37	-1	41	50													Vb 18	CASSQTDRGYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCAAACAGGGGGAAATGAAAAACTGTTTTTTGGCAGT	CASSQTGGNEKLFF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	1	5	4	1	24	35	47	39	48													Vb 18	CASSQTGGNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGGAGTAACTATGGCTACACCTTCGGTTCG	CASSPGSNYGYTF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	8	2	1	0	0	24	-1	-1	38	44													Vb 18	CASSPGSNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGAGCTAGCCAAAAACATTCAATACTTCGGCGCC	CASSPGELAKNIQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	2	4	7	16	6	13	24	39	50	45	63						01,02							Vb 18	CASSPGELAKNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD02-01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGGGACAGGGGGCAGCTACGAGCAGTACTTCGGGCCG	CASSGTGGSYEQYF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	0	3	1	2	24	35	48	36	50													Vb 18	CASSGTGGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGGAATAACTATGGCTACACCTTCGGTTCG	CASSPPGNNYGYTF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	0	0	8	1	1	1	24	41	46	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPGNNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCAATGCAGGGACAGCGGACCATCAGCCCCAGCATTTTGGTGAT	CASSPNAGTADHQPQHF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	5	5	7	6	24	38	52	45	58													Vb 18	CASSPNAGTADHQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGTTGCGGAGGGCCCGGACGAGCAGTACTTCGGGCCG	CASSPPVAEGPDEQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	0	5	6	5	24	41	53	47	58													Vb 18	CASSPPVAEGPDEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGCCTCGGCGGGAGTAGCTACGAGCAGTACTTCGGGCCG	CASSPSLGGSSYEQYF	In	VDJ	1	52	1.954086483358323E-4	2.3136921632576786E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	7	2	3	7	3	24	39	53	46	56													Vb 18	CASSPSLGGSSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAGCCGGACGTCAGAGAGTGGAAAACTGTTTTTTGGCAGT	CASSSRTSESGKLFF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	5	1	7	10	4	12	24	36	44	40	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSSRTSESGKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCAACGATAGCGCACTCCTACGAGCAGTACTTCGGGCCG	CASSPPTIAHSYEQYF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	5	6	0	5	2	24	41	51	46	53						01,02							Vb 18	CASSPPTIAHSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCAGTAGCGGGAGCTACGAGCAGTACTTCGGGCCG	CASSPSSGSYEQYF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	2	3	3	0	24	38	-1	41	50													Vb 18	CASSPSSGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCGGGACACCGAAAGAGACGAGCAGTACTTCGGGCCG	CASSPRDTERDEQYF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	3	0	6	5	2	9	24	38	46	40	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRDTERDEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGACAGGGGGTCATTTGAAAAACTGTTTTTTGGCAGT	CASSPDRGSFEKLFF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	1	7	1	5	24	38	48	39	53													Vb 18	CASSPDRGSFEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGGGACTAGCGGGAGAAACGAGCAGTACTTCGGGCCG	CASSPGTSGRNEQYF	In	VDJ	1	59	2.217136586887328E-4	2.625150723696212E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	0	2	5	1	2	24	38	53	39	55													Vb 18	CASSPGTSGRNEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCAAAACGACAGGGGCGGCTACACCTTCGGTTCG	CASSQNDRGGYTF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	2	8	7	1	24	35	50	42	51													Vb 18	CASSQNDRGGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSPGVTGELFF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	3	6	1	4	0	1	24	-1	43	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGVTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGCCGCGACAGGGGGATACGCCTACGAGCAGTACTTCGGGCCG	CASSAATGGYAYEQYF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	1	2	5	5	24	36	50	41	55													Vb 18	CASSAATGGYAYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGTAGGAGTGGCTTCCTACGAGCAGTACTTCGGGCCG	CASSPVGVASYEQYF	In	VDJ	1	63	2.3674509317610454E-4	2.803127043946803E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	2	1	4	5	24	38	46	42	51													Vb 18	CASSPVGVASYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCGACAAGGTGGCAGGGTATGAACACTGAAGCTTTCTTTGGACAA	CASSPTRWQGMNTEAFF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	0	13	2	24	35	53	48	55													Vb 18	CASSPTRWQGMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACAGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPTGANTGELFF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	2	0	0	0	24	-1	-1	38	46													Vb 18	CASSPTGANTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGGGCCGCGAGCAGTACTTCGGGCCG	CASSPRGREQYF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	5	2	6	0	3	24	-1	44	39	47													Vb 18	CASSPRGREQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTGGGACAGCGGTAAAGAGACCCAGTACTTCGGGCCA	CASSPWDSGKETQYF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	5	3	2	5	24	38	47	40	52													Vb 18	CASSPWDSGKETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATGGCAGACAATGAGCAGTTCTTCGGGCCA	CASSPMADNEQFF	In	VDJ	1	71	2.6680796215084796E-4	3.159079684447984E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	5	5	4	0	24	39	-1	43	46													Vb 18	CASSPMADNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGGACAGGGGACCGACACTGAAGCTTTCTTTGGACAA	CASSGQGTDTEAFF	In	VDJ	1	72	2.7056582077269087E-4	3.203573764510632E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	2	3	0	4	24	-1	45	36	49													Vb 18	CASSGQGTDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGATTGGGACAGGGGGCGCAGATACGCAGTATTTTGGCCCA	CASSPIGTGGADTQYF	In	VDJ	1	74	2.7808153801637674E-4	3.2925619246359274E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	0	4	4	1	24	38	54	42	55													Vb 18	CASSPIGTGGADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCTGCTGGCCTCCCAAGAGACCCAGTACTTCGGGCCA	CASSPLLASQETQYF	In	VDJ	1	74	2.7808153801637674E-4	3.2925619246359274E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	9	0	1	6	3	24	38	47	44	50													Vb 18	CASSPLLASQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCTAGCGGCCTCCTACGAGCAGTACTTCGGGCCG	CASSPLAASYEQYF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	5	0	1	1	24	38	46	39	47						01,02							Vb 18	CASSPLAASYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCAATCAGGGGCAGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSPQSGAGTGELFF	In	VDJ	1	80	3.0062868974743435E-4	3.559526405011813E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	2	5	5	5	24	38	49	43	54													Vb 18	CASSPQSGAGTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTAGACAGACTAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPVDRLATNEKLFF	In	VDJ	1	83	3.119022656129631E-4	3.693008645199756E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	2	8	0	7	0	24	39	-1	46	52						01,02							Vb 18	CASSPVDRLATNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATCGGGACAGACTACGAGCAGTACTTCGGGCCG	CASSPIGTDYEQYF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	5	3	3	1	24	39	49	42	50													Vb 18	CASSPIGTDYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCCCGGACAGGGGAAGAGACCCAGTACTTCGGGCCA	CASSSRTGEETQYF	In	VDJ	1	86	3.231758414784919E-4	3.826490885387699E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	2	3	4	0	24	36	-1	40	49													Vb 18	CASSSRTGEETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTACAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSPTGAGELFF	In	VDJ	1	87	3.269337001003348E-4	3.870984965450347E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	2	6	1	0	24	38	-1	39	46													Vb 18	CASSPTGAGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATGACAGGAAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	89	3.344494173440207E-4		44	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	4	2	1	3	24	39	46	40	49													Vb 18	X+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGACCGGGACGGGACCTACGAGCAGTACTTCGGGCCG	CASSDRDGTYEQYF	In	VDJ	1	89	3.344494173440207E-4	3.9599731255756423E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	5	0	7	2	4	4	24	36	45	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSDRDGTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATGGACACTATACAATGAGCAGTTCTTCGGGCCA	CASSWTLYNEQFF	In	VDJ	1	89	3.344494173440207E-4	3.9599731255756423E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	6	4	1	3	24	36	42	37	45													Vb 18	CASSWTLYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCCGGACAGTCTAGCTCTGGAAACACCATATATTTTGGAGAG	CASSSGQSSSGNTIYF	In	VDJ	2	91	3.4196513458770655E-4	4.048961285700938E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	5	0	3	5	24	36	45	39	50													Vb 18	CASSSGQSSSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTTCCAGGGGGCTATAATTCACCCCTCCACTTTGGGAAC	CASSPFPGGYNSPLHF	In	VDJ	2	92	3.4572299320954946E-4	4.093455365763585E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	1	3	4	0	24	39	-1	43	50													Vb 18	CASSPFPGGYNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCCAGGGGAGGGCCGAATTTGAGCAGTTCTTCGGGCCA	CASSLQGRAEFEQFF	In	VDJ	2	95	3.5699656907507823E-4	4.226937605951528E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	9	0	9	5	7	24	37	49	42	56													Vb 18	CASSLQGRAEFEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTACAAGACAGGGCGAAAACATTCAGTACTTCGGCGCC	CASSLTRQGENIQYF	In	VDJ	2	96	3.607544276969212E-4	4.271431686014176E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	2	3	5	6	2	24	37	50	43	52													Vb 18	CASSLTRQGENIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAACAACAGGGATACGAGCAGTACTTCGGGCCG	CASSQQQGYEQYF	In	VDJ	2	98	3.6827014494060707E-4	4.360419846139471E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	3	4	4	1	24	37	47	41	48													Vb 18	CASSQQQGYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTACAGGGGACCACTGAAGCTTTCTTTGGACAA	CASSLQGTTEAFF	In	VDJ	2	101	3.7954372080613584E-4	4.4939020863274143E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	2	4	1	2	24	37	45	38	47													Vb 18	CASSLQGTTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTACTGGCCCAGACAGAGAAGGAGCAGTACTTCGGGCCG	CASSLLAQTEKEQYF	In	VDJ	2	102	3.8330157942797875E-4	4.538396166390062E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	5	7	10	5	24	37	52	47	57													Vb 18	CASSLLAQTEKEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGCCCCGGGACAGGGGGTGCGATACGCAGTATTTTGGCCCA		Out	VDJ	2	112	4.2088016564640804E-4		47	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	1	6	5	3	24	37	53	42	56													Vb 18	X+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCTAACAGGGAAACTGAAGCTTTCTTTGGACAA	CASSPPNRETEAFF	In	VDJ	2	113	4.24638024268251E-4	5.027831047079186E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	3	5	5	2	24	38	49	43	51													Vb 18	CASSPPNRETEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGGACGAAGGTCTCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	114	4.283958828900939E-4		46	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	1	1	7	6	1	8	24	40	45	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCACCAACAGGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	114	4.283958828900939E-4		44	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	3	2	1	0	24	41	-1	42	48													Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCTCCGGTAAGAACACTGAAGCTTTCTTTGGACAA	CASSSGKNTEAFF	In	VDJ	2	117	4.396694587556227E-4	5.205807367329777E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	5	1	3	3	24	35	41	38	44						01,02							Vb 18	CASSSGKNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCAGGGGTGTACGAGCAGTACTTCGGGCCG	CASSPPGVYEQYF	In	VDJ	2	119	4.4718517599930856E-4	5.294795527455073E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	5	2	4	0	2	24	-1	46	41	48													Vb 18	CASSPPGVYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGGAGACGTCCAATTCACCCCTCCACTTTGGGAAC	CASSETSNSPLHF	In	VDJ	2	120	4.5094303462115147E-4	5.33928960751772E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	10	2	7	0	6	24	-1	39	35	45													Vb 18	CASSETSNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGAAGGGACACCATCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPRRDTISGANVLTF	In	VDJ	2	121	4.5470089324299443E-4	5.383783687580367E-4	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	0	6	0	3	4	24	40	49	43	53													Vb 18	CASSPRRDTISGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGCCATGGAGATACGCAGTATTTTGGCCCA	CASSPRHGDTQYF	In	VDJ	2	133	4.997951967051096E-4	5.917712648332139E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	3	0	10	5	7	0	24	38	-1	45	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRHGDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTGGGGACAGGATTTAACTGAAGCTTTCTTTGGACAA	CASSPWGQDLTEAFF	In	VDJ	2	137	5.148266311924812E-4	6.09568896858273E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	4	5	3	5	24	38	49	41	54													Vb 18	CASSPWGQDLTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAAACCTGCGACTGAAGCTTTCTTTGGACAA	CASSKPATEAFF	In	VDJ	2	138	5.185844898143242E-4	6.140183048645377E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	6	5	6	0	24	36	-1	42	45						01,02							Vb 18	CASSKPATEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACGACCGGGACAGGGGATTACAATGAGCAGTTCTTCGGGCCA	CASSPTTGTGDYNEQFF	In	VDJ	2	139	5.223423484361671E-4	6.184677128708026E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	2	4	6	2	24	39	55	45	57													Vb 18	CASSPTTGTGDYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTTCCGGGACAGGGGAGGACCCTCTCTGGAAACACCATATATTTTGGAGAG	CASSPLPGQGRTLSGNTIYF	In	VDJ	2	143	5.373737829235389E-4	6.362653448958616E-4	60	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	0	2	0	4	8	21	37	51	41	59													Vb 18	CASSPLPGQGRTLSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCGCCCGTAACTACGCAGATACGCAGTATTTTGGCCCA	CASARNYADTQYF	In	VDJ	2	146	5.486473587890677E-4	6.496135689146559E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	3	9	4	7	2	24	33	44	40	46						01,02							Vb 18	CASARNYADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATAAGGGGAAATGAGCAGTTCTTCGGGCCA	CASSPIRGNEQFF	In	VDJ	3	157	5.899838036293398E-4	6.985570569835683E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	5	2	7	3	1	24	39	47	42	48													Vb 18	CASSPIRGNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGGGAGCGATCAGCACAGATACGCAGTATTTTGGCCCA	CASSPRGAISTDTQYF	In	VDJ	3	161	6.050152381167115E-4	7.163546890086274E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	9	2	0	1	5	24	40	46	41	51													Vb 18	CASSPRGAISTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGCCTGGGACCACATGCGGGACAGGGGAATCACGAGCAGTACTTCGGGCCG	CASSRLGPHAGQGNHEQYF	In	VDJ	3	165	6.200466726040833E-4	7.341523210336865E-4	57	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	5	16	4	24	37	63	53	67													Vb 18	CASSRLGPHAGQGNHEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCACAACGGGACAGAACACAGATACGCAGTATTTTGGCCCA	CASSTTGQNTDTQYF	In	VDJ	3	166	6.238045312259263E-4	7.386017290399512E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	5	2	6	2	24	35	48	41	50													Vb 18	CASSTTGQNTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAGTAAACGGGACCCCACGAACACCATATATTTTGGAGAG	CASSSKRDPTNTIYF	In	VDJ	3	168	6.313202484696121E-4	7.475005450524808E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	5	0	7	7	7	6	24	36	48	43	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSSKRDPTNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCACATGATAGCGGCACTACAATGAGCAGTTCTTCGGGCCA	CASSPT**RHYNEQFF	Stop	VDJ	3	177	6.651409760661984E-4		48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	5	3	7	2	24	38	51	45	53						01,02							Vb 18	CASSPT**RHYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAATGCAGGGGCGAGAACTGAAGCTTTCTTTGGACAA	CASSPNAGARTEAFF	In	VDJ	3	178	6.688988346880414E-4	7.919946251151285E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	5	4	5	24	39	49	43	54													Vb 18	CASSPNAGARTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTAAATTGGGACAGAACATCTGAAGCTTTCTTTGGACAA	CASSPLNWDRTSEAFF	In	VDJ	3	180	6.764145519317272E-4	8.00893441127658E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	5	6	6	5	24	40	53	46	58													Vb 18	CASSPLNWDRTSEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCGGGAATGGACAGGCCCAACCTACGAGCAGTACTTCGGGCCG	CASSPREWTGPTYEQYF	In	VDJ	3	180	6.764145519317272E-4	8.00893441127658E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	4	2	8	5	24	38	53	46	58													Vb 18	CASSPREWTGPTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGATCGGAGGGCGTGACGATGGCTACACCTTCGGTTCG	CASSPPIGGRDDGYTF	In	VDJ	3	186	6.989617036627848E-4	8.275898891652465E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	0	6	4	7	24	41	51	45	58													Vb 18	CASSPPIGGRDDGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGAGGACAGGTAGGATACACAAGATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	189	7.102352795283136E-4		53	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	4	8	2	13	24	41	50	43	63													Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCTGGGGTCCTCTGTACGAGCAGTACTTCGGGCCG	CASSWGPLYEQYF	In	VDJ	3	192	7.215088553938424E-4	8.542863372028352E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	6	6	2	4	2	7	24	35	41	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSWGPLYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCGGACCACGGTAGAGACCCAGTACTTCGGGCCA	CASSPRTTVETQYF	In	VDJ	3	196	7.365402898812141E-4	8.720839692278942E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	3	1	7	4	2	6	24	38	44	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRTTVETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCTGCTCGTGGAGGCGGATACGCAGTATTTTGGCCCA	CASSPLLVEADTQYF	In	VDJ	3	203	7.628453002341145E-4	9.032298252717476E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	10	1	6	9	2	24	38	52	47	54													Vb 18	CASSPLLVEADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGTAGCTAGCGGGAGGGAACGAGCAGTACTTCGGGCCG	CASSPP*LAGGNEQYF	Stop	VDJ	4	210	7.891503105870151E-4		48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	4	0	5	4	1	24	41	57	45	58													Vb 18	CASSPP*LAGGNEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAATACTAGCGGGAACCACAGATACGCAGTATTTTGGCCCA	CASSILAGTTDTQYF	In	VDJ	4	216	8.116974623180727E-4	9.610721293531896E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	3	3	2	2	2	24	36	48	38	50													Vb 18	CASSILAGTTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGGACGGCACAGATACGCAGTATTTTGGCCCA	CASSPRDGTDTQYF	In	VDJ	4	219	8.229710381836015E-4	9.744203533719838E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	1	0	7	1	0	1	24	-1	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRDGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCCAGACCGTCAAGAGACCCAGTACTTCGGGCCA	CASSPPDRQETQYF	In	VDJ	4	219	8.229710381836015E-4	9.744203533719838E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	3	2	7	2	4	3	24	38	45	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPDRQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGATTTACGGGAGGGCTTACTTACGAGCAGTACTTCGGGCCG	CASSPRFTGGLTYEQYF	In	VDJ	4	220	8.267288968054443E-4	9.788697613782487E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	8	0	4	7	6	24	39	54	46	60													Vb 18	CASSPRFTGGLTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCGAAGTGATAATGAACACTGAAGCTTTCTTTGGACAA	CASSLEVIMNTEAFF	In	VDJ	4	222	8.342446140491303E-4	9.877685773907782E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	4	2	8	0	2	8	24	37	41	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLEVIMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTGGCGACAGGGGCTCTCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLATGALNTGELFF	In	VDJ	4	228	8.567917657801878E-4	0.0010144650254283669	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	2	2	2	4	5	24	40	52	44	57													Vb 18	CASSPLATGALNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACATCTAGCGGGGAGACCAGAGACCCAGTACTTCGGGCCA	CASSHLAGRPETQYF	In	VDJ	4	229	8.605496244020308E-4	0.0010189144334346316	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	4	3	4	2	5	24	37	48	39	53													Vb 18	CASSHLAGRPETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGACTAGCGGGATGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPRTSGMSSYNEQFF	In	VDJ	4	237	8.906124933767742E-4	0.0010545096974847496	54	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	1	3	0	0	4	24	-1	52	40	56													Vb 18	CASSPRTSGMSSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGAACTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGTSSYNEQFF	In	VDJ	4	251	9.432225140825752E-4	0.0011168014095724564	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	3	8	0	3	0	24	39	-1	42	47						01,02							Vb 18	CASSPGTSSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTCCCAGCGGGGGGTTTGGATACGCAGTATTTTGGCCCA	CASSPLPAGGLDTQYF	In	VDJ	4	253	9.50738231326261E-4	0.001125700225584986	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	6	1	6	4	4	24	40	53	44	57													Vb 18	CASSPLPAGGLDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAACCGGGACCTAACACTGAAGCTTTCTTTGGACAA	CASSPQPGPNTEAFF	In	VDJ	5	305	0.0011461468796620934	0.0013570694419107537	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	1	0	7	2	4	2	24	40	49	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPQPGPNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATCACCGGGGAGCTGTTTTTTGGAGAA	CASSPITGELFF	In	VJ	5	314	0.0011799676072586796	0.0013971141139671366	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	2	0	0	4	0	2	24	-1	39	-1	41													Vb 18	CASSPITGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTTCCCGACGCGTACGAGCAGTACTTCGGGCCG	CASSPLPDAYEQYF	In	VDJ	5	325	0.001221304052098952	0.0014460576020360492	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	1	2	7	4	5	3	24	40	48	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLPDAYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGGACTAGCTGTTTGGGATGAGCAGTTCTTCGGGCCA	CASSPGLAVWDEQFF	In	VDJ	6	349	0.0013114926590231822	0.0015528433941864035	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	7	8	1	8	24	38	47	39	55						01,02							Vb 18	CASSPGLAVWDEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCCGATTTACCTTCCTACGAGCAGTACTTCGGGCCG	CASSPPDLPSYEQYF	In	VDJ	7	409	0.001536964176333758	0.0018198078745622895	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	3	2	8	1	4	7	24	38	44	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPDLPSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAATCTAGCGGGCGCACAGATACGCAGTATTTTGGCCCA	CASSQSSGRTDTQYF	In	VDJ	9	513	0.0019277814730054225	0.002282546307213825	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	4	1	3	1	24	37	48	40	49						01,02							Vb 18	CASSQSSGRTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGTGGACTAGCGTGGTCGGTGAGCAGTTCTTCGGGCCA	CASSWTSVVGEQFF	In	VDJ	9	537	0.0020179700799296527	0.0023893320993641797	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	6	9	2	7	24	35	46	37	53						01,02							Vb 18	CASSWTSVVGEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCGAAATACGAACACTGAAGCTTTCTTTGGACAA	CASRNTNTEAFF	In	VDJ	9	555	0.0020856115351228256	0.0024694214434769456	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	8	2	8	1	1	5	24	33	36	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASRNTNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCACCTTACCTGGTCAGCCCCAGCATTTTGGTGAT	CASTLPGQPQHF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	36	unresolved						TCRBJ01	TCRBJ01-05	01	12	4	5	6	0	12	26	-1	34	31	46	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTLPGQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCAAGTCAGGGGTGACCGGGGAGCTGTTTTTTGGAGAA	CASSPKSGVTGELFF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	2	5	7	2	26	38	51	45	53		TCRBV12-03,TCRBV12-04												CASSPKSGVTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGAGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSFEGSYEQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	11	0	0	1	0	26	40	-1	41	46		TCRBV12-03,TCRBV12-04												CASSFEGSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTTTAAGCGATAATGGGGAAGATACGCAGTATTTTGGCCCA	XASSLSDNGEDTQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	45	unresolved						TCRBJ02	TCRBJ02-03	01	4	0	8	5	12	0	27	40	-1	52	56	TCRBV26,TCRBV28			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSLSDNGEDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCAGGGGGCGGGCGAGCAGTACTTCGGGCCG	CASSQGQGAGEQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	0	6	2	3	26	42	52	44	55		TCRBV03-01,TCRBV03-02												CASSQGQGAGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGGGGAACGAGAGGTACTATGGCTACACCTTCGGTTCG	CASSQVGNERYYGYTF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	48	TCRBV03						TCRBJ01	TCRBJ01-02	01	1	0	8	3	2	9	26	42	48	44	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVGNERYYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTATGGGACCGAACAATACGAGCAGTACTTCGGGCCG	CASSYGTEQYEQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	0	7	4	3	7	26	38	46	41	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGTEQYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCGCTCATCGTCGGGGGGTTACACTATGGCTACACCTTCGGTTCG	CSAALIVGGLHYGYTF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	1	3	12	4	26	34	53	46	57		TCRBV20-01,TCRBV20-or09_02												CSAALIVGGLHYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAGAGGACCACAGATACGCAGTATTTTGGCCCA	CSARDERTTDTQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	0	1	7	2	5	0	26	40	-1	45	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDERTTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGAAGTACGAGCGGGATCATTCTACGAGCAGTACTTCGGGCCG	CSARGEVRAGSFYEQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	6	3	3	10	5	26	39	56	49	61		TCRBV20-01,TCRBV20-or09_02												CSARGEVRAGSFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGAGTCAGAACTACTATGGCTACACCTTCGGTTCG	CSARVSQNYYGYTF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	1	4	5	3	5	4	26	39	47	44	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVSQNYYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGCGGGAGAAGTTACGAGCAGTACTTCGGGCCG	CSASSGRSYEQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	2	4	0	4	26	-1	46	37	50		TCRBV20-01,TCRBV20-or09_02												CSASSGRSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGGGGAAGTTACGATGGTGGCTACACCTTCGGTTCG	CSASRGSYDGGYTF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	5	2	7	1	12	26	37	43	38	55		TCRBV20-01,TCRBV20-or09_02												CSASRGSYDGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCAGCCTACAGGGTATCAGTAGCGAGCAGTACTTCGGGCCG	CASSLQGISSEQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	3	6	3	9	25	36	45	39	54	TCRBV24,TCRBV28													CASSLQGISSEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAAAATCCAGGGATACACTGAAGCTTTCTTTGGACAA	CASKIQGYTEAFF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	3	3	5	2	22	32	42	37	44	TCRBV09,TCRBV12													CASKIQGYTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCTAGGCCCTATGGTGGATACGCAGTATTTTGGCCCA	CASSLGPMVDTQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	8	6	1	11	22	33	38	34	49		TCRBV12-03,TCRBV12-04				01,02								CASSLGPMVDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCACAGGGGAACGAGCAGTACTTCGGGCCG	CATSDPQGNEQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	2	5	2	1	24	39	48	41	49		TCRBV24-01,TCRBV24-or09_02												CATSDPQGNEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGTTTTAGCGGGAGGGTAATGGAGACCCAGTACTTCGGGCCA	CASSFSGRVMETQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	5	0	5	1	5	23	36	48	37	53	TCRBV06,TCRBV27													CASSFSGRVMETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCAAGTCGCCGCGACCCAATTACGGGGGCGTGAAGTTCTTCGGGCCA		Out	VDJ	1	17	6.38835965713298E-5		44	unresolved						TCRBJ02	TCRBJ02-01	01	5	6	0	14	14	4	18	30	50	44	54	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATTTGGGGGCGGGAGAAAAACTGTTTTTTGGCAGT	CASSQDLGAGEKLFF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	45							TCRBJ01	TCRBJ01-04	01	0	6	0	8	3	4	18	35	44	38	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLGAGEKLFF+X+TCRBJ01-04			TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGTTGGCGCGGGGGGGTTAGATACGCAGTATTTTGGCCCA	CASSVGAGGLDTQYF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	7	0	5	5	2	23	36	50	41	52	TCRBV02,TCRBV12													CASSVGAGGLDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAAGAGCTCTAGCGGGAGGGCCGCGAGGAATGAGCAGTTCTTCGGGCCA	CASKSSSGRAARNEQFF	In	VDJ	1	17	6.38835965713298E-5	7.563993610650103E-5	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	0	7	6	8	23	33	51	39	59	TCRBV09,TCRBV12													CASKSSSGRAARNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTCTCGGGAACCTTCGGTGAAAAACTGTTTTTTGGCAGT	CASSLSGTFGEKLFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	8	3	7	5	8	26	37	47	42	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLSGTFGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*02	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGAGTCCGTCGGGGAGCTGTTTTTTGGAGAA	CASSESVGELFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	36	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	11	2	7	1	5	26	37	41	38	46		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSESVGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGGGACAGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSPGQGQETQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	1	2	0	26	38	-1	40	49		TCRBV12-03,TCRBV12-04												CASSPGQGQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATCACGGACTCGGGGGGGATCACCCCTCCACTTTGGGAAC	CASSLSRTRGGSPLHF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	2	8	0	10	9	1	26	41	58	50	59		TCRBV12-03,TCRBV12-04												CASSLSRTRGGSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD02-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCAAGATGGGGCTAGCGGGGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	18	6.764145519317272E-5		53	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	4	2	0	5	0	26	43	-1	48	58	TCRBV03,TCRBV12													X+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGGGGAGCAGTTCTTCGGGCCA	CASSQGGEQFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	33	TCRBV03						TCRBJ02	TCRBJ02-01	01	1	6	1	10	0	0	26	-1	-1	42	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGGGGACTCRGCCSTGTATSTCTGTGCCAGCAGCTCCCGGGTACAGAACCCTGATGGCTACACCTTCGGTTCG	CASSSRVQNPDGYTF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	45	unresolved						TCRBJ01	TCRBJ01-02	01	6	3	5	6	10	7	22	32	46	42	53	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRVQNPDGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGCAGCGGCGGCTATGGCTACACCTTCGGTTCG	CSAREGSGGYGYTF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	6	5	4	4	3	26	40	49	44	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAREGSGGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCCTTGGGCCAGGCCTATGGCTACACCTTCGGTTCG	CSARSLGQAYGYTF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	4	4	10	1	26	37	51	47	52		TCRBV20-01,TCRBV20-or09_02												CSARSLGQAYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTATTCCGACAGCAATATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	6.764145519317272E-5		38	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	15	2	5	0	5	5	24	27	37	32	42		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCAGTACCGGGACAGGCTTAACTATGGCTACACCTTCGGTTCG	CASSQYRDRLNYGYTF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	4	1	7	2	24	36	51	43	53		TCRBV24-01,TCRBV24-or09_02												CASSQYRDRLNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCAGGGACAGTCCTCGTATACACTGAAGCTTTCTTTGGACAA	CASSPGTVLVYTEAFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	3	3	9	24	36	46	39	55		TCRBV24-01,TCRBV24-or09_02												CASSPGTVLVYTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGTGGGATACTCAGGGCTCGGAGGCTACACCTTCGGTTCG	CASSVGYSGLGGYTF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	8	10	6	18	30	45	40	51	TCRBV07,TCRBV11													CASSVGYSGLGGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGTTACAGGGGGCGACTATGGCTACACCTTCGGTTCG	CASSLVTGGDYGYTF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	0	3	2	1	18	34	45	36	46	TCRBV07,TCRBV11													CASSLVTGGDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCGACCGGGGGGGAGCGGGAGTAGCAATGAGCAGTTCTTCGGGCCA	YASSRPGGSGSSNEQFF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	51				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	0	6	4	11	22	34	46	38	57	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01				01,02								YASSRPGGSGSSNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCCTTGCCAGGGGCCCCTATGGCTACACCTTCGGTTCG	CASSLARGPYGYTF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	2	4	5	3	19	31	42	36	45	TCRBV07,TCRBV11													CASSLARGPYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGGTAGCGGGGGGTCGACATATACGCAGTATTTTGGCCCA	CASSLGSGGSTYTQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	48	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	5	1	7	1	7	19	35	46	36	53		TCRBV05-06,TCRBV05-07												CASSLGSGGSTYTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTYRGCTKTGTATYTCTGTGCCAGCCCCGAACGAGTACTAGCGGGGCTGAATCGGGAGCAGTACTTCGGGCCG	CASPERVLAGLNREQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	8	3	3	7	11	9	22	31	52	42	61	TCRBV07,TCRBV09													CASPERVLAGLNREQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTGCAGGGCGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSAGRSNQPQHF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	0	2	2	24	35	42	37	44	TCRBV12,TCRBV21													CASSAGRSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGCGGGGTCTAGCGGGGGGTTAGATACGCAGTATTTTGGCCCA	CASSAGSSGGLDTQYF	In	VDJ	1	18	6.764145519317272E-5	8.00893441127658E-5	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	4	1	5	8	2	24	35	54	43	56	TCRBV02,TCRBV21													CASSAGSSGGLDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTATCGGGGTTAGCGGCTTTATACGAGCAGTACTTCGGGCCG	CASSLSGLAALYEQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	5	5	4	7	5	26	41	54	48	59		TCRBV12-03,TCRBV12-04				01,02								CASSLSGLAALYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGGGGGGGTTGGCGAGCAGTACTTCGGGCCG	CASSLGGVGEQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	9	1	6	0	4	26	-1	48	42	52		TCRBV12-03,TCRBV12-04												CASSLGGVGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAATCGACTAGCGGGATAGGCGGGGAGCTGTTTTTTGGAGAA	CAISESTSGIGGELFF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	2	3	7	3	4	24	38	52	41	56	TCRBV06,TCRBV10													CAISESTSGIGGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCACCCGTGACTAGCGGGGGGCTACAGATACGCAGTATTTTGGCCCA	CASTRD*RGATDTQYF	Stop	VDJ	1	19	7.139931381501565E-5		48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	2	1	3	5	2	26	36	54	41	56	TCRBV03,TCRBV09													CASTRD*RGATDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTTGGACAGACGAGGCACAGATACGCAGTATTTTGGCCCA	CASSQDLDRRGTDTQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	1	5	1	3	5	26	43	52	46	57		TCRBV03-01,TCRBV03-02												CASSQDLDRRGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAGAAGTAAACTATGGCTACACCTTCGGTTCG	CASSQGEVNYGYTF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	11	2	2	0	5	26	-1	45	42	50		TCRBV03-01,TCRBV03-02												CASSQGEVNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGGGGAGTGAACACTGAAGCTTTCTTTGGACAA	CASSPRGVNTEAFF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	3	0	2	2	26	39	46	41	48		TCRBV03-01,TCRBV03-02				01,02								CASSPRGVNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCTAGCATAGATGAGCAGTTCTTCGGGCCA	CSARPSIDEQFF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	4	7	8	1	4	26	38	44	39	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSARPSIDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGACAGCCGGGATTTCCCAGGAAGCTTTCTTTGGACAA	CSARDWTAGISQEAFF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	5	8	2	14	26	40	48	42	62		TCRBV20-01,TCRBV20-or09_02												CSARDWTAGISQEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCCTCTCCTAGCGGGCCTCTACAATGAGCAGTTCTTCGGGCCA	CSARAPLLAGLYNEQFF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	4	3	8	3	26	39	55	47	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSARAPLLAGLYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACTAGCGGTAGGACCCTTCTACGAGCAGTACTTCGGGCCG	CSARGLAVGPFYEQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	2	5	3	0	10	26	-1	48	39	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGLAVGPFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGCTGCAGGACCCCATTCACCCCTCCACTTTGGGAAC	CSARGAAGPHSPLHF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	45	TCRBV20						TCRBJ01	TCRBJ01-06	01	1	1	7	8	8	3	26	39	51	47	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGAAGPHSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCCACCGGGACAGGGGTTTTAGAGACCCAGTACTTCGGGCCA	CSASPTGTGVLETQYF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	2	4	7	4	26	37	54	44	58		TCRBV20-01,TCRBV20-or09_02												CSASPTGTGVLETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGCCCGACAGAAGGGCTAAGGAATGAAAAACTGTTTTTTGGCAGT	CASSPTEGLRNEKLFF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	5	5	1	11	33	46	52	47	63	TCRBV04,TCRBV25,TCRBV27,TCRBV28	TCRBV04-02,TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASSPTEGLRNEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGCTGGACTGTTAGCTGGCTACACCTTCGGTTCG	CATSDAGLLAGYTF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	1	10	7	3	6	24	39	47	42	53		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDAGLLAGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTGGGGACAGGCCTATTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	7.139931381501565E-5		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	1	2	6	24	37	47	39	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCTCTAATGGAGCGGGAGGGGGAAAAGACCCAGTACTTCGGGCCA		Out	VDJ	1	19	7.139931381501565E-5		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	11	6	0	6	10	5	24	31	51	41	56	TCRBV24,TCRBV27													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCAGATACTTTGCGGGAAAACTGTTTTTTGGCAGT	CASSLARYFAGKLFF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	45				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	7	4	10	10	0	18	35	-1	45	50	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLARYFAGKLFF+X+TCRBJ01-04		TCRBD02-01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
RRGACWCGGCMCTGTATCTCTGYGCCAGCAGCTTGTGGGCTAGCGGGAGGGTGACCGGGGAGCTGTTTTTTGGAGAA	CASSLWASGRVTGELFF	In	VDJ	1	19	7.139931381501565E-5	8.453875211903056E-5	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	4	0	5	8	2	20	31	51	39	53	TCRBV05,TCRBV23													CASSLWASGRVTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGACGGGACACCGAATCAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	7.139931381501565E-5		41	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	6	5	2	8	19	30	38	32	46		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGGCGGACTAGCGGGGGCTACGAGCAGTACTTCGGGCCG	CASRRTSGGYEQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	42				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	3	2	0	24	35	-1	37	50	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASRRTSGGYEQYF+X+TCRBJ02-07		TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACGGTTCAGGACAGGGCGCAACTATGGCTACACCTTCGGTTCG	CASSQRFRTGRNYGYTF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	3	2	7	3	26	41	56	48	59		TCRBV03-01,TCRBV03-02												CASSQRFRTGRNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATCAGGGGCTGGTGGCTACACCTTCGGTTCG	CASSQSGAGGYTF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	2	7	1	4	26	41	48	42	52		TCRBV03-01,TCRBV03-02												CASSQSGAGGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAATCGGACAGGGGAGCGGCTACACCTTCGGTTCG	CSAREIGQGSGYTF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	2	8	4	3	26	40	53	44	56		TCRBV20-01,TCRBV20-or09_02												CSAREIGQGSGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGCCCTTCTCGGAAGCAGCCCCAGCATTTTGGTGAT	CSARDSPSRKQPQHF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	5	7	7	0	12	26	-1	44	40	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDSPSRKQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGCCGGCTAGCGGGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CSAGRLAGGGTDTQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	0	1	6	1	26	35	53	41	54		TCRBV20-01,TCRBV20-or09_02												CSAGRLAGGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTCGGGATCGGGGGGAATACGCAGTATTTTGGCCCA	CASSVGIGGNTQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	1	7	9	1	22	33	49	42	50		TCRBV12-03,TCRBV12-04												CASSVGIGGNTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGGTAGCGGGAGTATTCTACGAGCAGTACTTCGGGCCG	CASRVAGVFYEQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	5	2	3	2	4	22	33	44	35	48		TCRBV12-03,TCRBV12-04												CASRVAGVFYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTAGACGGGACAGAGGAACACTGAAGCTTTCTTTGGACAA	CATSD*TGQRNTEAFF	Stop	VDJ	1	20	7.515717243685859E-5		48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	1	6	2	24	38	51	44	53		TCRBV24-01,TCRBV24-or09_02												CATSD*TGQRNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTTACGGGGGAGGGGGCCGGGAGGCCCAGAGACCCAGTACTTCGGGCCA	CATSDLRGRGPGGPETQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	57	TCRBV24						TCRBJ02	TCRBJ02-05	01	4	5	0	4	10	10	24	38	55	48	65		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLRGRGPGGPETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAAGGGACTAGCGGGGGTCACTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	7.515717243685859E-5		49	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	11	0	2	0	4	5	24	31	49	35	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAACCCCGAGGGGGGGTGGAATCAGCCCCAGCATTTTGGTGAT	CASNPEGGWNQPQHF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	7	9	0	4	7	3	23	33	47	40	50	TCRBV06,TCRBV10													CASNPEGGWNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCCCCAACTCTGGCAGCGTCCTGACTTTCGGGGCC	CASSPNSGSVLTF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	39	unresolved						TCRBJ02	TCRBJ02-06	01	6	4	5	12	12	0	23	34	-1	46	49	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPNSGSVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAACAGATAACACTGAAGCTTTCTTTGGACAA	CASSETDNTEAFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	39	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	5	2	0	2	23	-1	42	38	44		TCRBV06-01,TCRBV06-08												CASSETDNTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCCGGTCCGGGGTGATCCCCTACGAGCAGTACTTCGGGCCG	CASSRSGVIPYEQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	3	2	5	6	18	30	40	35	46	TCRBV05,TCRBV07													CASSRSGVIPYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCGCGGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSQDRGGQETQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	7	1	2	2	0	18	35	-1	37	45	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDRGGQETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGCCAAGAGGACCGAGCCCAATTTAAAGGAGCTTTCTTTGGACAA		Out	VDJ	1	20	7.515717243685859E-5		53	unresolved						TCRBJ01	TCRBJ01-01	01	3	1	7	10	8	17	18	32	44	40	61	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCGCGGACAGGGGGCGGTCGGGGAGCTGTTTTTTGGAGAA	XASSRGQGAVGELFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	0	7	3	3	22	34	48	37	51	TCRBV01,TCRBV07,TCRBV17													XASSRGQGAVGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCTTCAACGAGGCGAACACTGAAGCTTTCTTTGGACAA	CASSFNEANTEAFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	11	1	1	4	1	19	33	41	37	42	TCRBV05,TCRBV11													CASSFNEANTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTKTATSTYTGYGCCAGCAGCTTGGATGCGGGAGCGTTCTACAATGAGCAGTTCTTCGGGCCA	CASSLDAGAFYNEQFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	2	3	2	4	19	35	44	37	48	TCRBV05,TCRBV11													CASSLDAGAFYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGAAGCTTAGGACTAGCGGACAATGAGCAGTTCTTCGGGCCA	CARSLGLADNEQFF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	42	TCRBV07			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	5	5	2	0	22	35	-1	37	47		TCRBV07-01,TCRBV07-05				01,02								CARSLGLADNEQFF+TCRBV07-X+TCRBJ02-01	TCRBV07	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCGGGGGGACAGGGAGAACAGATACGCAGTATTTTGGCCCA	CASSAGGTGRTDTQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	3	6	3	24	36	51	42	54	TCRBV09,TCRBV21													CASSAGGTGRTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGGATCTCTAGCGGGGGGGCCGGAGATACGCAGTATTTTGGCCCA	CASRISSGGAGDTQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	4	0	5	5	4	24	35	52	40	56	TCRBV02,TCRBV21													CASRISSGGAGDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCCCTCCCAAACATCTGTGTACTTCTGTGCCAGCAGTTACTCCGGGGGAGATCAGCCCCAGCATTTTGGTGAT	CASSYSGGDQPQHF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	42	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	8	2	5	0	2	25	-1	48	42	50		TCRBV06-02,TCRBV06-03												CASSYSGGDQPQHF+TCRBV06-X+TCRBJ01-05	TCRBV06	TCRBD02-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGAGAACAGCGAAACAAGGTCTGGGAGCAGTACTTCGGGCCG	CASREQRNKVWEQYF	In	VDJ	1	20	7.515717243685859E-5	8.898816012529533E-5	45	unresolved						TCRBJ02	TCRBJ02-07	01	5	3	5	7	3	15	23	34	41	37	56	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASREQRNKVWEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCCACACCTCGGTAAAACTGTTTTTTGGCAGT	CASSHTSVKLFF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	36							TCRBJ01	TCRBJ01-04	01	6	3	6	10	2	7	24	35	40	37	47	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHTSVKLFF+X+TCRBJ01-04			TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGACGGAGGGAGCGCAGATACGCAGTATTTTGGCCCA	CAISDGGSADTQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	10	0	4	1	4	24	38	45	39	49	TCRBV06,TCRBV10													CAISDGGSADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTAGGGGGGACGTTAAACATTCAGTACTTCGGCGCC	CSARLGGTLNIQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	42	TCRBV20						TCRBJ02	TCRBJ02-04	01	2	5	1	6	2	6	26	38	46	40	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARLGGTLNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20		TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCACAGGCAGGGCTTTTTTTATGGCTACACCTTCGGTTCG	CSARDHRQGFFYGYTF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	4	5	2	12	26	40	47	42	59		TCRBV20-01,TCRBV20-or09_02												CSARDHRQGFFYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGGGGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	7.891503105870151E-5		40	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	3	0	2	0	26	40	-1	42	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGGGGCGCGGGAGAGGGGCAGATACGCAGTATTTTGGCCCA	CSARDRGRGRGADTQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	7	2	4	8	5	26	40	55	48	60		TCRBV20-01,TCRBV20-or09_02												CSARDRGRGRGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGTCAGACATCAAAAACATTCAGTACTTCGGCGCC	CSARDLSDIKNIQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	2	6	3	7	1	26	40	51	47	52		TCRBV20-01,TCRBV20-or09_02												CSARDLSDIKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACGCCAGGGGCGAGTACACTGAAGCTTTCTTTGGACAA	CSARDARGEYTEAFF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	3	6	5	26	37	49	43	54		TCRBV20-01,TCRBV20-or09_02												CSARDARGEYTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCARCCARACAKCTWTGTACYTCTGTGCCAGCAGTTTACAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VJ	1	21	7.891503105870151E-5		37	unresolved						TCRBJ01	TCRBJ01-05	01	2	0	0	1	0	1	25	-1	40	-1	41	TCRBV22,TCRBV28													X+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGACGCGGACAGGGGCGCAATCAGCCCCAGCATTTTGGTGAT	CASRRGQGRNQPQHF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	2	2	4	1	24	35	48	39	49	TCRBV06,TCRBV24													CASRRGQGRNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGTCACAGGGGTTGGGGAGCAGTACTTCGGGCCR	CASSLVTGVGEQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	unresolved		2	3	2	7	4	5	19	33	44	37	49	TCRBV07,TCRBV11							TCRBJ02-05,TCRBJ02-07						CASSLVTGVGEQYF+X+TCRBJ02-X	unresolved	TCRBD01-01*01	unresolved	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATTTAACTAGCGGCTACAATGAGCAGTTCTTCGGGCCA	CASSQDLTSGYNEQFF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	5	3	4	0	18	35	-1	39	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQDLTSGYNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAGGGGGCGGCATAGATACGCAGTATTTTGGCCCA	CASSLAGGGIDTQYF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	5	0	5	0	5	18	-1	42	35	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGGGIDTQYF+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCGGGACAGGGTTGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	7.891503105870151E-5		46				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	3	4	1	3	18	35	45	36	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCAGGGCCCGTGGACTGAAGCTTTCTTTGGACAA	CASSLAQGPWTEAFF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	3	5	1	7	18	35	41	36	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAQGPWTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGTTTTGGACAGGGGGCTAAGGGAGCAGTTCTTCGGGCCA	CASSLVLDRGLREQFF	In	VDJ	1	21	7.891503105870151E-5	9.34375681315601E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	0	10	4	5	18	34	49	38	54	TCRBV07,TCRBV11													CASSLVLDRGLREQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTCCCTGTGGCTGGGAATCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	21	7.891503105870151E-5		49	unresolved						TCRBJ02	TCRBJ02-01	01	5	0	8	1	11	1	24	36	51	47	52	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCTAGCTGGGATTCACCCCTCCACTTTGGGAAC	CASSPSWDSPLHF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	6	4	7	8	2	4	26	37	44	39	48		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSPSWDSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD02-01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGGGACAGGTTATGGGGCTACACCTTCGGTTCG	CASSRDRLWGYTF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	4	8	2	6	26	37	47	39	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRDRLWGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGACCGGGACGTTGTCCTACAATGAGCAGTTCTTCGGGCCA	CASRTGTLSYNEQFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	TCRBV12						TCRBJ02	TCRBJ02-01	01	6	0	7	1	4	4	26	37	46	41	50		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRTGTLSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCTAGCGGGAGGTGGTTAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	22	8.267288968054444E-5		44	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	1	7	1	5	26	38	50	39	55		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCTTAAGTACAGGGGCCATCCTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	8.267288968054444E-5		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	4	6	7	23	35	48	41	55	TCRBV01,TCRBV04													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTTAATCCCCGACATCGGGACTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	8.267288968054444E-5		49	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	0	10	4	15	0	26	38	-1	53	59	TCRBV03,TCRBV11					01,02								X+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCGGGACAGGGGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	22	8.267288968054444E-5		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	1	3	4	0	26	34	-1	38	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTTGACCGGGGGGGCACTGGAGATACGCAGTATTTTGGCCCA	CSALDRGGTGDTQYF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	0	5	7	6	26	34	49	41	55		TCRBV20-01,TCRBV20-or09_02												CSALDRGGTGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTTGGGGCAGCGGAACTATGGCTACACCTTCGGTTCG	CSALGQRNYGYTF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	7	0	2	3	5	26	34	42	37	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALGQRNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCACCGACGTAACCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	22	8.267288968054444E-5		40	unresolved						TCRBJ02	TCRBJ02-03	01	7	2	7	2	2	6	23	33	38	35	44	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAAACGCGGGACACCGGGGAGCTGTTTTTTGGAGAA	CATSETRDTGELFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	7	4	3	3	0	24	38	-1	41	46		TCRBV24-01,TCRBV24-or09_02				01,02								CATSETRDTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCTGGACGGCTACGAGCAGTACTTCGGGCCG	CASSSLDGYEQYF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	39	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	1	7	3	5	2	24	36	45	41	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSLDGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GMGACWCGGCWSTGTATCTCTGYGCCAGCACTCCTCCGGGCCTCACTTTAGGCGGTGGCTACACCTTCGGTTCG	CASTPPGLTLGGGYTF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	48	unresolved						TCRBJ01	TCRBJ01-02	01	8	8	0	7	9	14	19	27	40	36	54	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPPGLTLGGGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCCCCTGGACTAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSPWTSGTDTQYF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	6	1	4	0	18	30	-1	34	43	TCRBV07,TCRBV11					01,02								CASSPWTSGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACGGACTAGCGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSQDGLAVYNEQFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	1	5	3	1	1	18	35	46	36	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQDGLAVYNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTCRGCYGTGTATSTCTGTGCTAGCAGCCCACCGGAGACTGGGTAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	22	8.267288968054444E-5		44	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	10	5	8	4	18	30	42	38	46	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GMGACWCGGCWSTGTATCTCTGYGCCAGCAGCGCAGACAGGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSADRASYNEQFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	0	4	1	20	31	42	35	43	TCRBV07,TCRBV23													CASSADRASYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGGACTCRGCCMTGTATCKCTGTGCCAGCAGCTGAGGGACTAGCGGGGGATACCGAAACTACGAGCAGTACTTCGGGCCG	CASS*GTSGGYRNYEQYF	Stop	VDJ	1	22	8.267288968054444E-5		54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	3	2	9	19	32	48	34	57	TCRBV05,TCRBV07													CASS*GTSGGYRNYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTYRGCTKTGTATYTCTGTGCCAGCAGCGTAGAGTCGGGGCTAGCGGGTCCCCAGTACTTCGGGCCA	CASSVESGLAGPQYF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	4	4	9	12	2	22	34	54	46	56	TCRBV07,TCRBV09					01,02								CASSVESGLAGPQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGTCCACTGGGAGGGGGCGACTATGGCTACACCTTCGGTTCG	CASSPLGGGDYGYTF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	unresolved						TCRBJ01	TCRBJ01-02	01	6	5	0	3	9	1	22	33	49	42	50	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLGGGDYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGTCGAATGGGCGCCAGAAACTGAGCAGTTCTTCGGGCCA	CASSVEWAPETEQFF	In	VDJ	1	22	8.267288968054444E-5	9.788697613782486E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	9	8	9	23	34	46	42	55	TCRBV02,TCRBV09													CASSVEWAPETEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TKTACTTCTGTGCCACCAGTGGGGGACAGTGAGGTCAGAGGCGGAGGATCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	22	8.267288968054444E-5		64	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	5	0	2	20	8	20	29	22	49	TCRBV24,TCRBV27													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCGCCCCGGTCGGCCTTTTCTCGCTGGGCCG		Out	VDJ	1	23	8.643074830238736E-5		35	unresolved						TCRBJ02	TCRBJ02-07	01	6	9	0	19	10	11	26	37	50	47	61	TCRBV03,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCACAGGAATTCCTTGAAGCTTTCTTTGGACAA	CASSSQEFLEAFF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	4	7	1	7	26	39	45	40	52		TCRBV12-03,TCRBV12-04												CASSSQEFLEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTCTGCGCGGGGCCGAGGAGCAGTACTTCGGGCCG	CASSFLRGAEEQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	3	7	5	5	26	40	51	45	56		TCRBV12-03,TCRBV12-04												CASSFLRGAEEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACACTAGCGGGGGGAAAATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	8.643074830238736E-5		47	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	3	1	7	1	3	26	43	56	44	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTAGCGGGGGGGCATAGGGATACGCAGTATTTTGGCCCA	CSARLAGGHRDTQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	4	0	6	0	6	26	-1	50	38	56		TCRBV20-01,TCRBV20-or09_02												CSARLAGGHRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGATGACAGGGATGAACACTGAAGCTTTCTTTGGACAA	CSARGMTGMNTEAFF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	3	0	4	1	26	39	50	43	51		TCRBV20-01,TCRBV20-or09_02												CSARGMTGMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCGGGGACAGGGGGCTACGAGCAGTACTTCGGGCCG	CSARSGTGGYEQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	1	3	3	0	26	38	-1	41	52		TCRBV20-01,TCRBV20-or09_02												CSARSGTGGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCAGCCAACCCGGGACAGGGCGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	8.643074830238736E-5		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	0	3	4	23	38	50	41	54	TCRBV01,TCRBV04													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTACGGGGACAGGGTAGAGCATGAGCAGTTCTTCGGGCCA	CASSYGDRVEHEQFF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	8	3	6	22	35	47	38	53		TCRBV12-03,TCRBV12-04												CASSYGDRVEHEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTCCGGACCGGGGCAGGGGTGGGAACTGAAGCTTTCTTTGGACAA	CASSLRTGAGVGTEAFF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	5	13	5	24	36	55	49	60		TCRBV24-01,TCRBV24-or09_02												CASSLRTGAGVGTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCACGCCGACGGGACAGCACAATGAGCAGTTCTTCGGGCCA	CASSSTPTGQHNEQFF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	5	11	1	24	36	54	47	55		TCRBV24-01,TCRBV24-or09_02												CASSSTPTGQHNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCTCCCAGACATCTGTRTAYTTSTGYGCCAGCTGCACTAGCGGGGGGGCCTACGAGCAGTACTTCGGGCCG	CASCTSGGAYEQYF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	8	3	0	2	3	0	23	32	-1	35	48	TCRBV06,TCRBV10													CASCTSGGAYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGTCGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLVGSNQPQHF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	8	5	0	3	0	19	33	-1	36	39	TCRBV07,TCRBV11					01,02								CASSLVGSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCGCCCGAAGCGGTCTCACTTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	8.643074830238736E-5		49				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	6	5	1	6	8	18	30	41	36	49	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03				01,02								X+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGGGATTAGCAGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQEGLADSYNEQFF	In	VDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	51							TCRBJ02	TCRBJ02-01	01	0	0	8	0	0	8	18	-1	39	35	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGLADSYNEQFF+X+TCRBJ02-01			TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGTTCGCTTGTCCGCTGGTTAGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	23	8.643074830238736E-5		49	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	5	8	2	17	0	19	30	-1	47	50		TCRBV05-06,TCRBV05-07				01,02								X+TCRBV05-X+TCRBJ01-02	TCRBV05	TCRBD02-01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCGGCCGTGTATGTCTGTGCCAGCAGCTCGCCGGGACAGGGGGCGGTGATAGCGGGAGTAAGGTTGAATGAGCAGTTCTTCGGGCCA	CASSSPGQGAVIAGVRLNEQFF	In	VDDJ	1	23	8.643074830238736E-5	1.0233638414408963E-4	66				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	2	7	5	8	15	44	58	49	66	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												CASSSPGQGAVIAGVRLNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTCCGTCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	23	8.643074830238736E-5		38	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	8	6	1	1	2	23	37	40	38	42	TCRBV09,TCRBV21					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCCCACCCAGAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPTQNSGANVLTF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	5	0	6	2	24	36	45	42	47	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSPTQNSGANVLTF+X+TCRBJ02-06		TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCTTAGATACTCCTGAAGCTTTCTTTGGACAA	CASSLDTPEAFF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	3	10	6	6	1	26	38	47	44	48	TCRBV03,TCRBV09					01,02								CASSLDTPEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGTGGGTCTGGCGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASGSGATNEKLFF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	42	TCRBV03						TCRBJ01	TCRBJ01-04	01	9	0	9	0	1	7	26	34	38	35	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGSGATNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCGCAGCCTCTACAGAGACTAGCACAGATACGCAGTATTTTGGCCCA	CAAASTETSTDTQYF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	45	TCRBV03						TCRBJ02	TCRBJ02-03	01	11	3	5	0	9	5	26	32	45	41	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAAASTETSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
RGGGGACTCAGCYSTGTATCTCTGTGCCAGCAGCTTAGAAGGCCAGGGGACCTCTGAAGCTTTCTTTGGACAA	CASSLEGQGTSEAFF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	6	7	4	22	36	49	43	53	TCRBV05,TCRBV07													CASSLEGQGTSEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGTCTGAGGCCTGGGAGCAGTACTTCGGGCCG	CSASEAWEQYF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	1	7	4	5	26	34	42	38	47		TCRBV20-01,TCRBV20-or09_02												CSASEAWEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTTTTCTTACTAGCGGGGGGATAGATGAGACCCAGTACTTCGGGCCA	CSARGFLTSGGIDETQYF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	54	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	3	1	5	8	6	26	39	59	47	65		TCRBV20-01,TCRBV20-or09_02												CSARGFLTSGGIDETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCACTGGCGAGCATACTGAAGCTTTCTTTGGACAA	CSAITGEHTEAFF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	4	9	0	5	5	6	26	36	44	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAITGEHTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCAGTGGGGGGGGTGGTGAAAAACTGTTTTTTGGCAGT	CASSSGGGGEKLFF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	9	0	7	4	4	22	33	44	37	48		TCRBV12-03,TCRBV12-04												CASSSGGGGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAAGACCACGGAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	24	9.01886069242303E-5		35	TCRBV24						TCRBJ01	TCRBJ01-04	01	11	1	8	8	10	0	24	31	-1	41	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTCTTTAGGAATAGCTCTCACAGATACGCAGTATTTTGGCCCA	CASSSLGIALTDTQYF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	7	2	10	3	24	36	50	46	53	TCRBV24,TCRBV27					01,02								CASSSLGIALTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTGGGACAGCTTAATGAAAAACTGTTTTTTGGCAGT	CASSLGQLNEKLFF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	4	3	2	20	31	41	34	43	TCRBV05,TCRBV07,TCRBV23													CASSLGQLNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGTCAGGGACTAGCGGGAGAGGCCCGTCCCTATGAGCAGTACTTCGGGCCG	CASSQGLAGEARPYEQYF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	54	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	0	2	7	3	14	19	30	47	33	61		TCRBV05-06,TCRBV05-07												CASSQGLAGEARPYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTGCTGGCTGTTGGCCTAGCGGCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	9.01886069242303E-5		52	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	5	3	14	2	22	35	56	49	58	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTGGCCGCTAGCGGGAGATCTGGGGAGACCCAGTACTTCGGGCCA	CASSLAASGRSGETQYF	In	VDJ	1	24	9.01886069242303E-5	1.067857921503544E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	4	2	5	6	7	22	35	51	41	58	TCRBV07,TCRBV11													CASSLAASGRSGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTAACCATGAACACTGAAGCTTTCTTTGGACAA	CASSLTMNTEAFF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	4	9	0	1	4	26	37	41	38	45		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSLTMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAACCGGGAAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSNRETSTDTQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	8	3	0	3	4	26	38	46	41	50		TCRBV12-03,TCRBV12-04												CASSNRETSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTCCACGGACAGGACAAGAGACCCAGTACTTCGGGCCA	CASSPRTGQETQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	4	2	4	1	26	38	49	42	50	TCRBV12,TCRBV21													CASSPRTGQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGAGGACACTACGGGGTTGAAAAACTGTTTTTTGGCAGT	CASRGHYGVEKLFF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	42	unresolved						TCRBJ01	TCRBJ01-04	01	6	1	6	7	1	9	24	35	41	36	50	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGHYGVEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTGTGGCGGAGGCGCAAAGAGGCGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	25	9.394646554607322E-5		52	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	10	1	5	8	11	26	39	52	47	63		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCCTACTTGGGGGGGCAGAGGGTTCACCCCTCCACTTTGGGAAC	CASSLLGGAEGSPLHF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	4	9	0	9	5	7	26	39	51	44	58	TCRBV03,TCRBV11													CASSLLGGAEGSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCAATACGGGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLNTGAGANVLTF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	4	8	2	2	6	0	26	39	-1	45	51		TCRBV03-01,TCRBV03-02												CASSLNTGAGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD02-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACATCGGGGCAATCAGCCCCAGCATTTTGGTGAT	CSARHRGNQPQHF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	8	4	2	3	0	26	38	-1	41	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSARHRGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCAGGCTATGGCTACACCTTCGGTTCG	CSARAGYGYTF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	4	4	0	0	26	-1	-1	39	43		TCRBV20-01,TCRBV20-or09_02												CSARAGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGTTGAGAGGCAGGAAAAACTGTTTTTTGGCAGT	CSARGVERQEKLFF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	1	11	1	8	7	3	26	39	50	46	53		TCRBV20-01,TCRBV20-or09_02												CSARGVERQEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*02	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGCGGGACAGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CSASAGQGAGELFF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	1	6	3	0	26	37	-1	40	51		TCRBV20-01,TCRBV20-or09_02												CSASAGQGAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTTCGAGCGGGGGGGCGTACAATGAGCAGTTCTTCGGGCCA	XASSSSGGAYNEQFF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	6	0	4	2	2	25	38	50	40	52	TCRBV26,TCRBV28													XASSSSGGAYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAATTCCGAAGAGGCAGGGCGGGAAAAACTGTTTTTTGGCAGT	CASNSEEAGREKLFF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	4	3	8	12	3	22	32	49	44	52	TCRBV02,TCRBV12													CASNSEEAGREKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGACTAGCGGGGGCCCCGACGGGGGAGCAGTACTTCGGGCCG	CASRLAGAPTGEQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	3	2	7	0	11	22	-1	44	33	55		TCRBV12-03,TCRBV12-04												CASRLAGAPTGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCCTCGGGGGGGGTGGGACAGATACGCAGTATTTTGGCCCA	CASSLGGGGTDTQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	0	3	3	5	22	33	44	36	49	TCRBV12,TCRBV21													CASSLGGGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTCGGCAGGGCATTTTACTATGGCTACACCTTCGGTTCG	CASSFGRAFYYGYTF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	3	3	6	22	36	44	39	50		TCRBV12-03,TCRBV12-04												CASSFGRAFYYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTACTTCTGTGTCAGCAGCGTAGGCGGGGGGCGAACCTACAATGAGCAGTTCTTCGGGCCA	CVSSVGGGRTYNEQFF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	1	2	5	4	22	33	46	38	50		TCRBV12-03,TCRBV12-04												CVSSVGGGRTYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGGGACAGAATATGGCTACACCTTCGGTTCG	CATSDGTEYGYTF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	5	1	2	24	38	46	39	48		TCRBV24-01,TCRBV24-or09_02												CATSDGTEYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGGAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLGAKNIQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	39	TCRBV24						TCRBJ02	TCRBJ02-04	01	6	0	9	0	2	0	24	36	-1	38	41		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGAKNIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24		TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGGTAGGGCGCAGTCCCCAGATACGCAGTATTTTGGCCCA	CASSGRAQSPDTQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	5	5	3	4	3	9	23	35	42	38	51	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGRAQSPDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTCCTACTAGCGGGGGGGCCTGTGGGGAGCACAGATACGCAGTATTTTGGCCCA	CSALLLAGGPVGSTDTQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	57	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	3	0	0	6	9	24	32	51	38	60		TCRBV20-01,TCRBV20-or09_02												CSALLLAGGPVGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCTTCCTCTTTGGGGGGCTAGCGGGGCACCGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	25	9.394646554607322E-5		58	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	3	18	5	23	33	60	51	65		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCGGGACAGGCAGTGTAGAGACCCAGTACTTCGGGCCA	CASSPGTGSVETQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	4	4	3	6	18	30	41	33	47	TCRBV07,TCRBV11													CASSPGTGSVETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTYGGSCSTRTATKTCTGTGCCAGCAGCCGGGGACAGGGCTACTATGGCTACACCTTCGGTTCG	CASSRGQGYYGYTF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	3	2	2	18	30	41	32	43	TCRBV11,TCRBV12													CASSRGQGYYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTACTAGCCCAGATACGCAGTATTTTGGCCCA	CASSLATSPDTQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	3	7	4	1	1	18	35	42	36	43	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLATSPDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCCAAGTTGACAGGCATTCACCCCTCCACTTTGGGAAC	CASSQVDRHSPLHF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	2	4	8	6	1	19	31	43	37	44	TCRBV05,TCRBV07													CASSQVDRHSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCGTGATGCGTATCTCGCGAAAGACCTATGGCTACACCTTCGGTTCG	CASVMRISRKTYGYTF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	48	TCRBV05						TCRBJ01	TCRBJ01-02	01	7	2	7	4	20	0	19	28	-1	48	51		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASVMRISRKTYGYTF+TCRBV05-X+TCRBJ01-02	TCRBV05		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGGGGACTYRGCTKTGTATYTCTGTGCCAGCAGCTCGACAGGGGGCAATGGCTACACCTTCGGTTCG	CASSSTGGNGYTF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	0	6	0	1	22	-1	46	36	47	TCRBV07,TCRBV09													CASSSTGGNGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGTTCATATACCTACGAGCAGTACTTCGGGCCG	CASSVGSYTYEQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	5	5	4	2	2	8	24	36	41	38	49	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGSYTYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCGGCCSTSTATSTCTGTGCCAGCAGCTTGGTCCGGGCGTCCGGGAGCGGGGGGCCGTACGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLVRASGSGGPYDTGELFF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	66	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	6	1	3	16	7	15	29	54	45	61	TCRBV05,TCRBV07,TCRBV11													CASSLVRASGSGGPYDTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCCGACAGGGGGCTTGGGAGACCCAGTACTTCGGGCCA	CASRQGAWETQYF	In	VDJ	1	25	9.394646554607322E-5	1.1123520015661916E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	2	0	5	1	4	23	32	43	33	47	TCRBV09,TCRBV21													CASRQGAWETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGCGGGACAACCGAATGAAAAACTGTTTTTTGGCAGT	CASSAGQPNEKLFF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	42	TCRBV12						TCRBJ01	TCRBJ01-04	01	5	0	6	5	2	4	26	38	46	40	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAGQPNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCAGGACAACAATGGAAACTTTTGGACAA	CASSSRTTMETF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	6	17	3	12	26	39	47	42	59		TCRBV12-03,TCRBV12-04												CASSSRTTMETF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAACCCCACGTCTAGCGGGTACAATGAGCAGTTCTTCGGGCCA	CASNPTSSGYNEQFF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	4	4	4	9	0	26	36	-1	45	53		TCRBV03-01,TCRBV03-02				01,02								CASNPTSSGYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCAGGGGGCGGTAATAGGGGAGCAGTACTTCGGGCCG	CSAQGAVIGEQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	0	7	1	10	26	34	43	35	53		TCRBV20-01,TCRBV20-or09_02												CSAQGAVIGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAACCTTGGGCGGGGGGGCTAGTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	26	9.770432416791615E-5		49	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	0	5	9	5	26	37	55	46	60		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGAGGGCCTCGGATGAGCAGTTCTTCGGGCCA	CSAGRASDEQFF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	0	8	0	6	26	-1	42	35	48		TCRBV20-01,TCRBV20-or09_02												CSAGRASDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTCGGGCCCCTAGCGGACACAGATACGCAGTATTTTGGCCCA	CASSVGPLADTDTQYF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	5	2	10	1	22	33	50	43	51		TCRBV12-03,TCRBV12-04				01,02								CASSVGPLADTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGGGGGGGTCGAAGCTTTCTTTGGACAA	CATSDGGVEAFF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	36	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	0	8	0	2	24	-1	46	39	48		TCRBV24-01,TCRBV24-or09_02												CATSDGGVEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCATTCCAGGACCTAACTATGGCTACACCTTCGGTTCG	CASIPGPNYGYTF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	7	1	7	0	5	0	23	33	-1	38	42	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIPGPNYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTCGGCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFGANTGELFF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	42	unresolved						TCRBJ02	TCRBJ02-02	01	2	9	0	0	1	1	19	33	37	34	38	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGANTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GRAGACWCGGCMCTGTATCTCTGCGCCAGCAGCCAAGATGGTCCAGGGAACTATGGCTACACCTTCGGTTCG	CASSQDGPGNYGYTF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	2	5	0	21	38	-1	43	48	TCRBV04,TCRBV23													CASSQDGPGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGAGGGAAACCGGGGAGCTGTTTTTTGGAGAA	CASSLARETGELFF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	42				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	11	0	5	0	2	18	-1	40	35	42	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLARETGELFF+X+TCRBJ02-02		TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTCTGAGACGGCTTGGTCACCCCTCCACTTTGGGAAC	CASSSETAWSPLHF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	42	unresolved						TCRBJ01	TCRBJ01-06	01	6	2	7	10	6	7	20	31	40	37	47	TCRBV11,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSETAWSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ARRRRGACTCAGCYGYGTATCTCTRCACCAGCAGCCAAGATGGGACAGGACCTTTTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	26	9.770432416791615E-5		56	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	0	4	0	14	8	22	26	48	40	56	TCRBV01,TCRBV17													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCCAGCGGACAGGGGGGATAAGACACCATATATTTTGGAGAG	CASSSSGQGG*DTIYF	Stop	VDJ	1	26	9.770432416791615E-5		48	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	1	1	8	5	6	19	32	47	37	53		TCRBV05-06,TCRBV05-07												CASSSSGQGG*DTIYF+TCRBV05-X+TCRBJ01-03	TCRBV05	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCATCAAGGGTAGCTTGTCCTACAATGAGCAGTTCTTCGGGCCA	CAIKGSLSYNEQFF	In	VDJ	1	26	9.770432416791615E-5	1.1568460816288393E-4	42	unresolved						TCRBJ02	TCRBJ02-01	01	10	5	3	1	3	7	28	35	42	38	49	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIKGSLSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCTGGACATTTCTACGAGCAGTACTTCGGGCCG	CASSPGHFYEQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	6	3	3	3	26	38	46	41	49		TCRBV12-03,TCRBV12-04												CASSPGHFYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCTGGGACCGGTGAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	27	1.0146218278975909E-4		50	TCRBV12						TCRBJ02	TCRBJ02-03	01	0	0	7	0	1	6	26	43	49	44	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGCGGGTATTGTCAACGAGCAGTACTTCGGGCCG	CASSFAGIVNEQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	7	4	5	1	8	26	40	46	41	54		TCRBV12-03,TCRBV12-04				01,02								CASSFAGIVNEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGGACTCSGCCGTGTATSTCTGTGCCAGCAGCCAAATGGGCCAAACAGGGGTTGAGACCCAGTACTTCGGGCCA	CASSQMGQTGVETQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	2	5	12	2	20	32	51	44	53	TCRBV07,TCRBV11													CASSQMGQTGVETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGGGACAGGGGTTCTCAGAGACCCAGTACTTCGGGCCA	CSAPGQGFSETQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	2	4	3	5	26	34	47	37	52		TCRBV20-01,TCRBV20-or09_02												CSAPGQGFSETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATAGGGGGGAGGGTAATGAGCAGTTCTTCGGGCCA	CSANRGEGNEQFF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	9	0	7	6	1	26	36	49	42	50		TCRBV20-01,TCRBV20-or09_02												CSANRGEGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCGGGACTAGCGGGAGGTTGGCCTACAATGAGCAGTTCTTCGGGCCA	CSARGGTSGRLAYNEQFF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	0	1	2	2	4	26	39	56	41	60		TCRBV20-01,TCRBV20-or09_02												CSARGGTSGRLAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCAGACTTCGTTACAACTACGAGCAGTACTTCGGGCCG	CSAARLRYNYEQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	10	3	4	9	26	35	43	39	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAARLRYNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCACCCACCCTGCGGGTGAGCAGTTCTTCGGGCCA	CASSTHPAGEQFF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	7	4	9	10	0	22	33	-1	43	48	TCRBV09,TCRBV12					01,02								CASSTHPAGEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTACAGGACAGGGGGACTATGGCTACACCTTCGGTTCG	CASSTGQGDYGYTF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	1	3	3	0	24	36	-1	39	49	TCRBV24,TCRBV27													CASSTGQGDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCARCCAGACMKMTCTKTACYWCTGTGCCAGCAGTTTTATTCTGGGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSFILGDSNQPQHF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	48	unresolved						TCRBJ01	TCRBJ01-05	01	6	6	1	0	8	1	24	36	49	44	50	TCRBV08,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFILGDSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGGGCGGTAGGGGACAATGAGCAGTTCTTCGGGCCA	CASRAVGDNEQFF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	5	2	5	6	0	18	29	-1	35	40	TCRBV07,TCRBV23													CASRAVGDNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCCTAGCGGCACAGATACGCAGTATTTTGGCCCA	YASSPSGTDTQYF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	39				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	6	1	1	0	22	34	-1	35	41	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01				01,02								YASSPSGTDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTCATCAGGGGGTATAATTCACCCCTCCACTTTGGGAAC	CASSFIRGYNSPLHF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	1	4	3	0	19	33	-1	36	43		TCRBV05-06,TCRBV05-07												CASSFIRGYNSPLHF+TCRBV05-X+TCRBJ01-06	TCRBV05	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GRGACWCGGCMCTKTATCTYTGCGCCAGCAGCCAAGATACGGGGACAACATTCTACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDTGTTFYTGELFF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	6	3	9	7	19	31	46	40	53	TCRBV05,TCRBV23													CASSQDTGTTFYTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGCAAGCCACGTTTGGTGGTCAGGAGACAAGCACGGTATTTCTGTGCCAGCAGCGTCTATGGGAACACTGAAGCTTTCTTTGGACAA	CASSVYGNTEAFF	In	VDJ	1	27	1.0146218278975909E-4	1.201340161691487E-4	39	TCRBV21			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	4	9	1	2	3	42	54	59	56	62		TCRBV21-or09_02,TCRBV21-01				01,02								CASSVYGNTEAFF+TCRBV21-X+TCRBJ01-01	TCRBV21	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTAGTGCACGTGGAACTGAAGCTTTCTTTGGACAA	CASSFSARGTEAFF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	1	8	5	10	0	26	40	-1	50	53		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSARGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCGACGGTCCGCGACGAGCAGTACTTCGGGCCG	CASSPTVRDEQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	39	unresolved						TCRBJ02	TCRBJ02-07	01	4	2	7	5	1	8	23	36	40	37	48	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTVRDEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGACACGGTAATGAAAAACTGTTTTTTGGCAGT	CSARHGNEKLFF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	8	5	4	2	0	26	38	-1	40	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSARHGNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGATGGACAGGGGGCTGAAGCTTTCTTTGGACAA	CSADGQGAEAFF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	1	6	4	0	26	34	-1	38	48		TCRBV20-01,TCRBV20-or09_02												CSADGQGAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTACGACTAGGCTACGAGCAGTACTTCGGGCCG	CSARVRLGYEQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	2	8	3	3	1	26	39	48	42	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVRLGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCAAGGACTAGCGGGAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CSASQGLAGAGGTDTQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	1	2	1	4	6	26	37	54	41	60		TCRBV20-01,TCRBV20-or09_02												CSASQGLAGAGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGATAGGCTAGCGTAAGTAGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	1.0522004141160201E-4		43	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	6	6	7	8	26	35	48	42	56		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACATACCTCTCAGTACCTCTGTGCCAGCAGTCCCCTCTATGCTATTCCCTGGACAGCCCCTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	28	1.0522004141160201E-4		61	TCRBV25			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	5	2	19	5	20	32	57	51	62		TCRBV25-01,TCRBV25-or09_02												X+TCRBV25-X+TCRBJ02-03	TCRBV25	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGAGCAGACAGGGGCGCCAACTATGGCTACACCTTCGGTTCG	CASRADRGANYGYTF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	2	2	4	4	22	33	45	37	49	TCRBV02,TCRBV12													CASRADRGANYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCACACTAGCGGGAGGGCCTTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	28	1.0522004141160201E-4		50	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	8	3	0	0	3	4	19	27	43	30	47	TCRBV07,TCRBV11													X+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCAGACCAAGTCGGAGGCACTGAAGCTTTCTTTGGACAA	CASSPDQVGGTEAFF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	1	4	12	0	18	30	-1	42	47	TCRBV07,TCRBV11													CASSPDQVGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCGCCTAGGAGTACTAGGCCATGAGCAGTTCTTCGGGCCA	CASSRLGVLGHEQFF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	8	8	11	3	18	30	46	41	49	TCRBV05,TCRBV11					01,02								CASSRLGVLGHEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCGTAGGCCGAGATACGCAGTATTTTGGCCCA	CASSLAVGRDTQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	42							TCRBJ02	TCRBJ02-03	01	0	5	4	5	3	3	18	35	41	38	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAVGRDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GMGACWCGGCWSTGTATCTCTGYGCCAGCAGCTTAGCGGGGGGTCAGGTAGGGATCAATGAGCAGTTCTTCGGGCCA	CASSLAGGQVGINEQFF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	5	1	6	2	12	20	31	43	33	55	TCRBV07,TCRBV23													CASSLAGGQVGINEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGAGCCCGAATATGGAGACCCAGTACTTCGGGCCA	CASSLSPNMETQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	6	7	5	0	9	19	-1	37	34	46	TCRBV05,TCRBV11					01,02								CASSLSPNMETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGGTGGAGCGGGGTCGGGCACGAGCAGTACTTCGGGCCG	CASRWSGVGHEQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	6	3	5	4	6	23	34	45	38	51	TCRBV02,TCRBV09													CASRWSGVGHEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTCGCAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSRSGGTDTQYF	In	VDJ	1	28	1.0522004141160201E-4	1.2458342417541346E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	6	3	1	4	0	23	34	-1	38	45	TCRBV02,TCRBV09													CASSRSGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTATAGGGGGACGGTAGACAATGAGCAGTTCTTCGGGCCA	CASSYRGTVDNEQFF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	5	1	5	2	7	26	39	47	41	54		TCRBV12-03,TCRBV12-04												CASSYRGTVDNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGGGAGGGCTCTACGAGCAGTACTTCGGGCCG	CASSSGGLYEQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	0	3	0	2	26	-1	47	39	49		TCRBV12-03,TCRBV12-04												CASSSGGLYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGACCGGCACACGTAACGAGCAGTACTTCGGGCCG	CASSLTGTRNEQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	42	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	2	7	5	0	11	26	-1	43	40	54		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTGTRNEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGRYGACTCKGCYSTGTATYTCTGTGCCAGCGCGGGACAGCCGTCTGAAAAACTGTTTTTTGGCAGT	CASAGQPSEKLFF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	5	7	2	5	20	29	38	31	43	TCRBV03,TCRBV05													CASAGQPSEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACAGGGTTTGGGGAGCTGTTTTTTGGAGAA	CASSQTGFGELFF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	3	3	8	0	3	26	-1	47	41	50		TCRBV03-01,TCRBV03-02												CASSQTGFGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAATCAATCAGCCCCAGCATTTTGGTGAT	CASSQGINQPQHF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	39	TCRBV03						TCRBJ01	TCRBJ01-05	01	1	2	8	3	0	2	26	-1	44	42	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGINQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCGATACCAGCGGACCTCTCCTACGAGCAGTACTTCGGGCCG	CSAAIPADLSYEQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	6	5	0	9	4	26	34	48	43	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAAIPADLSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGCACCAGAGAGATTCACCCCTCCACTTTGGGAAC	CSATHQRDSPLHF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	39	TCRBV20						TCRBJ01	TCRBJ01-06	01	4	4	5	8	5	4	26	36	44	41	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATHQRDSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGCGCGACAACTAATGAAAAACTGTTTTTTGGCAGT	CSARSATTNEKLFF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	6	6	0	0	3	26	-1	42	38	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSATTNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGGGCGCGAACTATGGCTACACCTTCGGTTCG	CSARDGGANYGYTF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	6	0	2	1	3	26	40	47	41	50		TCRBV20-01,TCRBV20-or09_02												CSARDGGANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGGAAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	29	1.0897790003344495E-4		35	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	9	1	5	0	3	26	-1	43	37	46		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAGGGACTAGCGGGAGATAATGGGGCCAACGTCCTGACTTTCGGGGCC	CSASEGLAGDNGANVLTF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	3	0	2	3	3	4	26	37	54	40	58		TCRBV20-01,TCRBV20-or09_02												CSASEGLAGDNGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01*02	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGGGGCGGGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	29	1.0897790003344495E-4		37	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	7	2	0	4	0	26	33	-1	37	44		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTCCGGGACAGGGGGCGCCTCCCCGGAACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	29	1.0897790003344495E-4		59	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	0	3	3	12	22	35	50	38	62		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCGAGACAGGGAAACGAGCAGTACTTCGGGCCG	CASSPRQGNEQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	5	5	2	22	33	45	38	47		TCRBV12-03,TCRBV12-04												CASSPRQGNEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCTTGAGAAACACTGAAGCTTTCTTTGGACAA	CASSFLRNTEAFF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	11	2	2	5	1	24	36	44	41	45		TCRBV24-01,TCRBV24-or09_02												CASSFLRNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCCACCCACTTCCACGGACAGGGGGCGTTCAGGGAGACCCAGTACTTCGGGCCA	CATHFHGQGAFRETQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	12	1	0	5	13	7	18	23	47	36	54	TCRBV07,TCRBV12													CATHFHGQGAFRETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCTTCCGGGGGGCGCTTGGTATGGCTACACCTTCGGTTCG	CASSLPGGAWYGYTF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	1	5	4	7	18	30	41	34	48	TCRBV07,TCRBV11													CASSLPGGAWYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTACCTAGCGGGAGTGCAGATACGCAGTATTTTGGCCCA	CASSLPSGSADTQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	4	2	4	1	2	18	33	44	34	46	TCRBV05,TCRBV11													CASSLPSGSADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASGACTCRGCCMTGTATCKCTGTGCCAGCAGCTTGGTCTACAGGGCGACAAACACTGAAGCTTTCTTTGGACAA	CASSLVYRATNTEAFF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	3	2	5	5	19	33	44	38	49	TCRBV05,TCRBV07													CASSLVYRATNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGACCGGACTAGCGGTTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	29	1.0897790003344495E-4		41	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	5	4	3	2	19	30	43	33	45		TCRBV05-06,TCRBV05-07				01,02								X+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCCGTCCACAGGGACTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRPQGLNTGELFF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	48	unresolved						TCRBJ02	TCRBJ02-02	01	4	3	3	1	5	3	19	31	42	36	45	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRPQGLNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCACCCCGGGCGGGCAGGGTGGGATGGAGACCCAGTACTTCGGGCCA	CASTPGGQGGMETQYF	In	VDJ	1	29	1.0897790003344495E-4	1.2903283218167823E-4	48	unresolved						TCRBJ02	TCRBJ02-05	01	10	4	3	5	14	7	24	31	50	45	57	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPGGQGGMETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGCCGACCGGGACTAGCGTCGAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	1.1273575865528787E-4		50	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	6	7	9	4	26	38	57	47	61		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTACTCCCAAAGCGGGGTATTTTGGCCCA		Out	VDJ	1	30	1.1273575865528787E-4		34	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	6	4	14	8	0	26	39	-1	47	53		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCTCGGACAGGGGTTGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CSAARTGVGSNQPQHF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	2	1	5	5	26	34	48	39	53		TCRBV20-01,TCRBV20-or09_02												CSAARTGVGSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTAACGGAGCGAGCGGCTACGAGCAGTACTTCGGGCCG	CSATNGASGYEQYF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	6	5	3	11	0	26	36	-1	47	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSATNGASGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGGGACTAGCGGGGGGGCCCCTCGAGCAGTACTTCGGGCCG	CSASRGLAGGPLEQYF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	0	0	6	3	5	26	37	56	40	61		TCRBV20-01,TCRBV20-or09_02												CSASRGLAGGPLEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTCGGACAGGAGACGTCGGGGAGCTGTTTTTTGGAGAA	CASSPRTGDVGELFF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	4	7	4	6	24	36	47	40	53		TCRBV24-01,TCRBV24-or09_02												CASSPRTGDVGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCTTACAGGGGGATTATCCTACGAACAGTACTTCGGGCCG	CASSLTGGLSYEQYF	In	VDJ	1	30	1.1273575865528787E-4	1.33482240187943E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	1	10	3	13	18	30	41	33	54	TCRBV07,TCRBV11													CASSLTGGLSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCRTGTATSKCTGTGCCAGGGGCGGAAGTTGGAGAGGGTCCACGGGGGCTACACCTTCGGTTCG		Out	VDJ	1	30	1.1273575865528787E-4		47	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	9	11	0	8	14	8	19	27	46	41	54	TCRBV07,TCRBV11,TCRBV12													X+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTCTATCTCTGTGCCAACAGCTTATCCGCGCGAGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	1.1273575865528787E-4		40	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	7	6	7	4	4	19	33	40	37	44		TCRBV05-06,TCRBV05-07				01,02								X+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTATCAGACAGGGCAGCACAGATACGCAGTATTTTGGCCCA	CASSIRQGSTDTQYF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	3	0	4	1	26	38	49	42	50	TCRBV12,TCRBV21													CASSIRQGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGTTCGGCGGCGGACTGAAGCTTTTTTTGGACAA		Out	VDJ	1	31	1.164936172771308E-4		41	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	1	10	17	10	9	26	40	55	50	64		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACAGGGTACCGGGGAGCTGTTTTTTGGAGAA	CASSPQGTGELFF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	3	5	1	1	26	39	46	40	47		TCRBV03-01,TCRBV03-02												CASSPQGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGGGGGCGGGGCTCACAGATACGCAGTATTTTGGCCCA	CSARGAGLTDTQYF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	1	2	0	8	26	-1	41	34	49		TCRBV20-01,TCRBV20-or09_02												CSARGAGLTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATAGGGGCTGGGGATGAAAAACTGTTTTTTGGCAGT	CSARDIGAGDEKLFF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	2	6	3	6	26	40	48	43	54		TCRBV20-01,TCRBV20-or09_02												CSARDIGAGDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTATACTAAAGCTAACTATGGCTACACCTTCGGTTCG	CSAYTKANYGYTF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	3	9	0	3	3	26	35	42	38	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSAYTKANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGCGCGGGGACTAGCGTGGGTGGGTACAATGAGCAGTTCTTCGGGCCA	CASSAGTSVGGYNEQFF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	6	4	4	8	22	33	47	37	55	TCRBV02,TCRBV12					01,02								CASSAGTSVGGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
SRGGGACTYRGCTGTGTAYYTCTGTGCCAGCAGCTTAAGCAGGGATGGTGGCTACACCTTCGGTTCG	CASSLSRDGGYTF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	7	2	4	22	37	44	39	48	TCRBV07,TCRBV12													CASSLSRDGGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCTTAAGGAGATCTAGCGGGAGTTCCTACGAGCAATACTTCGGGCCG	CASSLRRSSGSSYEQYF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	51	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	4	2	13	7	13	22	37	54	44	67		TCRBV12-03,TCRBV12-04												CASSLRRSSGSSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGGGGTGGGACAGGTGGCTACACCTTCGGTTCG	CASRGGTGGYTF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	4	7	4	0	23	34	-1	38	46	TCRBV24,TCRBV27													CASRGGTGGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCAGGGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGGYTGELFF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	42	TCRBV07						TCRBJ02	TCRBJ02-02	01	1	6	1	3	0	1	19	-1	40	35	41		TCRBV07-01,TCRBV07-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGGYTGELFF+TCRBV07-X+TCRBJ02-02	TCRBV07		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGGGGGACCCACAGATACGCAGTATTTTGGCCCA	CASSLGGPTDTQYF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	9	1	2	0	3	18	-1	38	32	41	TCRBV07,TCRBV11													CASSLGGPTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAATAAAGGACAGGGCACAGATACGCAGTATTTTGGCCCA	CASNKGQGTDTQYF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	1	4	1	5	0	18	28	-1	33	40	TCRBV07,TCRBV11													CASNKGQGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCCCAACCGTCCCGGGTCCCCGGGGGTACGAGCAGTACTTCGGGCCG	CASSPTVPGPRGYEQYF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	2	4	19	0	20	31	-1	50	56	TCRBV11,TCRBV23													CASSPTVPGPRGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCCCCGGACAGGGGCCTACGAGCAGTACTTCGGGCCG	YASSPRTGAYEQYF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	2	4	0	22	34	-1	38	47	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01												YASSPRTGAYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTCTATCTCTGTGCTAGCAGCTTTGACGGGACAGGTACTCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSFDGTGTPSTDTQYF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	54	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	4	0	4	7	19	33	45	37	52		TCRBV05-06,TCRBV05-07												CASSFDGTGTPSTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCAAAAACTAGCGCACCTTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	31	1.164936172771308E-4		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	6	4	4	6	22	34	45	38	51	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCATGCGGACATCCTCTAACTATGGCTACACCTTCGGTTCG	CASSMRTSSNYGYTF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	6	0	4	4	22	34	43	38	47	TCRBV07,TCRBV11													CASSMRTSSNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGAAATGCAGGCCGGACTAGCGGGAGCCAATGAGCAGTTCTTCGGGCCA	CASSEMQAGLAGANEQFF	In	VDJ	1	31	1.164936172771308E-4	1.3793164819420777E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	1	2	6	13	1	24	35	61	48	62	TCRBV02,TCRBV21													CASSEMQAGLAGANEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGTCCTCTAGCGGATACAATGAGCAGTTCTTCGGGCCA	CASRSSSGYNEQFF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	5	4	5	1	26	37	49	42	50		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASRSSSGYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGATTACCAGGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	32	1.2025147589897372E-4		43	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	4	4	6	6	0	26	42	-1	48	52		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCTCTAGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSFSRAYNEQFF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	42	TCRBV12						TCRBJ02	TCRBJ02-01	01	3	5	3	2	4	0	26	40	-1	44	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSRAYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTAGGCCGGGGGCAGTTCTTCGGGCCA	CASSQVGRGQFF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	36	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	3	12	5	0	26	42	-1	47	52		TCRBV03-01,TCRBV03-02												CASSQVGRGQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCCTTCGAGGCAGGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSQVLRGRANEKLFF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	3	3	10	0	26	42	-1	52	57		TCRBV03-01,TCRBV03-02												CASSQVLRGRANEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTGCTCCCCGGGACTAAAGGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVLPGTKGNTGELFF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	54	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	9	2	9	5	26	38	54	47	59		TCRBV03-01,TCRBV03-02				01,02								CASSVLPGTKGNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGGGGGGTAGGCACAGATACGCAGTATTTTGGCCCA	CSAGGVGTDTQYF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	0	1	0	3	26	-1	42	34	45		TCRBV20-01,TCRBV20-or09_02												CSAGGVGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCCGAGCATAAAAGATACGCAGTATTTTGGCCCA	CSATPSIKDTQYF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	6	7	5	5	5	26	36	44	41	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSATPSIKDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCACTAGTGGGAGTGGGGCGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	32	1.2025147589897372E-4		49	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	7	0	4	15	3	26	37	57	52	60		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGCCAGCAGCGAGTAGCACAGATACGCAGTATTTTGGCCCA	CSAEPAASSTDTQYF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	6	0	8	3	26	35	47	43	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSAEPAASSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCCGGGAGGGCCCCCCCCAATGAGCAGTTCTTCGGGCCA	CASSPGRAPPNEQFF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	0	6	3	7	22	33	44	36	51		TCRBV12-03,TCRBV12-04												CASSPGRAPPNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCATTCCTCTTCTACTACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	32	1.2025147589897372E-4		47	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	7	3	10	2	12	0	24	35	-1	47	50		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCAGGGGCCCCCACAGATACGCAGTATTTTGGCCCA	CATSDSGAPTDTQYF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	2	0	4	24	-1	46	40	50		TCRBV24-01,TCRBV24-or09_02												CATSDSGAPTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGGCCGATGGGCTACACCTTCGGTTCG	CATSDWPMGYTF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	9	0	8	0	5	24	-1	43	40	48		TCRBV24-01,TCRBV24-or09_02												CATSDWPMGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGTTTGGGCTTACTAGCGGGGCCGCTAGCACAGATACGCAGTATTTTGGCCCA	CASRFGLTSGAASTDTQYF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	57	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	3	3	0	10	5	24	35	55	45	60		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRFGLTSGAASTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAACCTCATAGGGTCCAGGGGGCGCGGAAGGGAAAAACTGTTTTTTGGCAGT	CASNLIGSRGRGREKLFF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	4	0	8	15	8	19	27	50	42	58	TCRBV07,TCRBV11													CASNLIGSRGRGREKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTACTAAGGGGAGACGGATACGAGCAGTACTTCGGGCCG	CASSLLRGDGYEQYF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	45	TCRBV05						TCRBJ02	TCRBJ02-07	01	2	5	2	4	4	7	19	33	42	37	49		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLRGDGYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTTGGGCGGGAGTGGGACGAGCAGTACTTCGGGCCG	CASSFGREWDEQYF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	7	2	5	3	4	19	33	43	36	47	TCRBV05,TCRBV11													CASSFGREWDEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGATAGGGGGACCGCGGGGAATACGCAGTATTTTGGCCCA	CASSVDRGTAGNTQYF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	48	unresolved						TCRBJ02	TCRBJ02-03	01	5	5	1	7	6	10	24	36	48	42	58	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVDRGTAGNTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGTCCATGGACTAGCGGACAAATACGAGCAGTACTTCGGGCCG	CASSVHGLADKYEQYF	In	VDJ	1	32	1.2025147589897372E-4	1.4238105620047252E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	1	5	4	4	5	23	37	51	41	56	TCRBV09,TCRBV12					01,02								CASSVHGLADKYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAAGGGGGGGAGTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQKGGSSSYNEQFF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	9	0	0	2	5	26	41	50	43	55		TCRBV03-01,TCRBV03-02												CASSQKGGSSSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTTGAAGGTGAAGCTTTCTTTGGACAA	CASSQDLEGEAFF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	39	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	5	4	7	6	0	26	43	-1	49	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLEGEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACCGGGTCCCAGGGCCCAGATACGCAGTATTTTGGCCCA	CSATGSQGPDTQYF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	3	4	10	2	26	34	49	44	51		TCRBV20-01,TCRBV20-or09_02												CSATGSQGPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCCTCTACGGGAGAACACCTACGAGCAGTACTTCGGGCCG	CSATPLRENTYEQYF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	2	2	8	4	26	36	50	44	54		TCRBV20-01,TCRBV20-or09_02												CSATPLRENTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCAAGGGGGGGTTATGGCTACACCTTCGGTTCG	CSASSRGGYGYTF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	9	0	5	5	1	26	37	49	42	50		TCRBV20-01,TCRBV20-or09_02												CSASSRGGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAGGGACAGGGGTCTCTTCAACTATGGCTACACCTTCGGTTCG	CATSDRDRGLFNYGYTF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	2	2	1	7	24	39	50	40	57		TCRBV24-01,TCRBV24-or09_02												CATSDRDRGLFNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTTTAGACTAGCGGGAGTGTAGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	33	1.2400933452081666E-4		47	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	2	2	6	4	5	24	37	53	41	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTGTATCTCTGTGCCAGCAGCTTAGGGCCCCCTGGGAAAGATACGCAGTATTTTGGCCCA	CASSLGPPGKDTQYF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	45							TCRBJ02	TCRBJ02-03	01	2	0	8	5	10	1	19	33	47	43	48	TCRBV05,TCRBV11	TCRBV05-05,TCRBV11-01,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPPGKDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCGGGGGACAGAGCTCCTACGAGCAGTACTTCGGGCCG	CAGGQSSYEQYF	In	VDJ	1	33	1.2400933452081666E-4	1.468304642067373E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	0	5	0	2	2	23	29	38	31	40	TCRBV02,TCRBV09													CAGGQSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGAGATGCGGGGGGCCTACACTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	33	1.2400933452081666E-4		58	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	7	1	0	5	6	23	40	53	45	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCGCCGGGACTCCCTCAACGAGCAGTACTTCGGGCCG	CASSSRRDSLNEQYF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	10	5	6	6	26	39	51	45	57		TCRBV12-03,TCRBV12-04				01,02								CASSSRRDSLNEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTAATCCATTGGCGGTTGGCTACACCTTCGGTTCG	CSNPLAVGYTF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	8	7	5	7	9	1	26	32	45	41	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSNPLAVGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGCGGGGCGCTAACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	34	1.277671931426596E-4		46	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	6	3	5	2	5	26	40	49	42	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGGCTATCCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	34	1.277671931426596E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	7	0	6	1	4	26	40	46	41	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTCCGGGACAGCAAAGAGACCCAGTACTTCGGGCCA	CSAVRDSKETQYF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	5	3	4	2	26	35	46	39	48		TCRBV20-01,TCRBV20-or09_02												CSAVRDSKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGCATACGTAGGGTACGAGCAGTACTTTGGGCCG	CASSAYVGYEQYF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	39	unresolved						TCRBJ02	TCRBJ02-07	01	6	5	3	19	9	15	22	33	46	42	61	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAYVGYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGATGTTATCTTGGGGTGGGGCTACACCTTCGGTTCG	CASSDVILGWGYTF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	42	TCRBV12						TCRBJ01	TCRBJ01-02	01	5	6	2	8	11	3	22	34	49	45	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDVILGWGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCWMCCAGACMTCTSTGTACTTCTGTGCCACCTGGGACTCCTGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	34	1.277671931426596E-4		38	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	0	10	4	3	4	23	30	39	33	43	TCRBV10,TCRBV27					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCGGGGTACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDRGTSGANVLTF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	51				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	0	8	3	0	1	3	18	35	41	36	44	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDRGTSGANVLTF+X+TCRBJ02-06		TCRBD02-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGATGGCCCCTCTGGAAACACCATATATTTTGGAGAG	CASSLDGPSGNTIYF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	9	0	0	1	2	18	35	39	36	41	TCRBV07,TCRBV11													CASSLDGPSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATSTCTGTGCCAGGTAAGGTACAGGGGAAGCCCATAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	34	1.277671931426596E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	3	2	2	7	9	18	26	40	33	49	TCRBV11,TCRBV12													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGYYWGGWGACWCWGCWSKGTATTTCTGTGCCAGCAGCTCGGATAGCGCTGAAGCTTTCTTTGGACAA	CASSSDSAEAFF	In	VDJ	1	34	1.277671931426596E-4	1.5127987221300206E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	5	6	6	5	0	24	36	-1	41	46	TCRBV03,TCRBV21					01,02								CASSSDSAEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGATTATGGCGGGCCCCCCTACGAGCAGTACTTCGGGCCG	XASSQDYGGPPYEQYF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	7	4	2	5	4	23	40	50	45	54	TCRBV01,TCRBV04					01,02								XASSQDYGGPPYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTAGTCCGTTCCATTTTTGGCATCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	35	1.3152505176450253E-4		52	TCRBV03						TCRBJ01	TCRBJ01-05	01	5	9	0	5	17	3	26	38	58	55	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGCCCACCCCGTCCATTTGTCATGCAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	35	1.3152505176450253E-4		50	TCRBV03						TCRBJ02	TCRBJ02-03	01	8	3	7	5	4	19	26	35	41	39	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAACGTACTCGCTAGAGAGACCCAGTACTTCGGGCCA	CNVLARETQYF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	10	4	8	4	9	0	26	30	-1	39	43		TCRBV20-01,TCRBV20-or09_02				01,02								CNVLARETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCGGTACGGGGAATCAGCCCCAGCATTTTGGTGAT	CSARDLGTGNQPQHF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	8	3	4	8	0	26	40	-1	48	53		TCRBV20-01,TCRBV20-or09_02												CSARDLGTGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGATCAAGCGGGAGGGGGTACGAGCAGTACTTCGGGCCG	CSARDGSSGRGYEQYF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	6	0	4	7	2	26	40	57	47	59		TCRBV20-01,TCRBV20-or09_02												CSARDGSSGRGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAAGACAGGGGGCGGTCCACCCCTCCACTTTGGGAAC	CSARKTGGGPPLHF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	2	0	11	3	4	26	37	50	40	54		TCRBV20-01,TCRBV20-or09_02												CSARKTGGGPPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTATATGGGACGGAGCCAAGAGACCCAGTACTTCGGGCCA	CSARYMGRSQETQYF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	45	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	0	7	1	6	4	26	37	48	43	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARYMGRSQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCCCGACTAGCGGGATTCCACCCGTATGGGACCCAGTACTTCGGGCCA	CSASPRLAGFHPYGTQYF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	2	3	7	5	14	26	37	53	42	67		TCRBV20-01,TCRBV20-or09_02												CSASPRLAGFHPYGTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTGACGGGAGCCGGGAGCTATGGCTACACCTTCGGTTCG	CSALTGAGSYGYTF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	8	2	4	4	7	26	35	45	39	52		TCRBV20-01,TCRBV20-or09_02												CSALTGAGSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTCGAGACAGGGGGTCCTACGAGCAGTACTTCGGGCCG	XASSRDRGSYEQYF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	1	1	3	0	25	37	-1	40	49	TCRBV26,TCRBV28													XASSRDRGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTCCTGGACAAATTAATGAAAAACTGTTTTTTGGCAGT	CASSPGQINEKLFF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	6	4	3	3	22	34	42	37	45	TCRBV09,TCRBV12													CASSPGQINEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGCCGGACAGGACACAGATACGCAGTATTTTGGCCCA	CASSAGQDTDTQYF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	4	2	3	1	22	34	44	37	45	TCRBV09,TCRBV12													CASSAGQDTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGGGACTAGTGATCCACCGGGGAGCTGTTTTTTGGAGAA	CATRD**STGELFF	Stop	VDJ	1	35	1.3152505176450253E-4		42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	0	8	4	1	5	24	33	42	34	47		TCRBV24-01,TCRBV24-or09_02				01,02								CATRD**STGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCKGCYGTGTATYTCTGTGCCAGCAGCTTAGGGTGGCGTGAAAAACTGTTTTTTGGCAGT	CASSLGWREKLFF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	39	unresolved						TCRBJ01	TCRBJ01-04	01	1	9	0	7	3	1	18	34	40	37	41	TCRBV03,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGWREKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCACCTGTGCTTGATCGTGGGGATCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	35	1.3152505176450253E-4		52	unresolved						TCRBJ02	TCRBJ02-01	01	6	0	8	2	16	2	19	29	49	45	51	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCCGGACCGGCGGGGGGGCCGAGCAGTACTTCGGGCCG	CASSRTGGGAEQYF	In	VDJ	1	35	1.3152505176450253E-4	1.5572928021926683E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	7	0	6	7	1	19	31	47	38	48	TCRBV05,TCRBV07													CASSRTGGGAEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCAGGGATTTTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPGILAKNIQYF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	3	0	1	5	26	38	44	39	49		TCRBV12-03,TCRBV12-04												CASSPGILAKNIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGCAAGAACACTGAAGCTTTCTTTGGACAA	CASSLGKNTEAFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	1	4	6	1	1	1	26	42	45	43	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGKNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACCGGTTTTGGGGACAGGGGTCGGCTACACCTTCGGTTCG	CASSPPVLGTGVGYTF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	2	8	11	2	26	39	60	50	62		TCRBV03-01,TCRBV03-02												CASSPPVLGTGVGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACAGGCCAAGAGACCCAGTACTTCGGGCCA	CSARTGQETQYF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	4	1	0	0	26	-1	-1	38	43		TCRBV20-01,TCRBV20-or09_02												CSARTGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCCGGCGACAACAGGGTAACTATGGCTACACCTTCGGTTCG	CSARGRRQQGNYGYTF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	3	1	10	0	26	39	-1	49	55		TCRBV20-01,TCRBV20-or09_02												CSARGRRQQGNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGCGGTTACGAGCAGTACTTCGGGCCG	CSASRGYEQYF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	7	5	4	2	1	26	37	43	39	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSASRGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACAGGAGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CSARTGGSNQPQHF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	42	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	2	4	1	0	4	26	-1	43	37	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARTGGSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGCATGAGAGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CSAGMRGGSYEQYF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	1	0	8	0	26	35	-1	43	49		TCRBV20-01,TCRBV20-or09_02												CSAGMRGGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCTCGGGGAGAGGGCTTGGCTTTCTTTGGACAA	CSASRGEGLAFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	3	11	3	10	26	35	43	38	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSASRGEGLAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGACTGGCAATAGCAATCAGCCCCAGCATTTTGGTGAT	CSGTGNSNQPQHF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	1	10	0	0	5	26	-1	38	33	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSGTGNSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGAGACTAGCGGCCCTAGGAGACCCAGTACTTCGGGCCA	XASRD*RP*ETQYF	Stop	VDJ	1	36	1.3528291038634543E-4		42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	2	5	5	1	6	25	36	46	37	52	TCRBV26,TCRBV28					01,02								XASRD*RP*ETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAAGGATTACTAGCGGGAAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	36	1.3528291038634543E-4		44	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	3	3	5	6	1	24	34	50	40	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCACCGGGACAGGGAACGGGGAGCTGTTTTTTGGAGAA	CATTGTGNGELFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	3	7	2	2	24	34	45	36	47		TCRBV24-01,TCRBV24-or09_02												CATTGTGNGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGTCAGGGGGCTCTGAAGCTTTCTTTGGACAA	CATSESGGSEAFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	0	6	2	1	24	38	48	40	49		TCRBV24-01,TCRBV24-or09_02												CATSESGGSEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATACCGGGACTAGCCAGGATACGCAGTATTTTGGCCCA	CATSDTGTSQDTQYF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	7	6	3	3	24	39	51	42	54		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDTGTSQDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGAGTGACAGGGCGCTACACCTTCGGTTCG	CATSGVTGRYTF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	9	4	1	24	37	48	41	49		TCRBV24-01,TCRBV24-or09_02												CATSGVTGRYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACTTTGGACAGTGGCCTCTCCTACGAGCAGTACTTCGGGCCG	CATLDSGLSYEQYF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	1	5	0	3	6	24	32	41	35	47		TCRBV24-01,TCRBV24-or09_02												CATLDSGLSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCATCCGGGGCAGCCTCAACACCGGGGAGCTGTTTTTTGGAGAA	CAIRGSLNTGELFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	42	TCRBV24						TCRBJ02	TCRBJ02-02	01	11	7	0	2	3	6	24	31	39	34	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIRGSLNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTGGTCGGGCAGGGAGGCGCAGATACGCAGTATTTTGGCCCA	CASSLVGQGGADTQYF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	9	1	4	10	2	23	36	52	46	54	TCRBV06,TCRBV24													CASSLVGQGGADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASGACTCGGCYSTGTATCTCTGTGCCAGCAGACCACGGCGGGGACTTCACACCGGGGAGCTGTTTTTTGGAGAA	CASRPRRGLHTGELFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	0	10	3	12	2	19	27	45	39	47	TCRBV05,TCRBV07					01,02								CASRPRRGLHTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTGGTGTCCCAAGGGCCCTTAAACACTGAAGCTTTCTTTGGACAA	CASSLVSQGPLNTEAFF	In	VDJ	1	36	1.3528291038634543E-4	1.601786882255316E-4	51							TCRBJ01	TCRBJ01-01	01	0	5	3	2	7	6	18	34	45	41	51	TCRBV05,TCRBV07	TCRBV05-08,TCRBV07-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVSQGPLNTEAFF+X+TCRBJ01-01			TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTCAGGAGCCTCGAGGGGACCCAGTACTTCGGGCCA	CASSVRSLEGTQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	11	0	7	13	0	26	37	-1	50	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVRSLEGTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGACAGGGCGCAGTATTTTGGCCCA	CASSQGDRAQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	3	10	0	0	26	-1	-1	42	51		TCRBV03-01,TCRBV03-02												CASSQGDRAQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCTACCCGTGTGGGGCCAAAAGACCCAGTACTTCGGGCCA	CSALPVWGQKTQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	7	0	6	11	4	26	34	50	45	54		TCRBV20-01,TCRBV20-or09_02												CSALPVWGQKTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACACAGACAGGAGCGAACACTGAAGCTTTCTTTGGACAA	CSATQTGANTEAFF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	4	1	4	3	26	36	46	40	49		TCRBV20-01,TCRBV20-or09_02												CSATQTGANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAAAAGCGGGGGTGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSARKSGGGSYNEQFF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	6	2	1	3	4	26	38	49	41	53		TCRBV20-01,TCRBV20-or09_02												CSARKSGGGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGTCGGGGGGTTTTAGCGGGTGGTGGCAGTTCTTCGGGCCA	CSARGSGGFSGWWQFF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	4	12	13	5	26	39	59	52	64		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGSGGFSGWWQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGAACTAGCGGGAGGCCCAGATACGCAGTATTTTGGCCCA	CSASELAGGPDTQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	3	1	4	3	2	26	37	52	40	54		TCRBV20-01,TCRBV20-or09_02												CSASELAGGPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAGGAGGGGTACGGGCCCCAGCATTTTGGTGAT	CASSEEGYGPQHF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	10	0	9	2	6	22	34	42	36	48	TCRBV02,TCRBV12													CASSEEGYGPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCACGGACAGGATGGGAGGGAGCAGTTCTTCGGGCCA	CATSDHGQDGREQFF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	4	10	3	8	24	39	49	42	57		TCRBV24-01,TCRBV24-or09_02												CATSDHGQDGREQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCACTAGCGGGGGGGCCAATGAGCAGTTCTTCGGGCCA	CASTSGGANEQFF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	4	0	6	0	1	23	-1	45	33	46	TCRBV06,TCRBV24													CASTSGGANEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCATAGCGGAGAGGGACAGGGAGGCTATGGCTACACCTTCGGTTCG	CASSHSGEGQGGYGYTF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	4	11	3	18	30	50	41	53	TCRBV07,TCRBV11													CASSHSGEGQGGYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTACCGGGACAGGGGCAAGATACGCAGTATTTTGGCCCA	CASSLPGQGQDTQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	2	5	2	2	18	33	45	35	47	TCRBV07,TCRBV11													CASSLPGQGQDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGTTGGGTTCCAACTATGGCTACACCTTCGGTTCG	CASSLALGSNYGYTF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	45							TCRBJ01	TCRBJ01-02	01	0	0	9	2	3	4	18	35	41	38	45	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLALGSNYGYTF+X+TCRBJ01-02			TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAACGTCGGCTAGCGGCCAAGAGACCCAGTACTTCGGGCCA	CASSLTSASGQETQYF	In	VDJ	1	37	1.3904076900818837E-4	1.6462809623179637E-4	48	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	5	1	8	0	19	33	-1	41	48		TCRBV05-06,TCRBV05-07				01,02								CASSLTSASGQETQYF+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACGAAAGGGGGCAGATACGCAGTATTTTGGCCCA	CSARKGADTQYF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	1	4	5	0	26	34	-1	39	45		TCRBV20-01,TCRBV20-or09_02												CSARKGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGATGAGAGGCAGGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	38	1.427986276300313E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	2	10	0	26	34	-1	44	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATTCCGGGACAGGGGGACATTGAAGCTTTCTTTGGACAA	CSARIPGQGDIEAFF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	1	7	5	4	26	38	54	43	58		TCRBV20-01,TCRBV20-or09_02												CSARIPGQGDIEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCATAGGGGGATCCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	38	1.427986276300313E-4		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	5	1	4	4	4	26	36	46	40	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGAGGCCCAGGGGACGTGGGGAACACTGAAGCTTTCTTTGGACAA	CSAGGPGDVGNTEAFF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	2	1	3	7	26	39	48	42	55		TCRBV20-01,TCRBV20-or09_02												CSAGGPGDVGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTCTCAGGAGGGTCTGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	38	1.427986276300313E-4		53	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	10	0	2	6	4	23	40	52	46	56	TCRBV01,TCRBV04													X+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGCAGGCGATCAATCAGCCCCAGCATTTTGGTGAT	CATSGQAINQPQHF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	4	3	2	4	24	37	43	39	47		TCRBV24-01,TCRBV24-or09_02												CATSGQAINQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGAGGTCCAGGACACCCGGTGGGCTACACCTTCGGTTCG	CATGGPGHPVGYTF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	42	TCRBV24						TCRBJ01	TCRBJ01-02	01	9	1	6	8	9	7	24	33	47	42	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATGGPGHPVGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTCTAGGGGGAGACTATGGCTACACCTTCGGTTCG	CASSSLGGDYGYTF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	5	1	3	5	2	24	36	47	41	49		TCRBV24-01,TCRBV24-or09_02												CASSSLGGDYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACTGGTCAGAACACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	38	1.427986276300313E-4		50	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	3	6	0	12	2	24	36	51	48	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCGGGACTAGTTCCTTCGAGCAGTACTTCGGGCCG	CATGTSSFEQYF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	0	8	6	2	6	23	30	40	32	46	TCRBV06,TCRBV10					01,02								CATGTSSFEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACGTCAGTATAATTCACCCCTCCACTTTGGGAAC	CASSERQYNSPLHF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	42	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	5	4	3	0	23	38	-1	41	44		TCRBV06-01,TCRBV06-08												CASSERQYNSPLHF+TCRBV06-X+TCRBJ01-06	TCRBV06	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMMTGTATCKCTGYGCCAGCAGCTCGACTAGCGGAGGGGAGACCCAGTACTTCGGGCCA	CASSSTSGGETQYF	In	VDJ	1	38	1.427986276300313E-4	1.6907750423806112E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	2	5	5	3	4	20	31	43	34	47	TCRBV07,TCRBV23					01,02								CASSSTSGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCATTCGGACTAGCGGGGGGCTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIRTSGGLNTGELFF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	54	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	1	1	1	5	2	26	37	56	42	58		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSIRTSGGLNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTCAGTAAGCGCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	39	1.4655648625187424E-4		43	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	6	6	0	8	1	26	37	49	45	50		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCTAAGCCCCCGGGACTAGCTTACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	39	1.4655648625187424E-4		53	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	7	2	10	3	26	39	58	49	61		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGCAGGGGCCCAACAGACCGGGGAGCTGTTTTTTGGAGAA	CSAAGAQQTGELFF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	2	5	2	8	26	34	42	36	50		TCRBV20-01,TCRBV20-or09_02												CSAAGAQQTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTGCCTCGGCTTTCGAGACCCAGTACTTCGGGCCA	CSAIASAFETQYF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	4	9	0	5	7	4	26	36	46	43	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAIASAFETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGGACTCCAGGCGGGGGACAGGGGGTCGAGAGACCCAGTACTTCGGGCCA	CSAEDSRRGTGGRETQYF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	1	4	15	3	26	35	61	50	64		TCRBV20-01,TCRBV20-or09_02												CSAEDSRRGTGGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGTCACACAATTCCCCACATTGGTGGCTACGAGCAGTACTTCGGGCCG	CASSHTIPHIGGYEQYF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	6	3	2	19	23	34	39	36	58	TCRBV04,TCRBV23													CASSHTIPHIGGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCCACAGGGGGCGAGACCGGGGAGCTGTTTTTTGGAGAA	CATSDPTGGETGELFF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	0	5	3	3	24	39	51	42	54		TCRBV24-01,TCRBV24-or09_02												CATSDPTGGETGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGAGAGGGACAGGGGGTCTCTACGAGCAGTACTTCGGGCCG	CASRRGTGGLYEQYF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	1	3	4	3	24	35	50	39	53		TCRBV24-01,TCRBV24-or09_02												CASRRGTGGLYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTGCGGGGTGACGAGCAGTACTTCGGGCCG	CASSLLRGDEQYF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	7	3	5	5	2	24	36	47	41	49		TCRBV24-01,TCRBV24-or09_02												CASSLLRGDEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCRGCYRTGTATYKYTGTGCCAGCAGGTGATAGCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	39	1.4655648625187424E-4		41	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	7	0	4	1	18	29	37	33	38	TCRBV07,TCRBV12					01,02								X+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCGTGGCGGGGGACCCAAGAGACCCAGTACTTCGGGCCA	CASSPWRGTQETQYF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	7	2	1	5	2	18	30	42	35	44	TCRBV07,TCRBV11													CASSPWRGTQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTATTCGGCAGGGGGCCCTACGAGCAGTACTTCGGGCCG	CASSLFGRGPYEQYF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	0	2	5	0	18	33	-1	38	46	TCRBV07,TCRBV11													CASSLFGRGPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCCCGGGACAGGCAAAACCAGCAGTTCTTCGGGCCA	CASSSRDRQNQQFF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	4	11	3	7	19	32	43	35	50	TCRBV07,TCRBV11													CASSSRDRQNQQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGACGCGGGACACCCTATGGGGATACGCAGTATTTTGGCCCA	CASRRGTPYGDTQYF	In	VDJ	1	39	1.4655648625187424E-4	1.735269122443259E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	6	0	6	6	4	9	23	34	44	38	53	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRGTPYGDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACGCCCGTTCGATGGTGGCTACACCTTCGGTTCG	CSARPFDGGYTF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	0	10	7	13	0	26	34	-1	47	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPFDGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGACGGACAGGGGCTACGAGCAGTACTTCGGGCCG	CSARETDRGYEQYF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	2	3	3	0	26	40	-1	43	52		TCRBV20-01,TCRBV20-or09_02												CSARETDRGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCACCGTTGGGACAGGGACAATGAGCAGTTCTTCGGGCCA	CSAHRWDRDNEQFF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	5	7	0	26	35	-1	42	51		TCRBV20-01,TCRBV20-or09_02												CSAHRWDRDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCCCGGCTAGCGGGGGGGCAGGTGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	40	1.5031434487371717E-4		52	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	4	0	3	7	7	26	35	54	42	61		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCARCCARACMKCTYTGTACTTCTGTGCCAGCAGTATACGACTCGACCGTGGTACGCAGTATTTTGGCCCA	CASSIRLDRGTQYF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	13	2	10	8	13	9	25	28	45	41	54	TCRBV22,TCRBV27					01,02								CASSIRLDRGTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCTACTAGCACAGATACGCAGTATTTTGGCCCA	CASSPTSTDTQYF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	3	10	0	2	0	23	36	-1	38	41	TCRBV01,TCRBV04					01,02								CASSPTSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCGCAGGACAGGGGTGAGCTATGGCTACACCTTCGGTTCG	CASSRRTGVSYGYTF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	2	4	4	4	22	34	47	38	51		TCRBV12-03,TCRBV12-04												CASSRRTGVSYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCTCTTGGACAGCTTCCTACGAGCAGTACTTCGGGCCG	CASTSWTASYEQYF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	1	5	1	9	2	24	31	46	40	48		TCRBV24-01,TCRBV24-or09_02												CASTSWTASYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTGGCGACAGGGAGACGAGCAGTACTTCGGGCCG	CASSWRQGDEQYF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	5	4	2	24	36	47	40	49	TCRBV06,TCRBV24													CASSWRQGDEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCATGACAGCAGCCGACACCATATATTTTGGAGAG	CASSMTAADTIYF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	5	8	2	6	18	30	37	32	43	TCRBV07,TCRBV23													CASSMTAADTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGGACAGGGAAGTTCACCCCTCCACTTTGGGAAC	CASSLGQGSSPLHF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	2	3	9	0	3	19	-1	42	35	45	TCRBV07,TCRBV11													CASSLGQGSSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTAGGAGGGACAGGGCCCTCCTATGGCTACACCTTCGGTTCG	CASSLGGTGPSYGYTF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	3	4	4	5	19	33	46	37	51	TCRBV05,TCRBV11													CASSLGGTGPSYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCACGACAGGGGTGGGGGAGACCCAGTACTTCGGGCCA	CASSPTTGVGETQYF	In	VDJ	1	40	1.5031434487371717E-4	1.7797632025059066E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	2	5	5	5	23	35	48	40	53	TCRBV09,TCRBV21													CASSPTTGVGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAACGGTGGCCAACTCGGAATCGAGCAGTACTTCGGGCCG		Out	VDJ	1	41	1.5407220349556008E-4		49	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	1	8	6	14	2	26	43	60	57	62		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCGGGAGGACTGACCCAGTACTTCGGGCCA		Out	VDJ	1	41	1.5407220349556008E-4		41	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	8	1	7	2	3	26	42	51	44	54		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGGGACATCATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	41	1.5407220349556008E-4		44	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	6	0	2	3	26	39	47	41	50		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCACCGGAACAGGGATGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	41	1.5407220349556008E-4		34	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	3	3	5	5	4	26	30	41	35	45		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGCCGGGACTAGCGGGAGTTTTTCAGTACTTCGGGCCG		Out	VDJ	1	41	1.5407220349556008E-4		41	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	0	2	10	5	5	26	34	53	39	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTAGCGGGGGGCCGCACCACCCTTTACAATGAGCAGTTCTTCGGGCCA	CSARLAGGRTTLYNEQFF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	54	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	1	4	0	13	26	-1	49	38	62		TCRBV20-01,TCRBV20-or09_02												CSARLAGGRTTLYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGCAGGGGGCAATGAGCAGTTCTTCGGGCCA	CSARDAGGNEQFF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	1	6	2	0	26	40	-1	42	49		TCRBV20-01,TCRBV20-or09_02												CSARDAGGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGTCTAGCGGGAGAGACGAGCAGTTCTTCGGGCCA	CSARASSGRDEQFF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	4	2	10	3	4	26	39	52	42	56		TCRBV20-01,TCRBV20-or09_02												CSARASSGRDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAGGTCTAGCTATGGCTACACCTTCGGTTCG	CSARRSSYGYTF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	4	8	4	5	0	26	37	-1	42	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRSSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCAGATCAGTTACGTGATACCCAGTACTTCGGGCCA	CSAPDQLRDTQYF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	5	8	1	14	26	35	39	36	53		TCRBV20-01,TCRBV20-or09_02												CSAPDQLRDTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCAAAGAAGTCTCAGATACGCAGTATTTTGGCCCA	CASSKEVSDTQYF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	39	unresolved						TCRBJ02	TCRBJ02-03	01	0	5	5	4	0	3	23	-1	42	40	45	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKEVSDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCTAGTGAGGACGGCAACTAATGAAAAACTGTTTTTTGGCAGT	XASSLVRTATNEKLFF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	48	unresolved						TCRBJ01	TCRBJ01-04	01	4	1	7	0	6	2	23	36	46	42	48	TCRBV04,TCRBV07,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSLVRTATNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCRGCYGTGTAYKTCTGTGCCAGCAGACCACCGGGACAGGGGGCTGGAGGCTACACCTTCGGTTCG	CASRPPGQGAGGYTF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	0	8	6	4	22	33	51	39	55	TCRBV11,TCRBV12													CASRPPGQGAGGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAACCTGGGGGCTTCGGGGAGCTGTTTTTTGGAGAA	CATSEPGGFGELFF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	6	0	7	4	2	24	38	48	42	50		TCRBV24-01,TCRBV24-or09_02												CATSEPGGFGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACAGAAGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	41	1.5407220349556008E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	5	0	0	3	24	-1	41	38	44		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGACGCGCCACGGAAGTAGATACGCAGTATTTTGGCCCA	CASRRATEVDTQYF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	7	1	8	5	9	3	24	35	47	44	50	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRATEVDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCCCCAGACTAGCGGGAGGGCCAGCCTACGAGCAGTACTTCGGGCCG	CASSPRLAGGPAYEQYF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	2	0	2	4	4	18	30	48	34	52	TCRBV05,TCRBV07													CASSPRLAGGPAYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGCTTAGGACGGACTTTTAATGAAAAACTGTTTTTTGGCAGT	CASSLGRTFNEKLFF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	1	10	4	5	2	19	33	43	38	45	TCRBV05,TCRBV07					01,02								CASSLGRTFNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCAGACAGGTCTCTGGAAACACCATATATTTTGGAGAG	CASSRQVSGNTIYF	In	VDJ	1	41	1.5407220349556008E-4	1.8242572825685543E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	2	4	0	0	1	24	-1	43	37	44	TCRBV12,TCRBV21													CASSRQVSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGTGCCAGCAGCTTGGACTGGGTTAATGAAAAACTGTTTCTCTGGACTGGGTTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	41	1.5407220349556008E-4		71				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	1	10	4	27	4	0	16	48	43	52	TCRBV05,TCRBV07,TCRBV11	TCRBV05-04,TCRBV05-05,TCRBV05-08,TCRBV07-02,TCRBV07-03,TCRBV07-08,TCRBV11-02,TCRBV11-03				01,02								X+X+TCRBJ01-04		TCRBD02-01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGCCGCCGGGAACCCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	42	1.5783006211740302E-4		43	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	3	3	6	5	26	37	48	43	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCTTAAGTCCTCAAGAGACCCAGTACTTCGGGCCA	CASSLSPQETQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	39	TCRBV12						TCRBJ02	TCRBJ02-05	01	2	5	5	2	0	4	26	-1	43	41	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSPQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCAATTCAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSQFSGGTDTQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	3	1	3	0	26	41	-1	44	51		TCRBV03-01,TCRBV03-02												CASSQFSGGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACGAGCGGGAGGGACTCCTACGAGCAGTACTTCGGGCCG	CSTSGRDSYEQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	6	0	0	3	1	26	32	45	35	46		TCRBV20-01,TCRBV20-or09_02												CSTSGRDSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGAGGGTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	42	1.5783006211740302E-4		41	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	0	1	2	1	26	40	48	42	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGTGAGAACTAGCGGGGTCCCGGGAGATACGCAGTATTTTGGCCCA	CSARDVRTSGVPGDTQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	54	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	3	3	5	7	7	26	40	57	47	64		TCRBV20-01,TCRBV20-or09_02												CSARDVRTSGVPGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTAGGCGATCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	42	1.5783006211740302E-4		41	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	5	4	1	2	5	26	38	43	40	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGCGACCTTACGAGCAGTACTTCGGGCCG	CSARGRPYEQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	7	0	4	0	5	26	-1	42	37	47		TCRBV20-01,TCRBV20-or09_02												CSARGRPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGACAGGGGTGGGTGAAGCTTTCTTTGGACAA	CSASTGVGEAFF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	7	2	4	26	35	45	37	49		TCRBV20-01,TCRBV20-or09_02												CSASTGVGEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTAATACCGGGACAGGGACTTACGAGCAGTACTTCGGGCCG	CATSNTGTGTYEQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	4	6	3	24	36	51	42	54		TCRBV24-01,TCRBV24-or09_02												CATSNTGTGTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGACCGGGACAGGGGCCCCACGAGCAGTACTTCGGGCCG	CASRPGQGPHEQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	2	5	3	4	24	35	48	38	52	TCRBV24,TCRBV27													CASRPGQGPHEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCCCCCGGGACAATGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	42	1.5783006211740302E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	12	0	6	1	4	2	24	30	40	34	42		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGGGGACAGGGAAACACTGAAGCTTTCTTTGGACAA	CASSERGQGNTEAFF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	2	2	1	23	38	49	40	50		TCRBV06-01,TCRBV06-08												CASSERGQGNTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCTTGGGCTAGCGGGGGGGTGGTAGAGACCCAGTACTTCGGGCCA	CASSQDPWASGGVVETQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	57	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	0	4	8	4	24	41	61	49	65		TCRBV03-01,TCRBV03-02												CASSQDPWASGGVVETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGGGGACAGGGGCCCATAATTCACCCCTCCACTTTGGGAAC	CASSLGTGAHNSPLHF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	2	5	1	3	18	32	43	33	46	TCRBV05,TCRBV07,TCRBV11													CASSLGTGAHNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGGGACTAGCGGGGGGCTAATAGATACGCAGTATTTTGGCCCA	CASSLGTSGGLIDTQYF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	1	1	5	0	5	19	-1	49	35	54	TCRBV07,TCRBV11													CASSLGTSGGLIDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCCCAGGGGACCTCCCTATGGCTACACCTTCGGTTCG	CASSPRGPPYGYTF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	4	2	6	19	31	39	33	45	TCRBV05,TCRBV11													CASSPRGPPYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCACCACCGGAGGGGACCTCTATGGCTACACCTTCGGTTCG	CASTTGGDLYGYTF	In	VDJ	1	42	1.5783006211740302E-4	1.868751362631202E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	10	10	0	4	8	5	24	31	45	39	50	TCRBV09,TCRBV21													CASTTGGDLYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTCAAACGAAAAGGGGTATCACCCCTCCACTTTGGGAAC		Out	VDJ	1	42	1.5783006211740302E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	5	2	10	11	2	24	35	51	46	53	TCRBV12,TCRBV21													X+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACTTGCATATGGCTACACCTTCGGTTCG	CASSQLAYGYTF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	36	TCRBV03						TCRBJ01	TCRBJ01-02	01	2	4	6	5	4	0	26	41	-1	45	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQLAYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTTCGGGGAAGCGGGACAGGGAGGGAGACCCAGTACTTCGGGCCA	CSALRGSGTGRETQYF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	3	5	13	3	26	34	56	47	59		TCRBV20-01,TCRBV20-or09_02												CSALRGSGTGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCTAAAGATCAACTGAACACTGAAGCTTTCTTTGGACAA	CSAPKDQLNTEAFF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	4	9	0	2	9	26	34	39	36	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPKDQLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTCAGGGAGACCCCAACGTCCTGACTTTCGGGGCC	CSATQGDPNVLTF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	39	TCRBV20						TCRBJ02	TCRBJ02-06	01	4	4	3	8	2	5	26	36	43	38	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATQGDPNVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20		TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAAAGTTATGAAAAACTGTTTTTTGGCAGT	CSAQSYEKLFF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	33	TCRBV20						TCRBJ01	TCRBJ01-04	01	5	4	6	6	0	5	26	-1	37	35	42		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAQSYEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCAACAGGGGGCAACGTGGACGAGCAGTACTTCGGGCCG	CSAPTGGNVDEQYF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	0	5	3	7	26	35	47	38	54		TCRBV20-01,TCRBV20-or09_02												CSAPTGGNVDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAACCACTAGCGGGTACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	43	1.6158792073924595E-4		41	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	3	4	2	3	2	24	34	46	37	48		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCGCGGGACAGCAACTACAATGAGCAGTTCTTCGGGCCA	CATSARDSNYNEQFF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	5	3	3	3	24	37	47	40	50		TCRBV24-01,TCRBV24-or09_02												CATSARDSNYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGACAGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	43	1.6158792073924595E-4		37	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	5	2	0	1	24	-1	43	37	44		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTGGGCAGGGGGGCACTCTTGGGCCAACGTCCTGACTTTCGGGGCC	CASSWAGGHSWANVLTF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	4	1	5	3	8	18	31	41	34	49	TCRBV07,TCRBV11													CASSWAGGHSWANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGTGGGTCGACAGGGAACCCTGGAAACACCATATATTTTGGAGAG	CARSGSTGNPGNTIYF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	3	2	6	4	18	29	42	35	46	TCRBV05,TCRBV11,TCRBV12	TCRBV05-03,TCRBV11-03,TCRBV12-02												CARSGSTGNPGNTIYF+X+TCRBJ01-03		TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGCGGACAGGGTGGGGAACACTGAAGCTTTCTTTGGACAA	CASSADRVGNTEAFF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	1	2	4	18	30	40	32	44	TCRBV05,TCRBV11													CASSADRVGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTAGGGGGTAGAATGGATGAGCAGTTCTTCGGGCCA	CASSLGGRMDEQFF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-01	01	6	5	1	8	3	8	20	31	40	34	48	TCRBV11,TCRBV23			TCRBD01,TCRBD02										CASSLGGRMDEQFF+X+TCRBJ02-01	unresolved	unresolved	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCCTAAAGCGGGGCGCTACTACAATGAGCAGTTCTTCGGGCCA	YASSPKAGRYYNEQFF	In	VDJ	1	43	1.6158792073924595E-4	1.9132454426938495E-4	48				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	3	3	5	5	22	34	46	39	51	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01												YASSPKAGRYYNEQFF+X+TCRBJ02-01		TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCAACAGGGGACCGCGCCCAGTACTTCGGGCCA	CASSSTGDRAQYF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	2	9	2	6	26	39	48	41	54		TCRBV12-03,TCRBV12-04												CASSSTGDRAQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCTTGGGGCAGGGAGGTGGGAGACCCAGTACTTCGGGCCA	CASSHLGAGRWETQYF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	9	1	5	10	3	26	40	56	50	59		TCRBV03-01,TCRBV03-02												CASSHLGAGRWETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGACCTATACAGGGGGTACTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRPIQGVLNTGELFF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	1	1	7	4	26	39	54	46	58		TCRBV03-01,TCRBV03-02												CASSRPIQGVLNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGAGCCCAAACTCTGGACGAGACCCAGTACTTCGGGCCA	CRAQTLDETQYF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	36	TCRBV20						TCRBJ02	TCRBJ02-05	01	9	1	7	5	12	0	26	31	-1	43	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CRAQTLDETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGCAAAGGTTATTGAAGCTTTCTTTGGACAA	CSARDAKVIEAFF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	5	4	7	5	4	26	40	48	45	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDAKVIEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAAACGGGGGAACGCTGGAAACACCATATATTTTGGAGAG	CASKRGNAGNTIYF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	7	8	2	2	2	4	26	36	44	38	48	TCRBV06,TCRBV10													CASKRGNAGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCTCTTCGGCCCCGGACAGGGGGCCAGGAGAGACCCAGTACTTCGGGCCA	CASSSAPDRGPGETQYF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	1	0	4	11	4	18	27	49	38	53	TCRBV07,TCRBV11													CASSSAPDRGPGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCAGCTTGATTCTCGGGTTGACCGACCGGGCCTACGAGCAGTACTTCGGGCCG	CASSLILGLTDRAYEQYF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	54	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	8	4	2	5	13	19	34	43	39	56	TCRBV05,TCRBV23					01,02								CASSLILGLTDRAYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCACCGCTCCCAGCGGCTACAGCACAGATACGCAGTATTTTGGCCCA	CATAPSGYSTDTQYF	In	VDJ	1	44	1.6534577936108889E-4	1.9577395227564972E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	6	5	0	8	4	22	29	42	37	46	TCRBV07,TCRBV12					01,02								CATAPSGYSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGSGACTCRGCTGTGTATYTYTGTGCCAGCAGCCAAATGTCGGGGAATCAAGAGACCCAGTACTTCGGGCCA	CASSQMSGNQETQYF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	3	2	8	3	26	37	50	45	53	TCRBV07,TCRBV12													CASSQMSGNQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCACCGCACAGATACGCAGTATTTTGGCCCA	CASSQGHRTDTQYF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	9	0	1	0	3	26	-1	45	42	48		TCRBV03-01,TCRBV03-02												CASSQGHRTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGGGACTCCTGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CSAGTPENTGELFF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	10	1	1	5	26	34	41	35	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGTPENTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCGGGACTAGCGGGAGAGACCGGGAGACCCAGTACTTCGGGCCA	CSATGTSGRDRETQYF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	0	2	5	4	7	26	34	52	38	59		TCRBV20-01,TCRBV20-or09_02												CSATGTSGRDRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTGACAGGAAAGTCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	45	1.691036379829318E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	4	7	2	6	26	38	46	40	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACTACAGGGGTACCTTTAACACTGAAGCTTTCTTTGGACAA	CSARDYRGTFNTEAFF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	2	5	7	26	37	49	42	56		TCRBV20-01,TCRBV20-or09_02												CSARDYRGTFNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGTTGGGGACCCTGAACACTGAAGCTTTCTTTGGACAA	CSAMLGTLNTEAFF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	4	0	7	0	5	2	26	36	46	41	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAMLGTLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTACTGAGGGGTGAAAACACCGGGGAGCTGTTTTTTGGAGAA	CSALLRGENTGELFF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	45	TCRBV20						TCRBJ02	TCRBJ02-02	01	5	5	2	2	6	4	26	35	46	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALLRGENTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGACAGGGGAGGCCTATGGCTACACCTTCGGTTCG	CSGTGEAYGYTF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	2	4	0	4	26	-1	42	33	46		TCRBV20-01,TCRBV20-or09_02												CSGTGEAYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CACCAGSSAMWCAGCTKTGTACTTCTGTGCCAGCAGTGTTGAGGGGAGAACAGATACGCAGTATTTTGGCCCA	CASSVEGRTDTQYF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	13	5	2	3	13	3	25	28	46	41	49	TCRBV12,TCRBV22			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVEGRTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGACGGACAGGTACTCATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	45	1.691036379829318E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	4	8	3	5	22	34	44	37	49	TCRBV09,TCRBV12													X+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTGGACAGGGAATCAGCCCCAGCATTTTGGTGAT	CATSDWTGNQPQHF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	3	4	2	0	24	38	-1	40	48		TCRBV24-01,TCRBV24-or09_02												CATSDWTGNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTAAGCGGAAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	45	1.691036379829318E-4		41	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	6	5	2	1	2	24	36	42	37	44		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTCGCAGGGGGAAGGATCACCCCTCCACTTTGGGAAC	CASSSQGEGSPLHF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	4	1	10	2	5	18	31	40	33	45	TCRBV11,TCRBV23													CASSSQGEGSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGCCGGGTCGGGCAATGAAAAACTGTTTTTTGGCAGT	CASSLAGSGNEKLFF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	45	unresolved						TCRBJ01	TCRBJ01-04	01	0	8	0	5	6	0	18	35	-1	41	45	TCRBV05,TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGSGNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACKCRGCCRTGTAYSTSTGTGCCAGCAGCTTTGCCGGGACAGGGGGCTTATTCTCTGGAAACACCATATATTTTGGAGAG	CASSFAGTGGLFSGNTIYF	In	VDJ	1	45	1.691036379829318E-4	2.002233602819145E-4	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	0	0	4	5	18	32	48	36	53	TCRBV11,TCRBV15													CASSFAGTGGLFSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTTACCTTGGGAGGCCCCCCTACGAGCAGTACTTCGGGCCG	CASSYLGRPPYEQYF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	45	TCRBV06			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	9	1	2	3	4	24	39	48	42	52		TCRBV06-05,TCRBV06-06												CASSYLGRPPYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGTACACAGCCTATGGCTACACCTTCGGTTCG	CASSQGYTAYGYTF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	5	4	5	1	26	42	51	47	52		TCRBV03-01,TCRBV03-02												CASSQGYTAYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTAGCGGAGCCGGGGAGCTGTTTTTTGGAGAA	CASSQGSGAGELFF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	5	5	6	1	2	26	42	49	43	51		TCRBV03-01,TCRBV03-02				01,02								CASSQGSGAGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGACTTGGGGGGAAGAAGCTTTCTTTGGACAA	CSATWGEEAFF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	9	1	8	5	2	26	34	45	39	47		TCRBV20-01,TCRBV20-or09_02												CSATWGEEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAAGGCAGGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	46	1.7286149660477473E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	3	1	5	0	26	40	-1	45	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCAAAAGGAAGGGGACAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	46	1.7286149660477473E-4		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	6	5	10	0	24	35	-1	45	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGGTCAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASRSGAGELFF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	2	6	2	0	23	34	-1	36	42	TCRBV06,TCRBV24													CASRSGAGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCTAGCAGCTTAGTGCCTAGGGAGCAAGAGACCCAGTACTTCGGGCCA	CASSLVPREQETQYF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	9	2	2	6	0	19	35	-1	41	46	TCRBV07,TCRBV11													CASSLVPREQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACKCRGCCRTGTAYSTSTGTGCCAGCAGCCGTACAGGGGGCAGGGAGACCCAGTACTTCGGGCCA	CASSRTGGRETQYF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	0	5	3	3	18	30	42	33	45	TCRBV11,TCRBV15													CASSRTGGRETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGAATTGAGGGTCTCGCTCCTACGAGCAGTACTTCGGGCCG	CASSLAN*GSRSYEQYF	Stop	VDJ	1	46	1.7286149660477473E-4		51				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	0	0	5	5	18	35	45	40	50	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAN*GSRSYEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTATCGGGACTAGCGACTAATGAGCAGTTCTTCGGGCCA	CASSLSGLATNEQFF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	6	7	2	3	18	33	45	35	48	TCRBV07,TCRBV11					01,02								CASSLSGLATNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGTCCAGGGCGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLSRASYNEQFF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	1	3	2	18	32	40	35	42	TCRBV07,TCRBV11													CASSLSRASYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAACGGGGCCCAGGGCCCCAGCATTTTGGTGAT	CASSERGPGPQHF	In	VDJ	1	46	1.7286149660477473E-4	2.0467276828817926E-4	39	unresolved						TCRBJ01	TCRBJ01-05	01	2	7	0	9	1	5	23	38	44	39	49	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERGPGPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCCCGGGGCTGAGCACAGATACGCAGTATTTTGGCCCA	CASSPGLSTDTQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	42	TCRBV12						TCRBJ02	TCRBJ02-03	01	6	7	0	0	3	2	26	37	45	40	47		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGLSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTCAGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSFQGAYNEQFF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	1	2	1	0	26	40	-1	41	48		TCRBV12-03,TCRBV12-04												CASSFQGAYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACTCGGGGGACTCCTACGAGCAGTACTTCGGGCCG	CSANSGDSYEQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	2	0	3	1	26	36	45	39	46		TCRBV20-01,TCRBV20-or09_02												CSANSGDSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTAGCGGGAGGATCCAAAAACATTCAGTACTTCGGCGCC	CSARDLAGGSKNIQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	4	1	2	1	2	26	40	52	41	54		TCRBV20-01,TCRBV20-or09_02												CSARDLAGGSKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGGGCTAGCGGGAACAATGAGCAGTTCTTCGGGCCA	CSASRASGNNEQFF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	4	3	5	5	0	26	37	-1	42	51		TCRBV20-01,TCRBV20-or09_02												CSASRASGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCCGCCACAGATACGCAGTATTTTGGCCCA	CSASPATDTQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	10	0	2	4	0	26	37	-1	41	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASPATDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCACTAGCGCGGAGCACAGATACGCAGTATTTTGGCCCA	CSASSLARSTDTQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	3	6	0	3	3	26	37	47	40	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSASSLARSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCARCCAGACMKMTCTKTACYWCTGTGCCAGCAGGCCTACCGGGGTTAAGTTGAAACTGTTTTTTGGCAGT	CASRPTGVKLKLFF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	7	8	3	11	6	8	24	35	46	41	54	TCRBV08,TCRBV24													CASRPTGVKLKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCACTCCAGGGGGCTTATGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPLQGAYGANVLTF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	4	0	3	6	3	24	36	50	42	53		TCRBV24-01,TCRBV24-or09_02												CASSPLQGAYGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGAAATCACCCACAGATACGCAGTATTTTGGCCCA	CASSLKSPTDTQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	42	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	2	8	2	2	7	24	36	40	38	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKSPTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTTGGGGCTACGAGCAGTACTTCGGGCCG	CASSFWGYEQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	36	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	6	2	3	4	0	24	36	-1	40	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFWGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAGCGGGAGAGCACAGATACGCAGTATTTTGGCCCA	CASSERESTDTQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	6	2	0	1	0	23	35	-1	36	44	TCRBV06,TCRBV10													CASSERESTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAACTTAATTCCGGGACTAGCAGGAGATACGCAGTATTTTGGCCCA	CASNLIPGLAGDTQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	7	5	5	3	18	33	47	38	50	TCRBV07,TCRBV11					01,02								CASNLIPGLAGDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCCAAGGGACAGTTGAACACTGAAGCTTTCTTTGGACAA	CASSSKGQLNTEAFF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	0	4	1	18	31	42	35	43	TCRBV05,TCRBV11													CASSSKGQLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCTTTGGACCCCACCTCGGCCAAAAACATTCAGTACTTCGGCGCC	CASSLALDPTSAKNIQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	54	unresolved						TCRBJ02	TCRBJ02-04	01	3	1	7	1	6	9	18	32	42	38	51	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLALDPTSAKNIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCGGGGACAGGAGCACAGATACGCAGTATTTTGGCCCA	XASSGDRSTDTQYF	In	VDJ	1	47	1.7661935522661766E-4	2.0912217629444403E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	4	0	1	0	22	34	-1	35	43	TCRBV04,TCRBV07,TCRBV17													XASSGDRSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTTTATCTTTGCCAGCAGCTTGGCTTTGGACCCCACCTCGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	47	1.7661935522661766E-4		54	unresolved						TCRBJ02	TCRBJ02-04	01	3	1	7	1	6	9	17	31	41	37	50	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGTGTGGGGCACGGGGACTATGGCTACACCTTCGGTTCG	CASVGHGDYGYTF	In	VDJ	1	48	1.803772138484606E-4	2.135715843007088E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	9	7	0	3	3	6	26	34	42	37	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASVGHGDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGACAGGGGACAACTACGAGCAGTACTTCGGGCCG	CSARGTGDNYEQYF	In	VDJ	1	48	1.803772138484606E-4	2.135715843007088E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	3	1	4	26	37	48	38	52		TCRBV20-01,TCRBV20-or09_02												CSARGTGDNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCCGGAGCAATCAGCCCCAGCATTTTGGTGAT	CSAIRSNQPQHF	In	VDJ	1	48	1.803772138484606E-4	2.135715843007088E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	8	5	1	2	0	26	36	-1	38	41		TCRBV20-01,TCRBV20-or09_02				01,02								CSAIRSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCAAGATGTGGGGCAGGGTGGCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	48	1.803772138484606E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	5	11	5	18	30	46	41	51	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGTAGCTTGATTTACGGAAAAGAGACCCAGTACTTCGGGCCA	CASSLIYGKETQYF	In	VDJ	1	48	1.803772138484606E-4	2.135715843007088E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	9	5	7	3	0	13	20	-1	32	28	45	TCRBV11,TCRBV12,TCRBV23			TCRBD01,TCRBD02										CASSLIYGKETQYF+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCCGAAGGGTTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRRVSGANVLTF	In	VDJ	1	48	1.803772138484606E-4	2.135715843007088E-4	42	unresolved						TCRBJ02	TCRBJ02-06	01	8	5	3	1	3	2	19	28	35	31	37	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRVSGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACAGTACGAGCAGTACTTCGGGCCG	CASSQQYEQYF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	33	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	5	4	0	0	26	-1	-1	41	44		TCRBV03-01,TCRBV03-02												CASSQQYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTGGGGTAAACGCAGTATTTTGGCCCA		Out	VDJ	1	49	1.8413507247030353E-4		34	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	6	2	9	2	3	26	39	45	41	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCACCTGCAGCGCAAACGACAATGAGCAGTTCTTCGGGCCA	CTCSANDNEQFF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	6	6	5	5	6	26	30	39	35	45		TCRBV20-01,TCRBV20-or09_02				01,02								CTCSANDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCGGACAGGAGCTACCAAGAGACCCAGTACTTCGGGCCA	CSAPDRSYQETQYF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	4	0	3	4	26	34	44	37	48		TCRBV20-01,TCRBV20-or09_02												CSAPDRSYQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACGGGGACAGGGGGCACAGATACGCAGTATTTTGGCCCA	CATGTGGTDTQYF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	0	2	1	1	0	24	32	-1	33	43		TCRBV24-01,TCRBV24-or09_02												CATGTGGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAAACCCGGAAACTATGACTACGAGCAGTACTTCGGGCCG	CASKPGNYDYEQYF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	11	3	9	3	12	3	24	31	47	43	50		TCRBV24-01,TCRBV24-or09_02				01,02								CASKPGNYDYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGAAACGATCTCGAATGAGCAGTTCTTCGGGCCA	CASSLETISNEQFF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	42	unresolved						TCRBJ02	TCRBJ02-01	01	2	2	8	7	1	10	19	33	36	34	46	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLETISNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TATTTTTGTGCCAGCAGTCTCACCCTCGGCGTAGCGGGGCTTCTTACTCCCCTCAATGAGCAGTTCTTCGGGCCA	CASSLTLGVAGLLTPLNEQFF	In	VDJ	1	49	1.8413507247030353E-4	2.1802099230697355E-4	63	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	3	6	13	14	6	18	39	31	53		TCRBV12-03,TCRBV12-04												CASSLTLGVAGLLTPLNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAGGTGCGGGAGTAGATACGCAGTATTTTGGCCCA	CASSLGAGVDTQYF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	7	2	5	2	1	26	42	51	44	52		TCRBV12-03,TCRBV12-04												CASSLGAGVDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCGTCCCGGCTCAGCCCCAGCATTTTGGTGAT	CASSQGVPAQPQHF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	42	TCRBV03						TCRBJ01	TCRBJ01-05	01	1	9	0	6	7	0	26	42	-1	49	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGVPAQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTACAGCAAACCCTCTAGGTAATGAGCAGTTCTTCGGGCCA	CASSQGTANPLGNEQFF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	51	TCRBV03						TCRBJ02	TCRBJ02-01	01	1	3	5	7	2	14	26	42	48	44	62		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGTANPLGNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGACTAGTCCTCCCCAAGAGACCCAGTACTTCGGGCCA	CASSQGTSPPQETQYF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	8	1	1	6	26	40	49	41	55		TCRBV03-01,TCRBV03-02				01,02								CASSQGTSPPQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCCTAGCGGGGTTTAGCTACGAGCAGTACTTCGGGCCG	CASSLLAGFSYEQYF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	3	2	5	26	39	50	41	55		TCRBV03-01,TCRBV03-02												CASSLLAGFSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGCCCCAGGGGCCACTGAAGCTTTCTTTGGACAA	CSAAPGATEAFF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	4	5	1	26	34	45	39	46		TCRBV20-01,TCRBV20-or09_02												CSAAPGATEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATGGGAGGGCCGGCGAGCAGTTCTTCGGGCCA	CSANGRAGEQFF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	9	0	10	2	5	26	36	45	38	50		TCRBV20-01,TCRBV20-or09_02												CSANGRAGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGCGGTTTCCAGATACGCAGTATTTTGGCCCA	CSARDQRFPDTQYF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	6	5	4	2	4	26	40	47	42	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDQRFPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCGGGGGACTACGAGCAGTACTTCGGGCCG	CSARSGDYEQYF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	8	2	3	1	1	26	38	45	39	46		TCRBV20-01,TCRBV20-or09_02												CSARSGDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCAGGGCCTCAGCCCCAGCATTTTGGTGAT	CSASPGPQPQHF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	6	2	2	26	37	44	39	46		TCRBV20-01,TCRBV20-or09_02												CSASPGPQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACAACCTTCGACAGCCGCGGGGCAGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	50	1.8789293109214644E-4		49	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	10	7	3	5	14	3	24	32	52	46	55		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
SGACTCGGCYSTSTATCTCTGTGCAAGTCGCTGGGACCGCGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	50	1.8789293109214644E-4		40	unresolved						TCRBJ01	TCRBJ01-04	01	11	0	7	5	8	4	19	24	37	32	41	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAACTAGCGGGGGGGCCGGCGAGCAGTACTTCGGGCCG	CASSLTSGGAGEQYF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	3	0	6	0	4	18	-1	46	33	50	TCRBV07,TCRBV11													CASSLTSGGAGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGGGGAGGGGCCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	50	1.8789293109214644E-4		49				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	9	0	1	3	3	18	35	45	38	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-05		TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGTCCTCCGGGACAGAGGACAGATACGCAGTATTTTGGCCCA	CASSPPGQRTDTQYF	In	VDJ	1	50	1.8789293109214644E-4	2.2247040031323832E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	5	3	6	3	18	29	42	35	45	TCRBV05,TCRBV11													CASSPPGQRTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAYSRGSSAMWCAGCTTTGTAYTTCTGTGCCAGCAGAGAGGGACCACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	50	1.8789293109214644E-4		40	unresolved						TCRBJ01	TCRBJ01-05	01	5	0	7	3	3	2	23	34	42	37	44	TCRBV09,TCRBV22			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACGTGTTAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQDVLSSYNEQFF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	48	TCRBV03						TCRBJ02	TCRBJ02-01	01	0	5	5	0	7	0	26	43	-1	50	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDVLSSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACAAGACAGGGGGCAGATGAAAAACTGTTTTTTGGCAGT	CSATRQGADEKLFF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	0	6	5	2	26	34	49	39	51		TCRBV20-01,TCRBV20-or09_02												CSATRQGADEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGTTCCGGGGGCCTCGAATGAGCAGTTCTTCGGGCCA	CSAKVPGASNEQFF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	4	6	0	7	7	4	26	36	49	43	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKVPGASNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCCCTGGGGAGACCCAGTACTTCGGGCCA	CSARPPGETQYF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	36	TCRBV20						TCRBJ02	TCRBJ02-05	01	2	0	9	5	6	0	26	38	-1	44	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPPGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTACTAGCGGGAGAGACCCAGTACTTCGGGCCA	CSARVLAGETQYF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	3	4	4	1	0	26	39	-1	40	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVLAGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCACTAGCGGGGGGCCCAGATACGCAGTATTTTGGCCCA	CSASPLAGGPDTQYF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	3	1	4	3	2	26	37	52	40	54		TCRBV20-01,TCRBV20-or09_02												CSASPLAGGPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCGCCACGAGGGGGGGACCTACATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	51	1.9165078971398938E-4		50	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	9	0	5	9	6	26	37	53	46	59		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGACAACAGGGGAGACCCAGTACTTCGGGCCA	CSARGTTGETQYF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	6	5	1	6	26	37	44	38	50		TCRBV20-01,TCRBV20-or09_02												CSARGTTGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATACGGTCAAATCGGGATGAGCAGTTCTTCGGGCCA	CSAIRSNRDEQFF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	4	8	11	0	26	36	-1	47	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSAIRSNRDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACGAGGGGCCCACTATGGCTACACCTTCGGTTCG	CASSERGAHYGYTF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	42	TCRBV06						TCRBJ01	TCRBJ01-02	01	2	5	2	3	2	3	23	38	45	40	48		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERGAHYGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGACGACGCGGCTAGCGCACTTCAGATACGCAGTATTTTGGCCCA	CARRRG*RTSDTQYF	Stop	VDJ	1	51	1.9165078971398938E-4		45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	9	4	6	4	9	5	18	26	41	35	46	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02				01,02								CARRRG*RTSDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCATCGTAGCGGGAGCCACCTACGAGCAGTACTTCGGGCCA	CASSLAIVAGATYEQYF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	51				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	5	2	11	5	11	18	35	49	40	60	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAIVAGATYEQYF+X+TCRBJ02-05		TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGTCGGGGCCCCACCTCAATCAGCCCCAGCATTTTGGTGAT	CASSLSGPHLNQPQHF	In	VDJ	1	51	1.9165078971398938E-4	2.269198083195031E-4	48	unresolved						TCRBJ01	TCRBJ01-05	01	3	7	0	3	3	7	18	32	40	35	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGPHLNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGACTAGCGGGGACGCAAGAGACCCAGTACTTCGGGCCA	CASSLGLAGTQETQYF	In	VDJ	1	52	1.954086483358323E-4	2.3136921632576786E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	2	3	2	0	3	26	-1	53	42	56		TCRBV12-03,TCRBV12-04												CASSLGLAGTQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGCGTGAGGGTAAGCAATGAGCAGTTCTTCGGGCCA	CSARDGVRVSNEQFF	In	VDJ	1	52	1.954086483358323E-4	2.3136921632576786E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	11	0	6	6	4	26	40	51	46	55		TCRBV20-01,TCRBV20-or09_02												CSARDGVRVSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACGCCCGGGACATTTTCTGAGCAGTTCTTCGGGCCA	CSARTPGTFSEQFF	In	VDJ	1	52	1.954086483358323E-4	2.3136921632576786E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	6	9	7	5	26	37	50	44	55		TCRBV20-01,TCRBV20-or09_02												CSARTPGTFSEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGATACTCGGGGCCCTTTCGGGAGCAGTACTTCGGGCCG	CSAGYSGPFREQYF	In	VDJ	1	52	1.954086483358323E-4	2.3136921632576786E-4	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	5	7	0	7	8	8	26	35	48	43	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGYSGPFREQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCAGCCCCACCGCCCCGTGCGGGGCCACAGATACGCAGTATTTTGGCCCA	CTSSPTAPCGATDTQYF	In	VDJ	1	52	1.954086483358323E-4	2.3136921632576786E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	7	3	2	12	1	23	36	54	48	55	TCRBV01,TCRBV04													CTSSPTAPCGATDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGACCAATGGAAAACTGTTTTTTGGCAGT	CATSDLTNGKLFF	In	VDJ	1	52	1.954086483358323E-4	2.3136921632576786E-4	39	TCRBV24						TCRBJ01	TCRBJ01-04	01	0	0	10	10	6	0	24	42	-1	48	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLTNGKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTATAGGGGTCGGGGGCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	52	1.954086483358323E-4		47	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	4	8	2	2	8	0	18	31	-1	39	45	TCRBV03,TCRBV11													X+X+TCRBJ01-03	unresolved	TCRBD02-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGGGGGACAGGGGGTACCCCCTCGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	53	1.9916650695767524E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	1	8	1	9	24	37	49	38	58	TCRBV06,TCRBV10													X+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGCTGTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	53	1.9916650695767524E-4		40	TCRBV03						TCRBJ02	TCRBJ02-05	01	0	9	0	5	2	3	26	43	48	45	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAGGGACAGCAGAACACTGAAGCTTTCTTTGGACAA	CSAKGQQNTEAFF	In	VDJ	1	53	1.9916650695767524E-4	2.3581862433203263E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	1	3	2	26	34	44	37	46		TCRBV20-01,TCRBV20-or09_02												CSAKGQQNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCAAGGACAGGGGTTGGTGAGCAGTTCTTCGGGCCA	CATSDSRTGVGEQFF	In	VDJ	1	53	1.9916650695767524E-4	2.3581862433203263E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	2	9	3	4	24	40	52	43	56		TCRBV24-01,TCRBV24-or09_02												CATSDSRTGVGEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCTCAGACAGGACACTAGCACAGATACGCAGTATTTTGGCCCA	CASSLRQDTSTDTQYF	In	VDJ	1	53	1.9916650695767524E-4	2.3581862433203263E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	4	0	4	5	19	31	41	35	46	TCRBV05,TCRBV11													CASSLRQDTSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGGACAGATAATGAAAAACTGTTTTTTGGCAGT	CASSGTDNEKLFF	In	VDJ	1	53	1.9916650695767524E-4	2.3581862433203263E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	5	4	0	1	23	-1	42	36	43	TCRBV09,TCRBV21													CASSGTDNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAGGGACAGGGTACTATGGCTACACCTTCGGTTCG	CASRGTGYYGYTF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	3	1	1	26	37	47	38	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRGTGYYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTTCCCTAGCGGGGGCCCGATTTTACCTACGAGCAGTACTTCGGGCCG	CASSFP*RGPDFTYEQYF	Stop	VDJ	1	54	2.0292436557951818E-4		54	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	4	2	2	6	10	26	37	53	43	63		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSFP*RGPDFTYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAGGGACAGGGCGATGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	54	2.0292436557951818E-4		44	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	3	3	1	3	26	38	48	39	51		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGGACTCSGCCGTGTATSTCTGTGCCAGCACTAGCGGGAGGGCCGGGTACGAGCAGTACTTCGGGCCG	CASTSGRAGYEQYF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	4	0	4	0	5	20	-1	42	30	47	TCRBV07,TCRBV11													CASTSGRAGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTATCGCGGCCGTAGGAGCACTGAAGCTTTCTTTGGACAA	CSAYRGRRSTEAFF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	7	5	4	5	9	26	34	43	39	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAYRGRRSTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCTGACAGCCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	54	2.0292436557951818E-4		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	5	4	3	2	26	37	45	40	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCACGGGCGGCCAGATACGCAGTATTTTGGCCCA	CSAHGRPDTQYF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	8	0	4	3	3	26	35	42	38	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAHGRPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCTGATATAACCGGGTGCGGGACGAGCAGTACTTCGGGCCG	CASS*YNRVRDEQYF	Stop	VDJ	1	54	2.0292436557951818E-4		45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	7	4	5	15	0	24	35	-1	50	55		TCRBV24-01,TCRBV24-or09_02				01,02								CASS*YNRVRDEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTATACGGGGGGTCACGAGCAGTACTTCGGGCCG	CASSYTGGHEQYF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	1	5	4	2	24	36	47	40	49		TCRBV24-01,TCRBV24-or09_02												CASSYTGGHEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGACACCGGGCTAACCGGGGAGCTGTTTTTTGGAGAA	CASSLDTGLTGELFF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	45	unresolved						TCRBJ02	TCRBJ02-02	01	0	8	0	5	4	2	18	35	43	39	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDTGLTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTCATTAACAGGGGCGATGAGCAGTTCTTCGGGCCA	CASSFINRGDEQFF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	2	8	5	2	18	32	44	37	46	TCRBV07,TCRBV11													CASSFINRGDEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCCGGTGGGGGTCCTATGGCTACACCTTCGGTTCG	CASSRWGSYGYTF	In	VDJ	1	54	2.0292436557951818E-4	2.402680323382974E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	6	6	1	4	5	2	20	31	41	36	43	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRWGSYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAACCCCCCGTTGGGTCACGGTACGCAGTATTTTGGCCCA	CSANPPLGHGTQYF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	0	9	8	12	6	26	34	49	46	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANPPLGHGTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATGGCAGTGGTGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	55	2.066822242013611E-4		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	5	5	3	5	26	38	44	41	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGACTAGCGGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CSARLAGDTGELFF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	2	2	3	1	0	26	35	-1	36	48		TCRBV20-01,TCRBV20-or09_02												CSARLAGDTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCGGGGGGCAGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	55	2.066822242013611E-4		40	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	1	4	1	4	24	36	44	37	48		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGTCTGGGACCAACGTCCTGACTTTCGGGGCC	CASSLSSGTNVLTF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	42							TCRBJ02	TCRBJ02-06	01	6	0	8	8	9	0	24	36	-1	45	49	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSSGTNVLTF+X+TCRBJ02-06			TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGGGTTTGAGAACACTGAAGCTTTCTTTGGACAA	CASSQGFENTEAFF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	2	0	9	1	0	5	20	-1	38	35	43	TCRBV01,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGFENTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAACGGGGCGGAAACACCATATATTTTGGAGAG	XASSQRGGNTIYF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	39	unresolved						TCRBJ01	TCRBJ01-03	01	2	7	0	4	1	0	22	37	-1	38	43	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSQRGGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGTCAGCGGGGACAGAAAAAAGGCGAGACCCAGTACTTCGGGCCA	CASSQRGQKKGETQYF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	48	unresolved						TCRBJ02	TCRBJ02-05	01	6	0	5	5	6	9	19	30	43	36	52	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRGQKKGETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCACCCAGAGGGGGTTAGGACCCTTAGGAGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	55	2.066822242013611E-4		52	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	5	1	4	5	16	19	29	40	34	56	TCRBV05,TCRBV07													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGTCACTACCACTGAAGCTTTCTTTGGACAA	CASSVVTTTEAFF	In	VDJ	1	55	2.066822242013611E-4	2.447174403445622E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	3	9	4	6	1	24	36	46	42	47	TCRBV09,TCRBV21					01,02								CASSVVTTTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCACACCTCCCCGAGGACGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSHTSPRTGSGNTIYF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	54	unresolved						TCRBJ01	TCRBJ01-03	01	3	1	7	0	11	3	23	37	52	48	55	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHTSPRTGSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGGACAGGGGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	56	2.1044008282320402E-4		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	0	2	1	1	0	26	43	-1	44	54		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGTACGAGCAGTACTTCGGGCCG	CASSQGYEQYF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	33	TCRBV03						TCRBJ02	TCRBJ02-07	01	3	6	2	4	0	0	26	-1	-1	40	44		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGGGCAGCCATTTTACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	56	2.1044008282320402E-4		50	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	6	0	2	1	10	26	40	47	41	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGATTAGTCGGTCTCTACGAGCAGTACTTCGGGCCG	CSARGLVGLYEQYF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	5	8	3	3	7	26	39	45	42	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGLVGLYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGACCCCGGGACAGCTATAGTCTACGAGCAGTACTTCGGGCCG	CSASDPGTAIVYEQYF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	5	3	7	7	26	37	51	44	58		TCRBV20-01,TCRBV20-or09_02												CSASDPGTAIVYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGCAGCGGGGGCGATTGCACAGATACGCAGTATTTTGGCCCA	CSAGSGGDCTDTQYF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	6	2	1	3	5	26	35	46	38	51		TCRBV20-01,TCRBV20-or09_02												CSAGSGGDCTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCACCCTTAGGGGATACCCTCGGGGACCCAGTACTTCGGGCCA		Out	VDJ	1	56	2.1044008282320402E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	5	2	7	5	11	18	28	38	33	49	TCRBV05,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGTCACGGGTTCCTACGAGCAGTACTTCGGGCCG	CASSLVTGSYEQYF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	8	4	1	3	1	18	34	41	37	42	TCRBV07,TCRBV11					01,02								CASSLVTGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTTCAAACTAGCGGGAGGGTCGAGCAGTACTTCGGGCCG	CASSFQTSGRVEQYF	In	VDJ	1	56	2.1044008282320402E-4	2.491668483508269E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	3	0	6	4	1	18	32	49	36	50	TCRBV07,TCRBV11													CASSFQTSGRVEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTKGRKGACTCWGCYRTGTAYTTCTGTGCCAGCAGCCCCCCCGCTAAGGGGGACCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	56	2.1044008282320402E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	5	1	6	11	3	23	34	51	45	54	TCRBV02,TCRBV03													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGGACAGGCCACCTACGAGCAGTACTTCGGGCCG	CAISGQATYEQYF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	4	2	0	3	24	-1	43	37	46	TCRBV06,TCRBV10													CAISGQATYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGGCCGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CAISGRATNEKLFF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	8	4	0	2	0	24	37	-1	39	43	TCRBV06,TCRBV10					01,02								CAISGRATNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCTAGCGGGGGTATCAGAGACCCAGTACTTCGGGCCA	CASSQGLAGVSETQYF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	4	2	4	2	4	26	42	54	44	58		TCRBV03-01,TCRBV03-02												CASSQGLAGVSETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATGGGGGCGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSHGGGSGANVLTF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	6	0	0	1	2	26	40	47	41	49		TCRBV03-01,TCRBV03-02												CASSHGGGSGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAAGGGAGGCGGGGGAGCTGTTTTTTGGAGAA	CSAREREAGELFF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	9	1	8	2	2	26	40	48	42	50		TCRBV20-01,TCRBV20-or09_02												CSAREREAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGTTCAGGACAGGTACTACAATGAGCAGTTCTTCGGGCCA	CSARVQDRYYNEQFF	In	VDJ	1	57	2.1419794144504696E-4	2.536162563570917E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	4	3	6	2	26	37	50	43	52		TCRBV20-01,TCRBV20-or09_02												CSARVQDRYYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGTTATGCGGGGGGGAACAAGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	57	2.1419794144504696E-4		50	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	8	7	0	1	5	6	23	32	46	37	52	TCRBV06,TCRBV10													X+X+TCRBJ02-04	unresolved	TCRBD02-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCTGTGCCAGCAGTTACAAAACGGGACAGGGGCCCTACGAGCAGTACTTCGTGGGGACAGGGGCCCTACGAGCAGTACTTCGGGCCG		Out	VDDJ	1	57	2.1419794144504696E-4		79	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	2	2	21	1	2	32	63	53	64		TCRBV06-02,TCRBV06-03,TCRBV06-05,TCRBV06-06,TCRBV06-07												X+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTTCTTCGGGACTAGCGGGAGGGCTCGAGCAGTACTTCGGGCCG	CASSSSGLAGGLEQYF	In	VDJ	1	58	2.179558000668899E-4	2.5806566436335646E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	0	0	6	6	2	26	37	59	43	61		TCRBV03-01,TCRBV03-02												CASSSSGLAGGLEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCCCTGGAGGCGGACTGAACACCTACGAGCAGTACTTCGGGCCG	CSPGGGLNTYEQYF	In	VDJ	1	58	2.179558000668899E-4	2.5806566436335646E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	1	10	2	10	5	26	31	46	41	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSPGGGLNTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTAGTGAGGAAAAACTGTTTTTTGGCAGT	CSARGSEEKLFF	In	VDJ	1	58	2.179558000668899E-4	2.5806566436335646E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	5	8	8	1	4	26	39	43	40	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGSEEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGCCGTGGGACTAGCGGGGGACTACGAGCAGTACTTCGGGCCG	CSASAVGLAGDYEQYF	In	VDJ	1	58	2.179558000668899E-4	2.5806566436335646E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	3	6	1	26	37	57	43	58		TCRBV20-01,TCRBV20-or09_02												CSASAVGLAGDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAAGGCAGGGGGCGTAGTGAGCAGTTCTTCGGGCCA	CSAEGRGRSEQFF	In	VDJ	1	58	2.179558000668899E-4	2.5806566436335646E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	9	5	4	26	35	48	40	52		TCRBV20-01,TCRBV20-or09_02												CSAEGRGRSEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCTCGTACAGCTCGCAGACTGAAGCTTTCTTTGGACAA	CASSYSSQTEAFF	In	VDJ	1	58	2.179558000668899E-4	2.5806566436335646E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	5	5	4	7	23	32	40	36	47	TCRBV06,TCRBV10													CASSYSSQTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAGGACAGGGGGCTAGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	58	2.179558000668899E-4		46				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	0	4	0	3	22	-1	47	36	50	TCRBV04,TCRBV07,TCRBV17	TCRBV04-01,TCRBV07-03,TCRBV17-01												X+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTYGGCYRTGTATCTCTGTGCCAGCAGCTTGGCCGGGACAGCAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGTANTGELFF	In	VDJ	1	58	2.179558000668899E-4	2.5806566436335646E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	5	2	5	2	22	35	47	40	49	TCRBV07,TCRBV11													CASSLAGTANTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCTATTTGGGACGCAGTATTTTGGCCCA	CASSQGLFGTQYF	In	VDJ	1	59	2.217136586887328E-4	2.625150723696212E-4	39	TCRBV03						TCRBJ02	TCRBJ02-03	01	1	0	9	9	8	0	26	42	-1	50	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGLFGTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTCAGCGGGGGCACCTCCTACGAGCAGTACTTCGGGCCG	CASSFSGGTSYEQYF	In	VDJ	1	59	2.217136586887328E-4	2.625150723696212E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	6	2	0	1	3	18	32	41	33	44	TCRBV07,TCRBV11													CASSFSGGTSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTGAAGGGTGCTTAACCCCCTAAGGTTAGTTCTTCGGGCCA	CASSEGCLTP*G*FF	Stop	VDJ	1	59	2.217136586887328E-4		45	unresolved						TCRBJ02	TCRBJ02-01	01	1	5	4	14	16	2	23	39	58	55	60	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGCLTP*G*FF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGGACAGGTGGGGGGTGGCTACACCTTCGGTTCG	CASSGQVGGGYTF	In	VDJ	1	59	2.217136586887328E-4	2.625150723696212E-4	39	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	4	2	4	7	0	7	23	-1	42	36	49	TCRBV02,TCRBV09			TCRBD01,TCRBD02										CASSGQVGGGYTF+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGGACGCAACTAATGAAAAACTGTTTTTTGGCAGT	CSARDATNEKLFF	In	VDJ	1	60	2.2547151731057573E-4	2.66964480375886E-4	39	TCRBV20						TCRBJ01	TCRBJ01-04	01	6	0	7	0	2	1	26	34	41	36	42		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDATNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACCTAGGTAACACCGGGGAGCTGTTTTTTGGAGAA	CSARDLGNTGELFF	In	VDJ	1	60	2.2547151731057573E-4	2.66964480375886E-4	42	TCRBV20						TCRBJ02	TCRBJ02-02	01	3	1	7	2	0	6	26	-1	41	37	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLGNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTAGGGACAGGGGGACTCTACGAGCAGTACTTCGGGCCG	CASSLGTGGLYEQYF	In	VDJ	1	60	2.2547151731057573E-4	2.66964480375886E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	3	3	3	24	36	50	39	53		TCRBV24-01,TCRBV24-or09_02												CASSLGTGGLYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTGCAGGACAGGGCTGAAAAACTGTTTTTTGGCAGT	CASSVQDRAEKLFF	In	VDJ	1	60	2.2547151731057573E-4	2.66964480375886E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	1	3	7	3	1	23	37	48	40	49	TCRBV09,TCRBV21													CASSVQDRAEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGGACTAGCGGTTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	61	2.2922937593241867E-4		43	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	5	3	2	2	26	34	47	36	49		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGACACCGGGCCATTAGAAGACGAGCAGTACTTCGGGCCG	CSADTGPLEDEQYF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	6	5	0	15	26	-1	39	34	54		TCRBV20-01,TCRBV20-or09_02												CSADTGPLEDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCGACGACTCAGGACAGGGGAGGTAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	61	2.2922937593241867E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	12	1	2	3	9	5	23	28	46	37	51	TCRBV01,TCRBV04													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTCGGACTAGCGACAGATACGCAGTATTTTGGCCCA	CARSFGLATDTQYF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	1	6	3	1	0	18	32	-1	33	42	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03				01,02								CARSFGLATDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATACGGGGGTTTCCCGATATGAGCAGTTCTTCGGGCCA	CASSQDTGVSRYEQFF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	48				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	2	8	2	9	18	35	43	37	52	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDTGVSRYEQFF+X+TCRBJ02-01		TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGTTCGGCTAGCGGGGTGGTTGAGCAGTTCTTCGGGCCA	CASSSASGVVEQFF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	42				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	9	5	4	18	29	43	34	47	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02												CASSSASGVVEQFF+X+TCRBJ02-01		TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGGGTCCTCTGGGGGCTACGAGCAGTACTTCGGGCCG	XASSQGSSGGYEQYF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	1	6	1	3	8	0	22	38	-1	46	51	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSQGSSGGYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGTCTGTGCCAGCAGCTTAGTGTACGGCGGTGCGGGACTAGCGGGGGGACGAAGCCTCAATGAGCAGTTCTTCGGGCCA	CASSLVYGGAGLAGGRSLNEQFF	In	VDJ	1	61	2.2922937593241867E-4	2.7141388838215075E-4	69				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	0	1	6	13	9	4	20	48	33	57	TCRBV07,TCRBV11	TCRBV07-02,TCRBV07-08,TCRBV11-02,TCRBV11-03												CASSLVYGGAGLAGGRSLNEQFF+X+TCRBJ02-01		TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGGTTTGGGACAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CSARFGTGNTGELFF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	4	1	7	0	26	34	-1	41	49		TCRBV20-01,TCRBV20-or09_02												CSARFGTGNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAGGTTGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAKGWSSYNEQFF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	10	2	0	6	0	26	36	-1	42	46		TCRBV20-01,TCRBV20-or09_02												CSAKGWSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCTGGGACTAGCGACTACGAGCAGTACTTCGGGCCG	CSARPGTSDYEQYF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	6	3	3	1	26	38	51	41	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARPGTSDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGCCGTTACAGCATTCTAACTATGGCTACACCTTCGGTTCG	CSAMPLQHSNYGYTF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	5	0	7	4	26	36	47	43	51		TCRBV20-01,TCRBV20-or09_02												CSAMPLQHSNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGAGCGTAACCCTCCAAGAGACCCAGTACTTCGGGCCA	CSAWSVTLQETQYF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	6	6	1	3	7	26	35	42	38	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAWSVTLQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCATGGTCCAGTGGAAGACTGACAGGGTAAATTCACCCCTCCACTTTGGGAAC	CATMVQWKTDRVNSPLHF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	2	3	7	17	2	24	34	58	51	60		TCRBV24-01,TCRBV24-or09_02												CATMVQWKTDRVNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACCACCATTGGGACAGGTCCTGGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSDHHWDRSWANEKLFF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	57	TCRBV25			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	4	3	8	7	23	37	53	45	60		TCRBV25-01,TCRBV25-or09_02												CASSDHHWDRSWANEKLFF+TCRBV25-X+TCRBJ01-04	TCRBV25	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGCTTGGTGTCGGTTAGCACAGATACGCAGTATTTTGGCCCA	CASSLVSVSTDTQYF	In	VDJ	1	62	2.329872345542616E-4	2.7586329638841554E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	5	0	5	2	19	33	41	38	43	TCRBV05,TCRBV07					01,02								CASSLVSVSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCCAAGGCGGTCCCTACGGGCCCCGGTTGTGCGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	62	2.329872345542616E-4		62	unresolved						TCRBJ01	TCRBJ01-03	01	3	8	0	4	16	11	19	32	52	48	63	TCRBV05,TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TTCTGTGCCAGCAGTTTTCAACGGGATTTTCAACGCACCCCAAAAGGGGGGTAGACCGGGGAGCTGTTTTTTGGAGAA	CASSFQRDFQRTPKGG*TGELFF	Stop	VDJ	1	62	2.329872345542616E-4		69	unresolved						TCRBJ02	TCRBJ02-02	01	4	5	1	5	28	4	0	13	47	41	51	TCRBV06,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFQRDFQRTPKGG*TGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTAGACAGTAACTATGGCTACACCTTCGGTTCG	CSALDSNYGYTF	In	VDJ	1	63	2.3674509317610454E-4	2.803127043946803E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	5	1	3	0	26	35	-1	38	43		TCRBV20-01,TCRBV20-or09_02												CSALDSNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTGGACGGACAACACCGGGGAGCTGTTTTTTGGAGAA	CASSWTDNTGELFF	In	VDJ	1	63	2.3674509317610454E-4	2.803127043946803E-4	42	TCRBV24						TCRBJ02	TCRBJ02-02	01	6	1	7	2	1	4	24	36	41	37	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWTDNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGTCCCCCCGGGGCATCAGCCCCAGCATTTTGGTGAT	CASSVPPGHQPQHF	In	VDJ	1	63	2.3674509317610454E-4	2.803127043946803E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	5	7	0	5	9	0	23	34	-1	43	48	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVPPGHQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCGGGGGACAGGGGGCCGGCTGAAGCTTTCTTTGGACAA	CASSPGDRGPAEAFF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	0	6	3	3	23	36	51	39	54	TCRBV01,TCRBV04													CASSPGDRGPAEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACACCAAAGGGCTGGCTACACCTTCGGTTCG	CASSPHQRAGYTF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	4	5	3	7	8	1	26	39	51	47	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPHQRAGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGGGAGGGGGTCTGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	64	2.4050295179794745E-4		41	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	0	6	0	6	26	-1	48	40	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGACAAAACACCGGGGAGCTGTTTTTTGGAGAA	CSAREGQNTGELFF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	6	2	0	1	26	-1	46	40	47		TCRBV20-01,TCRBV20-or09_02												CSAREGQNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGTGGGACTAGCCGCAATGAGCAGTTCTTCGGGCCA	CSARDGGTSRNEQFF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	7	6	4	2	26	40	53	44	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDGGTSRNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTGGACAGGATTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSASWTGFSSYNEQFF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	4	0	2	6	26	37	46	39	52		TCRBV20-01,TCRBV20-or09_02												CSASWTGFSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTTTACTAGGACAGGGTATGACTGAAGCTTTCTTTGGACAA	XASSLLGQGMTEAFF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	3	5	3	4	25	40	51	43	55	TCRBV26,TCRBV28													XASSLLGQGMTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCCGAACAGGGCTAACCTACAATGAGCAGTTCTTCGGGCCA	CASSRTGLTYNEQFF	In	VDJ	1	64	2.4050295179794745E-4	2.8476211240094503E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	2	3	4	19	31	40	34	44	TCRBV05,TCRBV07													CASSRTGLTYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTGCGGGCCCCTACGAGCAGTACTTCGGGCCG	CSARGAGPYEQYF	In	VDJ	1	65	2.442608104197904E-4	2.8921152040720983E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	7	4	2	2	2	26	39	46	41	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGAGPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTCAGACAGGCGGACTATGGCTACACCTTCGGTTCG	CSAFRQADYGYTF	In	VDJ	1	65	2.442608104197904E-4	2.8921152040720983E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	4	3	4	3	26	35	45	39	48		TCRBV20-01,TCRBV20-or09_02												CSAFRQADYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTACACTAGCGGGAGGGATGAAGAGACCCAGTACTTCGGGCCA	CARSYTSGRDEETQYF	In	VDJ	1	65	2.442608104197904E-4	2.8921152040720983E-4	48				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	3	0	3	2	3	18	31	46	33	49	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												CARSYTSGRDEETQYF+X+TCRBJ02-05		TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCATTCCTAGCGGGAGTATCGAGACCCAGTACTTCGGGCCA	CASIPSGSIETQYF	In	VDJ	1	65	2.442608104197904E-4	2.8921152040720983E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	10	4	2	5	6	4	24	31	47	37	51	TCRBV12,TCRBV21													CASIPSGSIETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTCATACCATAGCGGGAGATTCGATGAGCAGTTCTTCGGGCCA	CASSSYHSGRFDEQFF	In	VDJ	1	65	2.442608104197904E-4	2.8921152040720983E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	2	8	8	5	23	35	52	43	57	TCRBV09,TCRBV21													CASSSYHSGRFDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCTTTGGAGACTACACCGGGGAGCTGTTTTTTGGAGAA	CASSSFGDYTGELFF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	2	10	3	8	0	26	39	-1	47	51		TCRBV12-03,TCRBV12-04				01,02								CASSSFGDYTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCAAGGACGGTCGGCCCAGCATTTTGGTGAT	CASSQGRSAQHF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	36	TCRBV03						TCRBJ01	TCRBJ01-05	01	1	2	7	11	0	6	26	-1	45	42	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGRSAQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGCAGATGGGTACGAGCAGTACTTCGGGCCG	CSAREADGYEQYF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	0	9	4	7	0	26	40	-1	47	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREADGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAACCCTATGGGGGAGGGCCTTGAGACCCAGTACTTCGGGCCA	XASNPMGEGLETQYF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	9	0	5	9	4	25	35	51	44	55	TCRBV26,TCRBV28													XASNPMGEGLETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTCAGCGGGAGGGCCCACAGATACGCAGTATTTTGGCCCA	CASSQDSAGGPTDTQYF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	6	0	2	3	2	23	40	53	43	55	TCRBV01,TCRBV04													CASSQDSAGGPTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGAGCGGGGCCCACGGAGGGCAGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	66	2.480186690416333E-4		56	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	3	5	0	15	24	-1	49	42	64		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCACAAAAAGAAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	66	2.480186690416333E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	3	6	1	1	6	24	33	37	34	43		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACKCRGCCRTGTAYSTSTGTGCCAGCAGCTTAGGCGGGACAGGGGACTACGAGCAGTACTTCGGGCCG	CASSLGGTGDYEQYF	In	VDJ	1	66	2.480186690416333E-4	2.936609284134746E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	3	6	1	18	30	46	36	47	TCRBV11,TCRBV15													CASSLGGTGDYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTTAGGCACGGGACGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	66	2.480186690416333E-4		43	unresolved						TCRBJ01	TCRBJ01-02	01	5	0	7	4	8	2	24	36	49	44	51	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGCGGGCGAGCAGTACTTCGGGCCG	CASSQGAGEQYF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	7	4	6	2	0	26	42	-1	44	49		TCRBV03-01,TCRBV03-02				01,02								CASSQGAGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCATCATTAGAAGGAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	67	2.517765276634762E-4		46	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	1	8	2	12	0	26	39	-1	51	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCTCCACCCGGGGGAACGACTACGAGCAGTACTTCGGGCCG	CSSTRGNDYEQYF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	9	8	2	3	7	5	26	31	44	38	49		TCRBV20-01,TCRBV20-or09_02												CSSTRGNDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGTAGCGGGAGGTCAGATACGCAGTATTTTGGCCCA	CSASRSGRSDTQYF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	1	4	3	1	26	37	50	40	51		TCRBV20-01,TCRBV20-or09_02												CSASRSGRSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGGAGAGTGGGGCCAACGTCCTGACTTTCGGGGCC	CSAPESGANVLTF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	10	2	3	2	2	26	35	41	37	43		TCRBV20-01,TCRBV20-or09_02												CSAPESGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01*02	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGCGAGGGGGACTAGCGGACAATGAGCAGTTCTTCGGGCCA	CATSERGGLADNEQFF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	5	5	6	0	24	38	-1	44	55		TCRBV24-01,TCRBV24-or09_02				01,02								CATSERGGLADNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCTTACAGCTATCCAAGAGACCCAGTACTTCGGGCCA	CASSQDLTAIQETQYF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	3	5	1	4	4	18	35	43	39	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDLTAIQETQYF+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGACTCACAGATACGCAGTATTTTGGCCCA	CASSLAGLTDTQYF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	10	2	0	0	18	-1	-1	35	41	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAGLTDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCGGGTTAACTAGCGGTGGGTTCGGGGAGCTGTTTTTTGGAGAA	CASGLTSGGFGELFF	In	VDJ	1	67	2.517765276634762E-4	2.981103364197394E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	3	5	7	8	6	24	31	47	39	53	TCRBV09,TCRBV21					01,02								CASGLTSGGFGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCAGACAGCTCTTTACTTCTGTGCCAGCAGACCTATTGGGACAGGGGGTATAGGCGGGAACAATGAAAAACTGTTTTTTGGCAGT	CASRPIGTGGIGGNNEKLFF	In	VDJ	1	68	2.555343862853192E-4	3.025597444260041E-4	60	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	1	5	7	13	21	32	50	39	63		TCRBV24-01,TCRBV24-or09_02												CASRPIGTGGIGGNNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCGACAGGGCCGAGCAGTACTTCGGGCCG	CSARPDRAEQYF	In	VDJ	1	68	2.555343862853192E-4	3.025597444260041E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	3	6	3	1	26	38	48	41	49		TCRBV20-01,TCRBV20-or09_02												CSARPDRAEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGACCCCGGGGGGTGATGAAGCTTTCTTTGGACAA	CSARETPGGDEAFF	In	VDJ	1	68	2.555343862853192E-4	3.025597444260041E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	1	7	5	3	26	40	52	45	55		TCRBV20-01,TCRBV20-or09_02												CSARETPGGDEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGAAACTAGCGGGGTGGCAGATACGCAGTATTTTGGCCCA	CSASETSGVADTQYF	In	VDJ	1	68	2.555343862853192E-4	3.025597444260041E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	3	3	4	4	3	26	37	51	41	54		TCRBV20-01,TCRBV20-or09_02												CSASETSGVADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGACAGGGGGTACGGCAGATACGCAGTATTTTGGCCCA	CSAETGGTADTQYF	In	VDJ	1	68	2.555343862853192E-4	3.025597444260041E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	1	4	2	5	26	35	46	37	51		TCRBV20-01,TCRBV20-or09_02												CSAETGGTADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTACGACCGGGACTAGCGGGATGTCGGTCGATGAGCAGTTCTTCGGGCCA	CSVTTGTSGMSVDEQFF	In	VDJ	1	68	2.555343862853192E-4	3.025597444260041E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	0	3	8	8	9	26	33	54	41	63		TCRBV20-01,TCRBV20-or09_02												CSVTTGTSGMSVDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGAATAACGACGAGCAGTACTTCGGGCCG	CASSLSNNDEQYF	In	VDJ	1	68	2.555343862853192E-4	3.025597444260041E-4	39							TCRBJ02	TCRBJ02-07	01	6	2	8	5	5	6	24	36	43	41	49	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSNNDEQYF+X+TCRBJ02-07			TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAGAGGGCTTAGGGACTGAAGCTTTCTTTGGACAA	CASSQGEGLGTEAFF	In	VDJ	1	69	2.592922449071621E-4	3.0700915243226886E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	11	0	5	2	7	26	42	49	44	56		TCRBV03-01,TCRBV03-02												CASSQGEGLGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCGAGGGACTAGCGGAACCTATACGCAGTATTTTGGCCCA	CASSQGRGTSGTYTQYF	In	VDJ	1	69	2.592922449071621E-4	3.0700915243226886E-4	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	0	5	7	5	5	26	42	58	47	63		TCRBV03-01,TCRBV03-02				01,02								CASSQGRGTSGTYTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGGACGTAGGGACAGGATCACCGGGGAGCTGTTTTTTGGAGAA	CSAGRRDRITGELFF	In	VDJ	1	69	2.592922449071621E-4	3.0700915243226886E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	4	4	8	2	26	34	50	42	52		TCRBV20-01,TCRBV20-or09_02												CSAGRRDRITGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCACCGAGGATATCCGAGATTCCGGGGAGCTGTTTTTTGGAGAA	CATEDIRDSGELFF	In	VDJ	1	69	2.592922449071621E-4	3.0700915243226886E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	10	11	1	6	2	12	23	30	36	32	48	TCRBV06,TCRBV10													CATEDIRDSGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGRGACWCRGCMSTGTATCTCTRCGCCAGCAGCCAAGATTTTGGCTCCTACAATGAGCAGTTCTTCGGGCCA	XASSQDFGSYNEQFF	In	VDJ	1	69	2.592922449071621E-4	3.0700915243226886E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	2	0	10	0	6	0	20	35	-1	41	43	TCRBV04,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSQDFGSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAGCCGTGGACAGGGGGAACTATGGCTACACCTTCGGTTCG	CASSEAVDRGNYGYTF	In	VDJ	1	69	2.592922449071621E-4	3.0700915243226886E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	1	2	3	0	23	40	-1	43	53	TCRBV02,TCRBV12													CASSEAVDRGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGAACAGCAGGGGTCCTACGAGCAGTACTTCGGGCCG	XASSQEQQGSYEQYF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	1	4	0	23	40	-1	44	50	TCRBV01,TCRBV04													XASSQEQQGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGACAAGGGGTCCTCTGATGGCTACACCTTCGGTTCG	CSADKGSSDGYTF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	6	6	0	12	26	-1	39	34	51		TCRBV20-01,TCRBV20-or09_02												CSADKGSSDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGGGACTCCGCCTAACCAAAAACATTCAGTACTTCGGCGCC	CSARDRGLRLTKNIQYF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	0	10	2	3	8	26	40	49	43	57		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDRGLRLTKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTCTACAGCCAGGGGGTGATGAGCAGTTCTTCGGGCCA	CSARVLQPGGDEQFF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	1	8	9	2	26	39	55	48	57		TCRBV20-01,TCRBV20-or09_02												CSARVLQPGGDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCATCGGGGGCGGTTGGGCACACAGATACGCAGTATTTTGGCCCA	CSARPSGAVGHTDTQYF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	51	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	6	0	2	6	9	26	37	49	43	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPSGAVGHTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTACTGATTCCTACGAGCAGTACTTCGGGCCG	CSASTDSYEQYF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	3	10	1	1	3	26	37	41	38	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSASTDSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAACTCCAGGACTAGCGGGGGATCTCGCTACAATGAGCAGTTCTTCGGGCCA	CASNSRTSGGSRYNEQFF	In	VDJ	1	70	2.6305010352900505E-4	3.1145856043853366E-4	54	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	11	1	2	3	9	6	24	31	53	40	59		TCRBV24-01,TCRBV24-or09_02												CASNSRTSGGSRYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCTGGGACCACCTGGGGAGACCCAGTACTTCGGGCCA	CASSLALGPPGETQYF	In	VDJ	1	71	2.6680796215084796E-4	3.159079684447984E-4	48							TCRBJ02	TCRBJ02-05	01	0	0	7	5	3	8	18	35	43	38	51	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLALGPPGETQYF+X+TCRBJ02-05			TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATGGTTAGGGGGGAGACCCAGTACTTCGGGCCA	CSAMVRGETQYF	In	VDJ	1	72	2.7056582077269087E-4	3.203573764510632E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	5	1	5	7	0	26	34	-1	41	47		TCRBV20-01,TCRBV20-or09_02												CSAMVRGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGACCTAACCAGGGTAACTATGGCTACACCTTCGGTTCG	CSAGPNQGNYGYTF	In	VDJ	1	72	2.7056582077269087E-4	3.203573764510632E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	1	10	0	26	34	-1	44	49		TCRBV20-01,TCRBV20-or09_02												CSAGPNQGNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VJ	1	72	2.7056582077269087E-4		37	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	0	0	0	0	1	26	-1	40	-1	41		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGTAACGCTAACACAGATACGCAGTATTTTGGCCCA	CSARGNANTDTQYF	In	VDJ	1	72	2.7056582077269087E-4	3.203573764510632E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	0	9	2	0	9	26	-1	40	37	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGNANTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTGGGACAGGGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	72	2.7056582077269087E-4		43				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	3	1	0	0	18	-1	-1	31	40	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACGACAGGCGTAGAGACCCAGTACTTCGGGCCA	CSATTGVETQYF	In	VDJ	1	73	2.7432367939453383E-4	3.2480678445732795E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	4	4	3	3	26	34	43	37	46		TCRBV20-01,TCRBV20-or09_02												CSATTGVETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGCCGTGGGACAGGCCACAGATACGCAGTATTTTGGCCCA	CATSDAVGQATDTQYF	In	VDJ	1	73	2.7432367939453383E-4	3.2480678445732795E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	4	2	5	1	24	39	52	44	53		TCRBV24-01,TCRBV24-or09_02												CATSDAVGQATDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCGCGGACAGGAGTCACTAGCGGTTCCAATGAGCAGTTCTTCGGGCCA	CASSLSRTGVTSGSNEQFF	In	VDJ	1	73	2.7432367939453383E-4	3.2480678445732795E-4	57	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	5	6	18	3	24	36	62	54	65	TCRBV24,TCRBV27					01,02								CASSLSRTGVTSGSNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTATAGGACTAGCGGGAGAGAATCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYRTSGRESNTGELFF	In	VDJ	1	73	2.7432367939453383E-4	3.2480678445732795E-4	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	1	2	0	3	5	18	31	47	34	52	TCRBV07,TCRBV11													CASSYRTSGRESNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCGAGGGACTAGCGGGAGTAGATACGCAGTATTTTGGCCCA	CASEGLAGVDTQYF	In	VDJ	1	73	2.7432367939453383E-4	3.2480678445732795E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	0	2	5	2	1	23	32	48	34	49	TCRBV02,TCRBV09													CASEGLAGVDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCTTCAGCGAATACGTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	74	2.7808153801637674E-4		44	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	6	6	2	7	7	26	34	45	41	52		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGGGGACAGGGGAACACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	74	2.7808153801637674E-4		56	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	2	0	1	6	24	42	53	43	59		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGACCCCGGGGACTAGCGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASRPRGLAGYTGELFF	In	VDJ	1	74	2.7808153801637674E-4	3.2925619246359274E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	3	6	1	24	35	54	41	55	TCRBV12,TCRBV21													CASRPRGLAGYTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTACAGGCCTCCCCGGGGGGCGAGCAGTACTTCGGGCCG	CASSVQASPGGEQYF	In	VDJ	1	74	2.7808153801637674E-4	3.2925619246359274E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	8	1	6	10	0	23	38	-1	48	55	TCRBV09,TCRBV21													CASSVQASPGGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAAAGGACCCCAGTGAGACCCAGTACTTCGGGCCA	CASRKDPSETQYF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	39	TCRBV12						TCRBJ02	TCRBJ02-05	01	6	1	7	5	3	6	26	37	44	40	50		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRKDPSETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGGGACAACCTGAGGGATATGGCTACACCTTCGGTTCG	CSARPGQPEGYGYTF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	6	5	2	10	26	38	46	40	56		TCRBV20-01,TCRBV20-or09_02												CSARPGQPEGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAGGGGGCTGCGGGAAAAACTGTTTTTTGGCAGT	CSASRGLREKLFF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	0	8	0	5	26	-1	45	37	50		TCRBV20-01,TCRBV20-or09_02												CSASRGLREKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGATTGGGACAGGGTGGTGAAAAACTGTTTTTTGGCAGT	CASRLGQGGEKLFF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	3	7	3	3	23	34	46	37	49	TCRBV24,TCRBV27													CASRLGQGGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTGCGAGGGTGGGCCCCTCTTCTTCAGGAAACACCATATATTTTGGAGAG	CASSARVGPSSSGNTIYF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	11	0	4	1	17	24	37	43	38	60	TCRBV06,TCRBV24													CASSARVGPSSSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCGGGAGTGGAGCAGGGCAGCCCCAGCATTTTGGTGAT	CAGSGAGQPQHF	In	VDJ	1	75	2.818393966382197E-4	3.337056004698575E-4	36	TCRBV24						TCRBJ01	TCRBJ01-05	01	12	4	3	7	10	0	24	30	-1	40	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAGSGAGQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCGCAGGGACATCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSAPRRDISGANVLTF	In	VDJ	1	76	2.855972552600626E-4	3.3815500847612223E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	6	0	7	1	26	35	48	42	49		TCRBV20-01,TCRBV20-or09_02												CSAPRRDISGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCCCACTCATGACTAGCGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CSVPLMTSGAYNEQFF	In	VDJ	1	76	2.855972552600626E-4	3.3815500847612223E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	2	3	2	10	0	26	33	-1	43	54		TCRBV20-01,TCRBV20-or09_02												CSVPLMTSGAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTTCTGTTCAGGGACGCTACGAGCAGTACTTCGGGCCG	CASSFSVQGRYEQYF	In	VDJ	1	76	2.855972552600626E-4	3.3815500847612223E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	3	0	7	3	9	1	18	32	46	41	47	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSVQGRYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGGTAACCGGGACACTTACGAGCAGTACTTCGGGCCG	CSGNRDTYEQYF	In	VDJ	1	77	2.893551138819055E-4	3.4260441648238703E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	0	6	4	8	2	26	31	45	39	47		TCRBV20-01,TCRBV20-or09_02												CSGNRDTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGCAGCGGGAGTCGCGCGGTGAGCAGTTCTTCGGGCCA	CSARVQRESRGEQFF	In	VDJ	1	77	2.893551138819055E-4	3.4260441648238703E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	6	2	9	3	8	26	39	50	42	58		TCRBV20-01,TCRBV20-or09_02												CSARVQRESRGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTAGCGGGACTAGCGGGAAGGGGAGCACCGGGGAGCTGTTTTTTGGAGAA	CSVSGTSGKGSTGELFF	In	VDJ	1	77	2.893551138819055E-4	3.4260441648238703E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	0	3	4	1	7	26	37	51	38	58		TCRBV20-01,TCRBV20-or09_02												CSVSGTSGKGSTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCGCGAGCTCGGGGTCTTGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSASSGSWAYNEQFF	In	VDJ	1	77	2.893551138819055E-4	3.4260441648238703E-4	51	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	3	2	7	7	19	31	43	38	50		TCRBV05-06,TCRBV05-07												CASSASSGSWAYNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAACGATTACAGGGCCGGGAATGAGCAGTTCTTCGGGCCA	CASSNDYRAGNEQFF	In	VDJ	1	78	2.931129725037485E-4	3.470538244886518E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	3	7	7	5	26	38	51	45	56		TCRBV12-03,TCRBV12-04												CASSNDYRAGNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCCTGAATCTGAACACTGAAGCTTTCTTTGGACAA	CASSQVLNLNTEAFF	In	VDJ	1	78	2.931129725037485E-4	3.470538244886518E-4	45	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	2	8	0	4	3	26	42	48	46	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVLNLNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCCAGGGCAGGACAATGAGCAGTTCTTCGGGCCA	CASSQPGQDNEQFF	In	VDJ	1	78	2.931129725037485E-4	3.470538244886518E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	5	2	4	26	40	47	42	51		TCRBV03-01,TCRBV03-02												CASSQPGQDNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCCAACGGCGGGGAACGGATACGCAGTATTTTGGCCCA	CASQRRGTDTQYF	In	VDJ	1	78	2.931129725037485E-4	3.470538244886518E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	7	3	6	5	4	26	35	46	40	50		TCRBV03-01,TCRBV03-02												CASQRRGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTGGGAGCAAAGCGAGCAGTACTTCGGGCCG	CSASWEQSEQYF	In	VDJ	1	78	2.931129725037485E-4	3.470538244886518E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	2	6	2	5	26	37	44	39	49		TCRBV20-01,TCRBV20-or09_02												CSASWEQSEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGGACAGGACGTACACCAGGGAGCTGTTTTTTGGAGAA	CATRDRTYTRELFF	In	VDJ	1	78	2.931129725037485E-4	3.470538244886518E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	1	4	9	0	10	24	-1	42	35	52		TCRBV24-01,TCRBV24-or09_02												CATRDRTYTRELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAATATGGCAGGGAATACCCATGAGCAGTTCTTCGGGCCA	CASNMAGNTHEQFF	In	VDJ	1	78	2.931129725037485E-4	3.470538244886518E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	4	3	8	9	7	24	31	45	40	52		TCRBV24-01,TCRBV24-or09_02												CASNMAGNTHEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCTCCACCCGGACTAGCGGGAGTGATACGCAGTATTTTGGCCCA	CASSSTRTSGSDTQYF	In	VDJ	1	78	2.931129725037485E-4	3.470538244886518E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	1	2	6	7	1	24	36	56	43	57	TCRBV12,TCRBV21													CASSSTRTSGSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAATCAGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLIRAGELFF	In	VDJ	1	79	2.968708311255914E-4	3.515032324949166E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	3	6	2	0	26	41	-1	43	48		TCRBV12-03,TCRBV12-04												CASSLIRAGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCCGGGACTAGCGCTTACAATGAGCAGTTCTTCGGGCCA	CSASGTSAYNEQFF	In	VDJ	1	79	2.968708311255914E-4	3.515032324949166E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	6	4	4	2	26	34	48	38	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSASGTSAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCTCCCCTGCGGGGGACTCCTACGAGCAGTACTTCGGGCCG	CSATSPAGDSYEQYF	In	VDJ	1	79	2.968708311255914E-4	3.515032324949166E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	7	2	0	8	1	26	36	51	44	52		TCRBV20-01,TCRBV20-or09_02												CSATSPAGDSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAGATGGCGGGGGGCACGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	80	3.0062868974743435E-4		49	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	7	1	3	3	4	26	42	53	45	57		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCCGAACCCTGGTTCGGAGACCCAGTACTTCGGGCCA	CASSPNPGSETQYF	In	VDJ	1	80	3.0062868974743435E-4	3.559526405011813E-4	42	unresolved						TCRBJ02	TCRBJ02-05	01	5	0	10	5	9	4	19	31	42	40	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPNPGSETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGCCACGGGGGGGACTGGAAACACCATATATTTTGGAGAG	CSARDATGGTGNTIYF	In	VDJ	1	81	3.0438654836927726E-4	3.6040204850744606E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	0	8	0	2	5	1	26	40	53	45	54		TCRBV20-01,TCRBV20-or09_02												CSARDATGGTGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCGGGGCAGAGTCAGCCTACGAGCAGTACTTCGGGCCG	CSASGAESAYEQYF	In	VDJ	1	81	3.0438654836927726E-4	3.6040204850744606E-4	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	5	7	0	2	3	8	26	35	43	38	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGAESAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGAGGGCCGGCACAGATACGCAGTATTTTGGCCCA	CSARGRAGTDTQYF	In	VDJ	1	82	3.0814440699112016E-4	3.6485145651371086E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	10	0	1	0	3	26	-1	45	39	48		TCRBV20-01,TCRBV20-or09_02												CSARGRAGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCACTTTGACACCCCTGGGCAGCCCCAGCATTTTGGTGAT	CSAPHFDTPGQPQHF	In	VDJ	1	82	3.0814440699112016E-4	3.6485145651371086E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	6	7	9	8	26	35	48	44	56		TCRBV20-01,TCRBV20-or09_02												CSAPHFDTPGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGGGGCCCTTAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQGALSSGANVLTF	In	VDJ	1	82	3.0814440699112016E-4	3.6485145651371086E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	8	0	0	0	6	23	-1	43	39	49	TCRBV04,TCRBV23													CASSQGALSSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGGAGCAATCAGCCCCAGCATTTTGGTGAT	CATSDRSNQPQHF	In	VDJ	1	82	3.0814440699112016E-4	3.6485145651371086E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	8	5	1	0	0	24	-1	-1	39	42		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDRSNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCACTAGCGGGGCCCATGGGTGAGCAGTTCTTCGGGCCA	CSARALAGPMGEQFF	In	VDJ	1	83	3.119022656129631E-4	3.693008645199756E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	3	3	9	1	8	26	39	50	40	58		TCRBV20-01,TCRBV20-or09_02												CSARALAGPMGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTGATCCGGGATCTTCTTCAACTAATGAAAAACTGTTTTTTGGCAGT	CSAPDPGSSSTNEKLFF	In	VDJ	1	83	3.119022656129631E-4	3.693008645199756E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	8	3	0	7	7	26	35	47	42	54		TCRBV20-01,TCRBV20-or09_02												CSAPDPGSSSTNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*02	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGAGCGGGGGGCAACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	83	3.119022656129631E-4		47	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	6	1	2	2	4	23	38	49	40	53		TCRBV06-01,TCRBV06-08												X+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACCGCGCGCGGGGGGAACACTGAAGCTTTCTTTGGACAA	CSTARGGNTEAFF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	8	7	2	1	7	0	26	32	-1	39	46		TCRBV20-01,TCRBV20-or09_02												CSTARGGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCCGGGGGGATCAATCAGCCCCAGCATTTTGGTGAT	CSARDSGGINQPQHF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	8	1	3	3	2	26	40	50	43	52		TCRBV20-01,TCRBV20-or09_02												CSARDSGGINQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCRGCYGTGTATYTYTGTGCCAGCAGCGAAGGGGGGGTCTATGGCTACACCTTCGGTTCG	CASSEGGVYGYTF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	9	0	4	3	1	18	30	40	33	41	TCRBV07,TCRBV12													CASSEGGVYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTATACAGGGGGAGAATCCTACGAGCAGTACTTCGGGCCG	CASSYTGGESYEQYF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	1	1	2	4	18	31	41	33	45	TCRBV07,TCRBV11													CASSYTGGESYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCACCGCCGACAGGTGACCTCTGGAAACACCATATATTTTGGAGAG	XASSHRRQVTSGNTIYF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	2	4	0	5	4	22	36	47	41	51	TCRBV04,TCRBV07,TCRBV17													XASSHRRQVTSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCCGCTAGCGGGGGGGCGACCCAGTACTTCGGGCCA	CASSSASGGATQYF	In	VDJ	1	84	3.1566012423480603E-4	3.737502725262404E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	4	0	7	3	1	19	32	47	35	48	TCRBV05,TCRBV11													CASSSASGGATQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGTCAACCGGGACAGGGGGCGCCCAGTACTTCGGGCCG	CASRSTGTGGAQYF	In	VDJ	1	85	3.1941798285664894E-4	3.7819968053250515E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	0	10	7	3	26	37	56	44	59		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRSTGTGGAQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGAGGAGGGGACAACGGGGCTACACCTTCGGTTCG	CASSQRRGQRGYTF	In	VDJ	1	86	3.231758414784919E-4	3.826490885387699E-4	42	TCRBV03						TCRBJ01	TCRBJ01-02	01	3	0	6	8	6	4	26	40	52	46	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRRGQRGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACAGACACCCGCTACGAGCAGTACTTCGGGCCG	CSARTDTRYEQYF	In	VDJ	1	86	3.231758414784919E-4	3.826490885387699E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	5	3	0	7	26	-1	42	37	49		TCRBV20-01,TCRBV20-or09_02												CSARTDTRYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGAGAGGGAGCCCCACAGATACGCAGTATTTTGGCCCA	CSARRGSPTDTQYF	In	VDJ	1	86	3.231758414784919E-4	3.826490885387699E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	9	2	2	6	3	26	35	46	41	49		TCRBV20-01,TCRBV20-or09_02												CSARRGSPTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGCCTGCGGGAGAGACCCAGTACTTCGGGCCA	CSAGPAGETQYF	In	VDJ	1	86	3.231758414784919E-4	3.826490885387699E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	7	4	4	6	0	26	35	-1	41	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGPAGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGGAGGAAGGGTGGGCGGGGGTGAAGAGACCCAGTACTTCGGGCCA	CATSDGGRVGGGEETQYF	In	VDJ	1	86	3.231758414784919E-4	3.826490885387699E-4	54	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	7	2	3	14	2	24	38	59	52	61		TCRBV24-01,TCRBV24-or09_02												CATSDGGRVGGGEETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCTTACAGGGAAGGGCCACTGAAGCTTTCTTTGGACAA	CASSLQGRATEAFF	In	VDJ	1	86	3.231758414784919E-4	3.826490885387699E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	3	4	3	6	24	35	44	38	50		TCRBV24-01,TCRBV24-or09_02												CASSLQGRATEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACCCGGGGGACAGCCCCCTACGAGCAGTACTTCGGGCCG	CASSQTRGTAPYEQYF	In	VDJ	1	87	3.269337001003348E-4	3.870984965450347E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	5	2	6	3	26	41	54	47	57		TCRBV03-01,TCRBV03-02												CASSQTRGTAPYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGAAGCTTGGGGCTAGCGGGGTGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	87	3.269337001003348E-4		49	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	4	2	3	18	34	45	36	48	TCRBV05,TCRBV07													X+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCGCCAGCCCCAGGGGGCTCTTCGAGCAGTACTTCGGGCCG	CASSASPRGLFEQYF	In	VDJ	1	87	3.269337001003348E-4	3.870984965450347E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	0	6	8	4	18	30	46	38	50	TCRBV07,TCRBV11													CASSASPRGLFEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTACGGACAGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSYGQGAYEQYF	In	VDJ	1	88	3.3069155872217777E-4	3.9154790455129943E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	1	2	2	0	26	39	-1	41	51		TCRBV12-03,TCRBV12-04												CASSYGQGAYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGGGGCTCCTATGGCTACACCTTCGGTTCG	CASSLGGSYGYTF	In	VDJ	1	88	3.3069155872217777E-4	3.9154790455129943E-4	39	TCRBV12						TCRBJ01	TCRBJ01-02	01	3	6	0	4	1	2	26	40	47	41	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGSYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCACGAGGTTAGCGGCTACAATGAGCAGTTCTTCGGGCCA	CSAHEVSGYNEQFF	In	VDJ	1	88	3.3069155872217777E-4	3.9154790455129943E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	5	3	8	0	26	35	-1	43	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAHEVSGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTTCTAGGAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSFLGGAGELFF	In	VDJ	1	88	3.3069155872217777E-4	3.9154790455129943E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	10	0	6	4	1	19	33	43	37	44	TCRBV07,TCRBV11													CASSFLGGAGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGAGACTAGCGGGCCCCTGGGGGTAGAGACCCAGTACTTCGGGCCA	CSETSGPLGVETQYF	In	VDJ	1	89	3.344494173440207E-4	3.9599731255756423E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	2	4	4	1	11	26	33	44	34	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSETSGPLGVETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCCCGGACAGGGACAAGAGACCCAGTACTTCGGGCCA	CSANPGQGQETQYF	In	VDJ	1	89	3.344494173440207E-4	3.9599731255756423E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	3	2	5	1	26	36	49	41	50		TCRBV20-01,TCRBV20-or09_02												CSANPGQGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGAAGGGCCGGGCTCTGAAGCTTTCTTTGGACAA	CSARVEGPGSEAFF	In	VDJ	1	89	3.344494173440207E-4	3.9599731255756423E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	1	5	3	6	4	7	26	39	47	43	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVEGPGSEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCCGACGGGTTCTTCTACGAGCAGTACTTCGGGCCG	CASSPDGFFYEQYF	In	VDJ	1	89	3.344494173440207E-4	3.9599731255756423E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	4	3	4	5	23	36	44	40	49	TCRBV01,TCRBV04					01,02								CASSPDGFFYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGTTCGGGGAGCCGGGGAGCTGTTTTTTGGAGAA	CASSLAVRGAGELFF	In	VDJ	1	89	3.344494173440207E-4	3.9599731255756423E-4	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	8	3	6	4	2	18	35	44	39	46	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAVRGAGELFF+X+TCRBJ02-02		TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGTCACTAGCGGGAGGTAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	90	3.382072759658636E-4		46	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	3	1	5	3	1	26	40	55	43	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCAGACAGGGCTGGCGAGCAGTACTTCGGGCCG	CSAPDRAGEQYF	In	VDJ	2	90	3.382072759658636E-4	4.00446720563829E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	6	4	4	26	34	45	38	49		TCRBV20-01,TCRBV20-or09_02												CSAPDRAGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCCCGTAGCGGCGCTGGAGACCCAGTACTTCGGGCCA	CSAPPVAALETQYF	In	VDJ	2	90	3.382072759658636E-4	4.00446720563829E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	5	5	5	7	5	26	35	48	42	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPPVAALETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGGGACAGGGAGGTTTGGCAGCCCCAGCATTTTGGTGAT	CASSRDREVWQPQHF	In	VDJ	2	90	3.382072759658636E-4	4.00446720563829E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	3	7	0	8	23	-1	45	36	53	TCRBV01,TCRBV04													CASSRDREVWQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTAGAGGTAGGGACAAAGCTTTCTTTGGACAA		Out	VDJ	2	91	3.4196513458770655E-4		34	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	6	9	9	0	26	34	-1	43	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGGTGGCACCGGACTATGGCTACACCTTCGGTTCG	CSAMVAPDYGYTF	In	VDJ	2	91	3.4196513458770655E-4	4.048961285700938E-4	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	4	9	0	3	4	5	26	36	43	40	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAMVAPDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGGCCCAGTTGTGGTTACGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	91	3.4196513458770655E-4		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	11	4	5	0	4	11	24	31	38	35	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTAAGGCCAGGGCCATACAATGAGCAGTTCTTCGGGCCA	CASSLRPGPYNEQFF	In	VDJ	2	91	3.4196513458770655E-4	4.048961285700938E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	3	4	4	3	18	33	42	37	45	TCRBV11,TCRBV23													CASSLRPGPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTCTGAGGGGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	91	3.4196513458770655E-4		43	unresolved						TCRBJ01	TCRBJ01-01	01	5	5	2	0	5	1	24	36	46	41	47	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTTCCCTGGGACAGGGATTTACAATGAGCAGTTCTTCGGGCCA	CSAFPGTGIYNEQFF	In	VDJ	2	92	3.4572299320954946E-4	4.093455365763585E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	4	7	3	26	34	50	41	53		TCRBV20-01,TCRBV20-or09_02												CSAFPGTGIYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCACCCGAGGAGGGCCTAACCAAGAGACCCAGTACTTCGGGCCA	CATRGGPNQETQYF	In	VDJ	2	92	3.4572299320954946E-4	4.093455365763585E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	10	10	0	0	5	4	22	29	40	34	44	TCRBV02,TCRBV12													CATRGGPNQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAATCCCTAGCGGGAGCCCGTACCAAGAGACCCAGTACTTCGGGCCA	CASSLIPSGSPYQETQYF	In	VDJ	2	92	3.4572299320954946E-4	4.093455365763585E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	4	2	0	4	5	18	33	47	37	52	TCRBV07,TCRBV11													CASSLIPSGSPYQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGAGGGCAGAATCAGCCCCAGCATTTTGGTGAT	CASSLGGQNQPQHF	In	VDJ	2	93	3.494808518313924E-4	4.1379494458262326E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	9	0	4	0	3	26	-1	47	40	50		TCRBV12-03,TCRBV12-04												CASSLGGQNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01*02	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCAGGGCAGCGGCCCTACGAGCAGTACTTCGGGCCG	CSAPGQRPYEQYF	In	VDJ	2	93	3.494808518313924E-4	4.1379494458262326E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	4	3	2	2	7	26	34	41	36	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPGQRPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCACTAGCGGGGGGGCCAGATACGCAGTATTTTGGCCCA	CSASPLAGGPDTQYF	In	VDJ	2	93	3.494808518313924E-4	4.1379494458262326E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	3	0	4	3	1	26	37	53	40	54		TCRBV20-01,TCRBV20-or09_02												CSASPLAGGPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGATTCCTAGCGGGGCCGAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	94	3.532387104532353E-4		49	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	4	3	5	5	3	26	42	56	47	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGACTAGCGGGGGATCCAATGAGCAGTTCTTCGGGCCA	CSASTSGGSNEQFF	In	VDJ	2	94	3.532387104532353E-4	4.1824435258888806E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	2	2	6	2	3	26	35	49	37	52		TCRBV20-01,TCRBV20-or09_02												CSASTSGGSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGTCACGGGACAGGGGGCTCTATGAGCAGTTCTTCGGGCCA	CASRSRDRGLYEQFF	In	VDJ	2	95	3.5699656907507823E-4	4.226937605951528E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	0	8	5	3	26	37	54	42	57		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRSRDRGLYEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCCCGGACAGGTACCTACGAGCAGTACTTCGGGCCG	CSAARTGTYEQYF	In	VDJ	2	95	3.5699656907507823E-4	4.226937605951528E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	4	2	5	2	26	34	46	39	48		TCRBV20-01,TCRBV20-or09_02												CSAARTGTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGAGGAGATTCGGCAGCTTATYYYKRWGMCAGCWSMYWSWMYAKCKGSAGTKCTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CXXSXXXXXXXGANVLTF	In	VJ	2	95	3.5699656907507823E-4	4.226937605951528E-4	33	unresolved			unresolved			TCRBJ02	TCRBJ02-06	01	5	0	0	1	0	0	26	-1	-1	-1	35	TCRBV18,TCRBV20			TCRBD02										CXXSXXXXXXXGANVLTF+X+TCRBJ02-06	unresolved	unresolved	TCRBJ02-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTATCTGCGGCCGGGACAGGGGGTGGGCGAGCAGTACTTCGGGCCG		Out	VDJ	2	95	3.5699656907507823E-4		52	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	6	12	4	24	36	59	48	63	TCRBV06,TCRBV24,TCRBV27													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAAGTCCTCATGCGGGAGCAGTTCTTCGGGCCA	CSAEVLMREQFF	In	VDJ	2	96	3.607544276969212E-4	4.271431686014176E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	5	10	11	0	26	35	-1	46	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSAEVLMREQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAACCACGAGAGACTAGCGGGGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	97	3.645122863187641E-4		50	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	1	10	0	26	37	-1	47	58		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCCGGACTAACACCTACAATGAGCAGTTCTTCGGGCCA	CASSPRTNTYNEQFF	In	VDJ	2	97	3.645122863187641E-4	4.3159257660768235E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	9	2	4	3	26	38	48	42	51		TCRBV12-03,TCRBV12-04				01,02								CASSPRTNTYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGAGGGACCATCAGCCCCAGCATTTTGGTGAT	CASSLRDHQPQHF	In	VDJ	2	97	3.645122863187641E-4	4.3159257660768235E-4	39	TCRBV12						TCRBJ01	TCRBJ01-05	01	3	0	7	5	2	1	26	40	47	42	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRDHQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGTTCCCAATTCACCGGGGAGCTGTTTTTTGGAGAA	CSGSQFTGELFF	In	VDJ	2	97	3.645122863187641E-4	4.3159257660768235E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	6	4	5	3	26	33	40	38	43		TCRBV20-01,TCRBV20-or09_02												CSGSQFTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGAGGTCCCCTACAATGAGCAGTTCTTCGGGCCA	CASSFEVPYNEQFF	In	VDJ	2	98	3.6827014494060707E-4	4.360419846139471E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	1	2	1	3	26	40	45	41	48		TCRBV12-03,TCRBV12-04												CASSFEVPYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGCCGGGACAGGGGGATGGATGAGCAGTTCTTCGGGCCA	CSARRDRGMDEQFF	In	VDJ	2	98	3.6827014494060707E-4	4.360419846139471E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	1	8	5	4	26	34	50	39	54		TCRBV20-01,TCRBV20-or09_02												CSARRDRGMDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCACGGGGTTTACGAAAAACTGTTTTTTGGCAGT	CSASHGVYEKLFF	In	VDJ	2	98	3.6827014494060707E-4	4.360419846139471E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	3	8	3	5	26	37	45	40	50		TCRBV20-01,TCRBV20-or09_02												CSASHGVYEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTTAATCGACTAGCGGGACCTAATGAGCAGTTCTTCGGGCCA	CSAVNRLAGPNEQFF	In	VDJ	2	98	3.6827014494060707E-4	4.360419846139471E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	2	3	7	7	3	26	35	53	42	56		TCRBV20-01,TCRBV20-or09_02												CSAVNRLAGPNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGGGACAGACATGGACTGAAGCTTTCTTTGGACAA	CASSLAGQTWTEAFF	In	VDJ	2	99	3.7202800356245E-4	4.404913926202119E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	5	5	0	6	26	-1	50	43	56		TCRBV12-03,TCRBV12-04												CASSLAGQTWTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAACCGGGACTACCCCAAGAGGGGGAGCTGTTTTTTGGAGAA	CSAKPGLPQEGELFF	In	VDJ	2	99	3.7202800356245E-4	4.404913926202119E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	9	8	4	9	26	36	47	40	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKPGLPQEGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGAAGCGACAGGGCTCATGAACACTGAAGCTTTCTTTGGACAA	CASREATGLMNTEAFF	In	VDJ	2	99	3.7202800356245E-4	4.404913926202119E-4	48	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	3	0	0	4	23	-1	47	40	51		TCRBV06-01,TCRBV06-08												CASREATGLMNTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTGCCCAGCGGGCAACAAGAGACCCAGTACTTCGGGCCA	CASSLPSGQQETQYF	In	VDJ	2	99	3.7202800356245E-4	4.404913926202119E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	6	4	2	7	3	20	31	44	38	47	TCRBV11,TCRBV23					01,02								CASSLPSGQQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTCATACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	100	3.757858621842929E-4		35	TCRBV12						TCRBJ02	TCRBJ02-03	01	6	4	6	3	3	1	26	37	42	40	43		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACTAGCCTTAACGACTACGAGCAGTACTTCGGGCCG	CSTSLNDYEQYF	In	VDJ	2	100	3.757858621842929E-4	4.4494080062647663E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	2	8	3	7	0	26	37	-1	44	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSTSLNDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGGGGTATGTGGGCCTAGAGACCCAGTACTTCGGGCCA	CSARGYVGLETQYF	In	VDJ	2	100	3.757858621842929E-4	4.4494080062647663E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	2	4	1	11	26	34	41	35	52		TCRBV20-01,TCRBV20-or09_02												CSARGYVGLETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAGACAAGGGTGAACTACGAGCAGTACTTCGGGCCG	CSARQTRVNYEQYF	In	VDJ	2	100	3.757858621842929E-4	4.4494080062647663E-4	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	2	2	6	3	2	8	26	38	44	40	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARQTRVNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGTCCCGACAGGGTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	100	3.757858621842929E-4		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	2	3	4	5	0	23	40	-1	45	52	TCRBV01,TCRBV04													X+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCTCCCCGTTATCAGCCCCAGCATTTTGGTGAT	CASSLSPRYQPQHF	In	VDJ	2	100	3.757858621842929E-4	4.4494080062647663E-4	42				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	4	10	5	4	7	24	36	42	40	49	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01				01,02								CASSLSPRYQPQHF+X+TCRBJ01-05		TCRBD02-01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCTGGAGGGGTGGGTCCTACGAGCAGTACTTCGGGCCG	CASWRGGSYEQYF	In	VDJ	2	100	3.757858621842929E-4	4.4494080062647663E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	11	10	0	1	3	5	24	31	40	34	45		TCRBV24-01,TCRBV24-or09_02												CASWRGGSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCSRGGGACTCAGCTGTGTATYTYTGTGCCAGCAGCATAGCGGGAGGGCCGGATACGCAGTATTTTGGCCCA	CASSIAGGPDTQYF	In	VDJ	2	101	3.7954372080613584E-4	4.4939020863274143E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	5	0	6	2	3	26	37	50	39	53	TCRBV07,TCRBV12													CASSIAGGPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGTACCGCAGGGAATGCGAACACTGAAGCTTTCTTTGGACAA	CASTAGNANTEAFF	In	VDJ	2	101	3.7954372080613584E-4	4.4939020863274143E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	4	3	1	6	5	24	31	42	37	47	TCRBV09,TCRBV21													CASTAGNANTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTATCGACAGATAACACTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	102	3.8330157942797875E-4		46				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	5	3	5	6	24	38	48	43	54	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03												X+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGGACAGGGTTGTGGACACCCCTCCACTTTGGGAAC	CSAGTGLWTPLHF	In	VDJ	2	102	3.8330157942797875E-4	4.538396166390062E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	3	11	1	7	26	34	44	35	51		TCRBV20-01,TCRBV20-or09_02												CSAGTGLWTPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGATAGCGGGAATTTACGAGCAGTACTTCGGGCCG	CSARIAGIYEQYF	In	VDJ	2	102	3.8330157942797875E-4	4.538396166390062E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	3	4	2	3	26	37	47	39	50		TCRBV20-01,TCRBV20-or09_02												CSARIAGIYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTCCGGGACCTAGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSFRDLGTGELFF	In	VDJ	2	102	3.8330157942797875E-4	4.538396166390062E-4	45	unresolved						TCRBJ02	TCRBJ02-02	01	3	0	7	5	2	6	18	32	39	34	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRDLGTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTCTCCGGGACCTTCAGGGAGACCCAGTACTTCGGGCCA	CASSFSGTFRETQYF	In	VDJ	2	102	3.8330157942797875E-4	4.538396166390062E-4	45	unresolved						TCRBJ02	TCRBJ02-05	01	3	0	7	5	4	7	18	32	41	36	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSGTFRETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGGGGACAGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSSGTGANTEAFF	In	VDJ	2	103	3.870594380498217E-4	4.582890246452709E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	2	1	2	1	26	39	51	41	52		TCRBV12-03,TCRBV12-04												CASSSGTGANTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACGGGGGGCCGGGAGAGACCCAGTACTTCGGGCCA	CASSHGGPGETQYF	In	VDJ	2	103	3.870594380498217E-4	4.582890246452709E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	1	4	0	5	26	-1	47	40	52		TCRBV03-01,TCRBV03-02												CASSHGGPGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAATGGGGGGAAGAGACCCAGTACTTCGGGCCA	CSAREWGEETQYF	In	VDJ	2	103	3.870594380498217E-4	4.582890246452709E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	9	1	3	2	0	26	40	-1	42	48		TCRBV20-01,TCRBV20-or09_02												CSAREWGEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGCGGGGGGCCCCTACGAGCAGTACTTCGGGCCG	CASSLAGGPYEQYF	In	VDJ	2	103	3.870594380498217E-4	4.582890246452709E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	7	1	2	1	2	19	33	42	34	44	TCRBV07,TCRBV11													CASSLAGGPYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGTGTCCAGGGTGGACAATCAGCCCCAGCATTTTGGTGAT	CASSVSRVDNQPQHF	In	VDJ	2	103	3.870594380498217E-4	4.582890246452709E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	3	6	4	23	34	45	40	49	TCRBV02,TCRBV09													CASSVSRVDNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGACAGGCCAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSTGQSSYNEQFF	In	VDJ	2	104	3.908172966716646E-4	4.627384326515357E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	4	0	1	6	26	39	46	40	52		TCRBV12-03,TCRBV12-04												CASSSTGQSSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGCGGTCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGGPSTDTQYF	In	VDJ	2	104	3.908172966716646E-4	4.627384326515357E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	7	5	0	0	4	26	-1	46	42	50		TCRBV12-03,TCRBV12-04				01,02								CASSLGGPSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACTACAGGRTAACACTGAAGCTTTCTTTGGACAA	CASSQLQXNTEAFF	In	VDJ	2	104	3.908172966716646E-4	4.627384326515357E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	2	2	1	26	41	49	43	50		TCRBV03-01,TCRBV03-02												CASSQLQXNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGGACGGCAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAGTASSYNEQFF	In	VDJ	2	104	3.908172966716646E-4	4.627384326515357E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	0	7	0	1	6	26	34	40	35	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGTASSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCACCCGGTCCCCGTTAGGCTATGGCTACACCTTCGGTTCG	CASSTRSPLGYGYTF	In	VDJ	2	104	3.908172966716646E-4	4.627384326515357E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	5	5	4	4	14	0	18	30	-1	44	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTRSPLGYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCCCCCGGACCCGGAAGGATGAAAAACTGTTTTTTGGCAGT	CASSPRTRKDEKLFF	In	VDJ	2	104	3.908172966716646E-4	4.627384326515357E-4	45	unresolved						TCRBJ01	TCRBJ01-04	01	4	1	7	6	4	8	23	35	43	39	51	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRTRKDEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCGGGCCCAAACACTGAAGCTTTCTTTGGACAA	CASSPGPNTEAFF	In	VDJ	2	105	3.9457515529350753E-4	4.6718784065780046E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	8	0	2	3	3	26	37	44	40	47		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGACAGGGGGCGAGTATCAGCCCCAGCATTTTGGTGAT	CSARTGGEYQPQHF	In	VDJ	2	105	3.9457515529350753E-4	4.6718784065780046E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	0	5	2	4	26	34	47	36	51		TCRBV20-01,TCRBV20-or09_02												CSARTGGEYQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAGTCAGCAGCACAGATACGCAGTATTTTGGCCCA	CSAIVSSTDTQYF	In	VDJ	2	105	3.9457515529350753E-4	4.6718784065780046E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	4	4	5	0	4	1	26	36	43	40	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAIVSSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCAAGCGGGGGTTTCGAGACCCAGTACTTCGGGCCA	CSAPSGGFETQYF	In	VDJ	2	105	3.9457515529350753E-4	4.6718784065780046E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	6	2	5	3	4	26	35	46	38	50		TCRBV20-01,TCRBV20-or09_02												CSAPSGGFETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCATGGGGACGTTCGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	105	3.9457515529350753E-4		38	unresolved						TCRBJ01	TCRBJ01-01	01	10	0	7	1	2	5	23	30	37	32	42	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGGGACTAGCCAACTCCTACGAGCAGTACTTCGGGCCG	CSAQGLANSYEQYF	In	VDJ	2	106	3.983330139153505E-4	4.7163724866406526E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	7	0	3	3	26	34	46	37	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAQGLANSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGCGTGGAGCGGTCTCTACAATGAGCAGTTCTTCGGGCCA	CSAPAWSGLYNEQFF	In	VDJ	2	106	3.983330139153505E-4	4.7163724866406526E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	6	5	3	9	3	26	35	49	44	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPAWSGLYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGATTTCACTAGGGAGGAGGACCCACTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	106	3.983330139153505E-4		58	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	9	1	3	10	8	22	34	50	44	58		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD02-01*02	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTACCAAGCGGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSTKRGSTDTQYF	In	VDJ	2	106	3.983330139153505E-4	4.7163724866406526E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	6	3	0	4	1	23	35	46	39	47	TCRBV06,TCRBV10													CASSTKRGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGGGGCTCCCAACACTGAAGCTTTCTTTGGACAA	CASSLGAPNTEAFF	In	VDJ	2	106	3.983330139153505E-4	4.7163724866406526E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	6	0	2	0	4	18	-1	38	32	42	TCRBV07,TCRBV11													CASSLGAPNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATCGAGTAGCGGGGGGCCCCTCGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	106	3.983330139153505E-4		56	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	5	1	1	5	7	25	39	54	44	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCCCTCGCGGGGTGGGACATGCCAATGAGCAGTTCTTCGGGCCA	CASSPRGVGHANEQFF	In	VDJ	2	106	3.983330139153505E-4	4.7163724866406526E-4	48	unresolved						TCRBJ02	TCRBJ02-01	01	4	0	6	6	11	3	23	35	52	46	55	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRGVGHANEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAATCCAGGGACATAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	107	4.020908725371934E-4		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	0	6	5	5	3	26	43	54	48	57		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGGCCTGACAGTCCCAGCACTGAAGCTTTCTTTGGACAA	CARPDSPSTEAFF	In	VDJ	2	107	4.020908725371934E-4	4.7608665667033E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	2	5	4	4	6	26	34	43	38	49		TCRBV03-01,TCRBV03-02												CARPDSPSTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATCGGCCTGAGGTCTACGAGCAGTACTTCGGGCCG	CSANRPEVYEQYF	In	VDJ	2	107	4.020908725371934E-4	4.7608665667033E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	11	1	3	8	1	26	36	48	44	49		TCRBV20-01,TCRBV20-or09_02												CSANRPEVYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTTGCGGGAGCCCTAGATACGCAGTATTTTGGCCCA	CASSLFAGALDTQYF	In	VDJ	2	107	4.020908725371934E-4	4.7608665667033E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	7	2	5	6	4	24	36	49	42	53		TCRBV24-01,TCRBV24-or09_02												CASSLFAGALDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAGCGGGAGCGAAAGAGACCCAGTACTTCGGGCCA	CASRAGAKETQYF	In	VDJ	2	108	4.0584873115903636E-4	4.805360646765948E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	6	2	3	0	3	26	-1	45	37	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRAGAKETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CSASSGSTDTQYF	In	VDJ	2	108	4.0584873115903636E-4	4.805360646765948E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	5	4	0	0	0	26	-1	-1	37	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSASSGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCTCGCTAGGGGCAAGCCCCAGCATTTTGGTGAT	CASSQDLARGKPQHF	In	VDJ	2	108	4.0584873115903636E-4	4.805360646765948E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	2	8	7	2	23	40	52	47	54	TCRBV01,TCRBV04													CASSQDLARGKPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCGAGCGGGAGGGGGCCATGAGCAGTTCTTCGGGCCA	CATSRAGGGHEQFF	In	VDJ	2	108	4.0584873115903636E-4	4.805360646765948E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	6	0	8	2	4	24	36	48	38	52		TCRBV24-01,TCRBV24-or09_02												CATSRAGGGHEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTACATGGGATGGGGACGCAGTATTTTGGCCCA	CASSLHGMGTQYF	In	VDJ	2	109	4.0960658978087927E-4	4.8498547268285955E-4	39	unresolved						TCRBJ02	TCRBJ02-03	01	2	0	8	9	3	5	26	41	48	44	53	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLHGMGTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTGGACAGGGGGCATAGAGACCCAGTACTTCGGGCCA	CSASWTGGIETQYF	In	VDJ	2	109	4.0960658978087927E-4	4.8498547268285955E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	0	4	2	2	26	37	50	39	52		TCRBV20-01,TCRBV20-or09_02												CSASWTGGIETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAAGACAGCTTCAATCGGGACGAGCAGTACTTCGGGCCG	CSAEDSFNRDEQYF	In	VDJ	2	109	4.0960658978087927E-4	4.8498547268285955E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	5	3	11	26	35	43	38	54		TCRBV20-01,TCRBV20-or09_02												CSAEDSFNRDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTACTAGCGGGAGACAATGAGCAGTTCTTCGGGCCA	CATSDLLAGDNEQFF	In	VDJ	2	109	4.0960658978087927E-4	4.8498547268285955E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	3	2	5	0	0	24	-1	-1	41	52		TCRBV24-01,TCRBV24-or09_02												CATSDLLAGDNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAAGACTAGCGGGAGCCACGAGCAGTACTTCGGGCCG	CASSKTSGSHEQYF	In	VDJ	2	110	4.133644484027222E-4	4.894348806891243E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	2	2	5	2	2	26	38	52	40	54		TCRBV12-03,TCRBV12-04												CASSKTSGSHEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACTAGCGGGAGGGATACGCAGTATTTTGGCCCA		Out	VDJ	2	110	4.133644484027222E-4		43	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	4	1	6	0	0	26	-1	-1	43	54		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGACAGGGGGATCCAATGAGCAGTTCTTCGGGCCA	CSARGTGGSNEQFF	In	VDJ	2	110	4.133644484027222E-4	4.894348806891243E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	1	6	1	3	26	37	49	38	52		TCRBV20-01,TCRBV20-or09_02												CSARGTGGSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCTCAGCGGGGGCGGTCAGATACGCAGTATTTTGGCCCA	CASSQAQRGRSDTQYF	In	VDJ	2	110	4.133644484027222E-4	4.894348806891243E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	6	2	4	3	4	23	39	50	42	54	TCRBV01,TCRBV04													CASSQAQRGRSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCYACCAAAAACAGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	110	4.133644484027222E-4		35	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	3	3	3	3	0	24	34	-1	37	43		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAATTTAGGGCTAGCGGGGAGCTGTTTTTTGGAGAA	CASSQFRASGELFF	In	VDJ	2	111	4.1712230702456514E-4	4.938842886953891E-4	42	unresolved						TCRBJ02	TCRBJ02-02	01	2	5	3	7	3	4	23	38	45	41	49	TCRBV01,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQFRASGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACGGACAGGGAAAACTATGGCTACACCTTCGGTTCG	CSATDRENYGYTF	In	VDJ	2	111	4.1712230702456514E-4	4.938842886953891E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	2	3	2	26	34	45	37	47		TCRBV20-01,TCRBV20-or09_02												CSATDRENYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTAGGGGACAGCGGTCCTACGAGCAGTACTTCGGGCCG	CASSRGQRSYEQYF	In	VDJ	2	111	4.1712230702456514E-4	4.938842886953891E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	1	2	3	23	35	44	37	47	TCRBV06,TCRBV10													CASSRGQRSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGATGGACAGGGCGAACACTGAAGCTTTCTTTGGACAA	CSAMDRANTEAFF	In	VDJ	2	112	4.2088016564640804E-4	4.983336967016538E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	1	3	1	26	34	45	37	46		TCRBV20-01,TCRBV20-or09_02												CSAMDRANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTAGGGGGACAGGGAGAGATCACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	112	4.2088016564640804E-4		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	4	3	6	24	36	48	39	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCTGGCCCCGTCCCCAGGGGCTTCTGACTGAAGCTTTCTTTGGACAA	CASWPRPQGLLTEAFF	In	VDJ	2	112	4.2088016564640804E-4	4.983336967016538E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	4	2	5	12	6	23	32	50	44	56	TCRBV06,TCRBV10													CASWPRPQGLLTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTGCGGACTAGCGGGGATCCCTACGAGCAGTACTTCGGGCCG	CSALRTSGDPYEQYF	In	VDJ	2	113	4.24638024268251E-4	5.027831047079186E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	1	3	2	5	3	26	34	51	39	54		TCRBV20-01,TCRBV20-or09_02												CSALRTSGDPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCAGGACAGCTTGGGGGAGACCCAGTACTTCGGGCCA	CSASQDSLGETQYF	In	VDJ	2	113	4.24638024268251E-4	5.027831047079186E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	5	5	3	7	26	37	46	40	53		TCRBV20-01,TCRBV20-or09_02												CSASQDSLGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCGCGGGACTAGGGACGATACGCAGTATTTTGGCCCA	YASSRGTRDDTQYF	In	VDJ	2	113	4.24638024268251E-4	5.027831047079186E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	8	6	3	4	22	34	45	37	49	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01				01,02								YASSRGTRDDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGGGAGTATCGCGGGGCACAGATACGCAGTATTTTGGCCCA	CASSVGGVSRGTDTQYF	In	VDJ	2	113	4.24638024268251E-4	5.027831047079186E-4	51	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	0	7	4	1	10	0	23	39	-1	49	54	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVGGVSRGTDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCGACTAGCGGGGGTTCCGGGCCAAGAGACCCAGTACTTCGGGCCA	CSATRLAGVPGQETQYF	In	VDJ	2	114	4.283958828900939E-4	5.072325127141834E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	2	2	1	3	7	26	36	51	39	58		TCRBV20-01,TCRBV20-or09_02												CSATRLAGVPGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATCCCCGGACAGGATAACACCGGGGAGCTGTTTTTTGGAGAA	CSARIPGQDNTGELFF	In	VDJ	2	114	4.283958828900939E-4	5.072325127141834E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	4	2	6	2	26	38	51	44	53		TCRBV20-01,TCRBV20-or09_02												CSARIPGQDNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCCCGGGGGGGCCTACGAGCAGTACTTCGGGCCG	CASRPGGAYEQYF	In	VDJ	2	115	4.321537415119368E-4	5.116819207204482E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	0	2	3	0	26	37	-1	40	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRPGGAYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAACCCCGGGACAGGGGGCGTCTACGAGCAGTACTTCGGGCCG	CSANPGTGGVYEQYF	In	VDJ	2	115	4.321537415119368E-4	5.116819207204482E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	0	3	7	2	26	34	53	41	55		TCRBV20-01,TCRBV20-or09_02												CSANPGTGGVYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCGACACTCCTTGTGGAGCAGTTCTTCGGGCCA	CSAATLLVEQFF	In	VDJ	2	115	4.321537415119368E-4	5.116819207204482E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	6	10	3	9	26	34	41	37	50		TCRBV20-01,TCRBV20-or09_02												CSAATLLVEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCACAGGGACTTCAAGAGACCCAGTACTTCGGGCCA	CSASPQGLQETQYF	In	VDJ	2	115	4.321537415119368E-4	5.116819207204482E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	3	3	3	2	3	4	26	37	46	40	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASPQGLQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTAAATCCAGGACAGGTCTTCAATGAGCAGTTCTTCGGGCCA	CASSLNPGQVFNEQFF	In	VDJ	2	115	4.321537415119368E-4	5.116819207204482E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	4	6	6	4	18	33	46	39	50	TCRBV07,TCRBV11													CASSLNPGQVFNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCCCCCTTAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	115	4.321537415119368E-4		43	unresolved						TCRBJ01	TCRBJ01-06	01	11	4	5	0	2	10	22	25	30	27	40	TCRBV04,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTGGATAGGAATGGCCGGGGAGCTGTTTTTTGGAGAA	CASSQDWIGMAGELFF	In	VDJ	2	116	4.359116001337798E-4	5.161313287267129E-4	48	TCRBV03						TCRBJ02	TCRBJ02-02	01	0	1	8	6	2	9	26	43	48	45	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDWIGMAGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCTCGTACGGGCGCGGGAGAGACCCAGTACTTCGGGCCA	CASSPRTGAGETQYF	In	VDJ	2	116	4.359116001337798E-4	5.161313287267129E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	7	4	4	11	0	23	36	-1	47	52	TCRBV01,TCRBV04					01,02								CASSPRTGAGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGAGAGCGGGGCACAGATACGCAGTATTTTGGCCCA	CSAGERGTDTQYF	In	VDJ	2	117	4.396694587556227E-4	5.205807367329777E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	4	1	0	0	26	-1	-1	40	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGERGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGATCGTTACCAGAGCGAGACCCAGTACTTCGGGCCA	CASSQDRYQSETQYF	In	VDJ	2	117	4.396694587556227E-4	5.205807367329777E-4	45	unresolved						TCRBJ02	TCRBJ02-05	01	0	4	5	5	7	3	23	40	50	47	53	TCRBV04,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRYQSETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCTGGCAGGGGTAATTTACCCCTCCACTTTGGGAAC	CSARDPGRGNLPLHF	In	VDJ	2	118	4.434273173774656E-4	5.250301447392424E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	4	2	12	6	6	26	40	52	46	58		TCRBV20-01,TCRBV20-or09_02												CSARDPGRGNLPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCCCGGGACACCTTATACTTCGGGCCA	CATSDPRDTLYF	In	VDJ	2	118	4.434273173774656E-4	5.250301447392424E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	6	14	5	5	24	38	49	43	54		TCRBV24-01,TCRBV24-or09_02												CATSDPRDTLYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCCTGACAAACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSALTNSYNEQFF	In	VDJ	2	118	4.434273173774656E-4	5.250301447392424E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	6	0	4	2	23	36	44	40	46	TCRBV09,TCRBV21													CASSALTNSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGTGGAGTGATTCACCCCTCCACTTTGGGAAC	CASRWSDSPLHF	In	VDJ	2	119	4.4718517599930856E-4	5.294795527455073E-4	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	10	2	8	2	2	26	37	43	39	45		TCRBV03-01,TCRBV03-02												CASRWSDSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01*02	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTAACGGGCCTCGGCTGGGATTCACCCCTCCACTTTGGGAAC	CSVTGLGWDSPLHF	In	VDJ	2	119	4.4718517599930856E-4	5.294795527455073E-4	42	TCRBV20						TCRBJ01	TCRBJ01-06	01	7	8	0	8	4	10	26	33	41	37	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVTGLGWDSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSFGGNTEAFF	In	VDJ	2	121	4.5470089324299443E-4	5.383783687580367E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	6	1	1	1	0	26	40	-1	41	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGGNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTGGCCTAGCAGATTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	121	4.5470089324299443E-4		49	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	2	4	7	0	5	5	26	38	48	43	53		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCCTTTCGGGGACCCGTAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	121	4.5470089324299443E-4		46	TCRBV24						TCRBJ02	TCRBJ02-03	01	5	0	7	5	8	4	24	37	50	45	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTGCCAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CATCQGNTGELFF	In	VDJ	2	122	4.5845875186483734E-4	5.428277767643015E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	4	3	1	3	0	24	33	-1	36	41		TCRBV24-01,TCRBV24-or09_02												CATCQGNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTTTAGGGGGCTGGACGAGCAGTACTTCGGGCCG	CSARFRGLDEQYF	In	VDJ	2	123	4.6221661048668025E-4	5.472771847705662E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	5	0	5	4	3	26	37	48	41	51		TCRBV20-01,TCRBV20-or09_02												CSARFRGLDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCAAGGGACAGGGGGCACATCATGAACACTGAAGCTTTCTTTGGACAA	CASSPRDRGHIMNTEAFF	In	VDJ	2	124	4.659744691085232E-4	5.517265927768311E-4	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	0	0	4	6	24	36	52	40	58		TCRBV24-01,TCRBV24-or09_02												CASSPRDRGHIMNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGGAGGGGGGCCCCGGAGTGAAAAACTGTTTTTTGGCAGT	CASSLGGGPRSEKLFF	In	VDJ	2	124	4.659744691085232E-4	5.517265927768311E-4	48	unresolved			unresolved			TCRBJ01	TCRBJ01-04	01	3	9	0	7	0	11	18	-1	39	32	50	TCRBV05,TCRBV11			TCRBD01,TCRBD02										CASSLGGGPRSEKLFF+X+TCRBJ01-04	unresolved	unresolved	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGCCCCTCACAGGAAACCCGGGGAGCTGTTTTTTGGAGAA	CASSAPHRKPGELFF	In	VDJ	2	125	4.697323277303661E-4	5.561760007830958E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	4	6	7	4	26	38	50	45	54		TCRBV12-03,TCRBV12-04												CASSAPHRKPGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGTGACATGAACACTGAAGCTTTCTTTGGACAA	CASSLGDMNTEAFF	In	VDJ	2	125	4.697323277303661E-4	5.561760007830958E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	6	0	4	0	26	40	-1	44	48		TCRBV12-03,TCRBV12-04												CASSLGDMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGGGACAGGGGTAAGAGAGACCCAGTACTTCGGGCCA	CASSPGTGVRETQYF	In	VDJ	2	125	4.697323277303661E-4	5.561760007830958E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	2	4	2	4	26	39	51	41	55		TCRBV03-01,TCRBV03-02												CASSPGTGVRETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCGGGACAGGCGGAGTTCACCCCTCCACTTTGGGAAC	CASSRDRRSSPLHF	In	VDJ	2	125	4.697323277303661E-4	5.561760007830958E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	4	9	2	5	26	37	47	39	52		TCRBV03-01,TCRBV03-02												CASSRDRRSSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTAAAGGGGCGGGCCTCACAGATACGCAGTATTTTGGCCCA	CSATKGAGLTDTQYF	In	VDJ	2	125	4.697323277303661E-4	5.561760007830958E-4	45	TCRBV20						TCRBJ02	TCRBJ02-03	01	4	5	2	2	4	7	26	36	45	40	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATKGAGLTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCAACCGGGGGGGGTCCGAGCAGTACTTCGGGCCG	CASTNRGGSEQYF	In	VDJ	2	125	4.697323277303661E-4	5.561760007830958E-4	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	11	8	0	6	8	3	24	31	47	39	50		TCRBV24-01,TCRBV24-or09_02												CASTNRGGSEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCACCCATATGGAATCGCTGAAGCTTTCTTTGGACAA	CASSHPYGIAEAFF	In	VDJ	2	125	4.697323277303661E-4	5.561760007830958E-4	42	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	1	8	6	9	4	24	36	48	45	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHPYGIAEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGCTACCCCGCAGGGAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CSAATPQGATNEKLFF	In	VDJ	2	126	4.734901863522091E-4	5.606254087893606E-4	48	TCRBV20						TCRBJ01	TCRBJ01-04	01	6	4	3	0	10	2	26	34	49	44	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAATPQGATNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCCGGACTAGCGGGGGCCAACACAGATACGCAGTATTTTGGCCCA	CATSDSGLAGANTDTQYF	In	VDJ	2	126	4.734901863522091E-4	5.606254087893606E-4	54	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	1	2	2	4	4	24	38	55	42	59		TCRBV24-01,TCRBV24-or09_02												CATSDSGLAGANTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGCTACCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAREATSYNEQFF	In	VDJ	2	127	4.77248044974052E-4	5.650748167956253E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	9	0	0	0	3	26	-1	43	40	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREATSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGGCAGCGTCCTAGCGGGGGGCAAGAATGAACAGTTCTTCGGGCCA		Out	VDJ	2	127	4.77248044974052E-4		49	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	1	13	8	10	24	35	54	43	64	TCRBV12,TCRBV21													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGAAGCTAGCGGGACAAACACAGATACGCAGTATTTTGGCCCA	CASSEASGTNTDTQYF	In	VDJ	2	127	4.77248044974052E-4	5.650748167956253E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	4	3	2	5	4	23	34	48	39	52	TCRBV09,TCRBV21													CASSEASGTNTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCCCCCCAAGGCGGGGGAACACTGAAGCTTTCTTTGGACAA	CSPPRRGNTEAFF	In	VDJ	2	128	4.810059035958949E-4	5.695242248018901E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	9	7	3	1	9	0	26	31	-1	40	46		TCRBV20-01,TCRBV20-or09_02												CSPPRRGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGGGGAGCGGGGGGGAAAGATCACAGATACGCAGTATTTTGGCCCA	CASSGERGGKITDTQYF	In	VDJ	2	128	4.810059035958949E-4	5.695242248018901E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	6	0	2	4	6	18	30	44	34	50	TCRBV07,TCRBV11													CASSGERGGKITDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGAGAGGGCAGGCTCAACTCCTACAATGAGCAGTTCTTCGGGCCA	CASREGRLNSYNEQFF	In	VDJ	2	129	4.8476376221773785E-4	5.739736328081549E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	0	0	1	9	26	37	43	38	52		TCRBV03-01,TCRBV03-02												CASREGRLNSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGGACTAGCGGGAGCACGAATCAATGAGCAGTTCTTCGGGCCA	CSARVGLAGARINEQFF	In	VDJ	2	129	4.8476376221773785E-4	5.739736328081549E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	1	2	6	2	7	26	39	54	41	61		TCRBV20-01,TCRBV20-or09_02												CSARVGLAGARINEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCCCAACGCGAGCAGTACTTCGGGCCG	CSARPQREQYF	In	VDJ	2	129	4.8476376221773785E-4	5.739736328081549E-4	33	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	3	7	6	6	1	26	37	45	43	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPQREQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGAGCCCGAACACTGAAGCTTTCTTTGGACAA	CSAESPNTEAFF	In	VDJ	2	129	4.8476376221773785E-4	5.739736328081549E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	6	7	1	3	2	26	35	41	38	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSAESPNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCCCACTCGGGAAACAGGAGAATGAAAAACTGTTTTTTGGCAGT	CASSPLGKQENEKLFF	In	VDJ	2	129	4.8476376221773785E-4	5.739736328081549E-4	48	unresolved						TCRBJ01	TCRBJ01-04	01	6	3	4	5	12	2	20	31	48	43	50	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLGKQENEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTGCCAGGGGCAAAGACCCAGTACTTCGGGCCA	CASSVPGAKTQYF	In	VDJ	2	129	4.8476376221773785E-4	5.739736328081549E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	2	6	4	3	24	36	46	40	49	TCRBV09,TCRBV21													CASSVPGAKTQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTACAGGGGGGAATCGTAGTGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	130	4.885216208395808E-4		49	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	1	8	1	12	26	40	49	41	61		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCACACCTAGCGGGGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	130	4.885216208395808E-4		47	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	4	3	2	6	0	26	40	-1	46	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGGGGACTAGCGGGAGTGACACCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	130	4.885216208395808E-4		56	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	0	2	2	2	5	24	39	55	41	60		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD02-01*02	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGAACAGGGGCCAAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	130	4.885216208395808E-4		47				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	2	3	7	5	24	36	50	43	55	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												X+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACCAGCGGCACCTACAATGAGCAGTTCTTCGGGCCA	CSARTSGTYNEQFF	In	VDJ	2	131	4.922794794614237E-4	5.828724488206844E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	5	2	3	2	26	38	46	41	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSARTSGTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGAGGAATACAATGAGCAGTTCTTCGGGCCA	CASSLEEYNEQFF	In	VDJ	2	131	4.922794794614237E-4	5.828724488206844E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	1	4	3	2	24	36	43	39	45		TCRBV24-01,TCRBV24-or09_02												CASSLEEYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGGGACTAGCGTGGAGACCCAGTACTTCGGGCCA	CASSQGTSVETQYF	In	VDJ	2	131	4.922794794614237E-4	5.828724488206844E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	0	6	5	0	2	20	-1	45	35	47	TCRBV01,TCRBV23					01,02								CASSQGTSVETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCGGAAGCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	XASSGSGNTGELFF	In	VDJ	2	131	4.922794794614237E-4	5.828724488206844E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	6	5	1	3	0	22	34	-1	37	42	TCRBV04,TCRBV07,TCRBV17					01,02								XASSGSGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGAGGTTCCCTTCCTACGAGCAGTACTTCGGGCCG	CASSQERFPSYEQYF	In	VDJ	2	133	4.997951967051096E-4	5.917712648332139E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	1	1	0	6	23	-1	44	40	50	TCRBV01,TCRBV04													CASSQERFPSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCAAGCGCCGGCGTCCGGACCCTAGGAGTTAGCAGTTCTTCGGGCCA		Out	VDJ	2	134	5.035530553269524E-4		52	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	1	7	11	15	10	24	36	55	51	65		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGGGACTAGAAATCTGGCACGCAGTATTTTGGCCCA	CATRD*KSGTQYF	Stop	VDJ	2	134	5.035530553269524E-4		39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	9	0	8	9	1	9	24	33	42	34	51		TCRBV24-01,TCRBV24-or09_02				01,02								CATRD*KSGTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCTTCGGGCAGGGGGGATCCGGGGAGCTGTTTTTTGGAGAA	CASSFFGQGGSGELFF	In	VDJ	2	134	5.035530553269524E-4	5.962206728394787E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	1	6	9	3	24	36	52	45	55		TCRBV24-01,TCRBV24-or09_02												CASSFFGQGGSGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGGAGGTCGGGAGGGGAGATACGCAGTATTTTGGCCCA	CASSLEVGRGDTQYF	In	VDJ	2	134	5.035530553269524E-4	5.962206728394787E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	8	0	5	4	1	18	34	46	38	47	TCRBV05,TCRBV07,TCRBV11													CASSLEVGRGDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATGGGTAGCGGGAGACCCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	134	5.035530553269524E-4		52				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	5	2	2	4	5	18	35	48	39	53	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												X+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGACCAGGGGCGGGCCTCAGATACGCAGTATTTTGGCCCA	CASSVDQGRASDTQYF	In	VDJ	2	134	5.035530553269524E-4	5.962206728394787E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	2	4	2	7	23	39	47	41	54	TCRBV09,TCRBV21													CASSVDQGRASDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCCAGGTGCCGGACAGGGGGCTTGGGGCTACACCTTCGGTTCG	XASSPGAGQGAWGYTF	In	VDJ	2	136	5.110687725706384E-4	6.051194888520082E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	0	8	8	4	23	36	55	44	59	TCRBV04,TCRBV07,TCRBV17													XASSPGAGQGAWGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGTCAGAATTCACCCCTCCACTTTGGGAAC	CSAGQNSPLHF	In	VDJ	2	137	5.148266311924812E-4	6.09568896858273E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	5	7	3	0	26	35	-1	38	41		TCRBV20-01,TCRBV20-or09_02												CSAGQNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGCGCTCAGGGCCGACGAGCAGTACTTCGGGCCG	CASSLALRADEQYF	In	VDJ	2	137	5.148266311924812E-4	6.09568896858273E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	5	3	3	18	35	43	38	46	TCRBV05,TCRBV07,TCRBV11													CASSLALRADEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTGAAAACCGGGACAGGGGAGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	138	5.185844898143242E-4		50	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	2	9	3	26	37	56	46	59		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCTCCTCCCAGAGGGCCAATATCGGAGACCCAGTACTTCGGGCCA	CASSQPPPRGPISETQYF	In	VDJ	2	138	5.185844898143242E-4	6.140183048645377E-4	54	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	11	0	5	10	9	26	41	56	51	65		TCRBV03-01,TCRBV03-02												CASSQPPPRGPISETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGGGACAGGGTGGGGAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	138	5.185844898143242E-4		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	3	2	0	6	24	-1	44	35	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTAGTGGGGGACTACTACGAGCAGTACTTCGGGCCG	CASSLVGDYYEQYF	In	VDJ	2	138	5.185844898143242E-4	6.140183048645377E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	9	3	5	0	19	33	-1	38	45	TCRBV05,TCRBV07					01,02								CASSLVGDYYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGAGACAGTACCTATCAGCCCCAGCATTTTGGTGAT	CASSRDSTYQPQHF	In	VDJ	2	139	5.223423484361671E-4	6.184677128708026E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	5	5	4	5	26	37	46	41	51		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSRDSTYQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGTAGCGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CSARSGGNTGELFF	In	VDJ	2	139	5.223423484361671E-4	6.184677128708026E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	5	2	1	3	0	26	34	-1	37	46		TCRBV20-01,TCRBV20-or09_02												CSARSGGNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCTCAGCTTGTTTGACACAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	139	5.223423484361671E-4		47				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	6	3	6	2	18	35	45	41	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-03		TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGGGGGTTGAGACCGGGGAGCTGTTTTTTGGAGAA	CSARGVETGELFF	In	VDJ	2	140	5.261002070580101E-4	6.229171208770673E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	1	5	0	6	26	-1	41	34	47		TCRBV20-01,TCRBV20-or09_02												CSARGVETGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGGAGTGAACAAAAACATTCAGTACTTCGGCGCC	CSARRGVNKNIQYF	In	VDJ	2	140	5.261002070580101E-4	6.229171208770673E-4	42	TCRBV20						TCRBJ02	TCRBJ02-04	01	2	5	2	3	0	6	26	-1	43	38	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRGVNKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20		TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCCGGGACCGTCCCAGAGACCCAGTACTTCGGGCCA	CATSDPGTVPETQYF	In	VDJ	2	140	5.261002070580101E-4	6.229171208770673E-4	45	TCRBV24						TCRBJ02	TCRBJ02-05	01	4	0	7	4	4	6	24	38	47	42	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDPGTVPETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGGGCCACACAGGCCCAAAGCAATCAGCCCCAGCATTTTGGTGAT	CASRATQAQSNQPQHF	In	VDJ	2	140	5.261002070580101E-4	6.229171208770673E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	4	1	6	5	23	34	45	40	50	TCRBV02,TCRBV09													CASRATQAQSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGCGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	XASSQAGNTGELFF	In	VDJ	2	141	5.29858065679853E-4	6.273665288833321E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	8	4	1	0	0	23	-1	-1	39	43	TCRBV01,TCRBV04					01,02								XASSQAGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGGGGCAAGAGACCCAGTACTTCGGGCCA	CSATGQETQYF	In	VDJ	2	141	5.29858065679853E-4	6.273665288833321E-4	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	8	3	2	0	0	26	-1	-1	36	41		TCRBV20-01,TCRBV20-or09_02												CSATGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAGGGGGGTCATACGCAGTATTTTGGCCCA	CSAREGGHTQYF	In	VDJ	2	141	5.29858065679853E-4	6.273665288833321E-4	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	5	1	7	2	3	26	37	45	39	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREGGHTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTGGGGCCAGATGAAGCTTTCTTTGGACAA	CSARLGPDEAFF	In	VDJ	2	142	5.336159243016959E-4	6.318159368895968E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	7	0	7	2	4	26	38	45	40	49		TCRBV20-01,TCRBV20-or09_02												CSARLGPDEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCACCTTAGCGGGAGCTAGGGAGACCCAGTACTTCGGGCCA	CASTLAGARETQYF	In	VDJ	2	143	5.373737829235389E-4	6.362653448958616E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	5	2	5	3	5	23	33	45	36	50	TCRBV02,TCRBV09													CASTLAGARETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAGTGGCGACAGGGGGAAGTTCACCCCTCCACTTTGGGAAC	CASSQGVATGGSSPLHF	In	VDJ	2	144	5.411316415453817E-4	6.407147529021264E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	2	1	9	7	3	26	42	58	49	61		TCRBV03-01,TCRBV03-02												CASSQGVATGGSSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCCCCGACTAGCCCAGTCTGGCACAGATACGCAGTATTTTGGCCCA	CASSPRLAQSGTDTQYF	In	VDJ	2	144	5.411316415453817E-4	6.407147529021264E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	2	7	1	3	8	23	36	46	39	54	TCRBV04,TCRBV23					01,02								CASSPRLAQSGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCTACGGACTAGCGGGGGGGGTTGCAGATACGCAGTATTTTGGCCCA	CASSYGLAGGVADTQYF	In	VDJ	2	144	5.411316415453817E-4	6.407147529021264E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	0	4	3	4	24	36	54	39	58	TCRBV02,TCRBV21													CASSYGLAGGVADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCGACCGGGACAGGGATGGGGCAATGAGCAGTTCTTCGGGCCA	CSATRPGQGWGNEQFF	In	VDJ	2	145	5.448895001672247E-4	6.451641609083911E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	6	7	6	26	36	52	43	58		TCRBV20-01,TCRBV20-or09_02												CSATRPGQGWGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGACGGCAGGGGGATGGACATTCAGTACTTCGGCGCC	CASSDGRGMDIQYF	In	VDJ	2	146	5.486473587890677E-4	6.496135689146559E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	1	8	5	4	22	34	46	39	50		TCRBV12-03,TCRBV12-04												CASSDGRGMDIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCACCGCTAGCGGGAGATGAGCAGTTCTTCGGGCCA	CSAPPLAGDEQFF	In	VDJ	2	147	5.524052174109105E-4	6.540629769209206E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	2	8	6	0	26	35	-1	41	51		TCRBV20-01,TCRBV20-or09_02												CSAPPLAGDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGCCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	147	5.524052174109105E-4		43	TCRBV24						TCRBJ01	TCRBJ01-03	01	0	10	0	0	0	1	24	-1	44	42	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-03	TCRBV24		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGGGCTCCCAGATACGCAGTATTTTGGCCCA	CASSQGLPDTQYF	In	VDJ	2	148	5.561630760327535E-4	6.585123849271855E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	7	0	4	0	3	23	-1	42	37	45	TCRBV01,TCRBV04													CASSQGLPDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGTGGAGGGATTATAATGAAAAACTGTTTTTTGGCAGT	CSARDGWRDYNEKLFF	In	VDJ	3	150	5.636787932764394E-4	6.67411200939715E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	10	0	4	5	4	26	40	51	45	55		TCRBV20-01,TCRBV20-or09_02												CSARDGWRDYNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*02	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATACCAAACCATTTCATACATCATAATTCACCCCTCCACTTTGGGAAC	CASSIPNHFIHHNSPLHF	In	VDJ	3	152	5.711945105201252E-4	6.763100169522445E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	6	5	17	2	26	38	58	55	60		TCRBV03-01,TCRBV03-02												CASSIPNHFIHHNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCGCATCCGGACTAGCGGGAAACACAGATACGCAGTATTTTGGCCCA	CAASGLAGNTDTQYF	In	VDJ	3	153	5.749523691419682E-4	6.807594249585093E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	11	1	3	2	6	2	26	32	50	38	52		TCRBV03-01,TCRBV03-02												CAASGLAGNTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGGGGGAGGTCTCCTACGAGCAGTACTTCGGGCCG	CASSQGGEVSYEQYF	In	VDJ	3	153	5.749523691419682E-4	6.807594249585093E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	9	1	0	0	4	23	-1	45	39	49	TCRBV01,TCRBV04					01,02								CASSQGGEVSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGACAGAACACTAAAGCTTTCTTTGGACAA		Out	VDJ	3	154	5.78710227763811E-4		43	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	5	9	2	7	26	43	51	45	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGACGGCAAACACCGGGGAGCTGTTTTTTGGAGAA	CSAMTANTGELFF	In	VDJ	3	154	5.78710227763811E-4	6.852088329647741E-4	39	TCRBV20						TCRBJ02	TCRBJ02-02	01	4	2	7	2	1	4	26	36	40	37	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAMTANTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTATACTAGCGGGGGGGTCGAGCAGTACTTCGGGCCG	CASSYTSGGVEQYF	In	VDJ	3	154	5.78710227763811E-4	6.852088329647741E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	3	0	6	3	1	24	36	52	39	53		TCRBV24-01,TCRBV24-or09_02												CASSYTSGGVEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCACGAAATCCGGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSHEIRGAGELFF	In	VDJ	3	155	5.82468086385654E-4	6.896582409710388E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	8	1	6	7	0	23	37	-1	44	51	TCRBV01,TCRBV04													CASSHEIRGAGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCGTCGTTAGGTGGAAACACCATATATTTTGGAGAG	CSARSSLGGNTIYF	In	VDJ	3	155	5.82468086385654E-4	6.896582409710388E-4	42	TCRBV20						TCRBJ01	TCRBJ01-03	01	3	5	4	3	9	0	26	37	-1	46	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARSSLGGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGGACAGGGCTTGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSGQGLSNQPQHF	In	VDJ	3	155	5.82468086385654E-4	6.896582409710388E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	3	1	0	4	18	-1	38	30	42	TCRBV07,TCRBV11													CASSGQGLSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCACTATAGGACAGGGTTCGAGGGCCTTAGAAACACCATATATTTTGGAGAG	XASSHYRTGFEGLRNTIYF	In	VDJ	3	156	5.86225945007497E-4	6.941076489773036E-4	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	1	3	5	5	13	22	36	49	41	62	TCRBV04,TCRBV07,TCRBV17													XASSHYRTGFEGLRNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCCAAGCGGCCCTGGAGACCCAGTACTTCGGGCCA	CASSQVQAALETQYF	In	VDJ	3	157	5.899838036293398E-4	6.985570569835683E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	6	5	5	4	5	26	42	51	46	56		TCRBV03-01,TCRBV03-02				01,02								CASSQVQAALETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAAGCGGGCCCTCTGCCTACGAGCAGTACTTCGGGCCG	CASRSGPSAYEQYF	In	VDJ	3	158	5.937416622511828E-4	7.030064649898331E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	6	4	2	1	7	26	37	44	38	51		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASRSGPSAYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGGGAGGGGACGAACACTGAAGCTTTCTTTGGACAA	CASREGTNTEAFF	In	VDJ	3	158	5.937416622511828E-4	7.030064649898331E-4	39	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	6	10	0	1	0	3	23	-1	40	34	43	TCRBV06,TCRBV10			TCRBD01,TCRBD02										CASREGTNTEAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGTATAACAGGGTTCGATGGGTGAAAAACTGTTTTTTGGCAGT	CSAV*QGSMGEKLFF	Stop	VDJ	3	160	6.012573794948687E-4		45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	3	7	6	9	26	34	46	40	55		TCRBV20-01,TCRBV20-or09_02												CSAV*QGSMGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCGGGCCCAGCCCCTACGAGCAGTACTTCGGGCCG	CASSPGPSPYEQYF	In	VDJ	3	160	6.012573794948687E-4	7.119052810023626E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	5	8	0	2	3	6	18	30	37	33	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPSPYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGTAGGGCTCGTGCTTTCTTTGGACAA	CASSPGRARAFF	In	VDJ	3	161	6.050152381167115E-4	7.163546890086274E-4	36	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	5	3	11	5	5	26	39	48	44	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGRARAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAATTAACAGGGGCCAAGATGGCTACACCTTCGGTTCG	CSAINRGQDGYTF	In	VDJ	3	162	6.087730967385545E-4	7.208040970148921E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	2	6	5	5	26	34	46	39	51		TCRBV20-01,TCRBV20-or09_02												CSAINRGQDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAAGGAGGGGGGGAACTTGGATCAGCCCCAGCATTTTGGTGAT	CATKEGGNLDQPQHF	In	VDJ	3	162	6.087730967385545E-4	7.208040970148921E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	8	9	0	5	4	7	24	34	45	38	52		TCRBV24-01,TCRBV24-or09_02												CATKEGGNLDQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCGGACAGGCTTAACCTACGAGCAGTACTTCGGGCCG	CASSSRTGLTYEQYF	In	VDJ	3	162	6.087730967385545E-4	7.208040970148921E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	4	2	4	5	24	36	47	40	52		TCRBV24-01,TCRBV24-or09_02												CASSSRTGLTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTAGCGGGCAGGACTTTGGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSVAGRTLVTGELFF	In	VDJ	3	163	6.125309553603975E-4	7.25253505021157E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	5	4	4	2	12	26	37	46	39	58	TCRBV12,TCRBV21					01,02								CASSVAGRTLVTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGGTTGGGCTAGCGGGAGTTTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	163	6.125309553603975E-4		52	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	4	2	3	7	3	23	35	52	42	55	TCRBV06,TCRBV10													X+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTGGGACACGTACAATGAGCAGTTCTTCGGGCCA	CSAWDTYNEQFF	In	VDJ	3	164	6.162888139822403E-4	7.297029130274217E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	6	4	2	2	26	34	42	36	44		TCRBV20-01,TCRBV20-or09_02												CSAWDTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGGGACTGGTGGGTACACTGAAGCTTTCTTTGGACAA	CASSLGTGGYTEAFF	In	VDJ	3	164	6.162888139822403E-4	7.297029130274217E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	0	10	3	3	7	24	36	45	39	52		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLGTGGYTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTCCTTCAGGCACCAAGAGACCCAGTACTTCGGGCCA	CASSSFRHQETQYF	In	VDJ	3	165	6.200466726040833E-4	7.341523210336865E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	4	0	4	1	26	39	47	43	48	TCRBV12,TCRBV21													CASSSFRHQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGCGGGTAGCGGGGACAATGAGCAGTTCTTCGGGCCA	CASSLAGSGDNEQFF	In	VDJ	3	165	6.200466726040833E-4	7.341523210336865E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	3	5	3	0	26	43	-1	46	54		TCRBV12-03,TCRBV12-04												CASSLAGSGDNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGGCAGACAGGGGGCTATACCGGGGAGCTGTTTTTTGGAGAA	XASRQTGGYTGELFF	In	VDJ	3	165	6.200466726040833E-4	7.341523210336865E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	0	5	3	3	23	34	47	37	50	TCRBV01,TCRBV17													XASRQTGGYTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGTACTTGGGGAACCAAGAGACCCAGTACTTCGGGCCA	CSAPYLGNQETQYF	In	VDJ	3	165	6.200466726040833E-4	7.341523210336865E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	5	0	8	0	9	0	26	35	-1	44	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPYLGNQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGGAACCGGGAGGAAGGGGAAAAACTGTTTTTTGGCAGT	CASRNREEGEKLFF	In	VDJ	3	166	6.238045312259263E-4	7.386017290399512E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	8	1	8	4	5	26	37	48	41	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRNREEGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*02	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTTAAGTAACCGTTGAAGCCCTCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	3	166	6.238045312259263E-4		55	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	6	7	0	13	4	25	38	54	51	58	TCRBV26,TCRBV28					01,02								X+X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCCCGACGATCTACAATGAGCAGTTCTTCGGGCCA	CASSPPTIYNEQFF	In	VDJ	3	167	6.275623898477691E-4	7.43051137046216E-4	42	TCRBV12						TCRBJ02	TCRBJ02-01	01	5	2	7	3	5	3	26	38	46	43	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPTIYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGCACCGCACATTTATACGAGCAGTACTTCGGGCCG	CSARGTAHLYEQYF	In	VDJ	3	167	6.275623898477691E-4	7.43051137046216E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	8	0	4	0	12	26	-1	41	37	53		TCRBV20-01,TCRBV20-or09_02												CSARGTAHLYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACCGGGACTAGCGTTGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLPGLALAGELFF	In	VDJ	3	167	6.275623898477691E-4	7.43051137046216E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	6	6	5	4	24	36	51	41	55		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLPGLALAGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCGCCGCTCGACAGGGAGGGCCGGGGAGCTGTTTTTTGGAGAA	XASSRRSTGRAGELFF	In	VDJ	3	167	6.275623898477691E-4	7.43051137046216E-4	48	unresolved						TCRBJ02	TCRBJ02-02	01	5	2	3	6	8	4	22	34	49	42	53	TCRBV04,TCRBV07,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSRRSTGRAGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGTGGGACATCAAAGAGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	168	6.313202484696121E-4		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	6	6	4	9	24	38	48	42	57		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTAGACTGGGAAAGTGAGCAGTTCTTCGGGCCA	CASSLDWESEQFF	In	VDJ	3	169	6.35078107091455E-4	7.519499530587456E-4	39	unresolved						TCRBJ02	TCRBJ02-01	01	1	0	8	9	3	3	18	34	41	37	44	TCRBV07,TCRBV11,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDWESEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTAAAAGGGCAGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	170	6.388359657132979E-4		38	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	5	3	4	3	3	24	36	43	39	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCCCGACAGGCTCAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	170	6.388359657132979E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	4	2	4	3	24	36	46	40	49	TCRBV24,TCRBV27													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAAGGACAGCGTTTCACAGATACGCAGTATTTTGGCCCA	CSAQGQRFTDTQYF	In	VDJ	3	173	6.501095415788268E-4	7.697475850838046E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	5	2	3	5	26	35	44	38	49		TCRBV20-01,TCRBV20-or09_02												CSAQGQRFTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGATAGGGGAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	3	173	6.501095415788268E-4		41	TCRBV24						TCRBJ01	TCRBJ01-03	01	9	5	2	0	3	2	24	33	41	36	43		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-03	TCRBV24		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTATTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CSATIATNEKLFF	In	VDJ	3	174	6.538674002006696E-4	7.741969930900694E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	4	9	0	0	3	26	-1	39	36	42		TCRBV20-01,TCRBV20-or09_02				01,02								CSATIATNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGCTTGCGGAGGAGTGAGTCGGTGGATACGCAGTATTTTGGCCCA	CSGLRRSESVDTQYF	In	VDJ	3	174	6.538674002006696E-4	7.741969930900694E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	10	1	6	6	12	26	33	44	39	56		TCRBV20-01,TCRBV20-or09_02												CSGLRRSESVDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGCAATCCAGGTGGAACACCATATATTTTGGAGAG	CASSQEQSRWNTIYF	In	VDJ	3	174	6.538674002006696E-4	7.741969930900694E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	4	7	6	3	18	35	45	41	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQEQSRWNTIYF+X+TCRBJ01-03		TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGTCCGGGACAGTGGAACACTGAAGCTTTCTTTGGACAA	CASSPGQWNTEAFF	In	VDJ	3	176	6.613831174443555E-4	7.830958091025989E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	1	1	2	20	33	41	34	43	TCRBV11,TCRBV23													CASSPGQWNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCCCAGGGACAGGAATGGGGAACACTGAAGCTTTCTTTGGACAA	CASSPGTGMGNTEAFF	In	VDJ	3	178	6.688988346880414E-4	7.919946251151285E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	4	1	4	6	20	31	43	35	49	TCRBV11,TCRBV23													CASSPGTGMGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGGGCGGAAACACCATATATTTTGGAGAG	CSARGGGNTIYF	In	VDJ	3	179	6.726566933098843E-4	7.964440331213932E-4	36	TCRBV20						TCRBJ01	TCRBJ01-03	01	3	6	0	4	1	0	26	37	-1	38	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGGGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAACACACTCGGGTCTTACACCGGGGAGCTGTTTTTTGGAGAA	CASSLNTLGSYTGELFF	In	VDJ	3	180	6.764145519317272E-4	8.00893441127658E-4	51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	8	4	3	11	4	24	36	51	47	55		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLNTLGSYTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCAGGGACTAGCGGGCCCCCAGGGCGGGACCCAGTACTTCGGGCCA	CSANQGLAGPQGGTQYF	In	VDJ	3	183	6.876881277972561E-4	8.142416651464523E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	4	7	4	12	26	36	52	40	64		TCRBV20-01,TCRBV20-or09_02				01,02								CSANQGLAGPQGGTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAACCCGCGGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSQEPAGGSTDTQYF	In	VDJ	3	186	6.989617036627848E-4	8.275898891652465E-4	51				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	0	0	4	0	18	35	-1	39	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQEPAGGSTDTQYF+X+TCRBJ02-03		TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCGGGGAACACTGAAGCTTTCTTTGGACAA	CSARSGNTEAFF	In	VDJ	3	188	7.064774209064707E-4	8.364887051777761E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	4	1	2	0	26	37	-1	39	43		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCARCCAGACMKMTCTKTACYWCTGTGCCAGCAGTTGCAGACATACCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	188	7.064774209064707E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	6	2	4	4	24	36	44	40	48	TCRBV08,TCRBV24													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAGTACGGGACAGGGTTAAATACGCAGTATTTTGGCCCA	XASSQYGTGLNTQYF	In	VDJ	3	189	7.102352795283136E-4	8.409381131840409E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	3	7	4	4	23	37	50	41	54	TCRBV01,TCRBV04,TCRBV07,TCRBV17													XASSQYGTGLNTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCGGATAGCGGGTGAAGCCTACGAGCAGTACTTCGGGCCG	CSANRIAGEAYEQYF	In	VDJ	3	189	7.102352795283136E-4	8.409381131840409E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	5	4	2	6	5	26	36	49	42	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSANRIAGEAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTGGACAGGGAACACTGAAGCTTTCTTTGGACAA	CSAWTGNTEAFF	In	VDJ	3	192	7.215088553938424E-4	8.542863372028352E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	4	1	2	0	26	34	-1	36	43		TCRBV20-01,TCRBV20-or09_02												CSAWTGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCGGGACAAAGGGGACACCTCCCCCTACGAGCAGTACTTCGGGCCG	CASSSRDKGDTSPYEQYF	In	VDJ	3	193	7.252667140156854E-4	8.587357452091E-4	54	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	6	2	3	15	26	39	48	42	63		TCRBV12-03,TCRBV12-04												CASSSRDKGDTSPYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCAAGTTGAAGGGGCGTTCGGCGAGCAGTACTTCGGGCCG	CASSQVEGAFGEQYF	In	VDJ	3	194	7.290245726375282E-4	8.631851532153647E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	5	2	6	4	7	26	42	51	46	58		TCRBV03-01,TCRBV03-02												CASSQVEGAFGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCGCTCACCGAGGGGCCGAATACGAGCAGTACTTCGGGCCG	CAAHRGAEYEQYF	In	VDJ	3	196	7.365402898812141E-4	8.720839692278942E-4	39	TCRBV24						TCRBJ02	TCRBJ02-07	01	12	5	2	4	8	5	24	30	43	38	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAAHRGAEYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACTAGCGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPLAGAYNEQFF	In	VDJ	3	197	7.40298148503057E-4	8.76533377234159E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	3	2	2	1	0	26	39	-1	40	51		TCRBV03-01,TCRBV03-02												CASSPLAGAYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGGGACCAACTAACTATGGCTACACCTTCGGTTCG	CSARDQGPTNYGYTF	In	VDJ	3	197	7.40298148503057E-4	8.76533377234159E-4	45	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	0	7	0	3	3	26	40	48	43	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDQGPTNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAATCAACAGGGGGCTGGTCAGCCCCAGCATTTTGGTGAT	CASNQQGAGQPQHF	In	VDJ	3	199	7.478138657467429E-4	8.854321932466885E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	0	6	4	3	22	32	45	36	48	TCRBV02,TCRBV12													CASNQQGAGQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCCAGGGGGCAGTAAAAACATTCAGTACTTCGGCGCC	CASRPGGSKNIQYF	In	VDJ	3	202	7.590874416122717E-4	8.987804172654829E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	4	0	4	2	3	26	37	47	39	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRPGGSKNIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCTAAAGAACGGCGGAGAGACCCAGTACTTCGGGCCA	CASSPLKNGGETQYF	In	VDJ	3	205	7.703610174778005E-4	9.121286412842771E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	7	5	4	13	0	24	36	-1	49	53		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPLKNGGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTAGAAGGACTAGCGGGGTTGCCTACAATGAGCAGTTCTTCGGGCCA	CSVRRTSGVAYNEQFF	In	VDJ	3	206	7.741188760996434E-4	9.165780492905418E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	1	3	2	1	3	26	38	51	39	54		TCRBV20-01,TCRBV20-or09_02												CSVRRTSGVAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCTGGCGGGGGGCAACAAGAGACCCAGTACTTCGGGCCA	CSARSGGGQQETQYF	In	VDJ	3	207	7.778767347214863E-4	9.210274572968067E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	1	2	5	3	26	37	50	42	53		TCRBV20-01,TCRBV20-or09_02												CSARSGGGQQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGAACCGGGGCCGAGGGGCCTGAAGCTTTCTTTGGACAA	CASRTGAEGPEAFF	In	VDJ	4	211	7.92908169208858E-4	9.388250893218658E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	6	5	2	6	11	1	18	29	45	40	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRTGAEGPEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGACAGGGAACTCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	217	8.154553209399156E-4		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	2	1	6	26	40	50	41	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACCCGGACAGGGGTCAACGGACATTCAGTACTTCGGCGCC	CASSLPGQGSTDIQYF	In	VDJ	4	220	8.267288968054443E-4	9.788697613782487E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	1	2	8	3	7	26	41	53	44	60		TCRBV12-03,TCRBV12-04												CASSLPGQGSTDIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD01-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAGGGGGCGTGGAAACACCATATATTTTGGAGAG	CATSDRGRGNTIYF	In	VDJ	4	220	8.267288968054443E-4	9.788697613782487E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	5	0	3	0	1	24	-1	46	39	47		TCRBV24-01,TCRBV24-or09_02												CATSDRGRGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATCGGGAGGTGTCGATACGCAGTATTTTGGCCCA	CASSLSGGVDTQYF	In	VDJ	4	221	8.304867554272873E-4	9.833191693845134E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	8	1	6	1	4	26	41	49	42	53		TCRBV12-03,TCRBV12-04												CASSLSGGVDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGACAGGGAATGAGCAGTTCTTCGGGCCA	CASSLTGNEQFF	In	VDJ	4	222	8.342446140491303E-4	9.877685773907782E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	7	2	0	24	36	-1	38	45		TCRBV24-01,TCRBV24-or09_02												CASSLTGNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAAGGCAGACGAACACTGAAGCTTTCTTTGGACAA	CASSERQTNTEAFF	In	VDJ	4	234	8.793389175112454E-4	0.0010411614734659553	42	unresolved						TCRBJ01	TCRBJ01-01	01	2	2	7	1	5	0	23	38	-1	43	46	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERQTNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGAGGGCAAAGGGGAGCTGTTTTTTGGAGAA	CASSLEGKGELFF	In	VDJ	4	235	8.830967761330883E-4	0.00104561088147222	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	11	0	8	3	4	24	36	44	39	48		TCRBV24-01,TCRBV24-or09_02												CASSLEGKGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACTCCCCGGACAGAAAAACGGGAGATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	236	8.868546347549312E-4		44	TCRBV24						TCRBJ02	TCRBJ02-01	01	10	1	5	8	5	11	24	32	43	37	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAATCCGGGGCAGAACACCGGGGAGCTGTTTTTTGGAGAA	CSANPGQNTGELFF	In	VDJ	4	238	8.943703519986171E-4	0.0010589591054910145	42	TCRBV20						TCRBJ02	TCRBJ02-02	01	6	7	0	1	6	1	26	34	45	40	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANPGQNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAATGGACCCTTGGCGGGAGGTTCAATGAGCAGTTCTTCGGGCCA	CSAEWTLGGRFNEQFF	In	VDJ	4	241	9.056439278641459E-4	0.0010723073295098088	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	1	6	13	2	26	35	56	48	58		TCRBV20-01,TCRBV20-or09_02												CSAEWTLGGRFNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCCCTTTTGGACGAGCAGTACTTCGGGCCG	CSARALLDEQYF	In	VDJ	4	244	9.169175037296747E-4	0.001085655553528603	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	9	0	5	0	8	26	-1	40	37	48		TCRBV20-01,TCRBV20-or09_02												CSARALLDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCACTCTGGACAGGGCCCAGATACGCAGTATTTTGGCCCA	CSASHSGQGPDTQYF	In	VDJ	4	245	9.206753623515176E-4	0.0010901049615348677	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	3	4	7	2	26	37	52	44	54		TCRBV20-01,TCRBV20-or09_02												CSASHSGQGPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTAGGGTGCCATTTCAGGCTTGACCGGGGAGCTGTTTTTTGGAGAA	CASS*GAISGLTGELFF	Stop	VDJ	4	246	9.244332209733605E-4		51	TCRBV03						TCRBJ02	TCRBJ02-02	01	5	4	4	5	13	4	26	38	55	51	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASS*GAISGLTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTATCAACAGATACGCAGTATTTTGGCCCA	CSALSTDTQYF	In	VDJ	4	254	9.54496089948104E-4	0.0011301496335912506	33	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	4	6	3	4	0	26	35	-1	39	41		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATTACGGACAGCTTCTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	4	255	9.582539485699469E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	1	5	0	4	5	23	30	40	34	45	TCRBV06,TCRBV10													X+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGCGGACTAGCTATTACGAGCAGTACTTCGGGCCG	CASSQRTSYYEQYF	In	VDJ	4	257	9.657696658136327E-4	0.0011434978576100449	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	1	7	4	2	3	23	37	47	39	50	TCRBV01,TCRBV04					01,02								CASSQRTSYYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCAATTCCCGGGACTAGGGAGCAGTTCTTCGGGCCA	CSARAIPGTREQFF	In	VDJ	4	263	9.883168175446903E-4	0.0011701943056476336	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	0	8	10	8	1	26	39	55	47	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSARAIPGTREQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGCAGGGGGTCGTACGAGCAGTACTTCGGGCCG	CASSLGRGSYEQYF	In	VDJ	4	263	9.883168175446903E-4	0.0011701943056476336	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	1	4	5	3	24	36	48	41	51		TCRBV24-01,TCRBV24-or09_02												CASSLGRGSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCGGACTAGCGGTTAGTTACGAGCAGTACTTCGGGCCG	CASSPGLAVSYEQYF	In	VDJ	4	265	9.958325347883762E-4	0.001179093121660163	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	1	5	4	3	5	24	36	49	39	54		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPGLAVSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCACATAGACAGGGGGAGCAATCAGCCCCAGCATTTTGGTGAT	YASSHIDRGSNQPQHF	In	VDJ	5	276	0.0010371689796286484	0.0012280366097290754	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	1	1	4	0	22	36	-1	40	49	TCRBV04,TCRBV07,TCRBV17	TCRBV04-01,TCRBV07-03,TCRBV17-01												YASSHIDRGSNQPQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTGGCTGGGGGGGACGGCACTGAAGCTTTCTTTGGACAA	CASSLAGGDGTEAFF	In	VDJ	5	287	0.0010785054244689207	0.001276980097797988	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	0	4	4	4	18	32	43	36	47	TCRBV11,TCRBV23													CASSLAGGDGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGACGCGCGTCGGGGGGCAGAGACCCAGTACTTCGGGCCA	CASSDARRGAETQYF	In	VDJ	5	287	0.0010785054244689207	0.001276980097797988	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	1	4	10	1	23	34	51	44	52	TCRBV02,TCRBV09													CASSDARRGAETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGGGCGGGAGACGGTACCGGGGAGCTGTTTTTTGGAGAA	CATSDRAGDGTGELFF	In	VDJ	5	297	0.00111608401068735	0.0013214741778606357	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	7	2	5	3	5	24	39	49	42	54		TCRBV24-01,TCRBV24-or09_02												CATSDRAGDGTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGAACGCTCTGGAAACACCATATATTTTGGAGAG	CASERSGNTIYF	In	VDJ	5	298	0.0011198418693091929	0.0013259235858669005	36	unresolved			unresolved			TCRBJ01	TCRBJ01-03	01	10	7	6	0	0	4	24	-1	34	31	38	TCRBV06,TCRBV10			TCRBD01,TCRBD02										CASERSGNTIYF+X+TCRBJ01-03	unresolved	unresolved	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGGTCAGGGGGCTTTGACTGAAGCTTTCTTTGGACAA	CASSGQGALTEAFF	In	VDJ	5	318	0.0011949990417460515	0.0014149117459921958	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	0	5	2	4	23	36	46	38	50	TCRBV02,TCRBV09													CASSGQGALTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTATCCGGGACAGGGGTACACTGAAGCTTTCTTTGGACAA	CASSYPGQGYTEAFF	In	VDJ	5	321	0.0012062726176115801	0.00142825997001099	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	2	3	4	1	18	31	45	35	46	TCRBV11,TCRBV23													CASSYPGQGYTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCTGACCACAACAATGAGCAGTTCTTCGGGCCA	CASSLSDHNNEQFF	In	VDJ	5	322	0.001210030476233423	0.0014327093780172548	42							TCRBJ02	TCRBJ02-01	01	6	2	7	5	6	4	24	36	45	42	49	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSDHNNEQFF+X+TCRBJ02-01			TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGACGGGCTAGCGGGGGAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	5	329	0.0012363354865863236		49	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	2	3	7	1	26	39	56	46	57		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTTAAGGACAGGTTCACCGGGGAGCTGTTTTTTGGAGAA	CSALKDRFTGELFF	In	VDJ	6	333	0.0012513669210736955	0.0014816528660861672	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	4	4	6	2	26	34	47	40	49		TCRBV20-01,TCRBV20-or09_02												CSALKDRFTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTAGACCAAACCGACAGGGAAAGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	6	333	0.0012513669210736955		49	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	2	3	3	11	4	26	33	51	44	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGACAGGCGGAAACACCATATATTTTGGAGAG	CASSPTGGNTIYF	In	VDJ	6	345	0.0012964612245358106	0.0015350457621613445	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	2	4	4	1	1	26	39	46	40	47		TCRBV03-01,TCRBV03-02												CASSPTGGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTCCCGGGACTAGCGGGGGCAATGAGCAGTTCTTCGGGCCA	CSAPPGTSGGNEQFF	In	VDJ	6	365	0.0013716183969726692	0.0016240339222866398	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	6	6	0	26	35	-1	41	55		TCRBV20-01,TCRBV20-or09_02												CSAPPGTSGGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGAGGCGGGGGGGCTGAAGAGCAGTACTTCGGGCCG	CASSQGGGGAEEQYF	In	VDJ	6	366	0.0013753762555945121	0.0016284833302929046	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	7	0	7	3	5	23	39	51	42	56	TCRBV01,TCRBV04													CASSQGGGGAEEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGAGGACAGTCGGGAGAAAAACTGTTTTTTGGCAGT	CSARGQSGEKLFF	In	VDJ	6	374	0.0014054391245692554	0.0016640785943430228	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	5	8	4	6	26	34	44	38	50		TCRBV20-01,TCRBV20-or09_02												CSARGQSGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCAACACGATAACCAAGAGACCCAGTACTTCGGGCCA	CASSHQHDNQETQYF	In	VDJ	6	377	0.0014167127004347843	0.001677426818361817	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	6	0	3	5	26	40	46	43	51		TCRBV03-01,TCRBV03-02												CASSHQHDNQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGCAAACTAGCGGTCCCCTACAATGAGCAGTTCTTCGGGCCA	CSASKLAVPYNEQFF	In	VDJ	7	418	0.0015707849039303444	0.0018598525466186724	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	5	2	6	3	26	34	48	40	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSASKLAVPYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGGGGGTTTTAGCCAAAAACATTCAGTACTTCGGCGCC	CSARGVLAKNIQYF	In	VDJ	8	480	0.0018037721384846059	0.002135715843007088	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	6	8	1	0	1	4	26	34	42	35	46		TCRBV20-01,TCRBV20-or09_02												CSARGVLAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*01	TCRBJ02-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACCTCAGGGGTCCGGGGAGCTGTTTTTTGGAGAA	CASSLPQGSGELFF	In	VDJ	8	501	0.0018826871695433074	0.002229153411138648	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	2	6	3	1	26	41	50	44	51		TCRBV12-03,TCRBV12-04												CASSLPQGSGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTACACCGTTGGGTGAAGCTTTCTTTGGACAA	CASSTPLGEAFF	In	VDJ	9	525	0.0019728757764675376	0.0023359392032890024	36	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	0	9	7	8	0	24	36	-1	44	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTPLGEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCAGGACTAGCGGGAGCTCAGATACGCAGTATTTTGGCCCA	CSAPRTSGSSDTQYF	In	VDJ	9	535	0.002010454362685967	0.0023804332833516502	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	1	2	4	4	2	26	35	52	39	54		TCRBV20-01,TCRBV20-or09_02												CSAPRTSGSSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAACAGCTAGCGGGAGATTCAATGAGCAGTTCTTCGGGCCA	CASSLTASGRFNEQFF	In	VDJ	10	580	0.002179558000668899	0.0025806566436335646	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	6	7	3	24	36	53	43	56		TCRBV24-01,TCRBV24-or09_02												CASSLTASGRFNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCGACCCTTAGGAAACACCATATATTTTGGAGAG	CSARPLGNTIYF	In	VDJ	10	604	0.002269746607593129	0.002687442435783919	36	TCRBV20						TCRBJ01	TCRBJ01-03	01	6	2	7	4	2	5	26	34	39	36	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPLGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCGCGACTAGCGCCGAAGTCGAGACCCAGTACTTCGGGCCA	CSVATSAEVETQYF	In	VDJ	12	741	0.0027845732387856105	0.003297011332642192	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	2	6	5	4	8	26	33	45	37	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSVATSAEVETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCAAGGAGGGCAGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSQGGQGAYEQYF	In	VDJ	13	754	0.0028334254008695685	0.003354853636723634	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	2	5	0	24	40	-1	45	52	TCRBV09,TCRBV21													CASSQGGQGAYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCATGGACAGTATTAGGCCCCAGCATTTTGGTGAT	CASSMDSIRPQHF	In	VDJ	13	774	0.002908582573306427	0.0034438417968489293	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	5	9	3	6	26	37	46	40	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSMDSIRPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCGGGAGTGCCACAGATACGCAGTATTTTGGCCCA	XASSGSATDTQYF	In	VDJ	13	800	0.003006286897474343	0.003559526405011813	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	9	2	2	0	3	23	-1	40	35	43	TCRBV01,TCRBV07,TCRBV17													XASSGSATDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCAACCGGGACATCGAATGAGCAGTTCTTCGGGCCA	CASSATGTSNEQFF	In	VDJ	14	823	0.0030927176457767307	0.0036618627891559026	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	6	7	6	3	24	36	48	42	51	TCRBV09,TCRBV21													CASSATGTSNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGCGGGTTGGACACCGGGGAGCTGTTTTTTGGAGAA	CSARDSGLDTGELFF	In	VDJ	15	904	0.003397104194146008	0.004022264837663349	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	5	4	3	0	4	26	-1	47	40	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDSGLDTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGATGACGACAGGGGGCAAGATACGCAGTATTTTGGCCCA	CASSVDDDRGQDTQYF	In	VDJ	16	934	0.0035098399528012956	0.004155747077851292	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	0	5	5	1	23	39	54	44	55	TCRBV09,TCRBV21													CASSVDDDRGQDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGAGGGGTAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLGGVATNEKLFF	In	VDJ	18	1050	0.003945751552935075	0.004671878406578005	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	10	0	0	3	4	24	36	45	39	49		TCRBV24-01,TCRBV24-or09_02												CASSLGGVATNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01*02	TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACCTGGGAGCGGCACGCACAGATACGCAGTATTTTGGCCCA	CASSQDLGAARTDTQYF	In	VDJ	18	1051	0.003949509411556918	0.00467632781458427	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	6	5	1	6	3	26	43	54	49	57		TCRBV03-01,TCRBV03-02				01,02								CASSQDLGAARTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGCGGGGCTGACGAGCAGTACTTCGGGCCG	CASSQGGADEQYF	In	VDJ	19	1118	0.004201285939220395	0.004974438151004009	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	7	3	5	0	3	23	-1	45	39	48	TCRBV01,TCRBV04													CASSQGGADEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGGGGTCCGGGACGGTTAATGAAAAACTGTTTTTTGGCAGT	CASRGSGTVNEKLFF	In	VDJ	20	1185	0.004453062466883871	0.005272548487423748	45	TCRBV24						TCRBJ01	TCRBJ01-04	01	7	0	7	4	7	3	24	35	47	42	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGSGTVNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
GACTCGGCCRTGTATSKCTGTGCTAGCAGCTTAGCCCTCGGGGAAGCGAGGGCGAAGCTTTCTTTGGACAA		Out	VDJ	20	1190	0.004471851759993086		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	3	8	3	10	18	35	43	38	53	TCRBV07,TCRBV11					01,02								X+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCGGACTAGCGGGGGGTGATGAGCAGTTCTTCGGGCCA	CASGLAGGDEQFF	In	VDJ	22	1340	0.005035530553269525	0.0059622067283947875	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	1	1	8	0	2	23	-1	46	32	48	TCRBV09,TCRBV21													CASGLAGGDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACGACTAGCGGGTACGAATGAGCAGTTCTTCGGGCCA	CASSQRLAGTNEQFF	In	VDJ	89	5327	0.020018112878557284	0.02370199644937241	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	2	4	7	1	4	26	41	52	42	56		TCRBV03-01,TCRBV03-02				01,02								CASSQRLAGTNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	7765A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment				5114	4319	716	78	0	2828	2337	448	43	0	266109	224749	37270	4090	0	0.0842590407	10.2475462	0.078009285	10.571146				20689	0.205408975	0.0237019956	0.0200181138	v2	Human-TCRB-PD2x	Published	08/10/2016 11:24:40	07/05/2016 03:54:06	Age (Range):65+ Years (Old Age),Age:79 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Tissue,Treatment Status:Pre-Treatment,os censored status (0 = alive, 1=dead):os censored status (0 = alive, 1=dead) 0,overall survival (days):overall survival (days) 1388,pfs censored status (0 = pf, 1=progressed):pfs censored status (0 = pf, 1=progressed) 1,progression free survival (days):progression free survival (days) 1274,treatment:nact,type of chemo:carbo/taxol	0.8445443649353764	MSKCC- Snyder- P01-01		4250.0	
